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Abstract 
Elucidating a prebiotic plausible nucleotide synthesis is considered one of the 
greatest challenges in the origins of life research. Although separate synthesis that 
account for the pyrimidine and purine ribonucleotides have been developed, no 
divergent synthesis from a single precursor has yet been developed that accounts 
for the synthesis of both pyrimidine and purine ribonucleotides. Furthermore, the 
reported prebiotic synthesis of pyrimidine and purine nucleotides are not mutually 
compatible and could not co-operate under similar conditions. This thesis proposes 
a divergent synthesis of both anhydro-pyrimidine and anhydro-purine 
ribonucleotides on a regiospecific sugar scaffold, followed by concurrent 
phosphorylation and chemical inversion to yield pyrimidines (3 and 4) and 8-oxo-
purines (93 and 187) in the natural β-ribo-stereochemistry.  
 
This concomitant approach employs only feedstock small molecules that are 
consider to be prebiotically plausible and condition that are consider to be 
reasonable under early Earth geothermal conditions. Moreover, given that 8-oxo 
purines and pyrimidines ribonucleotides share a common prebiotic synthetic route, 
it is hypothesised that 8-oxo purines could have predated natural purines in biology 
and that they could have played an important role in the transition of chemistry to 
biology and facilitated the modern Watson-Crick base pairing system. 
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 “Read: In the name of thy Lord Who createth, Createth man from a clot. Read: 
And thy Lord is the Most Bounteous, Who teacheth by the pen, Teacheth man that 
which he knew not.”  
Quran 96:1-5 
 
 
“Don't only practice your art, but force your way into its secrets, for it and 
knowledge can raise men to the divine.” 
Ludwig van Beethoven 
 
“We not only want to know how nature is (and how her transactions are carried 
through), but we also want to reach, if possible, a goal which may seem utopian and 
presumptuous, namely, to know why nature is such and not otherwise.” 
Albert Einstein  
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1. Introduction 
 
1.1. What is life? 
 
There are an approximately 8.7 million different species thriving on Earth.1 All living 
species are cellular, and all characterised species have been classified by biologist into 
the Tree of Life (Figure 1.1).2 
 
Figure 1.1: A new metagenomic view of the tree of life by Hug et al.2 
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Life can be found in almost all environments on Earth. Organisms have been found at 
the bottom of the ocean surviving chemotropically at deep-sea vents and in frozen 
lakes isolated for millions of years under the Antarctic ice. Even within rocks as deep 
as 11000 meters living species can be found.3 Though life has now come to dominate 
our planet it is self-evident that life must not have been present initially. The Earth 
and indeed the universe are known to be only 4.5 and 14 billion years old respectively. 
Life cannot predate the universe. However, fossil evidence for prokaryotes have been 
discovered in rocks dating to 3.5 billion years.4 In 2016, researchers in Australia 
discovered fossilised bacteria dating back 3.7 billion years (Figure 2).5 Further 
isotopic fractionation evidence suggest that life was present on Earth as long as 3.8 
billion years ago.6 However, the small sample size of geological data for this period 
of Earth history,7 make it difficult to say with any degree of certainty the nature of the 
first few hundred thousand years of Earth history. By June 2017, NASA’s Kepler 
satellite had discovered 219 planets bringing the total number of exoplanets to 4034, 
10 of which are presumed to be rocky and Earth-like. However, until now, life outside 
the boundaries of Earth has not been discovered.8 This makes the Earth the only sure 
candidate planet on which life originated. Therefore it is fundamental to understand 
the universe, and specifically our planet and our own history, to elucidate the 
mechanism by which life came to exist on our Earth, exploiting what is known about 
our own planet (and life on it) for the investigation of the origins of life. 
 
Figure 1.2: Plausible 3.7 billion year old fossilised bacteria (zigzag patterns) 
embedded within rocks in Australia.5 
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Many scientist and philosophers have tried to define life9 and there are no less than 
twenty definitions of “life” found in the Webster dictionary.10 In 1994 NASA arranged 
an international panel of experts to attempt to define a consensus definition of life, 
and the committee proposed that life is:  
“self-sustaining chemical system capable of Darwinian evolution” 11 
However, whether defining a catch all definition of life is valuable to understanding 
the origins of life is debated. Luisi, in a recent review developed the reductive 
suggestion that in the field of prebiotic chemistry researchers need to ignore the most 
complex properties of life (such as intelligence, consciousness and ethics) and 
concentrate on building minimal life.12 These simplest form of life might give us a 
more realistic approach to provide experimental evidence toward the chemical origins 
of life.13 But how simple could life be? Others, including Nobel Laureate Jack 
Szostak, have argued that any attempts to define life will not help to understanding 
the origins of life, rather what is important in field of origin of life research is 
developing a physical model to understand the transitions that led from chemistry to 
biology.14 This thinking leaves behind the philosophical aspect of defining life and 
demands an entirely experimental approach to investigating how life originated from 
simple organic molecules. 
Given the complexity and diversity of life, and the inaccessibility of irrefutable 
geological evidence for the earliest periods of Earth history there are some, including 
Albert Eschenmoser, who have suggested that the origins of life cannot be discovered, 
and that it must be reinvented. To quote Eschenmoser: “the aim of an experimental 
etiological chemistry is not primarily to delineate the pathway along which our 
(natural) life on Earth could have generated, but to provide decisive experimental 
evidence, through the realisation of model systems (‘artificial chemical life’) that life 
can arise as a result of the organisation of the organic matter”.13 
The work outlined in this thesis will specifically explore this principle outline by 
Eschenmoser aiming to experimentally delineate a pathway to the canonical structures 
that unpin biology through the reaction of prebiotically plausible chemicals. 
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1.2. Origins of life 
 
The origins of life is one of the greatest unsolved mysteries of all time.13, 15 There is 
evidence to suggest that (minimal) life is sustained by replication and so exploring 
how the replicable element of life could have chemically arisen must be key to 
understanding the origins of life. Nucleic acids RNA (ribonucleic acid) and DNA 
(deoxyribonucleic acid) are amongst the most fundamental, essential and universally 
conserved elements of living organisms.  
        
Figure 1.3: A) Universal genetic code. The amino acids specified by each mRNA 
codon. Multiple codons can code for the same amino acid. B) Schematic 
representation for Watson-Crick base pairing of purine (guanine, adenine) with 
pyrimidine (cytosine, thymine) nucleobases in RNA. (Credit: Nature Education)16  
B 
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There are 5 canonical nucleotides that are used by all living cells to store and transfer 
information by Watson-Crick base pair (Figure 1.3B), which is the simple, predictable 
coding system that underpins the universal genetic code (Figure 1.3A). Before 
considering the prebiotic origins of information transfer, it is worth considering 
information transfer in extant biology. Proteins are made of amino acids, which can 
fold into highly specific secondary and tertiary structures. The basic building blocks 
of all proteins are the 20 proteinogenic amino acids (Figure 1.3A), which are joined 
in different sequences to a make variety of polypeptides, which are folded into 
proteins, and are used to perform different (programmable) tasks in living systems and 
accordingly (usually) express the phenotype of a given genetic element. To appreciate 
the complex and intricate process of protein assembly (in living cells), a brief 
overview of transcription and translation in living cells will be given in the next 
section.  
 
1.2.1. Transcription and translation of the genetic code 
 
The library of living information required by modern living cells is stored in the DNA 
located in the nucleus of cell. When a protein is required to be synthesised, the genetic 
information for that protein has to be decoded from the DNA, a process known as 
transcription. During transcription RNA polymerase (green) and its associated 
transcription factors binds to the DNA helix and unwind the promoter region with the 
correct code ready to be transcribed by RNA polymer (Figure 1.4A). RNA polymerase 
(green) aligns against the single DNA strand and begins moving down the DNA 
template strand in the 5´3´ direction. As the polymerase moves along it polymerises 
complementary nucleotides (pink) and in this way the new strand of mRNA is 
prepared which will code for a specific protein (Figure 1.4B). However before the 
mRNA strand can be translated into proteins it has to be released from the DNA 
template. The final step of transcription is achieved when RNA polymerase reaches 
the termination sequence on the mRNA strand, causing RNA polymerase and the 
mRNA strand to fall off from the DNA template (Figure 1.4C). Now that information 
required for protein synthesis is extracted from DNA into the RNA transcript, the 
mRNA has to make a complex journey from the nucleus to the cytoplasm where the 
process of translation can begin.  
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Figure 1.4: Showing steps in transcription. A) RNA polymerase (green) binds to the 
DNA helix and unwind the promoter region (initiation). B) The DNA double helix 
unwinds and RNA polymerase reads the template DNA strand and adds nucleotides 
to the end of a growing RNA transcript (elongation). C) Transcription is terminated 
and the mRNA transcript and RNA polymerase are released from the complex 
(termination). (Credit: Nature Education)16  
 
Transfer RNAs (tRNAs) are responsible for matching the amino acids with the 
complementary mRNA docked at the ribosome. The tRNA molecule has two binding 
sites, one for the amino acid and the other for binding to the mRNA codon. Once the 
ribosome (grey) docks on the mRNA molecule, and charged tRNAs bring in amino 
acids by binding with the complementary mRNA codons. The tRNA mediated 
translation of genetic information is coordinated within the ribosome, and only two 
tRNAs can be next to each other within ribosome at any one time. Therefore, as a third 
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tRNA binds the mRNA codons, the first tRNA molecule is displaced, leaving its 
amino acid in the growing peptide chain. In this way, different length of specific 
peptides are synthesised as required by living cells (Figure 1.5). 
 
Figure 1.5: Steps in translation. A) Ribosome (grey) docks on a start codon (red) of 
an mRNA molecule. B) The tRNA molecules carrying amino acids (spheres) dock at 
the corresponding triplet codon sequence on the mRNA molecule. (C, D, and E). This 
process is continuously repeated, connecting successive amino acids into a growing 
peptide chain of specific length as initiated in the transcription process. F) 
Translation is terminated when ribosome encounters a stop codon, releasing the 
polypeptide for use in the cell. (Credit: Nature Education) 16  
 
1.2.2. The Central Dogma of Molecular Biology (CDMB) 
 
Proteins are made of one or more different chains of amino acids folded into highly 
specific secondary and tertiary structures. Proteins and nucleotides, are both essential 
to almost every biochemical processes in a living organism (Figure 1.4 and 1.5). 
Interestingly, despite the power of accuracy of protein catalysis, it is of note that 
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perhaps the most important catalytic function in every cell: the synthesis of sequence 
specific peptide bonds, and consequently the construction of primary structure of 
proteins is carried out by the ribosome. This is of particular interest because the 
ribosome is an RNA catalyst (Section 1.2.1); therefore, it can be said that nucleotides 
not only store and transfer genetic information, but are also responsible for the most 
essential and universally conserved catalytic function/structure in cells. By examining 
the structure of these universally conserved organelles and their relationship across 
the phylogenetic tree, raises some simple questions that need to be answered to 
understand the route from chemistry to biological organisation. DNA and RNA are 
essential to protein synthesis, however protein (e.g. DNA and RNA polymerases) are 
essential to DNA and RNA synthesis and replication. Therefore, which of the essential 
biopolymers DNA or RNA or proteins, was synthesised first? Given the simplicity of 
nucleotide-nucleotide information transfer, it seems reasonable that nucleotides would 
have predated peptides in biology (or at least in information transfer in biological 
systems). However, this raises more questions such as, is it possible to abiotically 
synthesise DNA or RNA? Are there simple robust mechanisms to transform 
abiotically plausible material into any (or indeed all) of the essential biopolymers of 
life? 
It is highly possible that we will never be able to fully answer these questions. 
However, these are the questions at the heart of understanding the origins of biology 
and life on Earth. Therefore, through incremental investigation of the molecular self-
assembly of biopolymers we seek to better understand their origins in biology. Whilst 
developing new derivatives and analogues of the natural nucleotides or mechanisms 
to synthesise nucleotides, countless applications in diagnostics17, medicine18 and 
antiviral drugs19 have also been found. 
1.3. The RNA World Theory 
 
The highly coordinated, systematic and optimised chemistry that DNA/RNA/proteins 
perform in the cell, make it ostensibly difficult to envisage how a living system could 
function without their interdependence. However, the RNA World Theory1 provides 
a mechanism to by-pass this “chicken and egg paradox” at the heart of biology 
(Central Dogma of Molecualr Biology).20 It postulates that before life was dependent 
26 
 
on an interrelationship between DNA/RNA/protein, there was an earlier stage of 
evolution in which life was entirely dependent upon RNA as the only biopolymer 
(Figure 1.6). 
 
 
Figure 1.6: The Central Dogma of Molecular Biology (CDMB). This figure shows 
schematically the flow of information starting from DNARNAProtein. The 
interrelationship of DNA/RNA/Protein in the modern cell makes it difficult to envisage 
origins of life if life must rely on this triad of polymers. To simplify the problem, it has 
been postulated that RNA alone was used to store information and achieved 
programmable catalysis at the origins of life (the RNA World Hypothesis). 
 
The RNA World poses a scientific challenge to chemists to elucidate an abiotic 
synthesis of all four components (Figure 1.7) of RNA from plausible prebiotic 
feedstock of molecules, without these feedstocks the RNA World could never have 
initiated. 
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Figure 1.7: Retrosynthetic analysis of ribonucleotide (RNA). Prebiotic synthesis of 1 
and 2 are the target of this thesis, the pyrimidine ribonucleotides 3 and 4 have already 
been synthesised.21, 22 G (guanine), A (adenine), C (cytosine), U (uracil). 
1.3.1. What makes RNA a better prebiotic candidate than DNA in 
the quest of the origin of life chemistry? 
 
A number of lines of evidence suggest that RNA is the earliest biopolymer. All genes 
are transcribed into mRNA, tRNA or rRNA before the biological phenotype is 
accessed from a gene. Furthermore, strikingly some plant pathogens such as the 
tobacco mosaic virus have genomes entirely composed of RNA.23 The biosynthesis of 
deoxyribonucleotides requires the enzymatic reduction of ribonucleotides, but the 
latter are synthesised in de novo biosynthetic pathways (Section 1.4), and many 
enzyme cofactors are derivatised ribonucleotides. 
However, the discovery of ribozymes in 1981 by Cech24 and Altman25 provided 
substantial evidence for the potential role of  RNA at the origin of life (and the first 
real validation of the catalytic process of RNA, essential to the RNA World 
hypothesis). Their discovery of catalytic RNA, or ribozymes, gave real credence to 
the proposed RNA world hypothesis. This work was recognised by awarding the 
Nobel Prize in Chemistry to Sidney Altman and Thomas Cech in 1981. Subsequent 
studies have also shown that certain RNAs can catalyse the synthesis of a 
complementary strand RNAs on a RNA template without any enzymatic 
intervention.26 
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RNA strands isolated from the genome of Tetrahymena thermophila have shown 
catalytic activity for the reactions of nucleotidyl,27 phosphoryl-transfer,28 hydrolysis 
of an aminoacyl ester29 and the synthesis of complementary RNA strands.30 The 
additional 2`OH group present in RNA, but missing in DNA, plays a significant role 
in the secondary structure of RNA molecule. For example, the 2` OH of RNA often 
plays an important role in the catalytic activity of ribozymes, due to its dual 
functionality (as a proton donor and acceptor, as well as provide a site for metal ion 
coordination) that facilitates a ribozyme to achieve stable 3D structures through 
increase intrastrand non Watson-Crick stabilising interactions, as well as supporting 
catalytic activity. It has also been shown that ribosomes (which are largely composed 
of RNA) can retain some catalytic activity, in spite of complete protein extraction.31 
 
Figure 1.8: Supposed molecular fossils of an RNA world. Nucleotides (red) are 
attached to different (bio)chemical structures. 
Many vital components of the modern cell are mostly composed of RNA or contains 
RNA derived structures such as enzyme cofactors (ATP, Acetyl-CoA, NADPH, FAD, 
Vitamin B-12). Coenzymes are complex organic structures, crucial to many enzyme 
29 
 
catalysed reactions, and more than half of the enzymes discovered so far require a 
coenzyme for full biochemical functioning.32 It has been proposed that the RNA 
component of nucleotidic coenzymes are molecular fossils that are vestigial from the 
RNA world (Figure 1.8).32  
1.4. De novo biosynthesis of purines 
Purines are synthesized de novo through biosynthesis, catalysed by a complex set of 
enzymes in biology (Scheme 1.1).33 Inosine monophosphate 10 is an intermediate in 
the synthesis of the canonical purine ribonucleotides (adenosine monophosphate 11 
and guanosine monophosphate 12) (Scheme 1.2).  
 
Scheme 1.1: De novo biosynthesis of inosine monophosphate 10 as purine nucleotide 
precursor of adenine and guanosine monophosphates 10 and 11. The colour scheme 
is as follow: enzymes, coenzymes, substrate names, metal ions, inorganic molecules.  
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The biosynthesis of purines starts by the displacement of pyrophosphate from PRPP 
by ammonia (NH3) to furnish 5-phosphoribosyl-1-amine (5-PRA, 5). The aminated 
ribotide 5, reacts with glycine, formylated by tetrahydrofolate (THFo) and is then 
converted to amidine (FGAR, 6). ATP induces cyclisation and amination in 6, 
followed by dehydration to give 5-aminiimidazole ribonucleotide (AIR, 7), which 
reacts with activated bicarbonate, followed by rearrangement to produce 
carboxyaminoimidazole ribonucleotide (CAIR, 8). Aminolysis of the carboxylate 
moiety in CAIR is achieved, by reaction with aspartate coupled by conversion of ATP 
to ADP, followed by loss of fumarate to give AICAR 9. AICAR then undergoes 
formylation by tetrahydrofolate (THFo), followed by cyclisation and dehydration to 
give inosine monophosphate 10. 
IMP 10 is then transformed into AMP 11 and GMP 12 in a series of enzyme-catalysed 
biochemical steps (Scheme 1.2). 
 
Scheme 1.2: Biosynthesis of purine nucleotides (AMP 11 and GMP 12) from common 
canonical purine intermediate, inosine monophosphate 10.  
The ribonucleotide reductase (RNR) enzyme catalyses the conversion of 
ribonucleotides into deoxyribonucleotides (Scheme 1.3). This is thought to be further 
evidence to show that RNA predates DNA in biology, as from a chemical perspective 
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conversion of DNA to RNA would be a difficult transformation to achieve without 
enzymatic control.34 
 
Scheme 1.3: Biosynthesis of deoxyribonucleotides (RNA) catalysed by ribonucleotide 
reductase (PNR). 
 
1.5. Prebiotic chemistry  
 
The origins of life has been studied for over 60 years, and has engaged researchers 
from many different scientific disciplines. One of the leading theories for origins of 
life is based on the assumption that the evolution of RNAs was instrumental in the 
transition from chemistry to biology (Figure 1.9).  
 
 
Figure 1.9: A time line of origins of life based on RNA as the first molecule of life. 
The dates are in billions of years. (Credit: Joyce)35 
 
Examination of a ribonucleotide, points to a simple approachable synthesis (Scheme 
1.4) through two condensation reactions. Accordingly, it was hypothesised that 
incubation of ribose, phosphate and the nucleobase would yield ribonucleotides and a 
4000 million years old problem of ribonucleotide synthesis will be ostensibly solved. 
However, for such a simple retrosynthetic approach to work, the prebiotic feedstock 
for these nucleotide precursors (ribose, nucleobases) are required. 
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Scheme 1.4: Retrosynthetic analysis of RNA. 
 
The nature of the early Earth’s atmosphere being reducing or oxidising has been 
highly debated, but it is now believed that the primitive atmosphere was weakly 
reducing,36 which can give rise to plausible reactions acting as feedstock of small 
prebiotic molecules (Scheme 1.5). However within the primitive atmosphere other 
localised environments would have co-existed, giving rise to highly oxidising or more 
reducing localised conditions.37  
 
Scheme 1.5: Plausible reactions in weakly reducing primitive atmosphere yielding 
major prebiotic small molecules. 
 
In an attempt to simulate the (then supposed to be) strongly reducing conditions of 
primitive Earth, a pioneering prebiotic chemistry experiment was conducted by 
Harold Urey and Stanley Miller in 1953.38 Urey and Miller observed that a range of 
organic molecules were synthesised upon passing an electric discharge through water 
vapour, ammonia, methane and hydrogen (Figure 1.10). Remarkably, in these spark 
discharge experiments proteinogenic amino acids (α-alanine, glycine and aspartic 
acid) were detected, along with other molecules of prebiotic importance including 
non-proteinogenic amino acids such as β-alanine.38  
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Figure 1.10: The apparatus used by Urey and Miller to synthesise amino acids and 
other organic compounds in a reducing atmosphere, the apparatus is made entirely 
of glass with the exception of electrodes which are made from tungsten (left).38 A 
diagrammatic representation of Urey Miller’s apparatus (right).25 
 
Perhaps, after the controversial synthesis of urea (an organic molecule) from 
ammonium cyanate (an inorganic molecule)  in 1828 by Friedrich Wohler,39 Urey-
Miller’s synthesis of amino acids by spark discharge were the most exciting prebiotic 
chemistry experiments to have been conducted at the time. For the first time, it was 
shown that the basic building blocks of the most complicated biological machines 
(proteins) can be obtained by bombarding gaseous carbon, oxygen and nitrogen matter 
with simple spark discharge. Detailed inspection of Urey-Miller experiments are now 
known to produce up to 40 different amino acids and amines, mainly via the Strecker 
or Bucherer-Bergs mechanisms (Scheme 1.6).40  
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Scheme 1.6: Prebiotic synthesis of amino acids. A) The Strecker mechanism for the 
formation of amino acids, and complementary synthesis of hydroxyacids. B) The 
Bucherer–Bergs mechanism for the synthesis of amino acids, which employs CO2 to 
promote synthesis for (Strecker product) aminonitriles. 
Following in the footsteps of Urey-Miller, others have shown that hydrogen cyanide 
14 can be synthesised by spark discharge through an atmosphere of methane, nitrogen 
and carbon monoxide gases,41 and similar laboratory experiments have shown to 
produce acetylene, cyanoacetylene 30 42 and cyanogen 25.43 
Many small molecules have also been detected in the interstellar dust clouds and 
meteorites,44 these molecules are assumed to be non-biological in origin, their non-
biological syntheses have also been confirmed by laboratory experiments to mimic 
the primordial environment of Earth and meteorite formation (Figure 11).45  
 
Figure 1.11: Prebiotic feedstock of molecules observed in the interstellar cloud. 
(Credit: Thaddeus)45 
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1.5.1  Prebiotic synthesis of ribonucleotide nucleobases  
 
Hydrogen cyanide 14 derivatives are known to be plausible precursors of purine 
nucleobases.38 Orό first demonstrated that the oligomerisation of 14 can lead to the 
synthesis of adenine 22. Adenine 22 (C5H4N5) is formally a pentamer of 14, and can 
be synthesised along with other important prebiotic compounds from 14-
oligomerisation.46-49 Ferris and Orgel meticulously studied Orό’s HCN 
oligomerisation reactions in order to seek plausible mechanisms for the formation of 
22 (Scheme 1.7).50-54  
 
Scheme 1.7: Prebiotic synthesis of purine nucleobases via hydrogen cyanide 14 
oligomerisation. Adenine 22 (12%) and guanine 23 (3.3%) is obtained under best 
possible prebiotic conditions. The photochemical reaction of HCN tetramer 18 was 
discovered by Orgel and Ferris. Heating of formamide 27 yielding 70% purine 29 
(inset, red). Traube’s synthesis of purines (inset, blue). 
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Incubation of a concentrated (~11M) mixture of hydrogen cyanide 14 yields HCN-
dimer 16, which can react with further HCN 14 to form aminomalononitrile 17, 
followed by another HCN 14 to give diaminomalononitrile 18. The tetramer 18 then 
undergoes intramolecular photochemical rearrangement (or reacts with formamidine 
19 synthesised from 14 and NH3) to furnish 5-aminoimidazole-4-carbonitrile (AICN) 
20 in near quantitative yield. Subsequent hydrolysis of 20 gives 5-aminoimidazole-4-
carboxamide (AICA) 21 (Scheme 1.7). Interestingly, during the formation of 
diaminomalononitrile 18, other molecules with prebiotic significance were also 
observed, these include cyanamide 68, urea 15, and cyanogen 25. Formylation and 
cyanation of 20 and 21 by various reagents leads to formation of several purine 
nucleobases including adenine 22, guanine 23 and hypoxanthine 24 (Scheme 1.7). 
However, the best yield achieved so far for adenine 22 and guanine 23 synthesis are 
12% and 3.3% respectively under plausible prebiotic conditions.55, 56 Other notable 
purine synthesis (with prebiotic implications) include polymerisation of formamide 
27 at elevated temperatures to give yield up to 70% purine 29,57 and Traube’s purine 
synthesise which yields purines by the reaction of derivatised diaminopyrimidines 
with formic acid 28 (Scheme 1.7).58-60  
 
Scheme 1.8: A) prebiotic synthesis of cytosine 32 and uracil 33 by reaction of 
cyanoacetaldehyde 31 and urea 15. B) Plausible mechanism for the prebiotic 
synthesis of pyrimidines as postulated by Miller and Cleaves.61  
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Pyrimidine bases have not received much attention as the purines in the prebiotic 
literature, but the highest yielding prebiotic conditions for synthesise cytosine 32 was 
reported by Miller et al. Miller and co-workers demonstrated that incubation of highly 
concentrated cyanoacetaldehyde 31 with urea 15 yielded up to 53% cytosine 32 
(Scheme 1.8A).62 The other pyrimidine nucleobase, uracil 33, can be obtained via 
hydrolysis of 32 (Scheme 1.8B).61 
The pyrimidine and purine nucleobases (assumed to be) required for the synthesis of 
ribonucleotides have been synthesised, but with pitfalls. The synthesis relies on 
concentrated HCN 14 pools which if uncontrolled can lead to the most deleterious 
pool of prebiotic chemistry. Upon synthesising such a diversity of compounds it is not 
clear how the “essential” biological compounds could be selected from such complex 
mixtures. Adenine 22 requires HCN 14 concentration of at least 0.01M.63 However,  
detailed modelling has estimated HCN 14 concentrations in the primitive oceans 
would have been 6 × 10-16 M, 7 × 10-13 M and 2 × 10-6 M at 200°C, 100°C and 0°C 
respectively.55 In dilute concentrations hydrogen cyanide 14 hydrolyses to formamide 
27, which then hydrolyses to formic acid 28 and ammonia (Scheme 1.9). Therefore, 
the plausibility of HCN 14 polymerisation taking place in the warm primitive oceans 
is rejected, in favour of eutectic freezing conditions or localised small bodies of water 
that have become concentrated in HCN 14. However, this still does not provide a 
solution for the uncontrolled HCN chemistry which predominantly yields polymers 
and non-biological aromatics. Moreover, the feedstock of cytosine 33, acetaldehyde 
31 (pKa = 8.1) readily undergoes homoaldol reaction, implying that the controlled 
synthesis of cytosine 33 would be prebiotically difficult to orchestrate.64, 65    
 
 
Scheme 1.9: Hydrolysis of hydrogen cyanide 14 under dilute conditions. 
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1.5.2. Prebiotic synthesis of sugars 
 
 
Figure 1.12: A) Simplified schematic representation of Butlerow’s formose reaction. 
B) Gas chromatogram of derivatives of sugars arising in the formose reaction. The 
arrows are pointing to two ribose 38 isomers. (Credit: Decker et al.)66 
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The formose reaction, discovered by Butlerow in 1861, is the polymerisation of 
formaldehyde 13 in the presence of divalent metal ion catalysts such as Ca(OH)2 in 
highly alkaline conditions to yield sugars and other small sugar-like molecules (Figure 
1.12).67, 68 The exact details of Butlerow’s sugar synthesis have still not been fully 
understood more than a centrury after it’s discovery, however it is thought to preceed 
via an autocatalytic process in which glycolaldehyde 34 acts as an autocatalyst for its 
own formation from formaldehyde 13 (following two aldol reactions with 
formaldehyde and a retro-aldol dissociation of tetrose sugars into two molecules of 
glycolaldehyde 34). Formose reaction lead to the synthesis of a plethora of sugars, 
yielding mixtures of trioses, tetroses, pentoses, and hexoses alongside many other 
related compounds.66, 69 Although the formose reaction leads to ribose 38 and related 
aldopentoses, it is debatable whether it could have led to the accumulation of these 
particular sugars on the early Earth, since ribose 38 is an extremely minor component 
(1% yield) of the sugars synthesised through the formose reaction and given that 
ribose is particularly an unstable (t1/2 = 5 h, pH 12.5) product of the reaction.
70-75 To 
add to the “ribose  problem”, it has been shown that ribose 38 equilibrates to yield a 
mixture of pentose sugars under mild aqueous conditions (pH 7, 25°C), where 
arabinose 39 (75%) predominates over ribose 38 (19%) at equilibrium.70 
 
 
 
Scheme 1.10: Stabilisation of pentose sugars by borate incorporation under formose 
reaction conditions. 
 
 
Many attempts to simplify the pattern of products synthesised by the formose reaction 
have been made, one such method exploits stabilisation of sugars by chelation to 
borate (Scheme 1.10).76 It has been found that complexation with borate minerals 
stabilizes pentoses sugars (ribose 42, arabinose 43, xylose 44 and lyxose 45,) under 
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formose reaction conditions.77, 78 Interestingly, the ribose-borate sugar complex 46 
exhibits greater stability relative to the other aldopentoses (47, 48 and 49), however, 
under formose reaction conditions this stability is modest (t1/2 = 45 hr, pH 12.5).
72, 79 
It is also important to note, that ribulose 37 has shown a greater degree of stabilization 
by borate than ribose 42.72  
 
Eschenmoser and colleagues have shown that phosphorus incorporation into sugars 
provide greater selectivity and stability of sugars (Scheme 1.11).80 Glycolaldehyde 
phosphate 50, formed by the selective α-phosphosphorylation of glycolaldehyde 34 
by amidophosphates (55 or 54) in near quantitative yields, undergo homoaldol 
condensation to produce hexose 2,4-6-triphosphates 52 in a remarkable 94% yield 
(Scheme 1.11).81, 82 Glycolaldehyde phosphate 50 can also react with formaldehyde 
13 at pH 10.7 to give glyceraldehyde-2-phosphate 51. The crossed aldol condensation 
reaction of glycolaldehyde phosphate 50 and glyceraldehyde-2-phosphate 51 give a 
mixture of phosphorylated pentoses containing 72% pentose-2,4-diphosphates 53 in 
which ribose 38 is the major component (33%).  
 
Scheme 1.11: Phosphorylation of sugars providing selectivity and milder Formose 
reaction conditions. Glycolaldehyde 34 undergoes selective α-phosphorylation by 
amidophosphates (54 or 55) to furnish glycoldaldehyde phosphate 50 in excellent 
yield (inset). Homoaldol condensation of 50 produces a mixture of rac-hexose 2,4,6,-
triphosphates 52 (94%). Adapted from Islam and Powner.83 
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In comparison with the formose reaction, the phosphate groups incorporated in the 
sugars, prevent the rearrangement of trioses, tetroses, and pentoses, therefore 
inhibiting the uncontrollable formation of sugars (tars) that is the characteristic of the 
formose sugar mixture. However, these reactions are still not completely 
disastereoselective, where a mixture of sugar phosphates mixture is still produced. 
Furthermore prebiotic nucleobase glycosylation with these phosphorylated sugars 
have not been reported.  
 
Until recently, the formose reactions and its variants were thought to be the prebiotic 
source of sugars.77, 84 However, these are extremely unselective and give a plethora of 
sugar.70, 85  Sutherland and colleagues have found a different solution to the sugar 
problem by exploiting the Kiliani-Fischer homologation (Scheme 1.12C)86, 87 of 
formaldehyde to find a prebiotic route for the synthesis of glycolaldehyde 34 and 
glyceraldehyde 35.88 Their rather simple system, which generates relatively complex 
organic biomolecule precursors, is termed by Sutherland “cyanosulfidic 
protometabolism” (Scheme 1.12A). These pathways form glycolaldehyde 34 and 
glyceraldehyde 35 (essential for the prebiotic synthesis of ribonucleotides, vide 
infra),22 the hydrophilic moiety 63 of glycerophospholipid membranes, and twelve of 
the proteinogenic amino acid precursors in high yielding reaction step.89  The key step 
of the reaction is the remarkable reduction step achieved by photochemical irradiation 
of cyanide 14 with hydrogen sulfide (H2S). The photochemical reduction of hydrogen 
cyanide 14 with H2S produces formaldehyde 13 and ammonia, 13 is rapidly trapped 
by 14 to generate glycolonitrile 59,  which can undergo further nitrile reduction to 
yield glycolaldehyde 34 (Scheme 1.12A).  
 
The formation of cyanohydrins such as 59 has been a major drawback of formose and 
HCN oligomerisation, as the formation of a cyanohydrin between formaldehyde 13 
and cyanide 14 is supremely favoured towards cyanohydrin 59.70, 90, 91. However, 
Sutherland and colleagues have utilised the highly efficient cyanohydrin formation to 
their advantage, since glycolonitrile 59 is irreversibly reduced to form glycolaldehyde 
34 by the photochemical irradiation in the presence of H2S.
88, 92 The C3 sugar 
glyceraldehyde 35 is also obtained, by Kilinai-Fischer reaction of glycolaldehyde 34.  
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Scheme 1.12: Cyanosulfidic protometabolism. A) Photochemical reduction of HCN 
14 with H2S and/or cyanocuprates leading to a network of systems chemistry 
furnishing glycolaldehyde 34 and glyceraldehyde 35, glycerol 63 (lipid precursor) 
and 12 proteinogenic amino acid precursors in high yields. B) Plausible mechanism 
for photochemical reduction of cyanide to form iminium species. C) Kiliani-Fischer 
homologation, where the reduction of the nitrile moiety is achieved using a poisoned 
palladium catalyst. Adapted from Islam and Powner.83 
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Furthermore, upon close inspection of glycolonitrile 34 reduction with H2S, 
acetaldehyde 56 is also detected as the photochemical deoxygenation product of 
glycolaldehyde 34. Interestingly acetaldehyde 56 is the precursor of amino acids 
threonine (Th) and alanine (Al). This led to the realisation that cyanohydrins 59 and 
60 could be converted to amino acid precursors as well as glycolaldehyde 34 and 
glyceraldehyde 35 (ribonucleotide precursors), establishing a prebiotic synthetic 
association between protein and ribonucleotides under “cyanosulfidic” conditions.  
Formaldehyde 13 and glycolaldehyde 34 are the Strecker aldehydes of glycine (Gly) 
and serine (Ser), and their cyanohydrins 59 and 60 are readily converted to the 
corresponding aminonitriles in the presence of ammonia. Moreover, 
dihydroxyacetone 36, the phosphate-catalyzed isomerisation product of 
glyceraldehyde 35, can undergo deoxygenation by irradiated H2S to yield acetone 64, 
which provides the branched backbone of valine (Val) and leucine (Leu). It is 
remarkable to observe these facile deoxygenation reactions with H2S and photons, 
given the levels of intricacy required to achieve desired and controlled chemical 
transformation under prebiotic condition. To complete the remarkable collection of 
12 different amino acids, copper-mediated cross-coupling of cyanide 14 and acetylene 
57 is used to produce precursors for asparagine (Asn), aspartate (Asp), glutamine 
(Gln), glutamate (Glu), proline (Pro), and arginine (Arg). To establish that the same 
network of reactions might have been used by biology to build membranes, glycerol 
63 provides a direct connection to phospholipids is obtained by the reduction of 
dihydroxyacetone 36. Although Sutherland’s cyanosulfidic protometabolism at this 
stage is preliminary in the sense that such a simple system gives rise to an ostensibly 
complex set of bimolecular chemicals. Further investigation into realising this 
chemistry in systems is required. Nevertheless the ‘cyanosulfidic protometabolism’ 
scenario is rather remarkable for the ease with which ribonucleotide, protein, and lipid 
precursors are formed. It has also reduced the invoking of notoriously messy and 
uncontrollable chemistry of the formose reactions and HCN oligomerisation, and 
spark-discharge experiments,46, 63, 70, 93, 94 and has opened up a more cohesive approach 
to tackling the origins of life chemistry.95  
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1.5.3. Condensation of sugars and nucleobases: Conventional 
synthesis of nucleotides 
As discussed in the last section, prebiotic synthesis of ribose 42 has many pitfalls and 
is generally considered impractical and implausible to have existed on the primitive 
Earth.70, 83, 85 Nevertheless, many continue to assume that a plausible pathway to ribose 
42 will be found and have continued with exploring glycosylation of canonical 
nucleobases with ribose 42. This, however, has proven very difficult to achieve 
(Scheme 1.13A). Ribosylation of canonical pyrimidines does not work at all, and 
incubation of adenine 22 with ribose 42 only gives 4% β-adenosine 66 in a solid-state 
reaction involving a large excess of ribose and a high concentration of Mg2+, followed 
by heating with concentrated ammonium hydroxide.96, 97 The reasons for the poor 
reactivity of ribose 42 and the canonical nucleobases are mainly due the unavailability 
of the right isomer of the ribose 65 and correct (nucleophilic) tautomer of each base 
(Scheme 1.13B). The sugar mixture consists mainly of β- and α-pyranose isomers with 
only 7% of the desired α-furanosyl isomer 65.98 In pyrimidines, the lone pair of the 
desired endocyclic nitrogen is delocalised into the ring in favour of aromaticity 
therefore no reaction is observed with 65 (Scheme 1.13B). In case of purines again 
the required tautomer (unprotonated N-9) is available at low levels at equilibrium, 
leading to reduced reactivity with the ribose (Scheme 1.13B).99  
Scheme 1.13:  A) Retrosynthetic analysis of ribonucleotides. B) The difficulties of 
selective ribosylation of adenine 32 and cytosine 33, due to the unavailability of the 
correct tautomer. The ideal isomer of ribose, 65 for ribosylation of nucleobase is a 
minor product (7%) in aqueous media (inset). 
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The most recent synthesis of purine nucleoside, reported by Carell and co-workers, 
exploiting a combination of this dry-state glycosidation strategy with Traube purine 
synthesis to overcome the problem of glycosidation (Scheme 1.14), however this 
synthesis remains low yielding, lacking regio- and stereo-selectivity, and does not 
(yet) provide a solution for selective incorporation of phosphorus to get purine 
nucleotides (1 and 2).59  
 
Scheme 1.14: Synthesis of purine nucleosides by dry state glycosidation of Traube 
purines yielding both furanosyl and pyranosyl nucleosides. A (adenine), G (guanine) 
and DA (diaminopurine). 
 
 1.6.  Pre-RNA World 
 
Given the synthetic complexity of ribonucleotides (and the difficult history that 
prebiotic chemist have had synthesising them), a pre-RNA World has also been 
suggested, where earlier “simpler nucleotides” where the first biopolymers and then 
RNA “appeared” later on and was incorporated into biology in a genetic takeover 
event.100. There are viable questions regarding nature’s selection of RNA. Why does 
RNA use the 4 canonical nucleobases (adenine, guanine, cytosine, uracil) from a 
possible selection of at least 36 similar purines and pyrimidines?13 Why did RNA 
assume the pentose sugar backbone instead of a hexose or tetrose sugar? Why is it 
ribo-furanose, instead of ribo-pyranose? Why are the nucleobases in β configuration 
instead of α? Why D sugar and not L? Why is the ionisable linker that connects RNA 
monomers a phosphate? And why is the 3`,5` phosphodiester linkage favoured rather 
than the 2`,5` phosphodiester linkage (Figure 1.13). In an attempt to answer some of 
these questions, plausible alternative candidates to ribonucleic acids, which are 
closely related to ribonucleic acid, have been chemically synthesised and their ability 
to undergo Watson-Crick pairing has been explored. 
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Figure 1.13: Nature’s selection of RNA from a clutter of plausible chemistry. The 
natural selected chemistry of RNA is shown in the coloured boxes, under each box are 
the possible routes that RNA could have taken during each individual assembly stages. 
(Adapted from Joyce)35 
 
1.6.1. Homo-DNA, p-RNA and TNA 
 
Eschenmoser and his colleagues have undertaken a ground-breaking systematic 
approach to studying the etiology of nucleic acids. They have chemically synthesised 
a broad spectrum of unnatural nucleic acids that are “in the chemical neighbourhood 
of RNA” i.e nucleic acids with canonical nucleobases with sugar-phosphate 
backbones that may have arisen by the same (or similar) prebiological chemical 
pathways that would have resulted in the ribose phosphate backbone of RNA. They 
have undertaken a thorough investigation to compare the Watson-Crick base pairing 
strength, the phosphodiester linkage, chemical properties, non-enzymatic self-
replication, and structural and functional properties of different analogues of DNA 
and RNA.13, 85, 101-103 Initially Eschenmoser and co-workers investigated the effects of 
replacing the furanosyl in DNA with a pyranosyl ring, this new pyranosyl nucleic acid 
was called homo-DNA (Scheme 1.15).  
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Scheme 1.15: Comparison of DNA and RNA with Eschenmoser’s unnatural nucleic 
acids (Homo-DNA, p-RNA and TNA). 
 Interestingly, homo-DNA displayed increased melting temperatures, and therefore 
stronger Watson-Crick base pairing, than either DNA or RNA.104  This increased 
strength was proposed to be due to the “greater rigidity in pyranose than furanose rings 
resulting in a preorganization of the strands backbone.”101 and consequently a smaller 
entropic penalty for duplex formation. These results were extremely interesting, since 
for the first time it was shown that Watson-Crick pairing was no longer a DNA or 
RNA phenomenon. Homo-DNA was a strictly model system (model system in the 
sense that a potential prebiotic synthesis of it seems highly unlikely due to its unusual 
reduced state of the sugar.) Members of the hexo-pyranosyl family (β-allo, β-altro and 
β-glucopyranosyl) were also explored. These hydroxylated pyranosyl nucleotides 
were not observed to form Watson-Crick base pairs with complementary strands, as a 
result of increased intrastrand steric clashes between additional hydroxyl groups and 
the nucleobases.  
Next, Eschenmoser’s group synthesised pyranosyl RNA (p-RNA). This polymer is of 
particular interest in the series studied as it is clearly most closely related to the natural 
RNA (Scheme 1.15). The pyranosyl oligonucleotide, p-RNA displayed a much 
stronger Watson-Crick base pairing than RNA or DNA and showed greater pairing 
specificity. It pairs exclusively via Watson-Crick pairing whilst completely avoiding 
Hoogsteen interactions (Scheme 1.16).103 A whole family of pento-pyranosyl nucleic 
acids (β-ribo-, β-xylo-, β-lyxo-, α-xylo- and α-arabino-pyranosyl)105 were synthesised 
and all of these showed enhanced Watson-Crick base pairing than RNA. In fact the α-
48 
 
arabino-pyranosyl is the strongest Watson-Crick base pairing system yet to have been 
encountered.106 Although unselective cross pairing was observed between all 
members of the pento-pyranosyl oligonucleotides, none of the p-RNA isomers cross-
paired with RNA, and so it is difficult to envisage how sequence information could be 
passed over to nascent RNA polymer. As these systems do not ‘crosstalk’ with RNA 
there is no direct mechanism for genetic transfer to take place. Therefore, it was 
concluded from these studies that nature did not choose RNA or DNA due to maximal 
pairing strength, as this would have stopped chemical evolution into RNA genetic 
system. Rather, it may have chosen RNA as it was the optimal base-pairing system. 
 
Scheme 1.16: Comparison of Hoogsteen and Watson-Crick pairing systems. 
Eschenmoser’s etiological studies of nucleic acids were not quite finished at this point, 
and it is a testament to the thoroughness of his group’s studies that they found that  
threose nucleic acid (TNA) displayed extraordinary properties. Threose nucleic acid 
(TNA) is a nucleic acid with a tetrafuranosyl sugar instead of the pentose sugar in 
oligonucleotides (Scheme 1.15).107, 108 Tetrose nucleotide were thought to be 
“simpler” than pentose nucleotides because the core sugar moiety could result from a 
C2 + C2 homo aldol reaction, unlike the five carbon sugar that appear to require crossed 
aldol reaction, leading to a plethora of other undesired sugars.70 Furthermore, the 
formation of phosphodiester linkages will be more selective in TNA due to absence 
of one hydroxyl group. Remarkably, it was found that TNA can not only efficiently 
and specifically self-base pair (TNA-TNA), but also capable of cross-pairing with 
DNA (DNA-TNA) and RNA (RNA-TNA), a phenomenon that had not been observed 
before with other unnatural oligonucleotides. To unravel chemical diversity of 
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nucleobases, the Swiss group exchanged adenine with 2,6-diaminopurine in TNA, 
leading to enhanced pairing.109 Eschenmoser’s mind opening functional studies of 
oligonucleotides have raised more questions: Why is there a need for a sugar backbone 
in nucleic acids, can it be negated? Are there even simpler nucleotides capable of 
genetic transfer and cross-pairing? 
1.6.2. Peptide nucleic acids (PNAs) 
 
PNA is another important example of a nucleic acid derivative that  can Watson-Crick 
base-pair, but does not have a sugar-phosphate backbone and has found wide use in 
antisense technologies (Scheme 1.17).110 It can efficiently Watson-Crick base pair 
with itself and DNA (duplex and triplex) and has largely been explored for its potential 
use in medicinal chemistry.111 It has been suggested, based largely on Urey-Miller 
experiments, that PNA is more prebiotically plausible than ribose or deoxyribose 
nucleotides.  A number of authors suggest the possibility that PNA was synthesised 
before RNA, hence there was a “peptide nucleic acid world”110 prior to the “RNA 
world”. It has already been shown that genetic information can be transferred from 
PNA to PNA, PNA to RNA (or DNA) and vice versa.112 However, the synthesis or 
oligomerisation of PNA monomers, despite nearly 20 years having passed since its 
design, remains to be demonstrated. Furthermore, it is important to note that 
monomers of PNA cyclise when they are activated, which will make prebiotic 
oligomerisation difficult to achieve. 
 
 
Scheme 1.17: Structure of peptide nucleic acid (PNA). 
 
  
 
50 
 
 
1.6.3. Glycol nucleic acid (GNA) 
 
Another novel nucleic acid is glycol nucleic acid (GNA) (Scheme 1.18).113 Compared 
to other potential prebiotic nucleic acids it is structurally simpler (and achiral) but still 
supporting stable duplex formation. The sugar backbone is at a low oxidation state, so 
a nucleobase can be stably attached to the backbone without the need for a cyclic 
acetal linkage, but how this ligation could be achieved prebiotically is difficult to 
envisage. The GNA oligonucleotide has an acyclic phosphodiester junction, which is 
capable of Watson-Crick base pairing with itself to form GNA duplex (GNA-GNA). 
However just like PNA, GNA monomers also cyclise when activated and have only 
been copied in trimer form.114 
 
Scheme 1.18: Structure of glycol nucleic acid (GNA). 
 
The ethological studies of nucleic acids by Eschenmoser and others does not solve the 
problem of why nature chose RNA, by finding an alternative to RNA that could 
perform RNA’s role. They all ended up falling back on “evolution” as the only 
possible answer to how RNA was selected by biology, but provide no real evidence 
for this transition. There is no clear evolutionary driving force which could explain 
the mechanism of evolution that leads from a precursor XNA to RNA (if both 
monomeric unit were not available).115 Therefore, perhaps RNA was nature choice, 
because there was no choice (or at least the choice was highly restricted) and that RNA 
is the simplest molecule to synthesise, oligomerise and replicate under prebiotic 
constraints.     
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1.7. Synthesis of Activated Ribonucleotides by avoiding 
Ribose and Nucleobases 
 
The problem of prebiotic ribosylation of nucleobases has persisted more than 60 years, 
and in 2004 Leslie Orgel stated that: “there is at present no convincing, prebiotic total 
synthesis of any nucleotide. Many individual steps that might have contributed to the 
formation of nucleotides on the primitive Earth have been demonstrated, but few of 
the reactions give high yield of products, and those that do tend to produce complex 
mixtures of products.”100 Since then, however there have been significant gains in 
prebiotic synthesis of ribonucleotides via a completely different methodology: a 
systems chemistry approach.83, 116-119 It is upon the system chemistry advance that this 
thesis will specifically build. 
 
The successful synthesis of activated β-cytidine-2`,3`-cyclic phosphate 3 and β-
uridine-2`,3`-cyclic phosphate 4 nucleotides under plausible prebiotic conditions were 
initiated by a systems chemistry approach to tackle the problem of prebiotic synthesis 
of ribonucleotides.21, 22, 118, 119 The relatively futile conventional method of reacting 
the unstable and elusive ribose 42, with pre-formed purines (adenine 22 and guanine 
23) or pyrimidine (cytosine 32 and uracil 33) and phosphate, is by-passed utilising the 
prebiotically available C2 and C3 sugars glycolaldehyde 34 and glyceraldehyde 35 
rather than ribose 42 (Scheme 1.19).88, 89, 92 The synthesis starts by reacting the C2 
sugar glycolaldehyde 34 with cyanamide 68 at pH 7 in the presence of inorganic 
phosphate to give 90% 2-amino-oxazole 69. Oxazole 69 then reacts with the C3 sugar 
glyceraldehyde 35 to furnish ribose pentose aminooxazoline 70 in near quantitative 
yield. The reaction exhibits remarkably diastereoselectivity for ribo-70 and arabino-
70, which make up 74% of the total composition of 70. The formation of 
aminooxazoline 70 with complete furanosyl selectivity is a crucial step of the 
synthesis as the desired pentafuranosyl backbone is made by by-passing free pentose 
sugars. More importantly, pentose aminooxazoline 70 is synthesised from 
prebiotically available molecules (glycolaldehyde 34, glyceraldehyde 35 and 
cyanamide 68) and orthophosphate is used throughout the reaction as acid base 
catalyst. It is also of note that ribo-70 (t1/2 > 1 week, pH 10, 55
oC) have shown 70 fold 
52 
 
greater stability than ribose 42 (t1/2 < 3h, pH 10, 55
oC) under comparable aqueous 
conditions and ribose aminooxazoline ribo-70 has been considered as a stable 
“organic mineral” that may have been exploited to direct prebiotic chemistry towards 
biological structures.71, 120 
  
 
Scheme 1.19: Systems chemistry approach to the synthesis of the pentafuranosyl 
backbone of ribonucleotides that avoids free pentose sugars. A) The synthesis of 
pentose aminooxazolines 70 utilising a combination of mixed nitrogenous and 
oxygenous chemistry to produces 2-aminooxazole 69 from the reaction of C2 sugar 
glycolaldehyde 34 and cyanamide 68. Oxazole 69 then reacts with glyceraldehyde 35 
to produce pentose aminooxazolines 70 with the highest ribo- and arabino-selectivity 
observed (so far) in prebiotic chemistry. B) Postulated mechanism for acid base 
catalysed coupling of 34 with 68 to furnish 69. C) Mechanism for acid-base catalysed 
reaction of 69 with 35 to give 70. Pi = inorganic phosphate; H-A = general acid; A
- 
= general base. 
 
The differential solubility of pentose aminooxazolines 70, leads to purification of 
ribo-70 from the crude mixture of all four aminooxazolines via spontaneous 
crystallisation.121 Interestingly, it has also been observed that reaction of scalemic 
glyceraldehyde 34 (60% enantiomeric excess) with 2-aminooxazole 69 can lead to 
spontaneous crystallisation of pure homochiral D-ribo-70, which will have greater 
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implications for the origins of prebiotic homochirality in ribonucleotides.122 
Phosphate is also exploited in the interconversion of ribo-70 to arabino-70, via a 
general acid-base catalysed C2` epimerisation (Scheme 1.20). Crystallisation of ribo-
70, leaves behind xylo-70 and lyxo-70 minor products in the crude mixture of 70. 
Furthermore xylo-70 and lyxo-70 are then not assessable (requiring C3` epimerisation) 
from ribo-70 crystals by phosphate catalysed epimerisation.123 The interconversion 
reaction of ribo-70 and arabino-70 can be used to permanently eliminate xylo-70 and 
lyxo-70 aminooxazolines, due to the privileged crystallinity of ribo-70, and an acidic 
C2` proton. 
 
 
Scheme 1.20: Plausible mechanism for phosphate catalysed interconversion between 
ribo-70 and arabino-70. H-A, general acid; A-, general base. 
 
The next step of the synthesis involves formation of the pyrimidine ring on the sugar 
scaffold via cyanovinylation. The reaction of ribo-70 with excess cyanoacetylene 30 
gives 20% α-ribo-cytidine α-72, which can photoisomerise to yield β-72 albeit, under 
the best photoanomerization conditions only giving 6% β-72 (Scheme 1.21).124, 125 
Furthermore, it is observed that a pH increase (>pH 7) during the cyanovinylation 
reaction leads to the hydrolysis of anhydropyrimidine, ribo-73 into α-72 and then a 
clutter of compounds, including multiple cyanovinylated products most of which have 
not been identified, but including α-72.22, 124 
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Scheme 1.21: Unbuffered (> pH 7.0) cyanovinylation of aminooxazoline ribo-70 
giving 20% α-cytidine α-72, which undergoes poor photoanomerization only yielding 
6% β-cytidine β-72. 
 
The underlying problem of the unselective chemistry observed between ribo-70 and 
cyanoacetylene 30 was resolved by employing inorganic phosphate to buffer the 
system at pH 7. The incorporation of inorganic phosphate in the aqueous reaction 
leads to remarkable chemoselectivity for the reaction of cyanoacetylene 30 with 
aminooxazoline ribo-70 and arabino-70 to furnish ribo-73 and arabino-73 in 
excellent yields (Scheme 1.22). The inorganic phosphate plays a dual role: it is used 
as an acid base catalyst for example to facilitate the coupling of glycolaldehyde 34 
with cyanamide 68 to give 2-aminooxazole 69 (Scheme 1.28) and it also acts as a 
buffer to maintain the pH at 7 to stop hydrolysis of anhydrocytidine arabino-73 and 
ribo-73. Furthermore phosphate is also ultimately then required as a reagent for the 
final phosphorylation step to form 2`,3`-cyclic phosphates from 73. 
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Scheme 1.22: Conversion of pentose aminooxazoline 70 to anhydrocytidines 73 and 
their conversion to pyrimidine ribonucleosides 72 and nucleotides 3. 
Aminooxazolines, arabino-70 and ribo-70, can be cyanovinylated in up to 92% yield 
with cyanoacetylene 30 to furnish anhydronucleoside, arabino-73 and ribo-73 
respectively. Arabino-73 proceeds further en route to ribonucleotides by being 
converted to activated pyrimidine 3 via phosphorylation. Destructive chemistry (red): 
unbuffered reaction of ribo-73 with cyanoacetylene 30 and/or its hydrolysis yields α-
cytidine α-72. B) Plausible mechanism for N1 cyanovinylation of aminooxazoline 70 
with cyanoacetylene 30.  
 
The prebiotic phosphorylation of arabino-70 proceeds via the secondary C3´-OH, 
instead of the ostensibly less hindered primary C5´-OH (Scheme 1.22). The key to 
this remarkable chemoselectivity was revealed by X-ray crystallographic studies of 
arabino-73, showing an intramolecular stereoelectronic effect that reduces reactivity 
of the C5´-OH by an nπ* interaction of the non-bonding lone pair of electrons on 
the C5´ hydroxyl with the antibonding orbital on the C2 carbon atom of the arabino-
73.126 The interaction of C5´-OH into C2 carbon also provides the needed protection 
from hydrolysis by blocking phosphate attack on C2 moiety in arabino-73. 
Interestingly, urea 15, the product of phosphate-catalysed hydration of cyanamide 68 
plays the crucial role of acting as a solvent in molten form and also activates inorganic 
phosphate (Pi) by forming the uredo-phosphate transient intermediate 74  (Scheme 
32). The C3´-phosphorylated anhydronucleoside 75 then cyclises to form β-cytidine-
2´,3´-cyclic phosphate 3, via the phosphates attack at C2´ carbon, breaking the C2´-
O-C2 linker, to give the correct sugar and the nucleobase stereochemistry as required 
for natural nucleotides (Scheme 1.23).  
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Scheme 1.23: X-ray structure of arabino-73 reveals an n π* interaction between the 
C5´-OH and C2, which provides selective phosphorylation of C3´-OH in favour of the 
primary C5´-OH, followed by intramolecular cyclisation of 75 to give 2´,3-cyclic 
phosphate 3. Urea 15, the phosphate-catalysed hydrolysis product of 69, activates 
phosphate by forming a phospho-uredo compound 74 (inset). DFT for arabino-73 
reported by Choudhary et al.126 
 
In order to obtain the second pyrimidine nucleotide, β-uridine-2`,3`-cyclic phosphate 
4, 3 is irradiated for 3 days in aqueous solution with UV light (254 nm) which gives 
4 in good yields with minimal destructive photochemistry (Scheme 1.24). A protective 
mechanism to conserve the activated pyrimidine ribonucleotides (3 and 4) was 
observed. This is due to the locking the 2`,3`-cyclic phosphate in ‘East-West’ 
conformation instead of the more conversionally predominate ‘North-South’ 
confirmations (found in RNA). The East-West conformation brings the C5`-OH in 
close proximity to the C5 carbon atom of the cytosine nucleobase. The C5` OH can 
undergo the intramolecular cyclisation to form 5,5`-bicyclic structure 76 upon 
irradiation that protect these specific nucleotide analogues from photochemical 
degradation. The C5-O5` bond provides pyrimidine nucleotides enhanced stability 
during photochemistry which destroys the other isomeric by-products and 
(potentially) permits the activated pyrimidines (3 and 4) to move on to oligomerisation 
phase and can be photochemically purified from other similar isomers. 
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Scheme 1.24: Photochemical hydrolysis of β-2´,3´-cyclic phosphate cytidine 3 to β-
2´,3´-cyclic phosphate uridine 4. The cyclic phosphate locks the sugar in West-East 
confirmation (not North-South), bringing close the C5´-OH of the sugar in close 
proximity to C5 atom of the pyrimidine nucleobases (cytosine, uracil) to from a 
bicyclic structure 76. The photoirradiation is also thought to proceed via 76 which 
provides protective mechanism for 3 and 4, whilst destroying other deleterious 
chemicals in the crude mixture.  
 
 
Recently, a second route to the synthesis of 3 and 4 has been published by the 
Sutherland group providing further proof for the intermediacy of pentose 
aminooxazolines 70 en route to ribonucleotides, and perhaps further validating the 
systems chemistry approach in ribonucleotide synthesis. This pathway proceeds via 
thioribocytidines.21 In their new synthesis, Sutherland and co-workers found a 
solution to the low yield of photoanomerization observed in α-72 by positioning a 
sulfur atom at the C2 position of the cytidine nucleobase, following the 
cyanovinylation and thiolysis of ribo-73 (Scheme 1.25). This sulfur promoted 
remarkable photoanomersation, therefore demonstrated that both ribo-73 and 
arabino-73 can be used for selective ribonucleotide synthesis allowing even greater 
yields of 3 and 4 en route to ribonucleotides (via 73).21, 22 Their reaction is a 
continuation of their cyanosulfidic protometabolism studies which used 
photoreductive hydrogen sulfide to find a network prebiotic synthesis of C2, C3 sugars 
and precursors for proteinogenic amino acids and lipids.88, 89, 92  The reaction of ribo-
73 with hydrosulfide (HS-) yields the corresponding α-thioribocytidine α-78 (84%) 
and α-ribocytidine α-72 (16%). However, under photoirradiations conditions, α-72 is 
degraded whilst α-78 undergo remarkable αβ photoanomerization to furnish β-78 
in excellent yields. The final step of the synthesis involves phosphorylation to get the 
activated pyrimidines, β-78 is dry phosphorylated in the presence of urea to furnish 3 
in good yields, which can then be irradiated under the same photochemical conditions 
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as the first synthesis to obtain 4 by hydrolysis/deaminiation of the cytosine 
nucleobase.  
 
 
 
Scheme 1.25: Synthesis of β-ribopyrimidines via thiolysis and photoanomerization 
reactions. Thiolysis of ribo-73 yields α-thioribocytidine α-78 by hydrosulfide. 
Irradiation of α-78 furnishes 74% β-78 via αβ photoanomerization, whilst α-72 is 
eliminated from the mixture by undergoing destructive photochemistry. Urea-
mediated phosphorylation converts β-78 to β-2`,3`-cyclic phosphate cytidine 3. 
Destructive chemistry of ribo-73 in unbuffered solution leads to α-72, which is 
relatively impervious to C1`-stereoinversion chemistry and is mostly destroyed in the 
mixture to give oxazolidinone 77 (red). As shown earlier arabino-72 also furnishes 3 
(46%) via chemical inversion induced by cyclo-phosphorylation (inset). 
 
There had been limited success to convert α-72 to β-72 via photoanomerization, for 
this C1´-stereoinversion to occur α-72 had to undergo C2´-phosphorylation to form α-
cytidine-2´-phosphate α-72-2´P , which is envision to be difficult and unselective 
(Scheme 1.26).127 Hence, the efficient (74%) photoanomerization in α-78 due to the 
presence of sulfur at C2 carbon atom of cytidine nucleobase, removes the requirement 
of the unnatural C2´-OH phosphorylation to control photoanomerization in 
pyrimidine ribonucleosides and opens up a new chapter for the role of sulfur in 
prebiotic stereochemistry.  
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Scheme 1.26: C1´ photoanomerization of α-cytidine-2´-phosphate α-72-2´P into β-
cytidine-2´-phosphate β-72-2´P. The nucleotide α-72-2´P was prepared employing 
conventional synthetic chemistry as a plausible prebiotic route to selectively synthesis 
α-72-2´P from α-72is not known. 
 
 
These two (potentially consecutive) synthesis of canonical pyrimidines via arabino-
73 and ribo-73, have undoubtedly led to a radically different strategy of tackling the 
prebiotic synthesis of ribonucleotides, however its compatibility with the synthesis of 
the remaining purine ribonucleotides still needs to be demonstrated. 
 
1.7.1 Multicomponent Prebiotic Chemistry  
 
In an attempt to find a congruent pathway for the synthesis of both purines and 
pyrimidines, preliminary studies have shown promising results based on the current 
prebiotic synthesis of activated pyrimidines.128 The three component reaction of 2-
aminooxazole 69, glyceraldehyde 35 and HCN cyclic oligomers (AICA 21 or AICN 
20) have furnished the purine ribonucleotide precursor 79 in excellent yields (Scheme 
1.27). Interestingly this multicomponent chemistry exhibits divergent pH dependence, 
which can be fine-tuned to control purine or pyrimidine selectivity. The mixed, three 
component reaction at pH 7 predominantly gives two component product 
aminooxazoline 70 (pyrimidines precursor), whist the purine precursor 79 is the 
prevailing product between pH 4 and 5, whereas a mixture of purine and pyrimidine 
precursors is observed between pH 5 and 6.5. Although this multicomponent reaction 
proceeds with absolute regiospecificity and high diastereoselectivity, unfortunately 79 
has yet to be fully elaborated into purine ribonucleotides, therefore a one pot prebiotic 
synthesis of purine and pyrimidine is still required. Interestingly, exchange of 2-
aminooxzole 69 with 2-aminothiazole 80 (synthesised prebiotically from 81 and 68) 
could potentially lead to the synthesis of DNA nucleotides, by C2` carbon atom 
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desulfurization in the final stages.129 These innovative studies clearly shows the 
inherent association of HCN oligomers with native purine nucleotide synthesis. 
However more investigations will be required to demonstrate the completion of a 
purine synthesis by this strategy.  
 
 
Scheme 1.27: Attempted one pot synthesis of purine and pyrimidines ribonucleotides 
from a mixture of glyceraldehyde 35, 2-aminooxazole 69 and AICA 21 or AICN 20 
compounds. The purine precursor 79 is obtained in excellent yields, however it has 
failed to give the canonical purine nucleotides so far. A plausible prebiotic link 
between DNA and RNA can also be established by exchanging 69 with 2-aminithiozole 
80, which can be prebiotically synthesised from the reaction of β-mercapto 
acetaldehyde 81 and cyanamide 68. Solid arrows, reported chemistry; dashed arrows 
proposed chemistry. 
 
 1.7.2. The problem of sequential addition and controlled chemistry 
in ribonucleotide synthesis  
 
The two concurrent synthesis of activated pyrimidines 3 and 4 (Scheme 1.25) are the 
most complete models of prebiotic pyrimidines ribonucleotides synthesis. However, 
this synthetic route has received some criticism mostly due to the use of pure 
glycolaldehyde 34 and glyceraldehyde 35 and the sequential addition of the 
components to control chemistry.115, 130-132 The synthesis of pyrimidine precursor, 
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aminooxazoline 70 is reliant on the reaction of 2-aminooxazole 69 (synthesised from 
phosphate catalysed reaction of 34 and cyanamide 68).  
 
 
Scheme 1.28: The dependence of pyrimidine synthesis in the controlled, sequential 
addition of C2 and C3 sugars in the system (black). In the absence of the ordered 
assembly of sugars (addition of 34 followed by 35, each equimolar), the synthesis 
gives rise to a series of undesired products, reducing the overall yield of the 
incremental synthesis. To add to the increasing number of problems, glyceraldehyde 
35 readily isomerises to dihydroxyacetone 36 in the presence of phosphate (inset).  
Adapted from Islam and Powner.83  
 
However formation of 69 in the presence of glyceraldehyde 35 gives the unwanted 
aminooxazole 82. Also, the reaction of 69 in the presence of glycolaldehyde 34 leads 
to the formation of tetrose and erythrose aminooxazolines 83. The co-existence of 
dihydroxyacetone 36, the predominant triose isomer at equilibrium, can cause further 
problems by reacting with cyanamide 68 and 2-aminooxazole 69 to furnish undesired 
aminooxazolines in the system (Scheme 1.28).133  
It is thought that the chemical clutter in this mixture could be decreased by extracting 
69 from the mixture via sublimation and then rained into a separate pool containing 
glyceraldehyde 35. However this method still exposes 69 to 34, 35, dihydroxyacetone 
36 and the prospect of finding an exclusive pool of glyceraldehyde 35 is minimal due 
to its synthetic reliance on glycolaldehyde 34 as a precursor.88, 89, 92 Furthermore the 
outlook of excluding phosphate from the mixture to eliminate dihydroxyacetone 36 
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cannot be considered, as the pyrimidine synthesis requires phosphate throughout the 
system as a catalyst, buffer and reagent.70, 100 
 
Islam et al. have found a valid and robust solution for all the questions raised, 
augmenting the credibility of the plausible prebiotic synthesis of pyrimidines.134 The 
synthesis employs 2-aminothiazole 80, which selectively forms aminal (84 and 85) 
with glycolaldehyde 34 and glyceraldehyde 35 in the presence of complex mixture of 
sugars (aldoses and ketose), including dihydroxyacetone 36 (Scheme 1.29). 
 
Scheme 1.29:  Prebiotic selection and assembly of natural nucleotides from complex 
mixtures. Aminal-induced selection of natural nucleotide precursors from a highly 
complex C2, C3, C4, C5, and C6 aldose and ketose sugar mixture via 80-induced 
crystallisation.  
 
The differential solubility of the C2 and C3 aminals was observed to lead to the 
spontaneous crystallisation of 84 from even complex mixture of sugars, and the 
mixture was completely devoid of glycolaldehyde 34. Sequestration of the 
glyceraldehyde 35 is slower, because it exists as a minor component in equilibrium 
with the thermodynamically more favoured ketose isomer dihydroxyacetone 36, 
which allows enough time for 84 to sequestered form the mixture, but also by 
physically separated from aminal 85. Remarkably, even after prolonged incubation 
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none of the C4, C5 or C6 aldoes/ketoses sugars crystallises from the mother liquor, 
therefore 2-aminithiazole 80 is completely selective to C2 and C3 aminal precipitation.  
 
To solve the problem of dihydroxyacetone 36 in the mixture, 36 is incubated with 80, 
and amazingly only the C3 aminal 85 is formed instead of the dihydroxyacetone 36 
aminal despite it being the predominant C3 sugar at equilibrium. 2-Aminothiazole only 
sequesters aminals of aldehydes, and not ketones (likely due to the steric constrain of 
positioning two aminothiazoles at a quaternary centre). After selective sequestration 
of the aminals from the complex mixture, 84 reacts with cyanamide 68 in phosphate 
buffer to give 2-aminooxazole 69. The canonical pyrimidine precursor, 70 is obtained 
by the reaction of C3 aminal 85 with 69 solving the inherent thermodynamic 
isomerisation problem of dihydroxyacetone 36. 
 
Given the importance of the cyanosulfidic protometabolism pointing towards a 
systems chemistry associated with nucleotides, proteins and lipids, the 
physiochemical role of 80 in the synthesis of proteinogenic amino acids has also been 
investigated.89 Interestingly, 80-induced crystallization also provides an absolute 
chemical selection for the Strecker aldehydes of the natural amino acids from a 
complex mixture (Scheme 1.30). The ability of 80 to form aminals with C2 and C3 
sugars, and the reaction of these aminals leading to the synthesis of aminooxazoline 
70 is an extremely powerful tool, providing sequential controlled chemistry for the 
synthesis of pyrimidine nucleotides. 
 
Scheme 1.30:  Prebiotic selection and assembly of proteinogenic amino acids from 
complex mixtures. Aminal-induced crystallization of Strecker aldehydes (blue) from a 
complex mixture containing closely related prebiotic ketones (red). The Strecker 
aldehyde-aminal 86, then reacts with cyanide to form α-aminonitriles 87. 
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1.8. Sulfur in Prebiotic Chemistry 
 
Sulfur is an essential element for life. Among the many organic building blocks of 
biochemical structures, sulfur is found in two of the proteinogenic amino acids, 
methionine (Met) and Cysteine (Cys). Sulfur is also incorporated in many cofactors 
including coenzyme A, which is used in the synthesis and oxidation of fatty acids and 
in the oxidation of pyruvate in the citric acid cycle. Interestingly, the pantetheine 
moiety of coenzyme A (CoA), has also been synthesized under plausible prebiotic 
conditions by Miller and Keefe, albeit in low yield.135 Sulfur also form clusters with 
iron, e.g. ferrodoxins (iron-sulfur proteins) which play an important role in the 
oxidation-reduction of mitochondrial electron transport.136 It is also suggested that 
iron-sulfur clusters might have played an important prebiotic role in the chemistry to 
biology transition phase.137, 138 Recently, Bonfio et al. have successfully shown a 
photochemical prebiotic synthesis of iron-sulfur clusters.139 Clusters, [2Fe-2S] and 
[4Fe-4S] have been successfully synthesised by the photooxidation of ferrous ions and 
the photolysis of organic thiols. These clusters have been stabilised by a wide range 
of cysteine containing peptides in model protocells. Sulfur adducts have a crucial role 
in the non-enzymatic polymerisation of amino acids. Thioesters have been extensively 
used in the synthesis and ligation of peptides.140, 141 Recently chemoselective 
acetylation of ribonucleotides with thioacetate have been used in the prebiotically 
plausible synthesis of oligoribonucleotide, enriched in 5`-3` phosphodiester 
linkages.142 Thioacids have also been used in amide bond formation and lipid 
synthesis.143, 144 Furthermore, Orgel et al. have used carbonyl sulfide 88, a simple 
volcanic gas as  a prebiotic condensing agent in the synthesis of peptides from amino 
acids in mild aqueous conditions.145 The cyanosulfidic protometabolism (Section 
1.5.2), in which glycolaldehyde 34, glyceraldehyde 35, 12 proteinogenic amino acids 
and glycerol 63 (phospholipid precursor) has been prebiotically synthesised, further 
point to the importance of sulfur in prebiotic chemistry.89 This network of systems 
chemistry relies on the prebiotic photochemical reduction with hydrogen sulfide 
(H2S). Lastly, Islam et al. (Section 1.7.2) have demonstrated that 2-thiooxazole 88 can 
be used in the sequestration and delivery of canonical ribonucleotides and 
proteinogenic amino acids.134 The importance of sulfur in prebiotic chemistry should 
not be underestimated and clearly warrants further future investigation (Scheme 1.31). 
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Scheme 1.31: Prebiotic application of sulfur in different (bio)chemical systems. 
Cofactors work together with enzymes to achieve optimum biological functioning. 
Amino acids are the building blocks of proteins. Iron sulfur clusters act as electron 
shuffles in living cells and are considered to be ancient providers of metabolism for 
early life. Thioacids and thioesters have been employed in the prebiotic 
polymerisation of protein and oligoribonucleotide. Sutherland’s cyanosulfidic 
protometabolism utilised photochemical hydrogen sulfide (H2S) to synthesise 
glycolaldehyde 34, glyceraldehyde 35, precursors for 12 amino acids and 
phospholipids. 2-Aminothioozole 80 has been used in the purification and delivery of 
ribonucleotide and proteinogenic amino acids by Islam et al. 
 
1.9. Aim of the project 
 
Whilst the RNA world theory provides a plausible solution to the central dogma of 
molecular biology (Section 1.2.2), there remain many other challenges to overcome 
in order to explain spontaneous emergence of life.115 The core aim of this thesis is to 
develop a new methodology and new chemistry to establish a chemo- and 
diastereoselective synthesis of β-2`,3`-cyclic phosphates (1 and 2). We specifically 
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seek to establish a route that is compatible with pyrimidine synthesis (as described in 
Section 1.7) by developing a pathway with parity to pyrimidine synthesis via 2,2`-
anhydrocytidine arabino-73. We anticipated that an anhydronucleoside ligation 
between the (purine) nucleobase and the sugar would once again be a key element in 
the synthesis, and could be accessed via a structure similar to arabino-73. Specifically 
we envisaged opening up the 8,2`-anhydro-arabino-cycloadenine 89 and 8,2`-
anhydro-arabino-cycloguanine 90 via C3`-OH phosphorylation (91 and 92) to yield 
β-8-oxo-2`,3`-cyclic phosphate adenine 93 and β-8-oxo-2`,3`-cycliic phosphate 
guanine 94 nucleotides respectively (Scheme 1.32). With direct analogy to 2,2`-
anhydro-arabino-cytidine arabino-73, 89 and 90 have iso-amide moiety embedded in 
the anhydronucleotide linkage that we expect could be exploited to induce 
intramolecular rearrangement to furnish the correct sugar structure of nucleotides by 
C2` inversion.146   
 
Scheme 1.32: Retrosynthetic analysis for urea-mediated phosphorylation of 89 and 
90 to yield 93 and 94 respectively (via 91 and 92) and its subsequent prebiotic 
reduction furnishing β-2´,3´-cyclic phosphates 1 and 2 respectively. Reported 
phosphorylation and chemical inversion of 2,2´-anhydrocytidine arabino-73 
furnishing 46% β-2´.3´-cyclic phosphate adenine 3 (inset). 
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Developing this idea further we then anticipated the established relationship between 
HCN 14 and purine nucleobases,47 would be exploited to yield amino nitrile 
nucleophiles 100 capable of synthesising the core structure of purines 89 and 90 
(Scheme 1.33) upon nucleophilic addition to an “activated” oxazoline scaffold. We 
suspect that position sulfur at C2 would lead to facile activation. We anticipated that 
weak sulfur-carbon orbital overlap and the precedence for electrophilic thioacids and 
thioamide in prebiotic chemistry could be exploited during the nucleophilic attack of 
100 at the C2 carbon atom of an oxazoline scaffold (e.g. 99) 
 
 
Scheme 1.33: Retrosynthetic analysis for furnishing 8,2´-anhydro-arabino-
cyclonucleosides 89 and 90 via cyanation with HCN 14 and cyanogen 25 of 95 and 
96 respectively. 
 
We hypothesised that the imidazole moiety 95 and 96 could be built by nucleophilic 
addition of an amino nitrile 100 to the electrophilically activated C2 carbon atom of a 
pentose oxazolidinone 99 to give aminooxazoline 101, following cyclisation to give 
imidazoles 95 and 96. Subsequent electrophilic annulation of pyrimidine moiety of 
the purines 95 and 96 by HCN 14 and cyanogen 25 (known precursors of adenine and 
guanine nucleobases) respectively would then be investigated to furnish 8,2`-anhydro-
arabino-cyclonucleosides 89 and 90. We recognised that our strategy would involve 
C2` inversion of 89 and 90 to yield 8-oxo-nucleotides 93 and 94, rather than the 
canonical purines 1 and 2. It is possible that subsequent reduction at the C8 position 
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could furnish the canonical purine moiety, and such reduction would certainly merit 
investigation. However, it is also of note that C-8 oxidation in purines is well known 
and 8-oxo-guanine (OG) is reported to be the main cause of mutation in DNA due to 
G-T and C-A transversion via DNA Hoogsteen pairing.147, 148 Furthermore, there are 
numerous reports demonstrating genetic information transfer via OG-A and OG-C 
base pairing systems (Scheme 1.34A).149-154 Interestingly, the prebiotic role of 8-
oxyguanine (OG), as a flavin mimic, has also been investigated, in which OG is used 
to photorepair pyrimidine bases (Scheme 1.34B). It is also important to note that RNA 
is more susceptible to C8-oxidation than DNA, as RNA is more distributed in the cell 
and is found as often as single strand form.155 Therefore, we hypothesis that 8-oxo 
purines may have played a vital role in the initial stages of RNA World and further 
studies to investigate its prebiotic function leading to the modern Watson-Crick base 
pairing in biology is required.  
 
Scheme 1.34: A) Showing stable Watson-Crick base pairing in OG-C and OG-A. B) 
Prebiotic role of 8-oxo-guanine (OG) as a flavin mimic to photorepair damaged 
bases. 
 
We propose to investigate the hypothesis that oxazolidinone thione 103 could have 
been a key intermediate en route to the formation of purine ribonucleotides, and that 
by positioning sulfur at the C2 position would give access to a species that could be 
selectively (electrophilically) activated at this carbon (where nucleobase elaboration 
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must occur). Here we anticipated that sulfur would allow the nucleophilic elaboration 
of the purine bases, rather than the previously described electrophilic elaboration of 
the pyrimidine structure (by cyanoacetylene 30) upon pentose aminooxazoline 
arabino-70. We envisage a stereo-selective synthesis of ribo/arabino 103 selectivity 
upon the masked aldol reaction of glyceraldehydes 35 and 2-thiooxazole 98 (Scheme 
1.35A), assuming that this selectivity would be controlled by internal H-bonding in 
glyceraldehydes 35 by direct analogy to the reaction of 35 with 2-aminooxazole 69 
(Scheme 1.35B). The C2 carbon atom of oxazolidinone thione 103 would then be 
activated electrophilically to facilitate nucleophilic construction of the purine 
nucleobase moiety.  
 
Scheme 1.35: A) Proposed retrosynthetic analysis for prebiotic formation of 
oxazolidinone thione 103 and its subsequent C2 electrophilic activation to form 
activated thione 99. Proposed hydrogen-bonding in glyceraldehydes 35 that controls 
stereochemical addition of oxazole nucleophiles (inset). B) Reported synthesis of 
aminooxazoline arabino-70 from the reaction of 2-aminooxazole 69 with 
glyceraldehyde 35 is with direct analogy to our proposed reaction of 2-thioooxazole 
98 with 35. 
 
And finally to establish a concomitant purine and pyrimidine ribonucleotide prebiotic 
route leading to the synthesis of RNA, we envisaged the addition of ammonia (NH3) 
to activated thione 99 may also yield aminooxazoline arabino-70, the key precursor 
of canonical pyrimidine ribonucleotides (Scheme 1.36). 
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Scheme 1.36: Plausible synthesis of aminooxazoline arabino-70 via the reaction of 
activated thione 90 with ammonia.  Bold arrows, reported chemistry and dashed 
arrows, proposed chemistry. 
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2. Synthesis and Activation of Oxazolidinone 
Thione 
2.1. Using free pentose sugars to form oxazolidinone thiones 
 
Oxazolidinone thione arabino-103, the key intermediates of our proposed prebiotic 
purine synthesis, bears a significant structural relationship to aminooxazolines 
arabino-70 (Scheme 1.19), which suggests that a similar synthetic strategy may be 
applied to its synthesis. Indeed outside the realms of prebiotic chemistry, Imbach et 
al. have exploited xylo-103 as an intermediate in the synthesis of purine nucleosides. 
(Scheme 2.1).156  
 
Scheme 2.1: Imbach’s synthesis of α-xylofuranosyl purine nucleosides 111 and 115 
via oxazolidinone thione xylo-103. The synthesis relies on organic regents and 
classical protecting strategies that are outside the constraints imposed by reasonable 
prebiotic conditions. 
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It is of note that Imbach et al. synthetic strategy is directly comparable to Orgel’s 
method of the synthesis of aminooxazoline arabino-70.124 Specifically, arabino-70 
and xylo-103 have been synthesised by direct reaction with ribose ribo-102 with either 
cyanamide 68 or thiocyanic acid 97, respectively. Girniene et al. have also extensively 
explored the use of oxazolidinone thione ribo-103 for the synthesis of 
quinazolinedione nucleoside analogues.157-159 To increase our understanding of the 
behaviour of oxazolidinone thiones, and their potential role in prebiotic chemistry we 
started our project by the synthesis of thiones 103 from their respective free sugars 
under acidic (pH 2) aqueous conditions (Scheme 2.2).159 We found that mineral acid 
catalysed formation of ribo-103, arabino-103, xylo-103 and lyxo-103 was readily 
achieved from their respective sugars (ribo-102, arabino-102, xylo-102 and lyxo-102) 
with acceptable isolated yields (ribo-103, 67%; arabino-103, 65%; xylo-103, 46% and 
lyxo-103, 20 %). To ensure correct assignment of furanosyl selectivity (in the ribo- 
and arabino-isomers) we then acquired crystal structures of all the thiones synthesised 
(Scheme 2.2). 
 
 
Scheme 2.2: Synthesis of oxazolidinone thione 103 via free pentose 102. X-ray 
structures of all oxazolidinone thiones showing the correct stereochemistry. 
 
It was found that all of the pentose oxazolidinone thione 103 were synthesised with 
complete furanosyl selectivity, except lyxo-isomer. Importantly this means that the 
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core furanosyl sugar moiety of ribonucleotides can be established during the synthesis 
of arabino-103. However, oxazolidinone thione lyxo-103 was observed to exist as an 
equilibrating mixture of furanosyl (f-lyxo-103) and pyranosyl (p-lyxo-103) isomers. It 
is thought that this equilibration occurs in the lyxo-isomer due to the increased steric 
bulk associated with locating all the lyxo-substituent on one face of the furanosyl ring 
(Scheme 2.3B).  
 
Scheme 2.3: A) Proposed mechanism for formation of oxazolidinone thiones from 
pentose sugars. Shown here for the synthesis of ribo-44. Equilibrium between 
thiocyanic acid 97 and iso-thiocyanate 116 (inset). B) Postulated mechanism for 
interconversion lyxo furanose oxazolidinone thione (f-lyxo-103) and lyxo pyranose 
oxazolidinone thione (p-lyxo-103). 
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The reaction of ribose ribo-102 and thiocyanic acid 97, was monitored, at room 
temperature by 1H NMR spectroscopy (with single water suppression). The 
disappearance of sugar resonances and the appearance of oxazolidinone thione ribo-
103 was observed to occur over the course of 228 h. However, the transient 
intermediates (depicted in Scheme 2.3), which are supposed to be accessed en route 
to ribo-103, were not detected during our time course experiment. It is possible that 
some of these intermediates may have been detected at lower temperatures, but no 
further efforts were made to observe these structures. 
 
Figure 2.1: A stack of 1H NMR spectra (600 MHz, D2O, 3.3 - 6.2 ppm)  to show 
products observed upon incubation of ribose ribo-102 (1.1 mM) and thiocyanic acid 
97 (2.2 mM) at rt and pH -1.5 for 228 h. The peaks for ribo-102 is decreasing and 
peaks for oxazolidinone thione ribo-103 is increasing over time. No intermediate 
species were detected in 1H NMR spectra with single solvent suppression. 
 
The formation of oxazolidinone thione ribo-103 was found to be synthesised at an 
increased initial rate than the other pentose oxazolidinone thiones (arabino-103 and 
xylo-103) from their corresponding pentose sugars (Figure 2.2).  The differences in 
reaction kinetics are attributed to the greater availability of the open-chain aldehydic 
form of ribose ribo-102 relative to the other pentose arabino-102, xylo-102 and lyxo-
102.98  
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Figure 2.2: Comparative reaction of ribo-102, arabino-102 and xylo-102 with 
potassium thiocyanate 97, over a period of 228h at rt to yield ribo-103, arabino-103 
and xylo-103 respectively. Each point in the graph is 1H NMR data obtained by 
integration of H-(C1´) of thione 103 against sugar 102 peaks at 3.39 and 4.75 ppm. 
Each pentose 102 (110 mM) was incubated with 97 (220 mM) at pH -1.5 and rt for 
228h and then data collected for all three oxazolidinone thiones, ribo-103, arabino-
103 and xylo-103 are plotted for comparison 
Despite the furanosyl selectivity of oxazolidinone thione synthesis being impressive 
and an excellent step toward chemoselective ribonucleotide synthesis, the synthesis 
and stability of free-pentose sugars 102 are highly problematic under prebiotic 
conditions.70, 71, 83 Therefore we next investigated a potential prebiotic route for the 
synthesis of oxazolidinone thiones 103 that bypasses the pentose sugars 102. Our 
strategy was designed to build directly on the observation that the pentose sugar 
moiety of pyrimidine ribonucleotides can be assembled by the condensation of C2 + 
C3 sugar fragments.
22, 121 The prebiotic synthesis of C2 and C3 sugars has been 
successfully reported by the Sutherland group,89 furthermore it has also been shown 
that these simple C2 and C3 sugars can be sequestrated via crystallization from 
complex prebiotic mixtures likely to have been present on early Earth (see Section 
1.7.2).134 
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2.2. Prebiotic synthesis of oxazolidinone thiones (by-passing   
free pentose sugars) 
 
2.2.1. Synthesis of 2-thiooxazole  
 
Powner et al. have previously reported that pentose aminooxazolines are key prebiotic 
intermediates for pyrimidine ribonucleotide synthesis.22, 121  The masked-aldol 
reaction of 2-aminooxazole 69 and glyceraldehyde 35 to give aminooxazoline 70 was 
essential to the chemoselective stereocontrolled synthesis of pyrimidine 
ribonucleotides by-passing free sugars, which are extremely unstable70, 71.  The 
heterocyclic molecule, 2-aminooxazole 69 is synthesised (under prebiotically 
plausible conditions) upon the addition of glycolaldehyde 34 to cyanamide 68 at pH 
7 with phosphate acting as a general acid/base catalyst, previously this reaction had 
only been reported at pH 10 with organic co-solvent (Schemes 2.4 and 1.19).160  
 
Scheme 2.4:  Prebiotic synthesis of aminooxazolines 70 from feedstock of prebiotic 
small molecules.  
 
We aimed to build our synthetic strategy by direct modification of the chemistry 
reported by Powner et al. Specifically, we aimed to modify aminooxazoline synthesis 
to develop oxazolidinone thione synthesis that could be applied to purine 
ribonucleotide synthesis, but retaining the prebiotic advantage of the previous reported 
oxazolines synthesis. 2-Aminooxazole 69 is a key ribonucleotide precursor, which 
derives from glycolaldehyde 34 and cyanamide 68 in the synthesis reported by Powner 
et al. (Scheme 2.4).22 The C2 carbon atom of 69 is regiospecifically positioned as the 
C2-pyrimidine carbon atom during abiotic pyrimidine synthesis upon sequential 
reaction with glyceraldehyde 35 and then cyanoacetylene 30. Whereas in our proposed 
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purine synthesis, the C2 carbon atom of oxazole 69 will be activated by introducing a 
sulfur atom at C2. It was envisaged that this C2 sulfur atom would provide the required 
chemoselectivity for in situ activation towards regiospecific purine nucleobases 
synthesis upon the thione sugar scaffold. Accordingly, it was hypothesised that 
synthesis should commence with prebiotically plausible thiocyanic acid 97,45, 92, 161 
which can be generated quantitatively from the reaction of hydrogen cyanide 14 with 
sulfur or hydrogen sulfide (H2S),
162 replacing cyanamide 68 that had been deployed 
in pyrimidine synthesis (Scheme 2.5).  
 
Scheme 2.5: Retrosynthetic analysis for prebiotic synthesis of oxazolidinone thione 
103, by-passing pentose sugars.  
 
We first synthesised 2-thiooxazole 98 via a literature procedure reported by Leconte 
et al.,163 and pleasingly this led to 85% isolated yield of 98 (Scheme 2.6). This was 
then used to investigate the masked-aldol reaction of thiocyanic acid 97 and 
glycolaldehyde 34. It is also of note that the literature procedure is a prebiotically 
plausible reaction. Glycolaldehyde 34 is a corner stone of prebiotic chemistry, which 
has been observed in non-biological environments (outside our biosphere),164 and 
recently its prebiotic synthesised from photoredox chemistry of hydrogen cyanide 
(H2S) has been reported (cyanosulfidic protometabolism, Section 1.52).
89  
Furthermore, glycolaldehyde 34 has also been used in the prebiotic synthesis of 
pyrimidine ribonucleotides.22 Interestingly, Montmorillonite clay, which has been 
proposed to be an important catalyst in template free oligomerisation of RNA 
monomers,165 was found to provide a suitable replacement for mineral acid in the 
synthesis of 98, giving 35% yield of thiooxazole 98 upon incubation of glycolaldehyde 
34 (416 mM) and potassium thiocyanate (416 mM) at 40°C for 4 days (Scheme 2.6). 
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Scheme 2.6: Reaction of thiocyanic acid 97 with glycolaldehyde 34 to produce 2-
thiooaxazole 98. X-ray structure obtained for 98 (right). 
The ambident nature of thiocyanate 97 nucleophilicity has been extensively 
investigated in the chemistry literature. Mayr and co-workers report that, under kinetic 
control thiocyanate 97 is observed to yield thiocyanates, but under thermodynamic 
equilibrium 97 lead to isothiocyanates 116.166 Accordingly, we speculated that 
specific acid catalysed thiooxazole synthesis is highly efficient at low pH due to the 
rapid equilibration of the two tautomeric forms of thiocyanic acid. Such that 97 reacts 
as an N-nucleophile rather than an S-nucleophile (Scheme 2.7). 
 
Scheme 2.7: Proposed mechanism for formation of 2-thiooxazole 98 from the reaction 
of glycolaldehyde 34 and thiocyanic acid 97. The two tautomers of 97 (inset). 
It is thought that the synthesis of 2-thiooxazole 98 proceeded via the addition of 116 
to the aldehydic form of the glycolaldehyde 34 (~5% in aqueous solution)167. The 
resulting intermediate, 117, undergoes 5-exo-dig cyclisation to yield 118 (Scheme 
2.7), followed by tautomerisation to form the initially observed hydrate 98.H2O, 
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which subsequently undergoes dehydration to yield the aromatic 2-thiooxazole 98 
(Figure 2.3). Alternatively the cyclised product 118 may undergo dehydration to form 
product 119, followed by tautomerisation to yield 98.  The driving force of the reaction 
is thought to be aromatisation.  This is different to the formation of 2-amininooxazole 
69,22 which needs phosphate catalysis and is more electron rich and therefore weakly 
aromatic/more polarised than 2-thiooxazole 98. Furthermore, it is also of note 
that compound 98 can be purified by crystallization directly from water and can 
also be transported by sublimation. These physical properties provide simple 
prebiotically plausible mechanisms for the purification, accumulation and transport 
of 2-thiooxazole 98.168, 169 
 
Figure 2.3:  1H NMR (600 MHz, D2O, 2.5 – 8.0 ppm) to show the reaction of 
glycolaldehyde 34 (100mM), thiocyanic acid 97 (500mM) and 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS, NMR standard) in D2O (1 mL) after incubated at 
80 °C for 24 h.  Calibration to internal standard indicates an 85% yield of 2-
thiooxazole 98 and a 15% yield of its hydrate, 4-hydroxyoxazolidine-2-thione 98.H2O. 
 
 
2.2.2. Reaction of 2-thiooxazole with glyceraldehyde 
 
After successfully establishing a prebiotic synthetic route for 2-thiooxazole 98, we 
next investigated the reaction of 98 with glyceraldehyde 35 to yield oxazolidinone 
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thiones 103. The reaction of 2-aminooxazole 69 with glyceraldehyde 35 has 
previously been reported to give a high yield of aminooxazolines, ribo-70 and 
arabino-70 aminooxazolines (44%  and 30%, Section 1.7).22 2-Aminooxazole 69 is a 
highly electron rich oxazole, and it has a high degree of enamine character, this renders 
69 as an excellent aldol donor in aqueous solution (Scheme 2.8). Although 2-
thiooxazole 98 is inherently less electronically activated than 2-aminooxazole 69, we 
predicted that the weak nitrogen-sulfur electronic overlap would result in appreciable 
enamine character in 98. Nonetheless we anticipated that the condensation of 98 with 
glyceraldehyde 35 might require more forcing conditions than the reaction of 35 with 
2-aminooxazole 69. 
 
 
 
Scheme 2.8. The nucleophilic character of 2-aminooxazole 69 and 2-thiooxazole 98 
illustrated by resonance stabilisation. 
 
Based on our knowledge of the synthesis of aminooxazolines,22 we reacted 2-
thiooxazole 98 with glyceraldehyde 35 to selectively position sulfur at the C2- 
position of the resulting pentose oxazolidinone thiones 103 (Scheme 2.9). At near 
neutral pH (pH 4 – 9; Figure 2.4), the reaction of 2-thiooxazole 98 (0.25-0.5 M) with 
glyceraldehyde 35 (0.5–1 M) in water at 60°C yielded a mixture of the pentose 
oxazolidinone thiones 103. The reaction was observed to be slow below pH 6, but 
more rapid above pH 7, yielding up to 74% thione 103 in 24 h. 
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Scheme 2.9: Synthesis of the oxazolidinone thione 103 from prebiotic feedstock of 
small molecules. A) Reaction of glycolaldehyde 34 with thiocyanic acid 97 give 85% 
2-thioooxazole 98, which undergoes masked-aldol reaction with glyceraldehyde 35 to 
give 74% oxazolidinone thione 103, arabino and ribo are the major isomers of the 
reaction. B) Tangible mechanism for the masked aldol reaction of 98 with 35. 
 
The reaction proceeds with high ribo-/arabino- diastereoselectivity (70%, ribo-
103/arabino-103 1:1; 30% xylo-103/lyxo-103), which is of note because both ribo-
103 and arabino-103 thiones are only one stereochemical inversion away from the β-
ribo-stereochemistry of RNA (Scheme 2.10).  
 
Scheme 2.10: Comparison of stereochemistry of oxazolidinone thiones arabino-103 
and ribo-103 with the required natural β-ribo-stereochemistry of RNA. Arabino-103 
will need to undergo C2´-α-stereochemical inversion and ribo-103 C1´-β-
stereochemical inversion to achieve β-ribo-stereochemistry of RNA. 
Furthermore, furanosyl selectivity is equally important en route to RNA, and X-ray 
crystallographic analysis of all the diastereomeric products of the reaction of 2- 
thiooxazole 98 and glyceraldehyde 35 had demonstrated that only the minor lyxose 
component was furnished as a mixture of furanosyl- and pyranosyl-isomers (p-lyxo- 
103/f-lyxo-103; 2:1; Figure 2.4).  
A 
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Figure 2.4: A) Yields of pentose oxazolidinone thiones 103 and their relative 
diastereomeric ratio across a variety of concentrations of 2-thiooxazole 98 and 
glyceraldehyde 35.  All reactions were heated for 24 h at 60°C in pH 9. B) 1H NMR 
spectrum (600 MHz, D2O, 3.4 – 7.7 ppm) showing reaction of 2-thiooxazole 98 with 
glyceraldehyde 35.  2-Thiooxazole 98 (0.25M) and glyceraldehyde 35 (1M) at pH 7 
were incubated at 60°C for 24 h. 
 
The identity of the furano and pyrano oxazolidinone thiones 103 were established by 
spiking with authentic furano and pyrano oxazolidinone thiones (Figure 2.5), which 
were synthesised using the conventional free pentose sugar synthesis reported in 
section 2.1. (Scheme 2.2).  
 
  % distribution of oxazolidinone thione 
products 103 
98 (M) 35 (M) 103 (%) 98 (%) arabino 
103 
ribo 
103 
xylo 
103 
p-lyxo 
103 
f-lyxo 
103 
0.25 0.5 51 36 35 35 12 11 7 
0.50 0.5 35 44 37 36 10 12 5 
0.50 1.0 59 25 35 36 12 11 6 
0.25 1.0 74 8 36 35 10 12 7 
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Figure 2.5: 1H NMR spectra (600 MHz, D2O, 5.1 – 6.1 ppm) showing reaction of 2-
thiooxazole 98 with glyceraldehyde 35.  A) 25 (0.25M) and 98 (1M) at pH 7, incubated 
at 60°C for 24 h.  B) Spiked with arabinose oxazolidinone thione arabino-103.  C) 
Spiked with ribose oxazolidinone thione ribo-103.  D) Spiked with xylose 
oxazolidinone thione xylo-44.  E) Spiked with lyxose oxazolidinone thione p-lyxo-44. 
 
A major by-product of the reaction of 2-thiooxazole 98 with glyceraldehyde 35 is 
dihydroxyacetone 36, which is produced from enol-tautomerisation of glyceraldehyde 
35 (Scheme 2.11). Due to the equilibration of 35 with 36, and thermodynamic 
preference for ketone 36 over aldehyde 35, an excess of glyceraldehyde 35 was 
required in the reaction with 98 to drive consumption of 98 to completion.  
 
 
Scheme 2.11: Equilibration of glyceraldehyde 35 into dihydroxyacetone 36 and 
hydrate 35.H2O. 
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The reaction of 98 with 35 is also, as expected, observed to be slower than with 2-
aminooxazole 69 with 35. The more sluggish nature of the addition of 98 to 35 
provides more time for equilibration of glyceraldehyde 35 to its ketose isomer 
dihydroxy acetone 36. Moreover, unlike the reaction of the 2-aminooxazole 69, no 
phosphate was used in this reaction, as phosphate catalyses formation of 36 from 35,133 
and therefore was observed to decrease the yield of oxazolidinone thiones 103 at the 
expense of 36. The problem of dihydroxyacetone 36 in the synthesis of activated 
pyrimidine ribonucleotides has recently been resolved by Islam et al. by selective 
sequestration of glyceraldehyde aminals from an equilibrating mixture of triose sugars 
(Section 1.7.2).134 The effect of these aminal crystallisations, have not been explored 
in the context of purine synthesis, however, the observed yield and stoichiometry 
limitation imposed by triose isomerisation in the purine pathway suggest that further 
investigation of these aminal chemistries coupled with thione 103 synthesis should be 
carried out in future investigation. It may be that iterative reactions of glyceraldehyde 
aminals with thiooxazole 98, followed by in situ recovery of dihydroxyacetone 36 
(through aminal crystallisation) could be used to overcome the requirement for excess 
glyceraldehyde 35 that has been exploited in these current investigations. It is also 
important to note that unlike 69 (which reacts readily with dihydroxyacetone 36), the 
reaction of 98 and 36 was not observed, it may be possible that future experiment can 
be designed to exploit this selectivity to realise a kinetic resolution of 35 and 36 to 
synthesis 103 from 36. However this kinetic resolution was not pursued at this time. 
 
2.3. Site specific thione activation 
 
2.3.1. Cyanovinylation of oxazolidinone thione 
 
With the ribo- and arabino-furanosyl pentose backbone now installed, we next 
investigated the selective electrophilic activation of oxazolidinone thiones 103 to 
facilitate our strategy to construct the core heterocyclic structure of purine nucleotides 
on the sugar-thione scaffold of 103. We began our investigation with cyanoacetylene 
30, which plays a fundamental and essential role in pyrimidine synthesis.22 
Cyanoacetylene 30 has been detected in abiotic environments45  and is observed to be 
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the second highest abundance product of reduced atmosphere spark discharge 
experiments.42, 170  Cyanoacetylene 30 reacts with aminooxazoline arabino-70 to yield 
2,2´-anhydrocytidine arabino-73 (<92%), however absolute pH control is required, if 
the pH of the reaction is unbuffered the reaction pH increases and causes rapid 
hydrolysis of arabino-73 and then subsequent unwanted reactions of the hydrolysis 
product with cyanoacetylene 30 (Scheme 1.22).22, 124  
 
 
Scheme 2.12: Cyanovinylation of oxazolidinone thione arabino-103 with 
cyanoacetylene 30 under plausible prebiotic conditions (pH 7, rt, 1h) to give 
quantitative yield for S-cyanovinylated oxazolidinone thione arabino-120. 
Crystallographic studies also confirmed the C1´-C2´ β-configuration in arabino-120. 
The reported phosphate buffered (pH <7) cyanovinylation of aminooxazoline 
arabino-70 to give 2,2´-anhydrocytidine arabino-73 (inset). 
We envisaged cyanoacetylene 30 was ideally suited to activate oxazolidinone thione 
103 in aqueous solution due the slow reaction of cyanoacetylene 30 with water and 
the excellent electron withdrawing propensity of the cyanovinyl moiety, which will 
activate the C-2 carbon atom of 103.42, 171 Upon treatment of arabino-103 (130 mM) 
with cyanoacetylene 30 (260 mM) at pH 7, a rapid and completely selective (exocyclic 
reaction at sulfur rather than endocyclic reaction at N1) S-cyanovinylation was 
observed with a click-like efficiency172 to give a quantitative yield of S-
cyanovinylated oxazolidinone thione arabino-120 (Scheme 2.12). Due to the higher 
pKa of anhydronucleoside 2,2´-anhydrocytidine arabino-73 compared to S-
cyanovinyl thione arabino-120,173 and sulfur-prohibited annulation, no increase in pH 
was observed during cyanovinylation of thione arabino-103 (Figure 2.6). Increasing 
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pH is a hallmark of the addition of cyanoacetylene 30 to aminooxazoline arabino-70 
in water, rendering pH buffered cyanovinylation essential to pyrimidine synthesis,22 
however no buffer was required to control the reaction of arabino-103 with 
cyanoacetylene 30. Thus cyanoacetylene provides a superbly controlled and 
quantitative activation of arabino-103 in water. Although the activated thione 
arabino-120 was used in the subsequent nucleophilic reactions without any 
purification (other than removal of excess cyanoacetylene 30 during concentration), 
arabino-120 can easily be purified by flash column chromatography. 
 
 
Figure 2.6: 1H NMR spectra (600 MHz, D2O, 3.4 – 8.6 ppm) comparing crude 
reaction for the cyanovinylation of aminooxazoline arabino-70 and oxazolidinone 
thione arabino-103. Unbuffered reaction of arabinose oxazolidinone thione arabiono-
103 with cyanoacetylene 30 at neutral pH after 1 h cleanly furnished S-cyanovinyl 
oxazolidinone thione arabnino-120 in quantitative yield (blue). Unbuffered 
cyanovinylation of aminooxazoline arabino-70 with 30 after 24 h giving rise to a 
plethora of hydrolysis and cyanovinylated products (red).  
Cyanovinylation of oxazolidinone thiones arabino-103 at pH 4.0 and pH 10 was slow 
with the latter also showing complex unidentified cyanovinyl peaks in the 1H NMR 
spectra, likely due to alkaline hydrolysis of cyanoacetylene 30. However at pH 7 the 
reaction was both rapid and clean. The sluggish reactivity of arabino-103 below pH 
5, is attributed to substrate protonation (arabino-103, pKaH = 5.2). Small quantities 
(~5-10%) of additional cyanovinylation were observed in extended incubation of 
arabino-103 with cyanoacetylene 30 at neutral pH, these were determined to be due 
to C3´-OH cyanovinylation.  
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Powner et al. have previously reported cyanovinylation of the 3´OH of 
aminooxazoline arabino-70 at pH 7.5 (Figure 2.7A). Based on the close structural 
relationship of S-cyanovinyl thione arabino-120 with aminooxazoline arabino-70 we 
suspected cyanovinylation of the 3´OH in arabino-120 to yield dicyanovinylated 
product 122. The structure of compound 122 was determined upon its partial isolation, 
both COSY and 1H NMR spectroscopic analysis indicated for the formation of 122 
(Figure 2.7B).  
 
 
Figure 2.7: A) 3´OH cyanovinylation of aminooxazoline buffered at pH 7.5. B) 3´OH 
cyanovinylation of S-cyanovinyl oxazolidinone thione arabino-120 at neutral pH and 
1H NMR spectra (600 MHz, D2O, 3.5 – 8.1 ppm)  of biscyanovinylated product 122, 
the C3´-H is shifted upfield due to the presence of cyanovinyl group on C3´-O. 
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Prebiotic protecting group strategies provide very powerful tools for chemical 
selectivity, however this is a largely unexplored field in prebiotic chemistry. Recently, 
selective acylation of nucleosides, nucleotides and glycerol-2-phosphocholine in 
water has been published in the Powner laboratory.174 We therefore hypothesise that 
the observed C3´-OH cyanovinylation may also find uses as protecting strategy due 
to its remarkable selectivity for the secondary C3´-OH (instead of the primary C5´-
OH). This selectivity was thought to be due to the partial donation of electron density 
of C5´-OH into C2 carbon atom through nπ* orbital overlap which has been 
observed in pyrimidine anhydronucleoside arabino-73.126 However, upon 
crystallographic analysis of S-cyanovinyl oxazolidinone thione arabino-120 a similar 
overlap was not observed. It is possible that crystal packing precludes this interaction 
for arabino-120 in the solid state, however it is also possible that the observed 
activation is inductively induced and results from the electronic withdrawing imposed 
upon C2´-oxygen atom through the cyanovinylated thione moiety. No further 
experiments were undertaken at this time to observe the average solution state bond 
angle at C5´-OH (for example NOE experiment). 
 
2.3.2. Methylation of oxazolidinone thione 
 
Shaw et al. have previously demonstrated both selective methylation of oxazolidinone 
thiones 103 and reported that S-methylated derivatives of thione 103 are “singularly 
unreactive towards nucleophiles”.175 For example, they did not observe reactivity of 
S-methyl oxazolidinone thione 126 with aqueous or methanolic ammonia. To our 
understanding, thiolate displacement from S-methylated thione 126 to yield 
aminooxazoline 70 has only been observed upon treatment with formamide at 90°C 
for 3 h (which was likely to be contaminated with ammonium formate and can slowly 
release ammonia and formic acid).176  However, Girniene et al. have previously 
reported the successful substitution of S-benzyl thione 123 with anthranilic acid 125 
to synthesise2 quinazolinedione ribo-124 (Scheme 2.13).158 Importantly, their studies 
demonstrated the concept of ambident reactivity that is essential to our purine 
synthetic strategy, albeit in reports that are limited to anthranilic acid derivatives in 
organic solvent (ethanol or t-butanol). 
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Scheme 2.13: Formation of quinazolinone ribo-124 via benzylthiooxazoline 
intermediate 123 using ethanol and protection of the free C3´OH and C5´-OH as 
benzyl ethers. 
 
We hypothesized that thione protonation and weak amine solvation were both 
essential to these limited examples in formamide or absolute alcohol solvents.  It was 
unclear to what scope the nucleophilic additions of methylated thiones were 
investigated by Shaw et al.175 and Davidson et al.176 Therefore, we decided to 
investigate methylation of oxazolidinone thiones 103 to gain further insight into their 
utility in nucleophilic addition reactions. 
 
 
Scheme 2.14: An adapted synthesis of methylated oxazolidinone thiones 126. Both 
ribo-126 and arabino-126 did not undergo displacement with aqueous ammonia to 
form aminooxazoline 70.  
 
Following an optimised procedure based on literature reactions,175 S-methylated 
oxazolidinone thiones, ribo-126 and arabino-126 were synthesised in excellent yields 
from the reaction of oxazolidinone thiones ribo-103 and arabino-103 respectively 
with iodomethane under basic conditions (Scheme 2.14). We then investigated the 
reactivity S-methyl thione 126 and in agreement with literature reports, we observed 
no detectable reaction between S-methyl thione 126 (pKaH = 2.4) and ammonia (pKaH 
= 9.2) in aqueous solution. However, we anticipated that S-cyanovinyl oxazolidinone 
thione arabino-120, may take part in nucleophilic displacement reactions due to the 
greatly increased electron-withdrawing effect of the cyanovinyl moiety which is 
unavailable in S-methyl and S-benzyl thiones (126 and 123). To test displacement of 
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cyanovinyl group, and to find a plausible prebiotic route to furnish 126, we 
investigated sulphide displacement in arabino-120. It was observed that sequential 
addition of cyanoacetylene 30 and then methanethiol 127 to thione arabino-103 
furnished arabino-126 in up to 50% yield at pH 6, providing a prebiotically plausible 
route to S-methylated oxazolidinone thione 126 (Figure 2.8).  
 
 
Figure 2.8: 1H NMR spectra (600 MHz, D2O, 3.5 – 6.5 ppm) showing conversion of 
S-cyanovinyl oxazolidinone thione arabino-120 to S-methyl oxazolidinone arabino-
126.  An aqueous solution of arabino-120 at pH 6 was treated with methanethiol 127 
for 6 h A) NMR to show conversion at 6 h, mixture contained 30% arabino-126, 30% 
oxazolidinone thione arabino-103, 10% oxazolidinone arabino-77. The solution was 
briefly sparged with nitrogen, an aqueous solution of cyanoacetylene 30 was added 
and the mixture was left to stand for 2 h. B) 1H NMR to show near complete conversion 
of arabino-120 to arabino-126. The solution was again saturated with methanethiol 
127 and incubated for 16 h. C) 1H NMR to show mixture containing 50% arabino-
126, 15% arabino-103 and 12% arabino-77 after 16 h incubation with methanethiol 
127. 
As preparative synthesis of S-methylated oxazolidinone thiones 126 was significantly 
easier and cheaper to achieve on large scale than S-cyanovinylated oxazolidinone 
thiones 120, which involves the use of cyanoacetylene 30 (which is not commercial 
and is unstable). These thiones were used as a model reaction system to develop thione 
displacement reactions. Prebiotically, it might also be argued that S-alkylated thione 
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126 are structurally simple and therefore, perhaps more readily available than S-
cyanovinyl thione 120, indeed alkyl thiols may have been widely accessible.177 The 
exchange of cyanovinyl thiol 128 for simple alkyl thiols may present a mechanism for 
the prolong storage/stabilisation of activated thiones in aqueous solution. 
Nevertheless, we have demonstrated two (related) pathways (cyanovinylation and 
cyanovinylation followed by thiol exchange) to access activated oxazolidinone 
thiones 120 and 126. 
 
2.3.3. Stability of S-cyanovinyl and S-methyl thiones 
 
The successful prebiotic synthesis of S-cyanovinyl thione arabino-120 and S-methyl 
thione arabino-126 were crucial to our proposed synthetic strategy of purine 
ribonucleotides, since at this stage we had selectively positioned the sulfur at the C2 
carbon atom and these activated thiones were ready to accept nucleophiles. Next, it 
was deemed necessary to study the stability of arabino-120 and arabino-126 to find 
suitable nucleophiles, leading toward elaboration of purine nucleobases. We 
hypothesised that S-methyl thione arabino-126 would be more stable than S-
cyanovinyl thione arabino-120 due to the enhanced electrophilicity of C2 carbon in 
the latter compound. To test our hypothesis we investigated stability of arabino-120 
and arabino-126 in water at varying pHs. When a solution of arabino-120 (50 mM) 
was incubated at room temperature at low pH (1.3 – 3.0), arabino-120 hydrolysed to 
form oxazolidinone arabino-77 and the dicyanovinylsulfide 129 as the only major 
products. It is thought that the protonated S-cyanovinyl thione arabino-120 
hydrolysed to arabino-77 and S-cyanovinyl thiol 128. The thiol 128 then combined to 
form the white precipitate of 129 and hydrogen sulfide gas (H2S) characterised by a 
strong rotten egg smell (Scheme 2.15). The dicyanovinylsulfide 129 isolated from the 
reaction was almost completely insoluble in water but dissolved readily in DMSO-d6 
for NMR analysis.142 Finally, an X-ray structure of 129 was obtained to 
unambiguously confirm the structure of this by-product. 
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Scheme 2.15: Stability of S-cyanovinylated oxazolidinone thione arabino-120 at 
lower pH (1.35-3.0) and plausible mechanism for acid hydrolysis of arabino-120 to 
form oxazolidinone arabino-77 and dicyanovinylsulfide 129 (inset). 
 
In order to test the stability of S-cyanovinyl thione arabino-120 at elevated pH, 
arabino-49 (50 mM) in water at pH 7.0 was stirred for 120 h. Interestingly, after 1 
week, 1H NMR spectroscopic analysis revealed 37% oxazolidinone thione arabino-
103, 12% dicyanovinylsulfide 129, 7% oxazolidinone arabino-77 and 33% of 
arabino-120 (Figure 2.9). When the reaction was repeated at pH 8.0 and 9.0 similar 
results were obtained, but with a slightly higher ratio of arabino-103 (41%). At pH 11 
the half-life (t1/2 = 15 h) of the S-cyanovinylated oxazolidinone thione arabino-120 
was considerably reduced; after 72 h the 1H NMR spectroscopic analysis indicated 
that all of arabino-120 had been consumed, leading to 31% arabino-103, 13% 
arabino-77 and 2% 129. From these experiments it was clear that at elevated pHs 
thione arabino-103 was the major product. We suspect that arabino-103 was being 
formed by Micheal addition of cyanovinyl thiol 128 into arabino-120 (Figure 2.9). 
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Figure 2.9: A) Stability of S-cyanovinylated oxazolidinone thione arabino-120 at 
higher pH (7.0-11) and plausible mechanism (addition elimination) for base 
hydrolysis of arabino-120 to form oxazolidinone arabino-77, oxazolidinone thione 
arabino-103 and dicyanovinylsulfide 129 (inset). B) Graph for pH stability of 
arabino-120 at pH 8.0. Each point in the graph is 1H NMR data obtained by 
integration of H-(C1´) of arabino-103, arabino-77 and H-(CS) of 129 against H-(C1´) 
of arabino-120. 
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Powner et al. demonstrated the dual role (acid/base catalyst and pH buffer) of 
inorganic phosphate in the synthesis of activated pyrimidines.22 Therefore, it was 
deemed important to investigate how S-cyanovinylated oxazolidinone thione arabino-
arabino-120 and S-methyl thione arabino-126 behaved in the presence of inorganic 
phosphate as phosphate is eventually required to synthesise ribonucleotides. This 
would also give us an indication for the potential one pot prebiotic synthesis of 
pyrimidine and purine ribonucleotides. 
 
 
Scheme 2.16: Postulated mechanism for hydrolysis of S-cyanovinylated 
oxazolidinone thione arabino-120 in the presence of inorganic phosphate. A) Three 
possible routes in which phosphate mediated hydrolysis of arabino-120 leads to 
formation of oxazolidinone arabino-77. B) Mechanism for formation of oxazolidinone 
thione arabino-103 and dicyanovinylsulfide 129 in the presence of inorganic 
phosphate.  
 
Solutions of arabino-120 (50 mM) and arabino-126 (50 mM) were stirred in a 
solution of sodium dihydrogen phosphate (100 mM) over a range of pHs (pH = 5, 7 
or 9) and at room temperature. 1H NMR spectroscopic analysis showed that the rate 
of hydrolysis was greatest at pH 5.0, and after 24 h all of S-cyanovinyl thione arabino-
120 converted to oxazolidinone arabino-77, while S-methyl thione arabino-126 
remained unchanged under same conditions. At pH 7 the rate of hydrolysis of arabino-
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120 decreased but for arabino-126 it increased, indicated by an increase in the 
production of the oxazolidinone thione arabino-103. At pH 9 no hydrolysis of the 
activated thiones (arabino-120 and arabino-126) was detected after 24 h (Figure 
2.10). It was concluded that the presence of phosphate buffer increased hydrolysis in 
both thiones (arabino-120 and arabino-126) and any “one-pot” synthesis of purine 
and pyrimidines will need to consider this issue carefully, since the use of phosphate 
buffer for pyrimidine ribonucleotide synthesis is vital.22 (N.B. Further observations in 
mixed reaction systems have demonstrated that this buffering requirement can be 
removed during the mixed cyanovinylation of thione 103 and aminooxazoline 70; vide 
infra, chapter 5). 
 
 
Figure 2.10: 1H NMR (600 MHz, D2O, 5.8 – 6.3 ppm) showing hydrolysis of S-
cyanovinyl oxazolidinone thione arabino-120 and S-alkyl oxazolinone thione arabino-
126 in the presence of inorganic phosphate across a range of pHs.   
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2.3.4. Activation of thione with acrylonitrile to prevent side 
reactions 
 
 
 
 
Figure 2.11: A) Cyanoethylation of the oxazolidinone thione arabino-103 proceeded 
via addition to N1 atom instead of the exocyclic sulfur, yielding product 131 (95%) 
and 132 (5%) in favour of the desired product 133. B) HMBC NMR (600 MHz, D2O, 
1H 2.7-6.7 ppm, 13C 10-200 ppm) of 131 showing coupling of C1´-H and C2´-H with 
C3 carbon of the cyanoethyl group (red arrows), confirming that the cyanoethyl 
moiety is attached to the endocyclic N1 atom instead of the exocyclic sulfur. 
High yields of oxazolidinone thione arabino-103 were being observed in the 
displacement reactions of S-cyanovinyl oxazolidinone thione arabino-120 (Figure 
2.9). This suggested that competing conjugate addition at the α-position of the β-
cyanovinyl moiety arabino-120 was occurring. Therefore, we next chose to explore 
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alternative electrophilic activation to prevent Michael addition to the cyanovinyl 
group of arabino-120 and improve regioselectivity of nucleophilic addition at the C2 
carbon atom. We investigated electrophiles that would result in a saturated thiolate 
leaving group. Our first electrophile, due to its ostensive similarity to cyanoacetylene 
30 and prebiotic plausibility was acrylonitrile 130.45 Interestingly, the reaction of 
oxazolidinone thione arabino-103 and 130 in water at pH 9 rapidly give a single 
product, which we initially assumed to be 133 (Figure 2.11A). This was then subjected 
to a range of displacement reactions, and disappointingly was found to be highly stable 
to all conditions, returning only starting material 133. At this point, further 
investigation (and particularly analysis of the HMBC spectrum) of the supposed 
compound 133 made it obvious to us that we had quite unexpectedly, cleanly 
furnished the N1-cyanoethyl adduct 131 and not S-cyanoethyl adduct 133 (Scheme 
2.17). We were initially surprised by the apparent change in reactivity; based upon 
our results with cyanoacetylene 30, which selectively reacted with exocyclic sulfur of 
thione arabino-103 to furnish S-cyanovinyl thione arabino-120 (Figure 11).  
 
However, Girniene et al. have previously observed a mixture of N1 and S-benzylation 
upon the reaction of oxazolidinone thione arabino-103 with benzyl bromide and 
sodium hydride (NaH).158 The N-benzylated derivative of oxazolidinone thione ribo-
103 has been isolated (24%), however there is no information on the mechanism and 
no rational is provided.158 A tentative mechanism for N-vinylation of  silylated-thione 
134 upon reaction with 1,2-bis-(phenylsulfonyl)ethylidene 137 under basic conditions 
has been proposed.157 Girniene et al. suggest that the initial reaction occurs, as we 
anticipated at sulfur giving the S-cyanoethyl product 135, followed by intramolecular 
rearrangement to give 136 (Scheme 2.17A).157 However, though Girniene at al. 
describe a plausible pathway for migration of phenylsulfonyl vinyl moiety, with a 
conjugated sp2 system, it seems difficult to translate the same migratory process to our 
observed selectivity in a saturated example. Therefore, we tentatively propose that an 
addition/elimination mechanism may be occurring under our aqueous conditions 
(Scheme 2.17B). Elimination would likely be inhibited in S-cyanovinyl oxazolidinone 
thione arabino-120 due to the high energy of the required vinyl anion, but be readily 
achieved at an sp3 centre adjacent to an anion stabilising cyano group. Furthermore, 
upon cyanovinylation, the β-cyanovinyl moiety of arabino-120 would likely 
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significantly decrease the electron density at N1, and therefore prevent bis-N1-
cyanovinylation, where alkylation would be expected to be electron donating and 
favour bis-cyanovinylation. An E1cB mechanism seems highly plausible for the 
cyanoethyl moiety 131. Indeed cyanoethyl protection and E1cB deprotection 
strategies are commonly used in phosphitylation methods for phosphomono- and 
phosphodiester synthesis (Scheme 2.17C).178-181 
 
Scheme 2.17: A) Tentative mechanism for N1-phenylsulfonyl vinylation of 135 via 
SN migration. B) Proposed mechanism for N1-cyanoethylation of oxazolidinone 
thione arabino-103 in aqueous solution. C) Use of cyanoethyl group in nucleotide 
oligomerisation. 
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Selective cyanethylation was not observed upon the reaction of oxazolidinone thione 
arabino-103 with acrylonitrile 130, therefore a different approach to the problem 
maybe required. Specifically it may be that steric blockade of the addition of 
nucleophiles to the cyanovinyl group could circumvent this problem. Therefore, in 
future it would be worth investigating how more hindered cyanovinylated products 
such as 139, which could be synthesised from methylcyanoacetylene 138, will behave 
to Michael addition of nucleophiles. (Scheme 2.18).  
 
Scheme 2.18: Plausible mechanism for formation of oxazolidinone thione arabino-
103 during nucleophilic attack on the S-cyanovinylated oxazolidinone thione arabino-
120. Cyanovinylation of arabino-103 by methylcyanoacetylene 138 to from 139 which 
might block Michael addition type reactions, based on steric grounds (inset).  
 
2.4. Choosing the nucleophile 
 
From the pH stability studies of S-cyanovinyl thione arabino-120 and S-methyl thione 
arabino-126, it was deduced that the nucleophile to be used needed to be meticulously 
chosen in order to achieve successful displacement of the thiolate group. If the pH is 
too low, N1 of activated thiones (arabino-120 and arabino-126) is protonated and 
hydrolysis will take over, forming oxazolidinone arabino-77 and at elevated pH 
Michael addition of cyanovinyl thiolate 128 leads to the formation of mainly 
oxazolidinone thione arabino-103 and dicyanovinylsulfide 129. Therefore, the pH 
needs to be fine-tuned to get to a pH environment which will maximise the addition 
of the respective nucleophile and minimise formation of arabino-77 and thione 
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arabino-103. Furthermore, we will specifically be using amine nucleophiles, as we 
need a nitrogen atom at the C2 carbon atom to give species capable for yielding 
nucleotides.  Alkyl amines normally have a pKa of >9, therefore at neutral pH, the 
amine will be substantially protonated and ineffective as a nucleophile.  Therefore an 
amine nucleophile with a lower pKa was required so protonation will not impede the 
amine’s reactivity at pHs where thione activation by protonation would occur 
(arabino-120 pKaH = 5.2, arabino-126 pKaH = 2.4). 
To recap, it is remarkable to note the difference in reactivity that has been observed 
in the reaction of aminooxazolines arabino-70 and oxazolidinone thione arabino-103 
with cyanoacetylene 30 (Section 2.3), the former reacting quantitatively on N1-
nitrogen atom whereas the latter is observed to react near quantitatively on sulfur 
(Scheme 2.12). As we are exploring sulfur displacement by nitrogen nucleophiles on 
thiones (S-cyanovinyl arabino-120 and S-methyl arabino-126). Once the 
displacement has occurred and we have synthesised an aminooxazoline from a thione. 
We would predict an interesting switch in reactivity, namely that upon addition the 
nitrogen adjacent to C2 of the aminooxazoline would become nucleophilic at N1. 
Therefore, if thiolate can be displaced for arabino-120 or arabino-126 with an 
ambident reagent, a nitrogen nucleophile tethered to an electrophile (such as 142), we 
would anticipate intermolecular nucleophilic trapping of the aminooxazoline 
generated upon nucleophilic addition at N1-nitrogen (e.g. intermediate 140 would 
generate 5 or 6 member ring 141). This mode of ambident reactivity would then lead 
to an opportunity to directly build fused tricyclic heterocyclic structures. However, 
the “electrophilic-amine” (such as 142) must be wisely chosen and/or judiciously 
positioned to avoid intramolecular trapping (Scheme 2.19). But, before embarking on 
our investigation of ambident nitrogen nucleophile, it was decided to choose simple 
or literature precedented nucleophiles to optimise the nucleophilic addition conditions 
(pH, concentration, temperature etc.). 
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Scheme 2.19: Schematic representation of displacing thiolate with a nitrogen 
nucleophile tethered to an electrophilic centre, in order to build the heterocyclic core 
of what is eventually going to become the purine nucleobases. The undesired 
intramolecular cyclisation of “electrophilic-amine” such as 142 (inset).  
 
2.4.1. Displacement of the S-methyl thiolate and S-cyanovinyl 
thiolate by a model ambident amine 
 
Having found that oxazolidinone thione arabino-103 can be converted to S-
cyanovinylated oxazolidinone thione arabino-120 with remarkable efficiency under 
milder and prebiotically plausible conditions, and also demonstrated the prebiotic 
synthesis of S-methyl oxazolidinone thione arabino-126 via efficient displacement of 
cyanovinyl thiolate 128 by methanethiol 127 (Section 2.3). Our next goal was to 
investigate the displacement of thiolate in arabino-120 and arabino-126 with amines.  
We first chose to investigate the reactivity of simple S-methyl thione 126 which is 
more stable than S-cyanovinyl thione 120 in aqueous conditions. Though Shaw et 
al.175 and Davidson et al.176 reported 126 to be unreactive with amines, we predicted 
that the reactivity of 126 could be controlled (switched on/off) through protonation. 
To test this hypothesize pH switch, we investigated the synthesis of quinazolinedione 
124 in water across a broader pH range. Interestingly, we observed near quantitative 
conversion of 126 via the addition product 143 to ribo-124 and arabino-124 in water 
between pH 2 and 6, supporting our hypothesis that thione protonation was essential 
for the activation of S-methyl thione. Moreover, the reaction was severely retarded 
under alkaline conditions, demonstrating that reactivity of 126 is readily modulated 
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through pH-control (Figure 2.12). We were able to detect the addition product 143 in 
the first hour of the reaction, identified by the relatively lower chemical shifts of C1´-
H (6.2 ppm) and C2´-H (5.4 ppm) in the 1H NMR spectroscopy.  X-ray structure of 
ribo-124 and arabino-124 were obtained to confirm identity of the quinazolinediones.  
 
Figure 2.12: Synthesis of quinazolinedione 124 by displacement of the S-methyl 126 
(250mM) by anthranilic acid 125 (500mM) in water at room temperature. The 
reaction mechanism is thought to proceed via the annulation of the addition product 
143 aided by the carboxylic acid group. 
We suspected S-cyanovinyl thiolate 128 to be an excellent nucleofuge, given the 
conjugation between S and CN groups (Scheme 2.20). Though the pKa of S-
cyanovinyl thiolate 128 is not known, Ferris et al. have reported the pKa of 
cyanoacetaldehyde 31 to be pKa 8.1 (previously Ferris and Orgel also reported pKa 
8.4). Therefore we would expect the mercapto analogue to have a comparable (or 
indeed perhaps lower) pKa, allowing for the difference in electronic overlap and 
polarizability of sulfur. 
 
Scheme 2.20: Conjugation between sulfur and nitrile in S-cyanovinyl thiolate 128. 
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Furthermore, 128 has been used recently as nucleofuge during prebiotically plausible 
oligoribonucleotide ligation by Sutherland and co-workers.142 To test the reactivity of 
S-cyanovinyl thione arabino-120 with amines, we next investigated the aqueous 
reaction of anthranilic acid 125 with arabino-120. Pleasingly, the reaction of arabino-
120 (250 mM) with anthranilic acid (500 mM) was found at pH 3.8 to successfully 
yield 96% (NMR) quinazolinedione arabino-124. However, intriguingly, we 
observed the reaction in water at all pH’s investigated (3 – 11).  
 
Figure 2.13: 1H NMR spectra (600 MHz, D2O, 3.5 – 6.9 ppm) showing reaction of S-
cyanovinyl thione arbino-120 with anthranilic acid 125.  A) Arabino-120 (250mM) 
and 125 (500mM) at pH 6, incubated at rt for 1 h.  B)  After 6 h, calibration against 
internal standard (DSS) gave yields of 81% anthranilic quinazolinone arabino-124 
and 12% oxazolidinone thione arabino-103.  C) Spiked with arabino-103.  D) Spiked 
with arabino-124. 
  
The pH dependence of quinazolinedione 124 synthesis is thought to be due to the 
protonation of N1 nitrogen, facilitating C2 reactivity instead of conjugate addition to 
cyanovinyl group (Scheme 2.21). However, it was hypothesised that higher pKa 
amine nucleophiles would have the potential to add to unprotonated S-cyanovinyl 
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thione arabino-120, if so a second route to aminooxazoline 70 (a key compound in 
the prebiotic synthesis of pyrimidine ribonucleotides)22 may be accessed and to test 
this hypothesis ammonia (NH3) was next investigated in the displacement reaction of 
the thiolate groups. 
 
 
Scheme 2.21: Plausible mechanism for the pH dependence of nucleophilic addition 
to S-cyanovinyl oxazolidinone thione arabino-120 and formation of oxazolidinone 
arabino-77, formed as the hydrolysis product during the nucleophilic additions to 
arabino-120 in almost all reactions with varying rates. Hydrolysis product of 
nucleophilic additions arabino-77 (inset). 
 
2.4.2. Displacement of the thiolate group by ammonia to form 
aminooxazoline 
 
Ammonia (pKa 9.2),92 as well as being itself a prebiotically plausible amine,182 
theoretically could displace S-cyanovinylated oxazolidinone thione arabino-120 to 
yield aminooxazoline arabino-70. This would provide access to a key pyrimidine 
nucleotide precursor via an alternative route (which would be an exciting discovery 
on its own), however perhaps more importantly would open the potential for arabino-
120 acting as a point of divergence in the synthesis of both pyrimidine and purines 
(Scheme 2.22). The divergent synthesis of pyrimidine and purine ribonucleotides will 
be discussed in more detail, later in this thesis (Chapter 5).  
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Scheme 2.22: Displacement chemistry of S-cyanovinylated oxazolidinone thione 
arabino-120 and its possible central role divergent synthesis of pyrimidine and purine 
ribonucleotides. Desired stereochemistry of oxazolidinone thione arabino-103 and 
arabinoe-120 shown by X-ray crystallography. 
 
As mentioned earlier (section 2.3.2) S-methylated derivatives of oxazolidinone thione 
126 were supposedly “singularly unreactive towards nucleophiles”.175 For example no 
reactivity with aqueous and methanolic ammonia has been observed. Unlike the case 
for simple S-alkyl thiones such as 126, aqueous ammonia efficiently displaces thiolate 
128 from S-cyanovinyl thione arabino-120. Pleasingly, we found that incubation of 
arabino-120 or ribo-120 (0.25M) with ammonium chloride (1M, pH 8.5-10.5) returns 
arabino- and ribo aminooxazoline 70 (15-21%), from their respective S-cyanovinyl 
thiones 120 (Figure 2.14). Interestingly the major by-products are the precursor thione 
103 and a white crystalline precipitate of dicyanovinyl sulfide 129;142 these by-
products suggested regeneration of thione 103 results from rapid nucleophilic addition 
of thiolate 128 to the cyanovinyl moiety of 120. However, the greatly increased 
efficacy of cyanovinylation of oxazolidinone thione 103 (Section 2.3) suggested that 
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S-cyanovinyl thione 120 could be regenerated in situ by the reactivation of 103 (in the 
presence of aminooxazoline 70) by cyanoacetylene 30.  
 
  
Figure 2.14: Showing 1H NMR (600 MHz, D2O, 3.4 – 6.2 ppm) spectroscopic 
evidence by sequential spiking for formation of aminooxazoline arabino-70 from the 
reaction of S-cyanovinyl thione arabino-120 and ammonia at pH 9.5. A) Arabino-120 
(250 mM) and ammonia (1M) were incubated at pH 9.5 at rt for 24 h. B) Spiked with 
oxazolidinone thione arabino-103. C) Spiked with oxazolidinone arabino-77. D) 
Spiked with aminooxazoline arabino-70. 
 
2.4.2.1. Regeneration of S-cyanovinylated thione in ammonia displacement 
reaction 
 
The successful displacement of the thiolate group 128 by ammonia shows that 
pyrimidine nucleotides can (in principle) be synthesised by our strategy, giving us 
further momentum to investigate purine synthesis. However, the main by-product of 
ammonia displacement reaction was oxazolidinone thione arabino-103, which likely 
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arises from Michael addition of ammonia to the cyanovinyl group. The thiolate 
displacement reaction also generates the nucleophilic thiolate 128, which can form 
arabino-103 via Micheal addition and lead to the formation of the observed (second 
major by-product) β-β-dicyanovinyl-thioether 129,142 which precipitates form the 
solution. We hypothesised that addition of cyanoacetylene 30 solution to the reaction 
of S-cyanovinylated oxazolidinone thione arabino-120 with ammonia would trap the 
thiolate 129 to form 128 and also regenerate the starting material arabino-120 by 
further reacting with the thione arabino-103.  
 
Interestingly, we observed that addition of cyanoacetylene 30 (0.25 M) to an aqueous 
solution of oxazolidinone thione arabino-103 (0.24 M) and aminooxazoline arabino-
70 (0.24 M) between pH 7 and 10.5, led to chemospecific cyanovinylation of arabino-
103, which then reacted with ammonia to yield aminooxazoline arabino-70  (60%, 
with respect to aranbio-103) (Figure 2.15). Furthermore, we observed that repeated 
cyanovinylation and incubation of thione arabino-103 in ammonia solution yielded 
up to 45% aminooxazoline arabino-70 (over two cycles of cyanovinylation at pH 
10.5, without need for any intermediate steps of purification) leading to a remarkably 
pure solution of aminooxazoline arabino-70 (Figure 2.15). The process of adding 
cyanoacetylene 30 can be continued for further cycles to completely consume all of 
the oxazolidinone thione arabino-103. The regeneration experiment was also repeated 
with ribo-103 to yield 33% ribo-70, ribo-70 was observed to spontaneously crystallize 
from the reaction mixture after two cycles of cyanovinylation and ammonolysis.134 As 
it has been demonstrated that aminooxazolines arabino-7022, 123 and ribo-7021, 134 are 
both key intermediates en route to pyrimidine ribonucleotides this additional synthetic 
strategy further augments the potential of aminooxazolines 70 as a prebiotically 
plausible precursor of RNA.  
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Figure 2.15:  1H NMR spectra (600 MHz, 2.95 – 6.3 ppm) showing reaction of S-
cyanovinyl oxazolidinone thione arabino-120 with ammonia (NH3).  A) Arabino-120 
(250 mM) and NH3 (1M) were incubated at pH 10.5 at rt for 24 h.  B) Oxazolinone 
thione arabino-103 was quantitatively converted back to arabino-120 by addition of 
cyanoacetylene 30.  C) After a further 24 h at pH 10.5 at rt.  D) After a 2nd 
recyanovinylation by addition of 30.  E) After another 24 h at pH 10.5 at rt. 
 
2.4.3. Displacement of the thiolate group by cyanamide  
 
The pH dependence of the reaction suggested that nucleophile’s pKa will be highly 
important in establishing efficient displacement of the thiolate 128. It would seem that 
the low pKa of aniline nitrogen (pKa 4.8) is ideally suited to retaining nucleophilicity 
where thione nucleophilic displacement is specific acid catalysed. To test the 
hypothesis that the protonation state of the nucleophile is highly important, we next 
investigated cyanamide 68 (pKaH = 1.1). We observed that cyanamide 68 (1M) 
reacted with S-cyanovinylated oxazolidinone thione arabino-120 (250mM) most 
efficiently at pH 6.5 to yield 26% aminooxazoline 144 (Figure 2.16).  
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Figure 2.16: 1H NMR spectra (600 MHz, 3.3.3 – 6.37 ppm) showing evidence by 
sequential spiking for formation of aminooxazoline 144 from the reaction of S-
cyanovinylated oxazolidinone thione arabino-120 and cyanamide 68 at pH 6.5. A) 
The crude reaction of cyanamide 68 (1M) and arabino-120 (250mM) at pH 6.5 in rt 
after 48 h. B) Spiked with oxazolidinone thione arabino-103. C) Spiked with 
oxazolidinone arabino-77.  
However, the yield considerably decreased in lower pH. At pH 4.3 we obtained 6% 
aminooxazoline 144, 75% oxazolidinone arabino-77 and 19% S-cyanovinylated 
oxazolidinone thione arabino-120. This suggested that at lower pH hydrolysis 
outcompeted the addition of cyanamide 68 and as a result mostly oxazolidinone 
arabino-77 formed by competing hydrolysis of water. Moreover, the lone pair in 
cyanamide 68 is highly conjugated into the nitrile group, as indicated by its very low 
pKa, this electron withdrawing effect have inhibited competition with hydrolysis. This 
further suggested that it would be essential to find the correct pKa of amine, to balance 
reactivity of the material (S-cyanovinylated oxazolidinone thione arabino-120), the 
desired nucleophile and water. If the pH of the reaction is too low hydrolysis takes 
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over and the major product will be oxazolidinone arabino-77. If the pH is too high 
then the thiolate 128 adds to the cyanovinyl group in arabino-120 via Michael addition 
giving oxazolidinone thione arabino-103 as the major product. Therefore, the 
interplay of reaction pH and nucleophile pKa appears to be very important. It seems 
likely that the availability of the amine nucleophile’s nitrogen lone pair is essential to 
achieve efficient displacement, and ideally we require an available nitrogen lone pair 
at a pH where the electrophilic thione is activated by (partial) protonation. To test this 
hypothesis we next chose to focus on our primary objective of purine ribonucleotide 
synthesis and the addition of aminonitrile nucleophiles.  
2.4.4. Displacement of the thiolate group by aminonitriles 
 
The observations and experimental analysis that was gained from the reaction of 
different nucleophiles led us to believe that we were at a stage to tether hydrogen 
cyanide 14 derivatives. As previously mentioned these are the potential nucleophiles 
which will help us achieve the abiotic synthesis of purines. HCN 14 can easily be 
formed from electric discharge experiments43, 101 and is present in our solar system, 
comets and atmosphere of other planets.183-185  Furthermore, the oligomerisation of 
hydrogen cyanide 14 has widely been proposed as a key route to purine nucleobases,46, 
59, 96, 146, 186 and guided by the recently reported synthesis of purine precursors from 
aminonitriles,59 we recognised that hydrogen cyanide derivatives,51, 52, 156, 187 have the 
ideal ambident reactivity to displace cyanovinyl thiolate 128 in S-cyanovinyl thione 
arabino-120 and then induce cyclisation in the aminooxazolines to build the imidazole 
moiety of purine nucleobases upon a sugar scaffold tethered by the 8,2´-anhydro-
linker required for phosphorylation and C2´-stereochemical inversion.22, 188 
2.4.4.1. 2-Aminoacetonitrile (glycine nitrile) 
 
Investigation into the nucleophilicity of aminonitriles was started by studying glycine 
nitrile 145, which can easily be synthesised from plausible prebiotic molecules (NH3, 
H2CO 13 and HCN 14) via a Strecker reaction (Scheme 2.23A). It is also a product of 
Urey-Miller discharge experiment and Sutherland’s cyanosulfidic protometabolism.38, 
89 In 2008 it was also discovered that glycine nitrile 145 was present in the interstellar 
cloud (Sagittarius B2).189 Furthermore, Commeyras et al. have reported extensive 
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kinetic and thermodynamic studies of glycine nitrile 145 to get a better understanding 
of the plausible prebiotic synthesis of the proteinogenic amino acid glycine 150, the 
first and (likely) the most abundant amino acid on the primitive Earth.190  
 
 
 
Scheme 2.23: A) Abiotic synthesis of glycine nitrile 145 from Strecker reaction of 
formaldehyde 13, ammonia (NH3) and hydrogen cyanide 14. B) Plausible mechanism 
for reaction of S-cyanovinylated oxazolidinone thione arabino-120  with glycine 
nitrile 145 to give aminooxazoline 146 and subsequent N1-cyanation of 146 with 
cyanogen 25 to give compound 147, leading towards the synthesis of potential purine 
precursor 95 via intramolecular cyclisation. Structure of proteinogenic amino acid 
glycine 150 (inset). 
 
Given that the α-proton of glycine nitrile 145 (~pKa = 20)191 is relatively acidic, we 
conjectured that the deprotonation of α-carbon will open up various functionalisation 
opportunities, such as carboxylation, which may be exploited en route to purine 
elaboration.192 However, structural similarity of aminooxazoline 146 and 
aminooxazoline arabino-70, suggested that electrophiles would preferentially react at 
N1 of 146 in water. We based this hypothesis on the selective N1-cyanovinylation of 
aminooxazoline arabino-70 in the synthesis of pyrimidines.22 Interestingly, if 
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cyanogen 25, by analogy to cyanoacetylene 30 was observed to furnish N1 cyanation 
of 146, formation of cyanated aminooxazoline 147 would be expected, then 
intramolecular cyclisation of 147 would yield the AICN tricyclic cyclic structure 95, 
a key intermediate in our purine ribonucleotide synthesis (Scheme 2.23B). This would 
then provide a way to by-pass HCN 14 oligomerisation chemistry, which despite being 
one of the most cited and referenced processes in chemical origins of life, is a very 
sluggish reaction that yields a large array of discrete products and polymers.90, 91 83 
When S-cyanovinylated oxazolidinone thione arabino-120 (250mM)) was reacted 
with glycine nitrile 145 (500mM) at pH 4.2 in water for 24 h, we successfully obtained 
52% aminooxazoline 146, as well as 34% thione arabino-103, and 14% oxazolidinone 
arabino-77. We confirmed the presence of thione arabino-146 and oxazolidinone 
arabino-77 by spiking the crude 1H NMR with authentic samples which were 
synthesised from known literature procedures. We already knew that at lower pH, 
hydrolysis of arabino-120 was more rapid. Therefore, to optimise the addition of 
glycine nitrile 145 and minimise hydrolysis the reaction was repeated at pH 5.2. 
Interestingly, at pH 5.2 the reaction furnished 70% aminooxazoline 146, 13% 
oxazolidinone thione arabino-103, and 14% the hydrolysis product arabino-77 
(Figure 2.17). At this pH N1 nitrogen of S-cyanovinyl thione arabino-120 would be 
partially protonated (pKa of arabino-120 = 5.2) and a significant proportion of glycine 
nitrile 145 (pKa = 5.6) would not be protonated. To further test if protonation of the 
N1 in arabino-120 or the protonation state of the amine nucleophile is important to 
displace the S-cyanovinyl thiolate 128, we repeated the reaction of glycine nitrile 145 
with arabino-120 at pH 7.0 and 10.0. These displacement reactions furnished 65% 
(pH 7.0) and 52% (pH 10.0) aminooxazoline 146. The result confirms that for 
optimum nucleophilic substitution at the C2 carbon atom of arabino-120, the pH of 
the reaction needs to be at a point where N1 is protonated, but there should also be a 
portion of the amine nucleophile unprotonated. However, this pH window of optimum 
reactivity will vary for other amine nucleophiles as we have seen in ammonia (pKa = 
9.2), cyanamide 68 (pKa = 1.1) and anthranilic acid 125 (pKa = 2.14).  
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Figure 2.17: 1H NMR spectra (600 MHz, D2O, 3.5 – 7.0 ppm) for reaction of S-
cyanovinyl oxazolidinone thione arabino-120 with glycine nitrile 145.  A) Arabino-
120 (250mM) and 145 (500mM) in D2O (500 µL) at pH 4.5, incubated at rt for 2 h.  
Calibration to an internal standard (DSS) gave yields of 70% arabinofuranosyl-N-
acetonitrile-aminooxazoline 146, 13% oxazolidinone thione arabino-103 and 14% 
oxazolidinone arabino-77.  B) Spiked with arabino-103.  C) Spiked with arabino-77.  
D) Spiked with 146.a 
After observing the successful reaction of glycine nitrile 145 with S-cyanovinyl thione 
arabino-120, next the reaction of 145 with S-methyl thione arabino-126 was 
investigated. It was hypothesised that the reaction of 145 with arabino-126 would be 
more feasible at a lower pH given the stability of arabino-126 over arabino-120 
                                                          
a Pure sample of 146 for NMR spiking was obtained from Dr Shaun Stairs in the Powner laboratory.  
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(Section 2.3). Indeed incubation of arabino-126 with glycine nitrile 145 at pH 4.5 at 
room temperature give 76% product 146 and 8% oxazolidinone arabino-77.  
 
Figure 2.18: 1H NMR spectra (600 MHz, D2O, 3.5 – 7.0 ppm) showing reaction of S-
methylated oxazolidinone thione arabino-126 with glycine nitrile 145.  A) Arabino-
126 (250mM) and 145 (500mM) at pH 4.5, incubated at rt for 4 h.  Calibration to an 
internal standard (DSS) gave yields of 76% aminooxazoline 146 and 8% 
oxazolidinone arabino-77.  B) Spiked with arabino-77.  C) Spiked with arabino-126.  
D) Spiked with 146. 
As hypothesised (Scheme 2.23), N1-cyanated product of aminooxazoline 146 will 
furnish an important prebiotic purine precursor AICN tricyclic moiety 95. However, 
before taking on the more complex task of investigating cyanation of N1, attempts to 
cyclise aminooxazoline 146 were undertaken. Initially, the intramolecular cyclisation 
of 146 would be expected to give an imine 152, which will significantly drop the pKa 
of the α-protons to produce an enamine 151 also aided by aromatisation. Enamine 151 
could be envisaged to be a potential nucleophile (for example Shaw et al. reported the 
reversible carboxylation of amino imidazole 153 to form 154) and would be expected 
to undergo carboxylation at C4 carbon atom to furnish the AICA tricyclic moiety 96, 
(Scheme 2.24).192, 193 Therefore, to test how aminooxazoline 146 reacted, we left the 
reaction mixture at pH 5.2 for 48 h but no visible change was observed. We 
hypothesised that probably the N1 protonation of 146 may be preventing the 
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intramolecular cyclisation (as the pKa of aminooxazoline = ~ 6.5), therefore the pH 
of the crude mixture was raised to pH 8.0 and then incubated at room temperature for 
another 48 h. Surprisingly, once again no evidence of cyclisation was observed from 
1H NMR spectroscopic analysis. 
 
Scheme 2.24: A) Postulated mechanism for cyclisation of aminooxazoline 146 to 
furnish the prebiotically plausible purine precursor 151 followed by prebiotic 
carboxylation based on Shaw et al. studies to yield AICA tricyclic moiety 96. B) 
Mechanism for aqueous carboxylation of aminoamidazoles 153 in potassium 
hydrogen carbonate by Shaw et al.192, 193 
 
In order to test if Thorpe-Ingold effect194 contributed to the cyclisation of 
aminooxazoline 146 reactions of alanine nitrile 155 and S-cyanovinylated 
oxazolidinone thione arabino-120 were explored.b Interestingly alanine nitrile 155 
(250 mM) successfully tethered with arabino-120 (500mM) to yield aminooxazoline 
156, however repeated attempts at various pH and temperature conditions to cyclise 
156 again failed to furnish the tricyclic compound 157.  
 
                                                          
bThis work was carried out by Dr Shaun Stairs in the Powner laboratory. 
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Scheme 2.25: Formation of aminooxazoline 156 from the reaction of S-
cyanovinylated oxazolidinone thione arabino-120 and alanine nitrile 155. 156 failed 
to cyclise to give the tricyclic compound 157, suggesting that Thorpe Ingold effect 
does not contribute to cyclisation in aminooxazolines. 
 
The reactions of amino nitriles gave us a very positive indication that we were heading 
in the right direction in our pursuit of finding a lead compound to prebiotically 
synthesise purine nucleotides. The missing link, however, was cyclisation of the 
aminonitriles to give us the important tricyclic compounds (95 and 96). We next 
hypothesised that substitution of tetrahedral centre with an electron withdrawing 
groups might induce desired cyclisation and the synthesis of the 5-membered 
imidazole ring. Accordingly, the HCN trimer 17 was perceived to be the mostly likely 
option to marry our desired reactivity with prebiotic plausibility. 
2.4.4.2. HCN trimer and tetramer 
 
HCN oligomers, amino malononitrile (trimer) 17 and diamino malononitrile 
(tetramer) 18 have already been used to synthesise purine precursors by Orgel and are 
observed intermediates in the formation of adenine by cyanide oligomerisation 
(Scheme 1.7).46, 52, 59, 96, 186 Orgel et al. have also shown that slow addition of 
thioformamide 158 buffered solution (0.1M, pH 8.75) to HCN trimer 17 (0.01M) 
yields 40%  isochrysean 159 (Scheme 2.26).52  
 
Scheme 2.26: pH controlled reaction of aminomalononitrile 17 with thioformamide 
158 giving 40% isochrysean 159 .52  
The trimer 17 is constitutionally the simplest nucleophile to tether to C2 carbon atom 
of S-cyanovinylated oxazolidinone thione arabino-120 and would lead towards the 
core AICA moiety of purine nucleotides. We predicted that the addition product of 
the trimer aminooxazoline 160 would readily undergo intramolecular cyclization to 
give the AICN derived product 95. We not only expected the electrophilicity of the 
nitrile moieties to be increased in 160 with respect to 146, but also recognised that 
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positioning two nitrile moiety on the same carbon atom would statistically increase 
the reactivity of both nitriles toward cyclisation (Scheme 2.27).  
Scheme 2.27: Tentative mechanism for reaction of S-cyanovinyl oxazolidinone thione 
arabino-120 with aminomalononitrile 17 and diaminomalononitrile 18. 
Intramolecular cyclisation of aminooxazoline 160 can lead to AICN tricyclic 95. 
Addition of HCN tetramer 18 can produce both key purine precursors AICN tricyclic 
moiety 95 and AICA tricyclic moiety 96 (blue). Oligomerisation of 17 into 18 (inset). 
Using the same conditions that were employed in the reaction of other nucleophiles 
with S-cyanovinyl thione arabino-120, trimer 17 (500mM) was reacted with arabino-
120 (250mM) at pH 4. However, disappointedly, we were unable to see any new 
product derived from 17. The reaction was repeated at pH 7 and 10, but again to our 
disappointment we did not observe any reaction between arabino-120 and HCN trimer 
17, instead only oxazolidinone arabino-77 and oxazolidinone thione arabino-103 
were observed. Presence of arabino-77 and arabino-103 was confirmed by spiking 
with authentic samples. The absence of reactivity of the trimer 17 addition reaction 
was suspected to be due to its half-life (10-3M, pH 9, rt, 1 h).52 We suspected that in 
our reactions the trimer 17 hydrolysed or decomposed prior to its addition to the C2 
carbon atom of arabino-120. It was therefore decided to follow Orgel’s method of 
slow addition of HCN trimer 17 to the S-cyanovinylated thione arabino-120 as this 
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should give enough time for the HCN oligomer 17 to react. But, when 
aminomalononitrile 17 solution (10mM) was added to arabino-120 (100mM) at pH 
4.0 over a 6 h period, however, again we were still unable to detect any displacement 
by the HCN trimer 17, the two major products were again oxazolidinone arabino-77 
and oxazolidinone thione arabino-103 (Scheme 2.28). 
 
Scheme 2.28: Reaction of S-cyanovinyl oxazolidinone thione arabino-120 with HCN 
trimer 17 and tetramer 18 in various pH and time scales returned oxazolidinone 
arabino-77, oxazolidinone thione arabino-103 and β-β-dicyanovinyl-thioether 129. 
No observable addition reaction of 17 and 18 with arabino-120 was detected. 
The HCN tetramer 18 is a classic of prebiotic chemistry. Diamino malononitrile 17 is 
the first stable and isolable intermediate of HCN 14 oligomerisation chemistry. We 
predicted that once the tetramer 18 is tethered to the C2 carbon atom centre of S-
cyanovinyl oxazolidinone thione arabino-120, it will undergo a similar intramolecular 
cyclisation as the trimer 17, however, given that the tetramer 18 is relatively more 
complex, we proposed that both AICN 95 and AICA 96 derived sugar moieties will 
be synthesised via our proposed mechanism (Scheme 2.27).  Therefore, we applied 
the same reaction conditions that we have been using in the reaction of other 
nucleophiles. However, we were unable to detect any new product from the reaction 
of the tetramer 17 at pH 4, 7 or 10, and were only able to confirm the presence of 
oxazolidinone thione arabino-103, oxazolidinone arabino-77, and dicyanovinyl-
thioether 129 (Scheme 2.28). 
After repeated attempts to displace the (more stable) S-cyanovinyl thione arabino-120 
with HCN trimer 17 and tetramer 18, we decided to use the S-methyl thione arabino-
126 in the displacement reactions (Figure 2.19).  
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Figure 2.19:  1H NMR spectra (600 MHz, D2O, 3.4 – 6.6 ppm) showing reaction of S-
methylated oxazolidinone thione arabino-126 with aminomalononitrile 17.  A) 
Arabino-126 (250mM) and aminomalononitrile p-toluenesulfonate 17 (1M) at pH 3 
and rt incubated for 3 h.  Aminooxazoline 160 was produced in a 15% yield.  B) 
Aliquot (50 µL) from A was added to ammonium hydroxide in D2O (450 µL, 100mM), 
the solution was adjusted to pH 9 with NaOH (4M) and incubated for 1 h at rt.  By-
products P-1 and P-2 are derived from arabino-126 and observed upon incubation of 
arabino-126 alone under comparable conditions. P-1 and P-2 are suspected to be the 
products of (intermolecular) S-N methyl migration.  Calibration to an internal 
standard gave yields of 15% aminoimidazole-4-carbonitrile-β-furanosylarabinoside 
95 and 8% oxazolidinone arabino-77.  C) Spiked with arabino-77.  D) Spiked with 
arabino-126.  E) Spiked with 95.  
It was hypothesised that the low pH required for the sustainability of the HCN trimer 
17 would also be decreasing the half-life of arabino-120, and knowing that arabino-
126 has a longer half-life than arabino-120 in acidic conditions, the reaction of HCN 
trimer 17 and S-alkyl thione arabino-126 was investigated. To our surprise, and 
delight incubation of thione arabino-126 (250mM) and aminomalononitrile 17 (1M) 
at pH 3 in room temperature for 3 h give 15% of aminooxazoline 160 which 
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quantitatively cyclised to the AICN moiety 95  in pH 9 (Figure 2.19). The identity of 
AICN was confirmed by spiking with authentic sample of AICN tricyclic 95 (prepared 
by Dr Shaun Stairs through derivatisation of arabino-inosine).195  
 
The prebiotic synthesis of AICN tricyclic moiety 95 meant that we were heading in 
the right direction, as 95 was one of our proposed tricyclic structure in our project 
aims, leading to the synthesis of 8-oxo purine ribonucleotides (Section 1.9). However, 
the 15% yield of 95 was low and therefore it was decided to investigate the 
displacement reaction of 2-amino-2-cyanoacetamide 106, the hydrolysis product of 
aminomalononitrile 17. 
 
2.4.4.4. 2-Amino-2-cyanoacetamide  
 
Given our observed stability problem with HCN 14 oligomers in displacement 
reaction of S-cyanovinyl oxazolidinone thione arabino-120, and the unsuccessful 
cyclisation attempts of the glycine nitrile product 146, we next looked to investigating 
other HCN-oligomer derivatives with a lower propensity to degrade by liberating 
HCN before reacting with arabino-120. This immediately suggested 2-amino-2-
cyanoacetamide 106, which is the first hydrolysis product of the HCN trimer 17 and 
is also significantly more stable than 17.196 Furthermore, Imbach et al. have used 106 
as an ambident nucleophile/electrophile in the conventional organic synthesis of  
xylofuranosyl nucleosides (Scheme 2.29 and 2.1).156 However, Imbach and co-
workers reported that 3´,5'-bis-O-(tert-butyldimethylsilyl) oxazoline 105 “readily 
hydrolyses” to give N-formyl-xylofuranosylamine 167, and therefore suggested it is 
essential the reaction is carried out in anhydrous methanol. Irrespective of the fact that 
this synthesis is not abiotically constrained, and all stereochemistry relationships in 
the product are incorrect for our purposes, the observed reactions reported by Imbach 
and co-workers suggests, the role of cyanoacetamide 106 in our own chemistry is 
worth investigating.  
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Scheme 2.29: Utilisation of 2-amino-2-cyanoacetamide 106 in the conventional 
systematic synthesis of xylofuranosyl nucleosides .156Under dry conditions 106 attacks 
the C2 carbon atom of 105 to make 107, however in aqueous conditions hydrolysis 
takes over the addition reaction leading to formation of 167 (red). 
 
It was initially found that no reaction between S-cyanovinyl oxazolidinone thione 
arabino-120 and 2-amino-2-cyanoacetamide 106 was observed at pH 7 and pH 10. 
However treatment of 106 (500mM)) with arabino-120 (250mM) at low pH furnished 
the desired aminooxazoline 168. The yield of 168 product was observed to be 25% 
and 52% at pH 5 and 4.5, respectfully. Mass spectroscopic analysis also showed the 
correct mass for the desired aminooxazoline 168 and 1H NMR spiking confirmed that 
it was indeed new product 168 (Figure 2.20).  
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Figure 2.20: Showing 1H NMR spectroscopic evidence by sequential spiking for 
formation of aminooxazoline 168 from the reaction of S-cyanovinyl oxazolidinone 
thione arabino-120 and 2-amino-2-cyanoacetamide 106 at pH 4.5. A) The crude 
reaction of 106 and arabino-120 at pH 4.5 after 8 h. B) Spiked with oxazolidinone 
thione arabino-103. C) Spiked with oxazolidinone arabino-77. D) Spiked with 
aminooxazoline arabino-70 (precursor for pyrimidine ribonucleotides). 
 
Aminooxazoline 168 is a set of distereoisomers due to the fact that 106 is racemic. 
The two diastereoisomers of 168 are evident in the 1H NMR spectra, where C3´-H 
peaks are distinguishable by two set of peaks and the C5´-H appear as multiples 
instead of ABX splitting due to overlap of C5´-H in the two diastereoisomers (Figure 
2.21A). There is literature precedence that aminooxazolines exist in its open chain 
form in aqueous solution.22, 123, 197 We hypothesised that aminooxazoline 168 can also 
exist as an open chain form and will lead to the deuteration of C2´-H in D2O. As a 
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result, the C2´-H peak of 168 was observed to be a broad as singlet, but on continued 
incubation in D2O it became fully deuterated (Figure 2.21B). 
  
Figure 2.21: A) 1H NMR (600 MHz, D2O, 3.5 – 6.7 ppm) showing partially purified 
1H spectrum of 168 after partially purified by preparative TLC indicating two set of 
distereoisomers.  B) Plausible mechanism for deuteration of C2´-H of aminioxazoline 
168 in D2O. 
Upon close inspection of the crude 1H NMR spectra for the formation of 
aminooxazoline 168, two new sets of coupled C1´-H and C2´-H at 6.45 and 5.67 ppm 
were observed. These are the expected chemical shifts for C1´ and C2´ protons of the 
anhydro-8-oxo-AICA-arabinoside 96 based on the chemical shift values for the C1´ 
and C2´ of anhydro-8-oxo-AICN-arabinoside 95 (6.5 and 5.8 ppm, Figure 2.19). It 
was hypothesised that although the formation of 168 was optimal at low pH (pH 4.5), 
the subsequent intramolecular cyclisation would require free base of aminooxazoline 
168 to produce AICA moiety 96. The anticipated pKa of 168 would be ~ 6 (based on 
previously reported aminooxazolines), and this was confirmed upon observed 
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chemical shift changes in 1H NMR spectra during a pH titration of an NMR sample 
of 168. Pleasingly, it was found that with pH elevation (pH > 8) the tricyclic moiety 
96 was obtained in up to 40% yield at the expense of aminooxazoline 168 (Figure 
2.22A). We observed an isolated 13% yield of 96 (2.92 M aminocyanoacetamide 106, 
and 4.4M S-cyanovinyl thione arabino-120, 40oC, pH 4.5) upon direct crystallisation 
from the reaction mixture. Crystals of 96 were then used for NMR and 
crystallographic studies to confirm its structure (Figure 2.22A and B).  
 
  
Figure 2.22: A) Intramolecular cyclisation of aminooxazoline 168 at elevated pH 
yielding upto 40% anhydro-8-oxo-AICA-arabinoside 96. X-ray crystallographic 
structure of 96, confirming the arabino stereochemistry required for the synthesis of 
ribonucleotides. B) 1H NMR (600 MHz, D2O, 1.5 – 8.2 ppm) spectrum of pure 96 
obtained via crystallisation. C) Structural relationship of 96 with aminoimidazole-4-
carboxamide ribonucleotide (AICAR 9).  
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It is worthy to note that direct crystallization of aminoimidazole 96 from water 
provides a prebiotic purification mechanism for accumulation and delivery of 96 
under plausible prebiotic conditions.83, 134 The crystallisation of pure 96 is perceived 
to offset the low observed yield, because it ensures a clean pathway towards purine 
ribonucleotides synthesis that can be followed after crystallisation. It is also important 
to note that anhydro-8-oxo-AICA-arabinoside 96 has a striking similarity with 
aminoimidazole-4-carboxamide ribonucleotide (AICAR 9) (Figure 2.22C). AICAR 9 
is the first intermediate in the modern de nova biosynthesis pathway of purine 
ribonucleotides to contain a heterocyclic moiety of the purine base (Section 1.4).128, 
198, 199 
 
The successful synthesis of AICN tricyclic 96 via the displacement reaction of S-
cyanovinylated oxazolidinone thione arabino-120 and 2-amino-2-cyanoacetamide 
106 has taken us a step closer in our pursuit of building the imidazole moiety of purine 
nucleobases upon a sugar scaffold tethered by the 8,2'-anhydro-linker required for 
phosphorylation and C2'-stereochemical inversion. It was hypothesised that the 
hydrolysed variant of aminomalononitrile 106 will also displace the S-methylated 
oxazolidinone thione arabino-126. To test this hypothesis, it was decided to react 106 
with arabino-126 so that the reaction can be scaled up to make a larger amount of 
AICA tricyclic 96 and investigate its forward chemistry. As S-methylated thione 
arabino-126 is accessible on a preparative scale relative to the S-cyanovinylated 
thione arabino-120. 
When 2-aminino-2-cyanoacetamide 106 (500mM) and S-methyl thione arabino-126  
(250mM) were reacted in water at pH 4.5 and heated to 45°C for 3 h, we were able to 
detect 82% aminooxazoline 168, 10% arabino-126 and 8% oxazolidinone arabino-
77. Furthermore, 168 cyclised to furnish up to 59% anhydro-8-oxo-AICA-arabinoside 
96 under basic conditions (Figure 2.23). 
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Figure 2.23: 1H NMR spectra (600 MHz, D2O, 3.1 – 7.0 ppm) for reaction of S-methyl 
oxazolidinone thione arabino-126 with 2-amino-2-cyanoacetamide 106.  A) Arabino-
126 (250mM) and 106 (500mM) in D2O (500 µL) at pH 4.5 incubated at rt for 8 h.  
Calibration to an internal standard gave a yield of 81% (aminooxazoline 168, 5.96 
ppm).  B) Aliquot (50 µL) of A incubated at pH 13 at rt for 1 h giving a yield of 59% 
96.  C) Aliquot (50 µL) of A was added to ammonium hydroxide in D2O (450 µL, 100 
mM), the solution was adjusted to pH 9 with NaOH (4M) and incubated for 24 h at rt.  
Calibration to an internal standard gave yields of 47% 96, 12% arabino-77 with 7% 
arabino-126 remaining.  D) Spiked with arabino-77. E) Spiked with arabino-126.  F) 
Spiked with 96. 
During the course of writing this thesis a second scable synthesise of 2,2´-anhydro-
arabinofuranosyl imidazoles was also established in the Powner laboratory (Scheme 
2.30).195  
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Scheme 2.30: Scalable synthesis of 2,2′-anhydro-arabinofuranosyl imidazoles (96 
and 96) by employing conventional organic methods. Reaction conditions (inset). 
 
2.5. Summary of nucleophilic additions 
 
In summary, the two important AICA and AICN tricyclic moieties 96 and 95 were 
successfully synthesised from plausible prebiotic molecules. And a perceived mutual 
synthetic relationship between pyrimidine and purine ribonucleotide was 
demonstrated by successful thiolate exchange in S-cyanovinyl thione arabino-120 by 
ammonia to furnish aminooxazoline aranino-70. Central to this remarkable 
concomitant chemistry is arabino-120, synthesised quantitatively from thione 
arabino-103 (Scheme 2.31), 
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Scheme 2.31: A summary of prebiotic synthesis of AICA 96 and AICN 95 
tricyclictricyclic compounds and mutal connection of pyrimdine and purines 
discussed in this chapter. X-ray structure for 95 was obtained from Dr Shaun Stairs 
in the Powner laboratory. 
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3. Purine cyclonucleosides 
 
With imidazoles 95 and 96 in hand our next goal was to investigate the synthesis of 
native tetracyclic motif of purine nucleotides 89, 90 and 170 by direct elaboration 
of these novel structures. Formally this required the addition of the fifth, and final 
carbon atom of the nucleotide structure between the C4 carboxyamide/nitrile 
moiety and C5 amine moiety of the tricyclic iminoimidazoles 95 and 96 to yield 
8,2´-anhydro-cyclopurines 89, 90 and 170 (Scheme 3.1). 
 
Scheme 3.1: 8,2´-anhydrocyclo- adenosine 89, guanosine 90 and inosine 170 are the 
required structures to give natural purine ribonucleotides after phosphorylation. It is 
thought that these tetracyclic compounds may be synthesised from 2,2′-anhydro-
arabinofuranosyl imidazoles 124 and 36. 
3.2. Plausible prebiotic synthesis of 8,2´-anhydro purine 
nucleosides 
 
Hydrogen cyanide 14 oligomerisation products aminomalononitrile 17 and 2-amino-
2-cyanoacetamide 106 are crucial to the synthesis of our AICA and AICN tricyclic 
moieties (95 and 96). Furthermore, hydrogen cyanide 14 chemistry has previously 
been widely exploited in the (prebiotic) synthesis of purine nucleobases (Section 
1.5.1).46-49 Therefore, HCN 14 derivatives again appeared to be the ideal prebiotic 
choice to convert arabinoside 95 and 96 to 8,2´-anhydro adenosine 89 and inosine 
170. To test this hypothesis, 95 and 96 were incubated in formamide 27 (first 
hydrolysis product of 14) at 100°C, and over the course of several days we observed 
the direct conversion of 95 to 89 (10%, 96 h) and 96 to 170 (3%, 72 h).c Pleasingly, 
addition of formamidine 19 (10 equiv.), which is the addition product of ammonia 
                                                          
c Prebiotic synthesis of 8,2´-anhydro purine nucleosides was carried out by Dr Shaun Stairs in the  
Powner laboratory. 
130 
 
(NH3) and HCN 14, significantly improved the yield and rate of 8,2´-anhydro-
adenosine 89 synthesis. Following the addition of formamidine 19 we observed 
both more rapid elaboration of the adenine moiety and a substantially improved 
yield, such that after only 5 h incubation we observed a 65% conversion to 89. 
Conversely, addition of formamidine 19 only marginally improved the yield of 
inosine 170 (11%, 48 h) and this chemistry remained sluggish (Scheme 3.2). 
 
Scheme 3.2:  Incubation of anhydro-8-oxo-AICN-arabinoside 95 (40mM) and 
formamidine.HCl 19 (400mM) in formamide 27 after 5 h at 100 °C gave a yield of 
65% 2ʹ,8-O-anhydro-9-β-arabinofuranosyl-cycloadenosine 89. Incubation of 
anhydro-8-oxo-AICA-arabinoside 96 (40mM) and 19 (400mM) in 27 after 48 h at 100 
°C gave a yield of 11% 2ʹ,8-O-anhydro-9-β-arabinofuranosyl-cycloinosine 170.  
Aminolysis and hydrolysis of HCN 14 yielding formamidine 19 and formamide 27 
respectively (inset). 
It is of note that canonical nucleobase adenine (A) is efficiently synthesized, but 
wobble base-pairing inosine (I)200 is only ineffectually synthesized under these 
conditions. It is thought that a mechanistic change from electrophilic derivatisation 
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of the amine moiety of 95 and 96 (which have substantial vinylogous urea 15 
character, and are consequently poor nucleophiles) to the initial nucleophilic 
addition of formamidine 19 to the nitrile moiety of 95 is responsible for the 
improved reactivity and increased yield of 89 (Scheme 3.2). The difference in 
adenine and inosine nucleobase syntheses observed suggests that further 
investigation of the concomitant elaboration of aminoimidazoles 95 and 96 may 
uncover conditions leading to both anhydro-adenosine 89 and anhydro-
guanosine 90. However, though numerous attempts were made to synthesise 
anhydro-guanosine 90 from 96, at this time conversion to 90 has not been 
observed within the limits of detection. Specifically, we investigated a range of 
reactions that have been reported to yield guanine 23 from AICA-riboside 21 
(Scheme 3.3),201-203 including cyanogen 25, cyanate, cyanamide 68 or urea 15, as 
well as thiourea, thiocyanate and carbonyl sulfide in formamide at temperatures up 
to 100 °C, but 90 was not observed during screening. At this time no further 
attempts were made to synthesise 90. This is ongoing research within the Powner 
group. We decided to shift our focus to phosphorylation and chemical inversion of 
8,2´-anhydro-cyclopurines 89, 90 and 170. 
 
Reagent Conditions Yield of 23 (%) 
Cyanogen 25 0.2M, pH (8-10), 100°C, 24 h 43 
Cyanate 0.1M, pH (8-10), 100°C, 19 h 20 
Cyanamide 68 0.1M, 100°C, 20 h 1-5 
Urea 15 0.5M, 100°C, 6 d 5-10 
 
Scheme 3.3: Reported synthesis of guanine nucleobase 23 from 5-aminoimidazole-4-
carboxamide (AICA) 21 under varying (prebiotic) conditions. These conditions were 
attempted with arabinoside 96, but failed to give 8,2-anhydro guanosine 90 within the 
limits of detection by 1H-NMR. 
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Therefore to facilitate our study of the chemistry of 8,2´-anhydro purines 89, 90 and 
170, we needed to develop conventional (non-prebiotic) methods to access large 
quantities of these materials to carry out detailed studies.  
 
3.3. Conventional chemical synthesis of 8,2´-anhydro purine 
nucleosides 
 
Purine cyclonucleosides differ from canonical purines through a covalent linkage, 
either directly or via a bridging atom (O or S) between the 2´, 3´, or 5´ carbon of the 
sugar moiety and C8 carbon of the purine moiety (Scheme 3.4). These nucleotide 
analogues have been extensively studied for more than half a century, and are found 
to have a variety of chemical, chemotherapeutic, biochemical and biophysical 
properties of interest.204-209  
 
 
 
Scheme 3.4: Anhydro purine and pyrimidine cyclonucleosides 
 
Structural comparison of pyrimidine and purine cyclonucleosides suggests that the C8 
position of an 8-oxo purine could react in an analogous manner to the C2 position of 
a pyrimidine nucleosides (Scheme 3.4). For example,  one could draw comparison to 
the synthesis of anhydro-cytidine-3´-phosphate 174 reported by Nagyvary et al.210 by 
intramolecular rearrangement of 2´,3´-cyclicphosphate cytidine 171, which is induced 
133 
 
by silylation of the cyclic phosphate moiety (Scheme 3.5), Ikehara has previously 
hypothesized that “if a keto or thioketo function could be introduced into the 8 position 
of a purine nucleoside, nucleophilic attack by either of these groups on a carbon of the 
carbohydrate moiety bearing an alkyl- or arylsulfonyloxy group should give rise to a 
cyclonucleoside”.211  
 
 
Scheme 3.5: Synthesis of cytidine-arabino-3´-phosphate 174 via hydrolysis of 2,2´-
anhydro-3´-phosphate-cytidine 173, which is induced by silylation of 2´,3´-
cyclicphosphate cytidine 3.  
 
 
We set out to develop a convenient synthetic route to obtain 8,2´-cyclopurines (89, 90 
and 170) so that it can be tested for prebiotic phosphorylations.  Therefore, we sought 
to synthesize 8,2´-O cyclonucleosides by established literature procedures. Chemical 
modification of purine nucleoside at C8 is readily achieved via oxidation and Ikehara 
et al. introduced an excellent methodology for the direct C8 brominiation of purine 
nucleosides, via the direct reaction of nucleosides and bromine water with acetate 
buffer (Scheme 3.6).211  
 
 
Scheme 3.6: Near quantitative bromination of purine nucleosides by bromine water 
with acetate buffer reported by Ikehara et al.211  
 
These brominated nucleosides could then be readily converted to purine 
cyclonucleosides, but requiring multistep protecting group strategies or selective C2´-
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OH tosylation catalyzed by dibutyltin oxide.212, 213 Further development of this 
chemistry has been reported by Ogilvie et al.207, 208, 214 however, exploiting the 
commercial available arabino-adenosine 169, given the simplicity of oxidation and 
ring closure in the arabino-series, removes the complication of stereochemical 
inversion, multistep protecting group chemistry, or the use of toxic tin oxide activation 
of C2´-OH. We therefore followed the synthetic procedure reported by Ryu et al. to 
make the 8-2´-O anhydro nucleosides by treatment of arabino-adenosine 169 in 
HCl/DMF and m-CPBA 176  to give 8-chloro adenine 175, followed by silica gel-
induced cyclisation to give 8,2´-O-anhydro-arabino-adnine 89 as the sole product.215 
(Scheme 3.7). However, despite repeated attempts with acidic and neutralized silica 
and both neutral and basic alumina, we were unable to collect any cyclisation product 
89. 
 
 
 
 
Scheme 3.7: Synthesis of 8,2´-O-anhydro-arabino-adenine 89 via cyclisation of 8-
cholro-arabino-adenine 175 reported by Ryu et al.215 
Ryu et al. also reported that treatment of 8-chloro adenine 175 with 1M NH4OH or 
1M NaOH gave 89 quantitatively (by TLC analysis).215 Therefore, we next decided to 
isolate 175 by flash column chromatography (FCC), then incubate 175 under alkaline 
conditions to induce cyclisation. Following oxidation, chloroadenine 175 was isolated 
(in 35% yield). Chloroadenine 175 was then treated with 1M NaOH and purified via 
silica gel to obtain 89 (18%). Although the overall yield of the reaction (6.5%) was 
low, we were pleased to obtain an authentic sample of 8,2´-O-anhydro adenine 89. 
The charactersation data for 89 matched that presented in the literature and 89 was 
also readily recrystallised from hot water to allow for single X-ray crystallographic 
analysis to further compare the structural relationship between anhydro purine 89 and 
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anhydro cytidine arabino-73. The X-ray structure unambiguously showed the 
anhydro-O linkage and arabino stereochemistry as expected, but interestingly we also 
observed a short interaction between the 5´-hydroxyl and the C8 carbon in 89 (Figure 
3.1). This interaction compares directly with similar observations in the crystal 
structure of anhydrocytidine arabino-73. The nπ* interaction observed in arabino-
73 has previously been proposed to kinetically favour 3´-phosphorylation under 
prebiotic phosphorylation conditions.22, 117 Therefore, the observation of a similar 
nπ* interactions in anhydro adenine 89 suggested that the 8,2´-O-anhydro-
cyclopurines such as 89 may be excellent candidates for chemoselective (prebiotic) 
phosphorylations and have the required activation to forming purine 2´,3´-cyclic 
phosphate, as previously seen in the pyrimidine series.22 However, we deemed it was 
important to optimize the synthesis of 8,2´-anhydro-cyclopurines before we undertook 
an investigation of phosphorylation reactions.  
 
 
 
Figure 3.1: X-ray crystal structures of 8,2´-anhydrocycloc adenine 89 and 2,2´-
anhydrocytidine arabino-73 showing the similarity of the n  π* interaction of the 
C5´-OH into the C2 carbon atom. X-ray structure for arabino-73 reported by Powner 
et al.22 and DFT structure for arabino-73 reported by Choudhary et al.126  
 
 
Reist et al., have reported that treatment of bromo-arabinoside 177 with methanolic 
ammonia at room temperature led to the formation of 89 in good yield. 216 
Anhydropurine 89 was also obtained when 177 was treated with sodium methoxide 
(Scheme 3.7). These reaction conditions both demonstrate ester cleavage but that once 
formed the C8 anhydropurine ligation appear relatively stable to nucleophilic attack 
(by methoxide and ammonia) and 89 is described as the sole product of these 
reactions. 89 was also the sole product, when 8-azide arabinoside 178 was 
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deacetylated under similar conditions.216 The efficiency of this reaction suggest that 
significant improvement could be made to the synthesis of 89, and gave the first 
indication of a difference in reactivity between anhydrocytidine arabino-73 and 
anhydroadenine 89. Whilst adenine 89 appear to be highly stable to nucleophilic attack 
under basic reaction condition, cytidine arabino-73 is known to be highly labile and 
readily undergoes hydrolysis at the C2,2’-anhydronucleoside linkage. 
 
 
 
Scheme 3.8: A) The reaction of arabinoside 177 and 178 with ammonia or sodium 
methoxide in methanol to form 8,2´-anhydrocycloc adenine 89 via the intramolecular 
SN
2 displacement of the C8 leaving group by the C2´-hydroxyl, rather than by the 
external nucleophile (MeO- or NH3). B) Plausible mechanism for nucleophilic base-
catalysed displacement of the C8 leaving group (bromo, chloro or azide) by the 2´ 
hydroxyl to make 89. 
 
 
Our next attempt to synthesise adenine 89 was undertaken by employing a 
combination of the methods describe by Ikehara et al. for the direct bromination of 
purine nucleosides,211 and the alkaline cyclisation reported by Reist et al.216 
Commercially available arabino adenosine 169 was reacted with saturated bromine 
water in sodium acetate buffer to cleanly give 8-bromo adenosine 179 in 56% yield as 
a white powder upon (direct) crystallization from reaction mixture (Scheme 3.9). The 
bromination of 179 (56%) was promising when compared to the lower yielding 
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chlorination reported by Ryu et al. particularly given that the latter required 
purification by flash column chromatography,215 whereas the former could be isolated 
by direct crystallisation. Interestingly, however, incubation of 179 with sodium acetate 
at pH 8.0 in room temperature furnished the desired 8,2´-anhydro-arabino-
cycloadenine 89 in 73% yield. Once again 89 was observed to crystallize directly from 
the reaction (Scheme 3.9). By telescoping the oxidation and cyclisation, and through 
exploiting the remarkable crystallinity of 89, we had in hand an excellent large-scale 
strategy for the synthesis of 89. Therefore, we next tested the generality of these 
condition by investigating the synthesis of 8,2´-anhydro-arabino-guanine 90. Arabino 
guanosine 180 was again directly brominated under mildly alkaline (pH 8) condition 
to again furnish 8-bromo arabino guanosine 181 in excellent yield (80%). Cyclization 
was induced in 181 by treatment with sodium acetate buffer (1M, pH 8.0) to give 90 
(80%) as a direct crystalline precipitate from the reaction solution (Scheme 3.9). 
Unfortunately, due to the poor quality of the crystals formed we were unable to get 
single crystal data for 90 directly, and no attempt to recrystallize 90 were made at this 
time. 
 
 
Scheme 3.9: An optimised large scale synthesis of 8,2´-anhydro-cyclopurines 89 and 
90 via the facile intramolecular cyclization of 8-bromo arabino adenosine 179 and 8-
bromo arabino guanosine 181 respectively. 
 
Finally, 8,2´-anhydro-arabino-inosine 170 was also synthesised employing a 
literature procedure from adenine 89 (Scheme 3.10).217 Pleasingly, 8,2´-anhydro 
cycloinosine 170 was obtained in 68% yield as pale yellow crystalline platelets 
(Scheme 3.10). An X-ray crystal structure confirmed the identify of 170.22  
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Scheme 3.10: 8,2´-anhydro-arabino-cycloinosine 170 via nitration of 8,2´-anhydro-
arabino-cycloinosine 89 by sodium nitrite. 
It may be important to note that the synthesis of 170 from 89 is potentially prebiotic 
plausible given that nitrous acid (HNO2) can readily be synthesised from nitric oxide 
and water.45, 218 However no further investigation of the prebiotic plausibility of this 
process was undertake here. Rather, with scalable synthesise of 8,2´-anhydro-arabino-
cyclopurines 89, 90, and 170 in hand and an indication that in the solid state 89 and 
170 showed n π* orbital overlap thought to block the C5´-OH reactivity we 
proceeded to investigate the desired selective C3´-OH phosphorylation of 89, 90, and 
170. 22, 126, 219  
3.4. Isomerisation of anhydro-cyclopurines 
 
During cyclisation studies of 8-bromo-arabino-adenosine 179, a batch was 
unintentionally treated with 2M sodium hydroxide. To our surprise, this led to the 
unforeseen discovery that 179 under extremely alkaline condition led to a second set 
of nucleoside peaks in the crude 1H NMR spectra. The proton resonances were similar 
to 89, suggesting that the sugar and the nucleobase moieties were intact and 
depurination had not occurred. We predicted the new resonance were likely due to 
8,5´-anhydro cycloadenine 182, because the C5´-proton resonances of the new 
product were more downfield shifted than those of 89, and the isomerisation of 89 to 
182 would be the final outcome of the reaction of 5’-OH with C8 which is 
foreshadowed by the nπ* interaction observed in the crystal structure of 89.  
We isolated the unknown nucleoside in 34% yield by flash column chromatography 
and obtained full characterisation data. However, we were unable to assign rational 
structures data to the predicted 8,5´-nucleoside 182. In the meantime, an analytically 
pure sample of the unknown was obtained by recrystallization and submitted for x-ray 
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diffraction studies demonstrating that under these highly alkaline conditions 
intramolecular rearrangement had occurred to furnish the epoxide moiety of 2´,3´-
cyclonucleoside 183 (Scheme 3.11A). Indeed these structures had previously been 
reported (Scheme 3.11B).220, 221  The confirmation that the 8-oxo-epoxy adenine 
arabinoside 183 was observed upon isomerisation of purine cyclonucleoside 89, and 
remarkable stability of anhydropurine, such as 89 to  alkaline hydrolysis prompted us 
to increase our understanding of isomerisation in purine cyclonucleosides. 
 
Scheme 3.11: A) X-ray structure of 2´,3´-8-oxy-adenosine 183 is shown to confirm 
the identity of the unknown nucleoside formed during incubation of 89 under 
extremely alkaline conditions. Structure of 8,5´-anhydro-arabino-cycloadenine 182 
(inset). B) Nucleophilic attack of the C2´-hydroxyl on the C3´-Cl moiety to yield 2´,3´-
cycloadenosine (67%) in methanol, at 0°C for 48h reported by Russell and Benitez. 
98,99 
Rees et al. have shown that treatment of 8,2´-anhydro-arabino-cycloadenine 89 with 
1.25M sodium hydroxide furnished 2´,3´-anhydro-8-oxyadenosine 183 in excellent 
yield (88%).222 They have also shown that conversion of 89 into 183 is reversible. 
Furthermore, Ikehara and Ogiso, have reported conversion of 89 into 8,5´-anhydro-
cycloadenosine 182 with 0.01M aqueous sodium hydroxide and also suggest that this 
reaction is reversible.223 Enlightened by the reports of Rees and Ikehara, we decided 
to reinvestigate this interconversion. 1H NMR spectroscopic analysis of the incubation 
of 89 (20mM) at pH 11 at 40°C for 24 h indicated that 8,5´-anhydro-cycloadenine 182 
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(35%), 89 (55%) and 183 (7%) had been obtained. We repeated the above reaction 
and isolated 182 (11%) as white prismatic crystals, and the structure of 182 was 
confirmed by X-ray analysis (Scheme 3.12A). Observing the formation of 8,5´-
anhydro linkage in the isomerisation of 182 was deemed to be of significant interest 
suggesting a possible method to get to the native purine nucleotides from 8-oxo 
purines (via the reductive cleavage of the 8,5´-linker, Scheme 3.12B), a topic that will 
be discussed later in this thesis.  
 
Scheme 3.12: A) Plausible mechanism for interconversion of 8,2´-anhydro 
cycloadenine 89 between 2´,3´-anhydro-8-oxo cycloadenine 183 and 8,5´-anhydro 
cycloadenine 182 under strong alkaline conditions. B) A postulated  reaction of 8-
oxy-2´,3´-cyclic phosphate adenosine 93 to form native 2´,3-cyclicphosphate 
adenosine 1 via the reductive cleave of 8,5´-anhydro linkage in 184. 
To test the isomerisation of 8,2´-anhydro-arabino-cycloadenine 89 in highly alkaline 
solutions, we next incubated 89 at pH 13 for 24 h at 40°C. 1H NMR analysis of the 
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mixture now showed that residual 89 (12%), was accompanied by 8,5´-anhydro 
cycloadenine 182 (20%) but now predominately 2´,3´-anhdyro-8-oxo cycloadenine 
183 (60%). Although Rees was unable to detect any 182 at pH 13, we were able to 
observe 20% 182 in our reaction. Indeed, we were surprised to observe both isomers 
182 and 183 in our reactions, since Ikehara and Rees had both reported the observation 
of only one isomer 182 or 183 respectively (Figure 3.2).  
 
Figure 3.2: 1H NMR (600, MHz, 3.4 – 6.8 ppm) showing isomerisation of 
anhydropurines.  8,2´-anhydro-arabino-cycloadenosine 89 (20mM) was incubated at 
pH 11 at 40°C.  A) Reaction after 24 h showing a mixture of 89 (55%), 8,5´- anhydro-
arabino-cycloadenosine 182 (35%) and 2ʹ,3ʹ-epoxy-arabino-8-oxoadenosine 183 
(7%).  The pH was increased to 13 and the reaction was again incubated at 40°C.  B) 
Reaction after 2 h showing a mixture of 89 (12%), 182 (20%) and 183 (60%). 
 
The isomerisation of 89 under alkaline condition (> pH 11), albeit the conditions being 
more alkaline than reasonable for prebiotic reactivity, are of note because of the 
intricate remarkable stability of the anhydropurine structures (89, 90 and 170) to 
hydrolysis. Conversely, the prebiotic synthesis of activated pyrimidine 
ribonucleotides requires the careful pH buffering at pH < 7, to avoid the deleterious, 
and rapid, hydrolysis of 2,2´-anhydrocytidine arabino-73 to arabino-cytidine 185 
(Scheme 3.13). This switch in stability was deemed to be of significant interest 
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because hydrolysis of arabino-73 to 185 has also been observed upon (prebiotic) urea-
mediated phosphorylation of arabino-73, and this hydrolysis prevents intramolecular 
C2-inversion and synthesis of 2´,3´-cyclic phosphate cytidine 3, and accordingly 
contribute to a major pathway for loss of prebiotic ribo-cytidine nucleotides during 
their synthesis. However, our studies have confirmed that 8,2´-anhydro-arabino-
cyclopurines, such as 89, are remarkably resistant to hydrolysis. Even upon extended 
incubation at elevated pH, 89 was not observed to not undergo hydrolysis. Instead, 89 
undergoes isomerisation to 8,5´-anhydronucleoside 182 (55%, pH 11, 40°C, 24 h) and 
2´,3´-anhydronucleoside 183 (60%, pH 13, 40°C, 24 h) (Scheme 3.13 and Figure 3.2). 
It was therefore anticipated that the isomerisation mechanism, which protected 89 
from alkaline hydrolysis, may also protect 89 from hydrolysis under prebiotic 
phosphorylation conditions. 
Scheme 3.13: Comparing the hydrolysis of pyrimidine ribonucleotides at pH 6.5-13. 
8,2´-Anhydro-arabino-cycloadenosine 89 does not hydrolyse under basic conditions 
(pH 10-13, 40°C) to give 186, but instead 89 isomerises to yield 8,5´-
anhydronucleoside 182 and 2´,3´-anhydronucleoside 183 (green). 2,2´-
Anhydrocytidine arabino-73 readily undergoes hydrolysis above pH 7 at rt to yield 
arabino-cytidine 185 (red), hence the prebiotic synthesis of pyrimidine 
ribonucleotides requires inorganic phosphate to maintain pH at 6.3.22  
With an optimised and large scale reproducible synthesis of 8,2´-anhydro cyclopurines 
(89, 90 and 170) and the knowledge that cyclopurines isomerise under highly alkaline 
conditions, forming 5´-8-O (182) or 3´-O-2´ (183) linkages, we next sought to 
investigate the phosphorylation and chemical inversion of these anhydro cyclopurines.  
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4. Phosphorylation and stereochemical 
inversion of anhydro cyclonucleosides 
 
The next vital step of this project was to investigate the prebiotic phosphorylation of 
8,2´-anhydro cyclonucleosides 89, 90, and 170 to furnish 8-oxo-2´,3-cyclphosphates 
93, 94, and 187 respectively (Scheme 4.1).  
 
Scheme 4.1: Proposed prebiotic phosphorylation of anhydronucleosides 89, 90 and 
170 yielding 8-oxo-2´,3-cyclphosphates 93, 94, and 187 respectively. 
Water is the most obvious solvent for prebiotic chemistry because it is the most 
abundant on Earth and has excellent physiochemical properties that enable it to solvate 
a broad spectrum of polar compound across a very large temperature range.224 
However, phosphorylation is formally a dehydration reaction, which engenders a 
number of challenges for aqueous phosphorylation.225, 226 The most widely exploited 
approach to the deal with the problem is the activation of orthophosphates with 
condensing agents such as cyanamide or cyanogen,227 and polyphosphate, such 
cTMP.81, 82, 228, 229 However, a more simple approach to the challenge of prebiotic 
phosphorylation is to avoid or limit the water activity in the system, through 
evaporation. Dry state phosphorylations, using simple orthophosphates as the source 
of phosphate, have been used extensively in the prebiotic synthesis of nucleotides.22, 
230-234 Ponnamperuma and Mack demonstrated phosphorylation yields (16%, 2h, 
160°C) for a series of nucleotides (including adenosine, guanosine, uridine, cytidine 
and thymidine).232 However, experiments at moderate temperatures (65-85°C) require 
several months to achieve similar results. The results were slightly improved by the 
use of ammonium phosphates, as evaporation of ammonium phosphates causes loss 
of ammonia and then provide an acidic environment for relatively faster 
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phosphorylations.234 However, the most important contribution to this area was 
realised when Lohrmann and Orgel incorporated urea in the phosphorylating 
mixture.231 
 
Scheme 4.2: Dry state phosphorylation of nucleosides using excess urea and 
Na2HPO4, giving a complex mixture of carbamoylated and phosphorylated 
nucleotides and nucleosides. 
Urea 15 is a classic component of prebiotic chemistry, and one of the products of 
Urey-Miller discharge experiments, has been observed in both meteorite and 
interstellar dust clouds,235 and is a by-product of pyrimidine ribonucleotide synthesis 
through the hydrolysis of cyanamide 68 under aqueous phosphate conditions.22, 146 
Importantly urea 15 melts at 140 oC to form a liquid that has excellent solvating 
properties for polar compounds and salts,38, 236, 237 and can form a part of a range of 
deep eutectic solvents and ionic liquids.230, 238  As well as urea’s remarkable solvation 
properties it is also a nucleophilic catalyst for the displacement of water from 
phosphate under mildly acidic conditions, such that in the dry state the displacement 
of water from mono-basic phosphates by urea leads to the formation of 
ureidophosphates that can propagate the reversible transfer of phosphate moieties 
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between alcohols (and water). Accordingly, Orgel reported that when water is 
evaporated from a phosphate/nucleoside/urea solution, leaving the nucleoside, 
phosphate and urea in close proximity for reaction,231 incubation (100°C, 24 h) gave 
excellent yields for phosphate incorporation into nucleotides (> 96% for pyrimidine 
nucleotides),231 but as a complex mixture of nucleotides with different 
phosphorylations patterns (Scheme 4.2). Interestingly, however, a strong preference 
for the formation of nucleotide-2',3'-cyclic phosphates and nucleotide-2',3'-cyclic-5'-
bis-phosphates was observed over extended reaction times and with excess 
phosphate.239 The exact mechanism for these phosphorylations is not known and 
Orgel proposed that the activation of phosphate was due to acid/base catalysis. 
However, it is not clear what is meant by this statement.219, 240 It is more likely that 
urea displaces water from the orthophosphate to generate an activated 
ureidophosphate intermediate 74, capable of transferring phosphate between hydroxyl 
moieties (Scheme 4.3A). This would account for both the reversibility of 
monophosphate synthesis and irreversible of cyclic phosphate synthesis.22, 225, 241 
Orgel also reported that carbamoylation was a major by-products in these urea 
mediated phosphorylations, but that addition of ammonium suppressed the 
carbamoylation of alcohols and the nucleobases. The carbamoylation is most likely 
due to the release of ammonia under elevated temperatures, to form the reactive 
intermediate, isocyanate 26, which readily reacts with hydroxyl and amines (Scheme 
4.3B).  
 
Scheme 4.3: Plausible mechanism for urea mediated phosphorylation and 
carbamoylation. A) Phosphorylation:  urea eliminates water from the orthophosphate 
to generate an activated ureidophosphate transient intermediate 74, which transfers 
phosphate to hydroxyl groups. B) Carbamoylation: Thermal decomposition of urea 
146 
 
releases ammonia and form isocyanate 26, which readily reacts with the nucleophile 
to form carbamoylated compounds. 
 
The widely accepted prebiotic synthesis of pyrimidine ribonucleotides utilises Orgel’s 
dry state phosphorylations to furnish 2´,3´-cyclic pyrimidine ribonucleotides, however 
with greater selectivity than free nucleosides (Scheme 4.4).22 The key to these 
reactions was thought to be the use of cyclonucleosides (2,2´-anhydrocytidine 
arabino-73) for phosphorylations instead of ribonucleosides.22 Efficient 
phosphorylation of arabino-73 is achieved by drying an aqueous solution 
of arabino-73, urea and inorganic phosphate. Phosphorylation is then observed to 
be selective for the 3′-OH, leading into intramolecular rearrangement via 75 to the 
cytidine-2′,3′-cyclic phosphate 1 with the desired β-ribo-stereochemistry. Both 
kinetic and thermodynamic properties of this system control are thought to control 
the regioselectivity; nπ* donation suppresses nucleophilicity of the C5′-hydroxyl 
and monophosphate synthesis is reversible, whereas 2′,3′-cyclic phosphates are 
generated by a different (associative phosphoryl transfer)  mechanism and are 
synthesized irreversibly.126, 146, 219, 231100, 242 
 
Scheme 4.4: Selective urea-mediated 3´-phosphorylation of pyrimidine 
anhydronucleoside arabino-73 giving β-2´,3´-cyclic phosphate cytidine 3 via the 
intramolecular cyclisation of the oxygen atom in the 3´-phosphate, β-2´,3´-cyclic 
phosphate.  
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4.1. Phosphorylation of 8,2´-anhydro-cyclopurines 
 
Based on the prebiotic synthesis of activated pyrimidine ribonucleotides22 and our x-
ray crystallographic data of 89 and 170 (Scheme 4.1), we hypothesised that treatment 
of 8,2´-anhydro purines (89, 90 and 170) with orthophosphates in urea/formamide will 
chemoselectively phosphorylate 3´-OH, due to thermodynamic and kinetic effect. 
Kinetically, phosphorylation on 3´-OH is favoured because of an nπ* 
stereoelectronic effect between the 5´- oxygen atom and C8 carbon atom of 8,2´- 
cyclopurines (89, 90 and 170), reducing electron density in 5´-O and reducing its 
electron density and increasing the steric encumbrance relative to the secondary 3´-
OH.126 Thermodynamically, 3´-phosphorylation will be favoured because the 3´-
phosphates can form cyclic phosphates which are stable to these reaction condition, 
however the 5´-phosphate cannot form a cyclic phosphate and can therefore undergo 
dissociative phosphate transfer (back to urea to form ureidophosphate intermediate 
74).243 We also hypothesised that the yields of 2´,3´-cyclic phosphates in purines 
ribonucleotides will be greater than in pyrimidine series due the suppression of purine 
C2 hydrolysis (see Section 3.3).  
4.2. Synthesis of β-8-oxo- 2´,3´-cyclic phosphate purine 
ribonucleotides 
 
We first investigated the phosphorylation of 8,2´-anhydro adenosine 89. We started 
the investigation by repeating the fibre glass disc experiments reported in the 
phosphorylation of pyrimidine ribonucleotides, in which fibre glass discs are used to 
stimulate dry surface and maximise surface area to facilitate drying.22 However when 
89, ammonium dihydrogen phosphate (1 equiv), and urea 15 (10 equiv) were 
dissolved in water (Method A of phosphorylation, see Experimental) and the resultant 
solutions were dried onto glass fibre disc after evaporation (40°C, 24h) and then 
heated at 100°C for 24 h, very disappointingly we were unable to detect any 
observable phosphorylation of 89 by 1H or 31P NMR spectroscopy. As purine 
ribonucleosides are significantly less soluble than pyrimidine ribonucleosides, and we 
had observed the readily crystallisation of 89, 90 and 170 from dilute aqueous 
solution, it occurred to us that substrate precipitation may be inhibiting this reaction. 
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Therefore, a prebiotic polar organic solvent, mixed with water, might increase 
solubility of 89 (during drying) and allow 89 be solvated in the urea/phosphate 
mixture. Formamide 27, the simplest naturally occurring amide (and the first 
hydrolysis product of HCN 14) has previously been used in prebiotic phosphorylations 
and has excellent miscibility with water,22, 242 and was chosen as our co-solvent. 
Formamide 27 can also be prebiotically produced from ultraviolet irradiation of icy 
mixtures of HCN 14, NH3 and H2O,
244 or pyrolysis of mixtures of carbon monoxide 
(CO), NH3 and H2O.
245 Furthermore, formamide 14 has been detected in numerous 
abiotic environments including planets, satellites, meteorites, gas clouds and even dense 
stars.246-248 Therefore the phosphorylation was repeated (Method B of phosphorylation, 
see Experimental), however in water/formamide (5:1) solution and pleasingly, 1H 
NMR analysis of the product mixture showed clearly that 89 had undergone 
transformation to two major and several minor species (Figure 4.1A). Inspection of 
the 31P NMR confirmed 45% phosphorus incorporation as 2´,3´-cyclic phosphates by 
the highly characteristic downfield shifted 31P NMR resonance (18-25 ppm) that is 
indicative of 2´3´-cyclic phosphates, as well as mono- and bis-phosphates species 
(Figure 4.1B). 
Figure 4.1: 1H and 31P NMR showing formation of complex mixture for the dried 
down phosphate reaction of 8,2´-anhydro-arabino-cycloadenine 89, which used 
water/formamide solution adsorbed onto glass fibre discs (Method B of 
phosphorylation). A) 1H NMR (400 MHz, D2O, 3.9 – 6.7 ppm) showing 
phosphorylation of 89 giving a mixture of complex species. 89 cannot be detect in the 
1H NMR. B) 31P NMR (162 MHz, D2O, -15 – 30 ppm) showing 2´,3´-cyclic phosphate 
species, mono and bis phosphorylated species.  
The successful phosphorylation of 89 under these conditions (Method B, See 
Experimental),  gave us optimism that the 8-O-2´ anhydro linkage can be exploited 
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for chemical inversion and phosphorylation, as seen in the prebiotic synthesis of 
pyrimidine ribonucleotides.22 However the 1H and 31P NMR for the mixture was 
complex and challenging to extract further specific information about the identities of 
the unknown 2´,3´-cyclic and mono phosphates, therefore a thorough investigation of 
the mixture was required. It was predicted that initially β-8-oxo-2´,3´-cyclic phosphate 
adenine 93 was formed in the reaction via the cyclisation of 3´-phosphate, 93 then 
undergoes bis phosphorylation and/or carbamoylation, this giving rise to a complex 
mixture of carbamoylated and phosphorylated nucleotide 2´3´cylcic phosphates. 
Although Orgel reported the observation of carbamoylation during dry 
phosphorylations of nucleosides, no data is available for these compounds, and 
therefore isolation and purification of the nucleotide mixture was necessary. 
The dry state phosphorylation was scaled up using the formamide/water (5:1) 
solvation system (Method B phosphorylation in the experimental section) and purified 
by HPLC to reveal five major compounds, in agreement with the 31P NMR of the 
crude mixture, which also showed 5 peaks in 23 ppm region associated with 2´,´3-
cyclic phosphates. Pleasingly, all 5 nucleotides were successfully isolated as white 
crystalline solids (Figure 4.2). 1H and 31P NMR spectroscopy analysis revealed that 
all 5 compounds were 2´,3´-cyclic phosphates of 8-oxo-adenosine. The presence of 
2´,3´-cyclic phosphate was could be readily confirmed by 31P-HMBC NMR 
spectroscopy, which clearly showed coupling of C2´-H and C3´-H with phosphorus 
for all 5 compounds. Furthermore, 31P also coupled with 13C, and pleasingly 
phosphorus-carbon coupling was also observed in 13C NMR spectroscopy of all 5 
compounds.249 To narrow down the identification process, high resolution mass 
spectroscopy analysis was also used to assign the functional groups and the presence 
of oxo-moiety at C8 was confirmed by the appearance of a sharp peak at 1650 cm-1 in 
IR spectrum. 
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Figure 4.2: A) Dry state phosphorylation of 8,2´-anhydro-cycloadenine 89 by 
inorganic phosphate in the presence of urea (Method B of phosphorylation) furnishing 
60% 2´,3´-cyclic phosphate adenines. The individual yields shown are only for 2,´3-
cyclic phosphates determined by the HPLC trace. Postulated mechanism for 
activation of phosphate by urea (inset). Enrichment of the nucleotidic mixture with β-
8-oxo-2´,3´-cyclic phosphate adenosine 93 by hydrolysis and aminolysis of acyclic 
phosphates (188 and 189) and carbamoylated species (190 and 191) respectively. The 
colour scheme for the arrows is as follow: phosphorylation, carbamoylation, 
aminolysis and hydrolysis. 
Interestingly 1H NMR analysis indicated that all 4 compounds, with exception of 93, 
had downfield shifted C5´-proton resonances (4.0-4.2 ppm, normally 3.7-3.9 ppm), 
indicating attachment of an electron withdrawing group at C5 and high resolution 
mass spectroscopy indicated these to be either carbamoylation (CONH2) as 
compounds 189 and 191 or phosphorylation (HPO3
-) in compounds 188 and 189 
(Figure 4.3). Further evidence for the structure of 188 and 189 was found in the dt 
(doublet of triplets) splitting pattern of the C5´-proton resonances in their 1H NMR 
spectrum indicating a 1H and 13P coupling (which was confirmed by 1H-31P HMBC 
cross coupling patterns), while C5´-H signal for 190 and 191 showed the characteristic 
ABX system, inherent in C5´-OH coupling of nucleoside moieties. Finally, the 
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downfield shift observed of the nucleobase C2-proton in compounds 190 and 191 
suggested that N6-carbamoylation had likely occurred.  
 
Figure 4.3: 1H NMR (600 MHz, D2O, 3.7-8.3 ppm) for β-8-oxo-2´,3´-cyclic phosphate 
adenine 93 and its bis phosphorylated and carbamoylated products (188-191). The 
products were isolated from the nucleotidic mixture of the dry state phosphorylation 
of 89. The downfield shift in C5´-H is due to presence of HPO3
- or CONH2 is clearly 
shown,as well as a visibly downfield shift of C2-H by the carbamoylation of NH2 in 
the nucleobases of 190 and 191. 
Although the dry state phosphorylation (Method B) of 8,2´-anhydro-arabino-
cycloadenione 89 produced a mixture of nucleotides (188-191), all the derivatives 
produced were 2´,3´-cyclic phosphates and other derivatives are deemed to be 
reversible to the core nucleotide 93.83, 225, 231, 239 Orgel et al. reported that use of 
ammonium salts in dry phosphorylation supressed carbamoylation.231, 239 Therefore 
we repeated the dry down phosphorylation experiment (Method C of phosphorylation 
in experimental) with the addition of ammonium chloride (1 equiv) to the 
phosphorylating mixture. Now 31P NMR analysis indicated that only two major 2´,3´-
cyclic products (presumably 93 and 188) were formed, alongside two other minor 
products thought to be acyclic nucleotides of adenine. Importantly, however, a 
significant decrease in the carbamoylation of 89 was observed.  
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The dry state phosphorylation of 89 (Method B) furnished approximately 30% more 
2´,3´-cyclic phosphates than the phosphorylation of adenosine as reported by Orgel.231 
However, in order to further increase the yield and selective of these phosphorylation, 
as well as reduce the reaction time to expedite further investigation, we decided to 
directly explore phosphorylation in a urea melt. Urea 15 melts have been employed as 
a solvent since 1950 and are observed to yield water-like solvation properties.236 Urea 
melts have also found use in the prebiotic synthesis of polypeptides.250 Accordingly 
we set out to investigate phosphorylation in urea-melts. A rapid screen of urea 
stoichiometry and melting temperatures indicated that the optimal conditions for 
phosphorylation required a large excess of urea 15 and incubation at 140°C, under 
these condition (for example when 8,2´-anhydro cycloadenine 89, ammonium 
dihydrogen phosphate (1 equiv.) and urea 15 (27 equiv.) were heated at 140°C 
(Method D)), 1H and 31P NMR spectroscopic analysis revealed that 22% 93 and 33% 
188 where synthesised in only 20 minutes (Figure 4.4).  
 
Figure 4.4: 1H - 31P HMBC NMR spectrum (400/162 MHz, D2O, 3.75 – 6.25; -2.0 – 
23.0 ppm) to show phosphorylation of 2ʹ,8-anhydro-arabino-cycloadenosine 89 by 
method D. 
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To investigate the practicality of formamide 27 solvent system in the prebiotic 
phosphorylation of 8,2´-anhydro cyclopurines, of 8,2´-anhydro adenosine 89, 
ammonium dihydrogen phosphate and urea were dissolved in formamide 27. The 
reaction mixture was heated to 100°C for 48 h (Method E of phosphorylation in the 
experimental section). Pleasingly, phosphorylation of 8,2´-anhydro cycloadenosine 89 
in formamide was very selective, furnishing 20% 93 and only 3% 188 (Scheme 4.5).  
 
Scheme 4.5: Phosphorylation of 2ʹ,8-anhydro-arabino-cycloadenosine 89 by method 
E. 
Having developed our model urea-mediate phosphorylation methods for cycloadenine 
89, we next investigated the phosphorylation of cycloguanosine 90 and cycloinosine 
170.  
 
Figure 4.5: Phosphorylation of 8,2´-anhydro cycloguanosine 90 using method D and 
E furnishing  β-8-oxo-guanine-2´,3´-cyclic phosphate 94 (41%, 18% respectively) and 
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β-8-oxo-guanine-2´,3´-cyclic-5´-bisphosphate 193 (23% and 14% respectively) also 
showing 1H NMR (600 MHz, D2O, 3.5-8.3 ppm) of HPLC purified 90 and 193. 
 
Following method D, cycloguanosine 90 was phosphorylated to furnish β-8-oxo-
guanine-2´,3´-cyclic phosphate 94 and β-8-oxo-guanine-2´,3´-cyclic-5´-bisphosphate 
193 in 41% and 18% yield respectively. To investigate phosphorylation of 8,2´-
anydro-arabino-cyclo guanosine 90 in formamide 27 solution, 89 was exposed to 
phosphorylating conditions of method E. Pleasingly, 1H and 31P NMR studies 
indicated, 23% 94 and 14% 193, giving an overall phosphorus incorporation of 37%. 
The cyclic phosphates of guanosine 94 and 193 were purified via HPLC and full 
characterisation data was obtained. NMR data of 94 and 193 was also compared with 
β-8-oxo-adenine-2´,3´-cyclic-5´-bisphosphate 93 and β-8-oxo-adenine-2´,3´-cyclic-
5´-bisphosphate 188 respectively to confirm structures of 94 and 193 (Figure 4.5).  
Next we concentrated on the phosphorylation of 8,2´-anhydro-arabino-cycloinosine 
170. Remarkably, application of method D and E on 170 give total 2´,3-cyclic 
phosphates in 70% and 57% yields respectively (Figure 4.6).  
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Figure 4.6: Phosphorylation of 8,2´-anhydro cycloinosine 170 using method D and E 
furnishing  β-8-oxo-inosine-2´,3´-cyclic phosphate 187 (38%, 32% respectively) and 
β-8-oxo-inosine-2´,3´-cyclic-5´-bisphosphate 194 (32% and 25% respectively) also 
showing 1H NMR (600 MHz, D2O, 3.5-8.3 ppm) of HPLC purified 187 and 194. 
The incredible 70% phosphorus incorporation in 170 once again show that the obvious 
prebiotic phosphorylation route must have proceeded via the chemical inversion of 8-
O-2´ linkage in cyclo anhydro nucleosides and not via the phosphorylation of 
nucleosides (cytidine, uridine, adenosine, guanosine and inosine) which are 
unselective and low yielding. Inosine is a wobble base pair.200 Wobble base pairs play 
a fundamental role in RNA secondary structures and for the correct translation of the 
genetic code. Thermodynamically wobble base pair can be compared with Watson-
Crick base pairing. Furthermore the incredible similarity (only differing by oxidation 
states) of inosine to adenosine and guanosine make inosine worthwhile candidate of 
prebiotic chemistry.  
It was deemed necessary to repeat Powner et al. phosphorylation of 2,2´-
anhydrocytidine arabino-73 under the conditions applied to purine 89, 90 and 170. 
These studies will be important if a one pot prebiotic synthetic route of both purine 
and pyrimidine ribonucleotides is to be pursued, a topic that will be discussed later on 
in this thesis.   Pleasingly, methods A, B, D and E all gave comparable 
phosphorylation yield to those previously report by Powner et al., giving a total 2´,3-
cyclic phosphate incorporation of 30, 46, 65 and 48% respectively (Figure 4.7). 
 
Method β-cytidine-2´,3´-cyclic 
phosphate 3 (%) 
β-cytidine-2´,3´-cyclic-5´ 
bisphosphate 195 (%) 
Total 2´,3´ P (%) 
A 18 12 30 
B 35 11 46 
D 47 18 65 
E 30 18 48 
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Figure 4.7: Incubation of 2,2´-anhydro cytidine arabino-73 utilising method A, B, D 
and E. Table to show yields of β-cytidine-2´,3´-cyclic phosphate 3 and β-cytidine-
2´,3´-cyclic-5´ bisphosphate 195 under A, B, D and E. 
 
 4.3. Phosphorylation of β-2´,3´-epoxy-8-oxo-adenine 
 
During our studies of cyclopurines we observed that cycloadenine 89 is remarkably 
resistant under alkaline conditions (Section 3.2). Even upon extended incubation at 
elevated pH 89 was not observed to undergo hydrolysis, instead, 89 undergoes 
isomerisation to 8,5´-anhydronucleoside 182 (55%, pH 11, 40°C, 24 h) and 2´,3´-
anhydronucleoside 183 (60%, pH 13, 40°C, 24 h) (Figure 3.9A). Given these observed 
isomerisation (albeit only at extreme pHs) we deemed it prudent to investigate 
phosphorylation of these isomers. It was hypothesised that 182 and 183 would 
undergo isomerisation with 89 under the condition of phosphorylation to re-establish 
the C2’-O-C8 linkage leading to the same (or similar) product distribution observed 
for the phosphorylation of 89. There is also literature precedence for formation of both 
N3-C2´ and N3-C3´ bond in cyclopurine ribonucleosides, albeit under conventional 
organic chemistry conditions (Scheme 4.6).199, 205, 251, 252  
 
Scheme 4.6: N3-C2´ and N3-C3´ bond in cyclopurine ribonucleosides. 
 
However, upon C3’-OH and C2’-OH phosphorylation, respectively, the N3-
anhydronucleotides would also be anticipated to undergo intramolecular 
rearrangement to furnish 2’,3’-cyclic phosphates. To examine our hypothesis, the 
epoxide 183 was exposed to phosphorylation conditions of method D. Pleasingly, 1H 
and 31P NMR spectroscopic analysis both showed formation of 2´,3´-cyclic phosphate 
(in 23% yield; as a mixture of adenines 93 and 188) (Figure 4.8).  
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Figure 4.8: Phosphorylation of isomers of 8,2´-anhydro adenine 89. A) 
phosphorylation (Method D) of epoxy 2´,3´-anhydro adenine 183 to form β-8-oxo-
2´,3´-cyclic phosphate adenine 93 and  β-8-oxo-2´,3´-cyclic-5´ bisphosphate adenine 
188. B) 31P NMR (162 MHz, D2O, -25 – 40 ppm) showing ~ 23% 2´,3´-cyclic 
phosphates (assumed to be 93 and 188. C) 1H NMR (400 MHz, D2O, 3.5 – 6.3 ppm) 
for phosphorylation of 183 via method D, C2´-H and C3´-H coupling with phosphorus 
can also be observed.  
The phosphorylation mechanism is thought to proceed either with re-equilibration 
with 89 and subsequent C3’OH phosphorylation or by nucleophilic addition of purine-
N3-nitrogen atom to C3´ carbon and concomitant epoxide ring opening, to form 196. 
The newly formed 2´-OH in 196 can then be phosphorylated and by a second SN
2-type 
nucleophilic attack of the C2´-phosphate at C3’ carbon atom, formation of β-8-oxo-
adenine-2´,3´-cyclicphosphate 89 would be achieved by a double stereochemical 
inversion at C3’ stereo-centre (Scheme 4.7). 
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Scheme 4.7: Plausible mechanism for phosphorylation of 2´,3´-epoxy adenosine 183 
with inorganic phosphate in the presence of molten urea or formamide solvent.  
Due to time limitation, this topic is outside the scope of this thesis, and no further 
investigation of the specific mechanism for phosphorylation of 183 was undertaken. 
However our results indicate that prebiotic phosphorylation of 2´,3´-epoxy adenosine 
183 yield 2´,3´-cyclic phosphates, further demonstrating the predisposed nature of the 
2´,3´-cyclic phosphate moiety under urea-mediated phosphorylation conditions. 
4.4.  5´ 3´ phosphorus migration in 5´-phosphate 
cyclonucleotides  
 
During our phosphorylation studies we were unable to apply method A or B to 
cyclopurines due to solubility issues during the drying phase of the reaction process. 
It therefore occurred to us that 5´-phosphorylation of these cyclopurines may increase 
their solubility in water due to ionic nature of the phosphate moiety. Moreover, we 
hoped that phosphoryl transfer across the nucleotide (5´-phosphate to 3´-phosphate) 
would give superior phosphorus integration. We suspected that the same methodology 
we had already developed for the synthesis of 8,2´-anhydro purines could be directly 
used to synthesis its 5’-phosphorylated analogues. 
Therefore we next incubated commercially available arabinose adenine 9-β-D-
arabinofuranoside-5´-monophosphate 198 in sodium acetate buffer at room 
temperature was treated with saturated bromine water, to oxidatively brominate the 
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C8 carbon atom. Cyclisation was induced at pH 8.0 upon addition of NaOH to produce 
8,2´-anhydro-arabino-5´-phosphate adenine 200. Surprisingly, crystals of 200 (63%) 
again spontaneously formed in the crude mixture as colourless sheets (Scheme 4.8).  
 
Scheme 4.8: Direct bromination of arabino-5´-phosphate adenosine 198 in bromine 
water to yield 8-bromo-arabino-5´-phospahte adenosine 199 which cyclizes under 
mild alkaline conditions to furnish 8,2´-anhydro-arabino-5´-monophosphate adenine 
200 (63%) via the elimination of bromine. 200 spontaneously crystalizes from the 
crude solution. 
Spontaneous crystallisation is an excellent prebiotic tool for purification.134 However 
we were surprised to observe 200 crystallise directly from aqueous solution, 
phosphorylated compounds usually being highly soluble as their sodium salts in water 
and often difficult to crystallise. However, 200 rapidly precipitated from the crude 
mixture, indicating a potentially plausible prebiotic purification strategy for 5´-
phosphorylated 8,2´-anhydro purines. As expected the C5´-proton resonances for 200 
were shifted downfield and the correct multiplet splitting due to 1H-31P coupling was 
observed as well as 31P NMR and 1H-31P HMBC spectra confirming the presence of 
the C5´-phosphate in 200 (Figure 4.9).   
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Figure 4.9: Comparison 1H NMR (600 MHz, D2O, 2.2 – 9.0 ppm) of 8,2´-anhydro-
cycloadenine 89 with 200. Expanded NMR indicating 1H-31P coupling in 200 has 
shifted the C5´-H to the left (down field) and given rise to multiple splitting. 
 
Orgel had previously demonstrated that when 5´-monophosphate nucleotides are 
heated in urea 15 a mixture of nucleotide product are observed, and 2´,3´-cyclic 
phosphates are the major product. Orgel’s results suggest that 5´3´ phosphate 
migration occurs under these condition (Scheme 4.9A).231, 239 However, to our 
knowledge, there are no literature reports of 5´3´ phosphorus migration in 
cyclonucleotides. We hypothesized that incubation of 200 in urea would yield 2´,3´-
cyclic phosphates via the intermediacy of ureidophosphate complex 74 (Scheme 
4.9B). We were particularly interested by this transformation, because installing the 
phosphate on cyclonucleoside prior to dry heating would allow the accurate control of 
nucleoside/phosphate stoichiometry and likely assist in the co-localisation of 
phosphate at the site of required phosphorylation.  
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Scheme 4.9: A) Orgel’s direct heating of 5´-phosphate nucleotides in urea 15 to 
furnish 2´,3´-cycli phosphates. B) Proposed mechanism for formation of 2´,3´-cyclic 
phosphates via 5´3´ phosphoryl transfer involving ureidophosphate complex 74 
when 8,2´-anhydro-arabino-5´-monophosphate adenine 200 is heated in urea 15 in 
the absence of stoichiometric inorganic phosphate. 
 
Therefore, to test 5´3´ phosphorus migration in cyclonucleosides, 200 was put 
through phosphorylating conditions of method D (without inorganic phosphate). 
Interestingly, 31P NMR spectrum clearly indicated the formation of 2´, 3´-cyclic 
phosphate even in the absence of inorganic phosphate. The 1H NMR spectroscopic 
analysis indicated at least 2 cyclic phosphate species, presumed to be 8-oxo-2´,3-
cyclic phosphate adenosine 93 and its 5´-bisphosphorylated variant 188 (Figure 4.10).  
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Figure 4.10: 1H NMR ( 400 MHz, D2O, 3.4 – 6.4 ppm) and 31P NMR (162 MHz, D2O, 
-14–36 ppm) showing incubation of 8,2´-anhydro-arabino-5´-monophospahte 
adenine 200 in urea at 140°C for 20 min (Method D). Both NMRs are clearly showing 
formation of 2´,3´-cyclic phosphates (resumed to be 93 and 188). Pyrophosphates also 
detected in the phosphorus NMR, indicating some dephosphorylation of 200. 
 
From these initial experiments it has been demonstrated that 5´-phosphates such as 
200 can furnish 2´,3´-cyclic phosphates (Method D). This potentially opens up a 
stoichiometrically controlled way of introducing phosphorus into pyrimidine and 
purine nucleotides, however for this to happen a prebiotic synthesis of 5´-phosphate 
nucleotides is required. Prebiotic synthesis of aminooxazoline-5´-phosphates 201 has 
already been established in the Powner laboratory by oxidative phosphorylation.174 
Crucial to this synthesis is acrolein 202, which can be prebiotically synthesized from 
acetaldehyde 31 and formaldehyde 13. Acrolien 202 is also implicated in the prebiotic 
synthesis of several amino acids.253, 254 It seem possible that further development of 
this oxidative phosphorylation strategy may lead to synthesis of 5´-phosphorylated 
anhydro purines  as well as the pyrimidine that have been investigated already 
(Scheme 3.22). 
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Scheme 4.10: A plausible one pot synthesis of pyrimidines and 8-oxo purines by 
application of 5´-phosphorylation chemistry. Dashed arrows, proposed chemistry and 
solid arrows, reported chemistry.  Arabino-5´aminooxazoline 201 could also be 
synthesised via the reaction of activated thione 206 with ammonia, 206 will be acting 
as the key precursor both for pyrimidine and 8-oxo purine synthetic pathways, leading 
to a (potentially) plausible one pot (prebiotic) synthesis of pyrimidine and purine 
ribonucleotides via 5´-phosphorylated intermediates. 
4.6. Phosphorylation summary  
 
From these phosphorylation studies we have successfully established that 8,2´-
cyclopurines can be phosphorylated to furnish 8-oxo-2´,3´-cyclic phosphates in good 
yields (32-70%, Figure 4.11). We have also demonstrated that these reactions can be 
scaled up and the products isolated so that further chemistry of these valuable 
compounds can be elucidated. We have also established that 8,2´-anhydro purines are 
not prone to alkaline hydrolysis (pH 11 - 13, 40°C) instead they isomerise to furnish 
8,5´-anhydro and 2´,3´-epoxy purines. We have successfully shown that the epoxide 
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isomer also forms 2´,3’-cyclic phosphates under urea mediated phosphorylation 
conditions. 
 
 
 
 
 
 
 
 
Figure 4.11: Summary table of yields of 2´,3-cyclic phosphate formation  from of 
cyclonucleoside 89, 90 and 170 under general methods D and E.  Yields were 
calculated based on comparison with an internal standard (DSS). 
 
 
 
 
 
 
 
Anhydro-
nucleoside 
Method 2ʹ,3ʹ-cyclic 
phosphate (%) 
2ʹ,3ʹ-cyclic-5ʹ-
bisphosphate (%) 
Total 
(%) 
2ʹ,8-O-anhydro 
cycloadenosine 89 
D 22 33 55 
E 24 8 32 
2ʹ,8-O- anhydro 
cycloguanosine 90 
D 41 18 59 
E 23 14 37 
2ʹ,8-O-anhydro 
cycloinosine 170 
D 38 32 70 
E 32 11 43 
Ancitabine 
 arabino-73 
D 47 18 65 
E 44 19 63 
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5. Divergent prebiotic synthesis of activated 
pyrimidines and 8-oxo purines  
 
Given the importance of the biochemical interplay between purines and 
pyrimidines, we next sought to investigate the concomitant synthesis of both classes 
of nucleotides together. Previous attempts to find a one pot synthesis of purine and 
pyrimidine nucleotides has been unsuccessful (Section 1.7.1).128, 129, 146 We have 
already shown in this thesis that displacement of S-cyanovinyl oxazolidinone thione 
arabino-120 by aqueous ammonia gave aminooxazoline arabino-70 (section 2.5.1).  
Furthermore, it was shown that the by-product oxazolidinone thione arabino-103, 
formed during displacement reactions, can be activated with cyanoacetylene 30 to 
regenerate arabino-120 (even in the presence of arabino-70 due to increase 
nucleophilicity of thione arabino-103 with respect to aminooxazoline arabino-70). 
Subsequent to re-cyanovinylation of thione arabino-103 and displacement with 
aqueous ammonia, the yield can be up to 60% yields of aminooxazoline arabino-70, 
the key pyrimidine ribonucleotide precursor (Scheme 5.1).22  
 
 
 
Scheme 5.1: Reaction of S-cyanovinyl oxazolidinone thione arabino-120 with 
aqueous ammonia in the presence of cyanoacetylene 30 to furnish 60% 
aminooxazoline arabino-70. The thione arabino-103 produced during displacement 
reactions can be re-cyanovinylated to regenerate arabino-120. 
 
For a concomitant reaction pathway to furnish both pyrimidine and purine 
ribonucleotide it has be to established that the different components of pyrimidine and 
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purines synthesis can be synthesised together under the same conditions, and this has 
never been achieved. For example, S-cyanovinyl thione arabino-120 can be 
chemoselectively formed in the presence of aminooxazoline arabino-70, and upon 
addition of cyanoacetylene 30 (250mM) to an aqueous solution of oxazolidinone 
thione arabino-103 (240mM) and arabino-70 (240mM) at pH 7 after 1 h at room 
temperature a quantitative conversion of arabino-103 to S-cyanovinyl thione arabino-
120 was observed whilst leaving arabino-70 untouched (Figure 5.1). 
 
 
Figure 5.1: 1H NMR spectrum (600 MHz, H2O/D2O, 3.0 – 8.0 ppm) of 1:1 mixture of 
oxazolidinone thione arabino-103 and aminooxazoline arabino-70 incubated with 
cyanoacetylene 30 showing chemoselective cyanovinylation of arabino-103 to give S-
cyanovinyl oxazolidinone thione arabino-120 in the presence of arabino-70.   
 
Cyanovinylation of aminooxazoline arabino-70 to furnish 2,2`-anhydrocytidine 
arabino-73 is, however, a vital intermediate in pyrimidine nucleotide synthesis. 
Moreover, this is a delicate step during the synthesis of activated pyrimidines, 
requiring careful pH control (pH < 7). Therefore, any cohesive synthesis of purine and 
pyrimidine ribonucleotides has to also guarantee that arabino-70 can be 
cyanovinylated near neutral conditions, whilst avoiding the hydrolysis of arabino-73  
(into the undesired arabino-cytidine 185, Scheme 3.12). Therefore, the 
cyanovinylation of arabino-70 in the presence of oxazolidinone thione arabino-103 
was then tested. An aqueous solution of arabino-103  (40 mM), arabino-70  (40 mM) 
and cyanoacetylene 30 (420 mM) was incubated at pH 7 for 24 h. Interestingly, co-
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cyanovinylation of both arabino-103 and arabino-70 to yield S-cyanovinyl thione 
arabino-120 and 2,2`-anhydrocytidine arabino-73 respectively in excellent yield was 
observed (Figure 5.2). Moreover, importantly, no hydrolysis of arabino-73 or 
arabino-120 was detected, even in the absence of phosphate, suggesting coexistence 
of arabino-73  and arabino-120 en route to the synthesis of pyrimidines and purines, 
respectively. 
 
Figure 5.2: 1H NMR spectrum (600 MHz, H2O/D2O, 3.25 – 8.5 ppm) to show the 
products of incubating a 1:1 mixture of oxazolidinone thione arabino-103 and 
aminooxazoline arabino-70 with cyanoacetylene 30 (10 eq.) at pH 7 in room 
temperature leading to cyanovinylation of S-cyanovinyl thione arabino-120 and the 
formation of ancitabine arabino-73.  
Having explored the prebiotic synthesis of arabino-73 in the presence of purine 
precursors (thione arabino-103 and arabino-120), we were intrigued to investigate the 
elaboration of the purine nucleobases by displacement of thiolate group 128 in S-
cyanovinyl thione arabino-120 by 2-amino-2-cyanoacetamide 106 in the presence of 
pyrimidine precursors (aminooxazoline arabino-70 and ancitabine arabino-73). 
Therefore, next an aqueous solution of arabino-120 (250mM), arabino-70 (250mM) 
and 106 (500mM) was incubated at pH 4.5 and room temperature for 8 h. Pleasingly, 
we observed successful addition of 106 to arabino-120 whilst aminooxazoline 
arabino-70 remained completely unaffected under these conditions.  We then test 
cyclisation in the presence of aminooxazoline arabino-70. To an aliquot from the 
above mixture was added ammonium hydroxide, the solution was adjusted to pH 9 
and incubated for 24 h at room temperature. Remarkably, we observed a 28% yield of 
AICA tricyclic moiety 96 (alongside 29% oxazolidinone thione arabino-103 and 26% 
oxazolidinone arabino-77), but 94% of the aminooxazoline arabino-70 remained 
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(Figure 5.3) demonstrating that our key purine precursor 96 can be synthesised in the 
presence of the key pyrimidine precursor arabino-70. 
Figure 5.3: 1H NMR spectra (600 MHz, D2O, 3.4 – 6.6 ppm) showing reaction of S-
cyanovinyl oxazolidinone thione arabino-120 with 2-aminocyanoacetamide 106 in the 
presence of aminooxazoline arabino-70.  A) arabino-120 (250mM), arabino-70  
(250mM) and 106 (500mM) at pH 4.5 incubated at rt for 8 h.  B) An aliquot (50 µL) 
was added to ammonium hydroxide, the solution was adjusted to pH 9 with NaOH 
and incubated for 24 h at rt.  Calibration to an internal standard gave yields of 28% 
2,2ʹ-anhydro-AICA-arabinoside 96, 29% oxazolinone thione arabino-103, 26% 
oxazolidinone arabino-77, additionally 94% arabino-70  remained.  C) Spiked with 
arabino-77.  D) Spiked with arabino-103.  E) Spiked with 95.  F) Spiked with arabino-
70. 
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From these experiments we were able to successfully demonstrate that the presence 
of aminooxazoline arabino-70 in the reaction mixture has no adverse effect in the 
synthesis of AICA 96. Next, we sought to investigate the formation of AICA 96 in the 
presence of 2`.2-anhydrocytidine arabino-73.  
 
Figure 5.4: 1H NMR spectra (600 MHz, D2O, 3.4 – 6.8 ppm) showing reaction of S- 
cyanovinyl oxazolidinone thione arabino-120 with 2-amino-2-cyanoacetamide 106 in 
the presence of ancitabine arabino-73.  A) Arabino-120 (250mM), arabino-73 
(250mM) and 106 (500mM) at pH 4.5 incubated at rt for 8 h.  B)  An aliquot (50 µL) 
was added to ammonium hydroxide, the solution was adjusted to pH 9 with NaOH 
and incubated for 24 h at rt.  Calibration to an internal standard gave yields of 23% 
2,2ʹ-anhydro-5-AICA-arabinoside 106, 19% oxazolinone thione arabino-103, 25% 
oxazolidinone arabino-77, additionally hydrolysis of arabino-73 gave 41% yield of 
arabino-cytidine 185 with 52% arabino-73 remaining.  C) Spiked with arabino-77.  
D) Spiked with arabino-103.  E) Spiked with 106.  F) Spiked with arabino-cytidine 
185.  G) Spiked with arabino-73. 
 
170 
 
 
It is important to note that arabino-73 undergoes facile hydrolysis (pH>6.5, room 
temperature) to form arabino-cytidine 185.21, 22 S-Cyanovinyl thione arabino-120 
(250mM), arabino-73 (250mM) and 106 (500mM) were incubated at pH 4.5 and room 
temperature for 8 h, after which we observed the successful nucleophilic addition of 
106 into arabino-120, whilst 30% cytidine 185 has formed by to hydrolysis of 
arabino-73 (70% arabino-73  remained unchanged). An aliquot of the crude reaction 
mixture was added to ammonium hydroxide  and the solution to adjusted the solution 
to pH 9. This aliquot was further incubated for 24 h at room temperature. Remarkably, 
analysis of the crude 1H NMR spectrum and through spiking with authentic samples, 
we were able to observe a 23% yield of AICA 96 (alongside 19% thione arabino-103 
and 25% oxazolidinone arabino-77) additionally though hydrolysis of arabino-73 
gave 41% yield of arabino-cytidine 185, 52% of the original arabino-73 was still 
remaining in the mixture (Figure 5.4).  
 
 
Finally, a one pot phosphorylation of purine and pyrimidine anhydronucleosides 
would be required to complete the divergent synthesis of activated purine and 
pyrimidine nucleotides. In the previous section (Section 4.4) we have already 
established optimised phosphorylation conditions. Therefore, to investigate 
simultaneous phosphorylation of 8,2`-cyclopurines and 2,2`-anhydropyrimidines, 
adenine 89 and 2,2`-anhydrocytidine arabino-73 were phosphorylated together 
(Method F). 1H and 31P NMR spectroscopic analysis of the crude reaction mixture 
revealed phosphorus incorporation of 34% and 44% yields for 89 and arabino-73 
respectively (Figure 5.5).  
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Figure 5.5: 1H NMR spectrum (400 MHz, D2O, 3.65 – 6.15 ppm) showing co-
phosphorylation of ancitabine arabino-73 and 2ʹ,8-O-anhydro-cycloadenosine 89.  A) 
phosphorylation of 89 by method E .  B) Phosphorylation of arabino-73 by method E.  
C) Co-phosphorylation of 89 and arabino-70 (1:1) by method F. 
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6. Conclusion 
 
Throughout this thesis we have pursued the goal of developing a divergent synthesis 
of purine and pyrimidine nucleotides. We have been able to show that the reaction of 
glycolaldehyde 34 with thiocyanic acid 97 furnishes 2-thiooxazole 98 in excellent 
yield and its addition to glyceraldehyde 35 establishes the furanosyl ring of 
ribonucleotide in excellent yield and with excellent selectivity for the ribo/arabino 
stereochemistries in the corresponding thione (103) products. The arabino thione 
arabino-103 was then be exploited in the first divergent prebiotic synthesis of 
ribonucleotides as a precursor of both pyrimidine nucleotides (3 and 4) and 8-oxo-
purine nucleotides (93 and 187). After oxazole 98 undergoes reaction with 
glyceraldehyde 34 to yield thione arabino-103 with complete pentose selectivity, 
thione arabino-103 is activated by cyanoacetylene 30 to furnish S-cyanovinyl 
oxazolidinone thione arabino-120. A second point of divergence (following the 
derivatisation of glycolaldehyde 34 with cyanamide 68 or thiocyanic acid 97) is 
observed by the nucleophilic displacement reactions of arabino-103, which yields 
pyrimidine precursor arabino-70 upon reaction with aqueous ammonia or purine 
precursors 95 or 96 upon reaction with hydrogen cyanide oligomers (17 or 106, 
respectively). Cyanovinylation of arabino-70 yields arabino-73 and formylation of 
95 and 96 yields 89 and 170, respectively. The anhydro cyclonucleosides (arabino-
73, 89 and 170) following subsequent urea-mediated phosphorylation leads to the 
congruent synthesis of pyrimidine nucleotides (3 and 4) and 8-oxo-purine nucleotides 
(93 and 187).  
In conclusion, we have demonstrated a synthetic relationship between pyrimidine and 
purine nucleotides by constructing both heterocycles on the same sugar scaffold. It is 
also of note that glycine nitrile adduct 146, which is not at the correct oxidation level 
to yield an aminoimidazole, was not observed to undergo cyclization; we only 
observed cyclization in hydrogen cyanide trimers 17 and 106 adducts forming the core 
imidazole motif of the purines (95 and 96). These highly selective cyclizations point 
towards a renewed investigation of prebiotic synthesis of aminonitrile 17,92, 255   which 
is a pitfall of HCN 14 oligomerisation. The recent reports of the “cyanosulfidic 
protometabolism” system chemistry by Sutherland and colleagues which avoids the 
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traditional uncontrolled high-pH formaldehyde oligomerisation during prebiotic C2 
and C3 sugar synthesis,
92 proposes that similar redox coupling network reactions may 
be used to synthesise HCN oligomers such as 17 and 106. The chemoselective 
(prebiotic) reduction of the 8-oxo-purine ribonucleotide-2′,3′-cyclic phosphates (93, 
94 and 187) to the canonical ribonucleotides 1, 2 and 207 is currently being 
investigated in the Powner laboratory (Scheme 6.1).  
 
 
Scheme 6.1: A summary of divergent prebiotic synthesis of pyrimidine and 8-oxo 
purine ribonucleotides. Plausible reductive cleavage of 8-oxo-2´,3´-cyclic phosphate 
purines 93, 94 and 187 furnishing native purine ribonucleotides 1, 2 and 207 is to be 
explored for future work (inset).   
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7. Further Future Work 
 
It is hypothesised that 8,2`-anhydro-S-purines may provide a possible solution for 
conversion of 8-oxo purines to natural purine ribonucleotides. Interestingly, the 
chemistry anticipated to yield 8,2`-anhydro-S-purines (212 and 213) may follow a 
very similar strategy to the chemistry that has been already described in this thesis, 
differing only by the introduction of sulfur at C2`. There is some literature precedence 
for the synthesis of 8,2`-S-anhydro nucleosides using conventional organic 
synthesis,208, 256 and these reactions would be a good starting point to investigate the 
phosphorylation and desulfuration of 8,2`-S-anhydro nucleosides, before embarking 
on the elucidation of a prebiotic synthesis of 212 and 213. However, tentatively it 
could be proposed that the thiozolidines 209 and 2-thiothiazole 208 that have also 
been reported in the literature,257, 258 may be chemical precursors of 212 and 213 
(Scheme 7.1). 
 
Scheme 7.1: Plausible prebiotic route for one pot synthesis of RNA and DNA purine 
ribonucleotides. This route provides possible solution to the reductive cleavage of 8-
oxo purines. Most of the chemistry is similar to what has already been established in 
this thesis, apart from the final reductive, desulfurization steps. 
175 
 
 
The reaction of 2-thiooxazole 98 with glyceraldehyde 35 produces 35% 
oxazolidinone thione ribo-103 in addition to other pentose thiones (arabino, xylo and 
lyxo). Ribo-103 has not been utilised or investigated in the synthesis reported here. 
However, based on a new pyrimidine ribonucleotide synthesis reported by Sutherland 
et al. exploiting the photochemical anomerisation of α-ribonucleotide to β-
ribonucleotides,21 an analogous synthesis for the purine series may also be explored 
using ribo-103 (Scheme 7.2).  
 
Scheme 7.2: Proposed synthesis of purines ribonucleotides via C1´ 
photoanomersation. The efficient (74%) photoanomersation of α-thiocytidine α-78 to 
β-thiocytidine β-78 reported by Sutherland et al. (red inset). Reaction of thiocyanic 
acid 97 with 2-thiooxazole 98 furnishing pentose oxazolidinone thiones 103 including 
35% ribo-103 (green inset).  
Synthesis of ribo-89 from ribo-103, followed by thiolysis is expected to produce α-
8-mercapto adenosine α-220. Given that α-thiocytidine α-78 can be readily be 
converted to β-thiocytidine β-78 (74%) via photoanomerization of C1` carbon, and 
the structural relationship between α-78  and α-220 (and the position of the 
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thiocarbonyl group and C1` hydrogen 5-atoms separate in each molecule) it is 
possible that α-220, like α-78, can also be converted to β-220 by anomerisation under 
photochemical irradiation. These similarities warrant further investigation of purine 
synthesis under photochemical conditions to complement those presented in this 
thesis.  
Furthermore, polymerisation reactions of pyrimidine and purine 2`,3`-cyclic 
phosphates would increase our understanding of RNA polymers in the initial steps of 
chemical to biological transitions.  
In a broader prospect and in the hope of a more concerted approach to the origins of 
life research, aqueous sulfur activation of amine nucleophiles in peptide ligation 
could be investigated so that a coinciding protein and RNA world can be envisioned. 
Finally, a more challenging and extremely important aspect of the origins of life 
research would be to carry out the divergent synthesis of purines and pyrimidines in 
protocells, so that the “first cell” capable of mimicking minimal life can be 
synthesised without any biological interference.    
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8. Experimental 
 
8.1. General Experimental Techniques 
 
Reaction conditions  
Moisture sensitive reactions were carried out under atmosphere of nitrogen using oven 
(80°C) or flame dried glassware. All transfers were performed using plastic or glass 
syringes using a positive pressure of nitrogen or argon gas. Degassed solutions were 
prepared by rapidly bubbling nitrogen gas through the required solvent for 
approximately 10-15 min prior to use. Stirring was achieved by an internal magnetic 
follower.  
 
Solvents 
Petroleum ether or petrol refers to the fraction of petroleum ether with a boiling point 
between 40°C and 60°C, unless otherwise stated. Anhydrous diethyl ether, 
dichloromethane, toluene and DMF were purified using a MBRAUN MB SPS-800 
solvent purification system. Acetone was distilled over magnesium sulphate. All other 
solvents were purified by standard procedures or used as supplied from commercial 
sources. Solvent removal under reduced pressure was carried out using a Büchi 
Rotavapor equipped with a water or dry ice condenser as appropriate. For heat or 
concentration sensitive produces water was removed by lyophilisation. 
Reagents 
Reagents and solvents were obtained and used without further purification, unless 
specified, from the following commercial sources: Sigma Aldrich, Alfa Aesar, 
Fluorochem, Acros Organics, Merck, Fisher Scientific, VWR International, 
Carbosynth, Manchester Organics, BDH, Lancaster, Apollo Scientific, Molekula, TCI 
and Santa Cruz Biotechnology. Dowex® 50W  8 ion-exchange resin (200-400 mesh) 
ion exchange resin was purchased from Acros Organics and was washed with 
methanol and sodium hydroxide solution before being regenerated with hydrochloric 
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acid solution. Deionized water was obtained from an Elga Option 3 purification 
system. The commercially available compound from Acros, 2-amino-2-
cyanoacetimide was purified by recrystallisation from hot ethanol. 
Chromatography 
Flash chromatography was carried out using Fluka silica gel 60 (220-240 mesh) 
(Brockmann 2-3); samples were applied as a concentrated solution in an appropriate 
solvent. Thin Layer Chromatography (TLC) was performed on pre-coated aluminum 
plates with either Merck Kieselgel 60 F254 or Merck Aluminum Oxide 60 F254. 
Visualization was either by ultraviolet light (λ = 254 nm) or by staining with aqueous 
potassium permanganate (KMnO4) solution followed by heating with a heat gun.  
Instrumentation 
1H, 13C and 31P NMR spectra were recorded on Bruker NMR spectrometers AVANCE 
III 600, AVANCE III 400 and AVANCE 300 equipped with a Bruker 5 mm cryoprobe 
(600 MHz) and a gradient probe (400 and 300 MHz). All chemical shifts (δ) are 
reported in parts per million (ppm) relative to residual solvent peaks, and 1H and 13C 
chemical shifts relative to TMS were calibrated using the residual solvent peak. When 
a mixed H2O/D2O solvent system was used a solvent suppression pulse sequence 
(noesygppr1d, Bruker) was used to obtain 1H NMR spectra. Coupling constants are 
reported in Hertz (Hz). Spin multiplicities are indicated by symbols: s (singlet); d 
(doublet); t (triplet); q (quartet); qn (quintet); spt (septet); oct (octet), m (multiplet); 
obs. (obscured/coincidental signals), or a combination of these.  Diastereotopic 
geminal (AB) spin systems coupled to one or two additional nuclei are reported as 
ABX and ABXY, respectively.  NMR data are reported as follows: chemical shift 
(number of protons, multiplicity, coupling constants (J), nuclear assignment). Spectra 
were recorded at 298 K. Melting points were determined using an Electrothermal 
standard digital apparatus for all solids and are quoted to the nearest ºC and are 
uncorrected.  Infrared spectra (IR) were recorded on a Shimadzu IR Tracer 100 FT-IR 
spectrometer.  Absorption maxima are reported in wavenumber (cm-1).  Ultraviolet 
spectra (UV) were recorded on a Shimzadu UV-2700 spectrometer at 298K using a 1 
mL quartz cuvette.  Absorption maxima are reported in nm.  Mass spectra and accurate 
mass measurements were recorded on a VG70-SE, Waters LCT Premier XE or Thermo 
Finnigan MAT 900XP instrument at the Department of Chemistry, University College 
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London.  Flash Column Chromatography (FCC) was carried out on a Biotage Isolera 
One purification platform using either Biotage SNAP or Kinesis TELOS cartridges. 
Solution pH values were measured using a Mettler Toledo Seven Compact or a 
Corning 430 pH meter equipped with either a Mettler Toledo InLab semi-micro pH 
probe or a Fisherbrand FB68801 semi-micro pH probe.  pD values were corrected 
according to Covington et al.1 D2-formamide was prepared by repeatedly (5×) 
lyophilising formamide (50 mL) with D2O (100 mL) until the amide proton signals 
were no longer visible by 1H NMR.  Unless otherwise stated reactions conducted in 
formamide were repeatedly (3x) lyophilised with D2O (10x volume of formamide) 
before analysis by 1H NMR. 
HPLC was carried out on an Agilent 1260 Infinity LC system using an Agilent Polaris 
5 C18-A 150  10.0 mm column.   
HPLC method used to purify nucleotide cyclic phosphates: 
Time (min) A B Flowrate (mL/min) 
0.0 100 0 0 
0.5 100 0 5 
4.0 100 0 5 
13.0 80 20 5 
13.5 10 90 5 
16.5 10 90 5 
17.0 100 0 5 
20.0 100 0 5 
20.5 100 0 0 
 
A = 100 mM triethylammonium formate at pH 5.0 
B = Acetonitrile 
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8.2. Prebiotic synthesis of 2-thiooxazole 37 
 
8.2.1. Method A 
 
2-Thiooxazole 98 
 
 
 
 
 
Following a literature procedure,163 glycolaldehyde 34 (1.00 g, 16.7 mmol) and 
potassium thiocyanate 97 (3.24 g, 33.3 mmol) were dissolved in minimum volume of 
water (3 mL). The mixture was cooled to -5°C and HCl (37%, 2.10 mL) was added 
drop wise. The reaction mixture was initially left for 2 h at rt and then left 24 h at 
80°C, completion of reaction was monitored by 1H NMR spectroscopy. The mixture 
was allowed to cool and then the organics were extracted with ethyl acetate (3 × 50 
mL). The organic layers were combined, washed with brine solution (3 × 30 mL), and 
then dried over MgSO4. The MgSO4 was removed by filtration and solvent was 
removed under reduced pressure. The resulting solids were crystallized from CH2Cl2 
to yield 2-thiooxazole 98 (1.43 g, 14.2 mmol, 85%) as a yellow crystalline solid: M.p 
140-144oC (Lit.168 147oC). IR (Solid, cm-1) 3117 (NH), 1587 (C=C), 1478 (C=S).  1H 
NMR (600 MHz, D2O) 7.33 (1H, d, J = 4.5, H-(CN)), 7.05 (1H, d, J = 4.5, H-(CO)). 
13C NMR (151 MHz, D2O) 188.1 (C=S), 130.0 (C-O), 117.2 (C-NH). HRMS (m/z) 
calculated for C3H3NOS [M]
+, 100.9930; found, 100.9930. 
Crystal structure obtained; see appendix for crystallographic data. 
 
8.2.2. Method B 
 
Montmorillonite KSF clay (1 g) was added to water (0.75 mL) and the pH of the 
mixture was adjusted to pH 4.0 with aqueous HCl and NaOH as required. To the 
resultant slurry was added glycolaldehyde 34 (125 mg, 2.08 mmol) and potassium 
thiocyanate 97 (404 mg, 4.16 mmol) dissolved in water (0.25 mL) and pre-adjusted 
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with to pH 4 with aqueous HCl. The reaction was stirred for 3 d at 70°C and then the 
clay was removed by filtration. The filtrate and washings were combined and 
lyophilised. The lyophilisate was dissolved in D2O (2 mL) and an accurately weighed 
sample of potassium hydrogen phthalate (5.0 mg) was added. The yield of 98 was 
calculated with reference to the phthalate 1H NMR standard by 1H NMR (600 MHz) 
signal integration. The calculated yield of 2-thiooxazole 98 was observed to be 35% 
and not starting material 34 observed due to loss on the clay.  
 
8.3. Synthesis of pentose oxazolidinone thiones  
 
8.3.1. Conventional synthetic protocol: From aldopentose sugars 
 
General procedure for synthesis of pentose oxazolidinone thiones (103) from free 
aldopentose sugars (102), adapted from Girniene et al.159 Pentose (1.00 g, 6.67 mmol) 
and potassium thiocyanate 97 (1.30 g, 13.4 mmol) were dissolved in water (60 mL). 
HCl (37%, 1.15 mL) was added drop wise at 0°C. The pink solution was kept at rt for 
2 h then incubated to 60°C. NMR spectra were periodically acquired until the reaction 
was complete.  Silica gel (10 mL, dry) was added and the mixture was then evaporated 
to dryness to give a free flowing powder. The powder was purified by silica gel flash 
coloumn chromoatography, eluting with EtOAc/MeOH (0-10% MeOH) resulting 
product was recrystallized from CHCl3/EtOH to yield the desired oxazolidinone 
thione.  Analytical samples were recrystallized from hot water.   
 
Arabinofuranosyl oxazolidinone thione arabino-103 
 
(8.28 g, 43.3 mmol, 65%) from arabinose arabino-102 (10.0 g, 66.6 mmol) after 6 d 
at 60°C. M.P. 137-139°C (Lit.259 132-133°C259). IR (solid, cm-1) 3394 (NH), 3299 
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(OH), 2991, 2943, 2931, 2871 (CH), 1482 (C=S).1H NMR (600 MHz, D2O) 6.07 (1H, 
d, J = 5.8 Hz, H-(C1`)), 5.33 (1H, d, J = 5.8 Hz, H-(C2`)), 4.51 (1H, d, J = 1.4 Hz, H-
(C3`)), 4.25 (1H, ddd, J = 7.2, 5.1, 1.4 Hz, H-(C4`)), 3.64 (1H, ABX, J = 12.3, 5.1 
Hz, H-(C5`)), 3.51 (1H, ABX, J = 12.3, 7.2 Hz, H-(C5``)).13C NMR (151 MHz, D2O) 
190.0 (C2), 92.5 (C1`), 90.5 (C4`), 87.8 (C2`), 75.2 (C3`), 61.6 (C5`). [α]D20.0 (c = 
1.00, H2O) -4.08. HRMS (m/z) calculated for C6H10NO4S [M+H
+]+, 192.0331; found, 
192.0332. 
Crystal structure obtained; see appendix for crystallographic data. 
 
Ribofuranosyl oxazolidinone thione ribo-103 
 
 
(4.40 g, 23.0 mmol, 69 %) from ribose ribo-102 (5.00 g, 33.4 mmol) after 4 d at 60°C. 
M.P. 172-175°C decomp. (Lit.259 167-168°C). IR (Solid, cm-1) 3438 (NH), 3329 
(OH), 2993, 2920, 2902 (CH), 1521 (C=S). 1H NMR (600 MHz, D2O) 5.80 (1H, d, J 
= 5.4 Hz, H-(C1`)), 5.13 (1H, t, J = 5.4 Hz, H-(C2`)), 4.18 (1H, dd, J = 9.5, 5.4 Hz, 
H-(C3ʹ)), 3.96 (1H, ABX, J = 12.7, 2.3 Hz, H-(C5ʹ)), 3.88 (1H, ddd, J = 9.5, 4.9, 2.3 
Hz, H-(C4ʹ)), 3.75 (1H, ABX, J = 12.7, 4.9 Hz H-(C5ʹ)). 13C NMR (151 MHz, D2O) 
161.1 (C2), 86.0 (C1ʹ), 80.4 (C4ʹ), 78.6 (C2ʹ), 70.4 (C3ʹ), 60.0 (C5ʹ).   [α]D20.0 (c = 
1.00, H2O) +8.73.  HRMS (m/z) calculated for C6H10NO4S [M+H
+]+, 192.0331; 
found, 192.0340.  
 
Crystal structure obtained; see appendix for crystallographic data. 
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Xylofuranosyl oxazolidinone thione xylo-103 
 
 
(1.46 g, 7.66 mmol, 46%) from xylose xylo-102 (2.50 g, 16.6 mmol) after 14 d at 
60°C.  M.P. 133-135°C (Lit.259 129-130°C).  IR (Solid, cm-1) 3251 (OH), 2930 (CH), 
1488(C=S).  1H NMR (600 MHz, D2O) 6.07 (1H, d, J = 5.5 Hz, H-(C1ʹ)), 5.29 (1H, 
d, J = 5.5 Hz, H-(C2ʹ)), 4.52 (1H, d, J = 2.8 Hz, H-(C3ʹ)), 4.04 (1H, ddd, J = 7.4, 4.3, 
2.8 Hz, H-(C4ʹ)), 3.96 (1H, ABX, J = 12.0, 4.3 Hz, H-(C5ʹ)), 3.84 (1H, ABX, J = 12.0, 
7.4 Hz, H-(C5ʹ)).  13C NMR (151 MHz, D2O) 190.3 (C2), 91.1 (H2ʹ), 89.5 (H1ʹ), 80.8 
(H4ʹ), 73.5 (H3ʹ), 59.5 (H5ʹ).  HRMS (m/z) calculated for C6H10NO4S [M+H+]+, 
192.0331; found, 192.0332. 
Crystal structure obtained; see appendix for crystallographic data. 
 
Lyxofuranosyl oxazolidinone thione p-lyxo-103 
 
 
(0.25 g, 1.31 mmol, 20%) from lyxose  lyxo-102 (1.00 g, 6.66 mmol) after 7 d at 60°C.  
M.P. 185-187°C (Lit.259 178°C).  IR (Solid, cm-1) 3342 (NH), 3237, 3130 (OH), 2975 
(CH), 1496(C=S).  1H NMR (600 MHz, D2O) 5.74 (1H, d, J = 6.1 Hz, H-(C1ʹ)), 5.16 
(1H, dd, J = 6.1, 3.2 Hz, H-(C2ʹ)), 4.02 (1H, dd, J = 7.5, 3.2 Hz, H-(C3ʹ)), 3.95-3.89 
(2H, m, H-(C4ʹ) and H-(C5ʹ)), 3.69 (1H, m, H-(C5ʹ)).  13C NMR (151 MHz, D2O) 
191.4 (C2), 84.0 (C2ʹ), 83.8 (C1ʹ), 70.3 (C3ʹ), 68.9 (C4ʹ), 66.2 (C5ʹ).  HMBC was 
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observed between H-(C1ʹ) and C5ʹ indicating pyranose structure.  HRMS (m/z) 
calculated for C6H10NO4S [M+H
+]+, 192.0331; found, 192.0328. 
Crystal structure obtained; see appendix for crystallographic data. 
 
Lyxopyranosyl oxazolidinone thione f-lyxo-103260 
 
1H NMR (600 MHz, D2O) 5.87 (1H, d, J = 5.8 Hz, H-(C1ʹ)), 5.40 (1H, t, J = 5.8 Hz, 
H-(C2ʹ)), 4.70 (1H, dd, J = 6.4, 5.8 Hz, H-(C3ʹ)), 4.31 (1H, ddd, J = 9.0, 6.4, 3.9 Hz, 
H-(C4ʹ)), 3.81 (1H, ABX, J = 12.4, 3.9 Hz, H-(C5ʹ)), 3.56 (1H, ABX, J = 12.4, 9.0 
Hz, H-(C5ʹ)). 
Crystal structure obtained; see appendix for crystallographic data. 
 
Method large scale synthesis of oxazolidinone thiones purified without 
chromatography:261 
Arabinose arabino-102 (120 g, 0.80 mol) and potassium thiocyanate 97 (156 g, 1.60 
mol) were dissolved in water (120 mL) and then HCl (37%, 148 mL) was added drop 
wise at 0°C. The pink solution was kept at rt for 2 h then heated to 60°C for 6 d. After 
6 d, the crude mixture was cooled, filtered to the remove yellow amorphous solids. 
The filtrate was then concentrated and air-dried over night to give glassy solids which 
were triturated with ethanol (3 × 500 mL). The ethanolic fractions were combined and 
concentrated to give yellow solids. The solids were dissolved in boiling ethanol (500 
mL) and mixed with activated charcoal (5.0 g). The organic mixture was filtered to 
remove all solids and then concentrated to dryness. The solids obtained were dissolved 
in boiling H2O (70 mL) and then left at 5°C overnight to give pale yellow crystals, 
which were further recrystallised from hot water (70 mL) to give of arabinofuranosyl 
oxazolidinone thione arabino-103 (50.0 g, 0.26 mol, 33%) as a crystalline product. 
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General procedure for time course reactions of aldopentose sugars with 
potassium thiocyanate.  
 
Aldopentose sugar 102 (100 mg, 0.66 mmol) and potassium thiocyanate 97 (130 mg, 
1.34 mmol) were dissolved in H2O (0.50 mL) and D2O (0.1 mL) and then HCl (37%, 
0.11 mL) was added drop wise at 0°C. The resultant solution was then transferred to 
an NMR tube and data was collected at the required intervals at rt to generate an NMR 
time course for the synthesis of different oxazolidinone thiones (arabino-103, ribo-
103 or xylo-103). The graphs were analysed to investigate any detectable 
intermediates during the reaction of the aldopentose sugars 102 with potassium 
thiocyanate 97. 
Ribofuranosyl oxazolidinone thione ribo-103 
Following the above method, ribose ribo-102 and potassium thiocyanate 97 to furnish 
ribo-103, the pH of the reaction was monitored and 1H NMR data was collected at 
different time intervals. 
Arabinofuranosyl oxazolidinone thione arabino-103 
Following the above method, arabinose arabino-102 and potassium thiocyanate 97 to 
furnish arabino-103, the pH of the reaction was monitored and 1H NMR data was 
collected at different time intervals. 
Xylofuranosyl oxazolidinone thione xylo-103 
Following the above method, xylose xylo-102 and potassium thiocyanate 97 to furnish 
xylo-103, the pH of the reaction was monitored and 1H NMR data was collected at 
different time intervals. 
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Figure 8.1: A stack of 1H NMR spectra (600 MHz, D2O, 3.3 - 6.2 ppm) for incubation 
of ribose ribo-102 (1.1 mM) and potassium thiocyanate 97 (2.2 mM) at rt, pH -1.5 for 
228h. The peaks for ribose ribo-102 are decreasing and peaks for oxazolidinone 
thione ribo-103 is increasing over time. No intermediate species were detected in the 
1H NMR with single solvent suppression. 
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Time (h) ribo-103 arabino-103 xylo-103 
1 2 2 0 
3 19 11 11 
6 32 19 19 
9 40 24 24 
12 47 29 30 
15 53 34 37 
18 57 39 42 
21 61 43 46 
24 63 47 49 
27 66 50 52 
30 68 53 54 
33 70 55 56 
36 71 58 57 
39 72 60 58 
42 74 61 59 
45 76 62 61 
58 81 68 66 
67 84 70 70 
85 87 75 76 
106 90 79 81 
130 92 83 84 
154 93 87 87 
228 97 94 91 
 
Figure 8.2: Comparative reaction of ribo-102, arabino-102 and xylo-102 with 
potassium thiocyanate 97, over a period of 228h at rt to yield ribo-103, arabino-103 
and xylo-103 respectively. Each point in the graph is 1H NMR data obtained by 
integration of H-(C1`) of thione 103 against sugar 102 peaks at 3.39 and 4.75 ppm. 
Each pentose 102 (110 mM) was incubated with 97 (220 mM) at pH -1.5 and rt for 
228h and then data collected for all three oxazolidinone thiones, ribo-103, arabino-
103 and xylo-103 are plotted for comparison. 
 
8.3.2. Prebiotic protocol: Bypassing free aldopentose sugars 
 
2-Thiooxazole 98 (75.6 mg, 0.75 mmol) and 4,4-dimethyl-4-silapentane-1-sulfonic 
acid (DSS; 20 mg; internal standard) were dissolved in D2O (1.5 mL) to give a 500mM 
solution of 98.  The solution was adjusted to pH 7 with NaOH (4M) and 250 or 500 
µL was added to glyceraldehyde 35 (500mM or 1M).  Solutions were made up to 500 
µL with D2O where necessary.  The solutions were stirred at 60°C for 24 h and the 
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solution was readjusted to pH 7 every 6 h (if necessary).  Aliquots (50 µL) were taken 
after 24 h, diluted with D2O (450 µL) and analysed by NMR spectroscopy.  The 
presence of oxazolinone thiones 103 was confirmed by spiking with authentic 
samples, prepared using conventional organic synthesis as reported above.  Yields 
were calculated by measuring the ratio of product 103:DSS at 24 h. 
 
 
 
 
 
Figure 8.3: Yields of pentose oxazolidinone thiones 103 and their relative 
diastereomeric ratio across a variety of concentrations of 2-thiooxazole 98 and 
glyceraldehyde 35.  All reactions were heated for 24 h at 60°C in pH 9. 
 
 
Figure 8.4: 1H NMR spectrum (600 MHz, D2O, 3.4 – 7.7 ppm) showing reaction of 2-
thiooxazole 98 with glyceraldehyde 35.  2-Thiooxazole 98 (0.25M) and 
glyceraldehyde 35 (1M) at pH 7 were incubated at 60 oC for 24 h. 
  % distribution of oxazolidinone thione 
products 103 
98 (M) 35 (M) 103 (%) 98 (%) arabino 
103 
ribo 
103 
xylo 
103 
p-lyxo 
103 
f-lyxo 
103 
0.25 0.5 51 36 35 35 12 11 7 
0.50 0.5 35 44 37 36 10 12 5 
0.50 1.0 59 25 35 36 12 11 6 
0.25 1.0 74 8 36 35 10 12 7 
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Figure 8.5: 1H NMR spectra (600 MHz, D2O, 5.1 – 6.1 ppm) showing reaction of 2-
thiooxazole 98 with glyceraldehyde 35.  A) 25 (0.25M) and 98 (1M) at pH 7, incubated 
at 60°C for 24 h.  B) Spiked with arabinose oxazolidinone thione arabino-103.  C) 
Spiked with ribose oxazolidinone thione ribo-103.  D) Spiked with xylose 
oxazolidinone thione xylo-44.  E) Spiked with lyxose oxazolidinone thione p-lyxo-44. 
 
8.4. Synthesis of pentose aminooxazolidinones  
 
Pentose aminooxazolines were synthesised using a protocol modified from Sanchez 
and Orgel.124 
Arabinofuranosyl aminooxazoline arabino-70 
 
To a syrup of arabinose arabino-102 (5.00 g, 33.3 mmol) in aqueous ammonia 
solution (3.5%, 50.0 mL) was added cyanamide 68 (2.28 g, 54.2 mmol). The resultant 
solution was heated at 60°C for 1 h. After this time the reaction was cooled to rt and 
MeOH (100 mL) was added to the solution to promote crystallisation. After 16 h at 
4°C the crystals were collected by filtration, washed with ice-cold MeOH (80 mL) 
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and dried under vaccum to yield of arabinofuranosyl aminooxazoline arabino-70  
(3.20 g, 18.4 mmol, 55%) as a fine white powder: M.p 195-197°C (Lit.124  175°C). IR 
(solid, cm-1) 3407 (NH2), 3140 (OH), 2919 (CH), 1660 (C=N). 
1H NMR (600 MHz, 
D2O) δ 5.91 (1H, d, J = 5.5 Hz, H-(C1`)), 4.94 (1H, d, J = 5.5 Hz, H-(C2`)), 4.33 (1H, 
d, J = 3.6 Hz, H-(C3`)), 4.02 (1H, ddd, J = 6.9, 5.4, 3.6 Hz, H-(C4`)), 3.61 (1H, ABX, 
J = 12.2, 5.4 Hz, H-(C5`)), 3.54 (ABX, J = 12.2, 6.9 Hz, H-(C5``)). 13C NMR (151 
MHz, D2O) 165.6 (C2), 99.29 (C1`), 89.3 (C4`), 85.0 (C2`), 75.9 (C3`), 61.8 (C5`). 
[α]D20.0 (c = 1.00, H2O) -8.31. HRMS (m/z) calculated for C6H10N2O4 [M+H+]+, 
175.0719; found, 175.0719. 
 
Ribofuranosyl aminooxazoline ribo-70 
 
To a syrup of ribose ribo-102 (2.00 g, 13.3 mmol) in aqueous ammonia solution 
(3.5%, 20.0 mL) was added cyanamide 68 (1.12 g, 26.6 mmol). The resultant solution 
was heated at 60°C for 1 h. After this time the reaction was cooled to rt and MeOH 
(40 mL) was added to the solution to promote crystallisation. After 16 h at 4°C the 
crystals were collected by filtration, washed with ice-cold MeOH (30 mL) and dried 
under vaccum to yield of ribofuranosyl aminooxazoline ribo-70 (1.63 g  9.36 mmol, 
70%) as a fine white powder: M.p 182-184°C (Lit.124 195°C). IR (solid, cm-1) 3426 
(NH2), 3319 (OH), 3147 (CH), 1664 (C=N). 
1H NMR (600 MHz, D2O) 5.80 (1H, d, 
J = 5.3 Hz, H-(C1`)), 4.98 (1H, t, J = 5.3 Hz, H-(C2`)), 4.13 (1H, dd, J = 9.6, 5.3 Hz, 
H-(C3`)), 3.93 (1H, ABX, J = 12.7, 2.3 Hz, H-(C5`)), 3.73 (1H, ABX, J = 12.7, 4.7 
Hz, H-(C5`)), 3.62 (1H, ddd, J = 9.6, 4.7, 2.3 Hz, H-(C4``)). 13C NMR (151 MHz, 
D2O) 166.7 (C1), 97.7 (C1`), 82.6 (C4`), 77.9 (C2`), 71.0 (C3`), 60.2 (C5`). [α]D20.0 (c 
= 1.00, H2O) +3.94. m/z (CI+) 175 (78%, M+). HRMS (m/z) calculated for C6H10N2O4 
[M+H+]+, 175.0719; found, 175.0721. 
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8.5. Synthesis of pentose oxazolidinones  
 
Pentose oxazolidinones were synthesised according to a procedure by Kovács et 
al.262 
Arabinofuranosyl oxazolidinone arabino-77 
 
To arabinose arabino-102 (3.00 g, 20.0 mmol), in H2O (20 mL) was added NH4Cl 
(1.60 g, 30.0 mmol) and potassium cyanate 26 (2.40 g, 30.0 mmol). The resultant 
mixture was heated at 60°C for 8 h, allowed to cool to rt and lyophilised to give a 
yellow oil. The oil was then purified by silica gel flash column chromatography 
eluting with (EtOAc:MeOH 9:1). After evaporation the residue was recrystallized 
from EtOH/H2O to give arabinofuranosyl oxazolidinone arabino-77 (1.60 g, 9.14 
mmol, 46%) as a white solid: M.p 164-168°C. IR (solid, cm-1) 3398 (NH), 3233 (OH), 
2956, 2935, 2897 (CH), 1747 (C=O). 1H NMR (600 MHz, D2O) 5.92 (1H, d, J = 5.7 
Hz, H-(C1`)), 5.08 (1H, d, J = 5.7 Hz, H-(C2`)), 4.44 (1H, s, H-(C3`)), 4.16 (1H, dd, 
J = 6.9, 4.8 Hz, H-(C4`)), 3.70 (1H, ABX, J = 12.3, 4.8 Hz, H-(C5`)), 3.60 (1H, ABX, 
J = 12.3, 6.9 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) 160.1 (C1), 87.6 (C1`), 87.2 
(C4`), 86.9 (C2`), 75.5 (C3`), 61.9 (C5`). [α]D20.0 (c = 1.00, H2O) -5.91. HRMS (m/z) 
calculated for C6H9NO5 [M+H
+]+, 176.0559; found, 176.0551. 
 
Ribofuranosyl oxazolidinone ribo-77 
 
To ribose ribo-102 (3.00 g, 20.0 mmol), in H2O (20 mL) was added NH4Cl (1.60 g, 
30.0 mmol) and potassium cyanate 26 (2.40 g, 30.0 mmol). The resultant mixture was 
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heated at 60°C for 8 h, allowed to cool to rt and lyophilised to give a yellow oil. The 
oil was then purified by silica gel flash column chromatography eluting with 
(EtOAc:MeOH 9:1). After evaporation the residue was recrystallized from EtOH/H2O 
to give ribofuranosyl oxazolidinone ribo-77 (2.20 g, 12.56 mmol, 63%) as a yellow 
solid: M.p 125-127°C (Lit.262 161-164°C). IR (solid, cm-1) 3341 (NH), 3217 (OH), 
3005,2934, 2879 (CH), 1715 (C=O). 1H NMR (600 MHz, D2O) 5.80 (1H, d, J = 5.4 
Hz, H-(C1`)), 5.13 (1H, t, J = 5.4 Hz, H-(C2`)), 4.18 (1H, dd, J = 9.5, 5.4 Hz, H-
(C3`)), 3.96 (1H, ABX, J = 12.7, 2.3 Hz, H-(C5`)), 3.88 (1H, ddd, J = 9.5, 4.8, 2.3 Hz, 
H-(C4`)), 3.75 (1H, ABX, J =12.7, 4.8 Hz H-(C5``)). 13C NMR (151 MHz, D2O) 161.1 
(C2), 86.0 (C1`), 80.4 (C4`), 78.6 (C2`), 70.4 (C2`), 60.0 (C5`). [α]D20.0 (c = 1.00, H2O) 
+6.76. HRMS (m/z) calculated for C6H9NO5 [M+H
+]+, 176.0559; found, 176.0555. 
 
8.6. Synthesis of cyanoacetylene  
 
 
Propiolamide 222 
 
Methyl propiolate 221 (9.45g, 10.0 mL, 112 mmol) was added to liquid ammonia (100 
mL) at -78°C and stirred. After 1 h excess ammonia was evaporated by warming the 
solution to rt, followed by co-evaporation with dry chloroform (100 mL), to yield 
solids. The solids were dissolved in hot anhydrous CH2Cl2 (30 mL) and left at -18°C 
to yield propiolamide 222 (5.74 g, 83.0 mmol, 74%) as long colourless needle-like 
crystals which were isolated by filtration: M.p 57-59°C (Lit.262 58-61°C). 1H NMR 
(600 MHz, D2O) 3.53 (1H, s, H-(C3). m/z (CI+) 70 (100%, M+). Spectra matched 
lietrature data.263 
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Cyanoacetylene 30 
 
Propiolamide 222 (5.00 g, 72.5 mmol) and oven dried sand (37.5 g) were thoroughly 
grounded together with a pestle and mortat. P2O5 (15.5 g, 109 mmol) was added and 
the mixture was rapidly transferred to a dry flask under an argon atmosphere. 
Cyanoacetylene 30 was then distilled from the brown sticky mixture at 130°C and 100 
torr over 1 h. During this time a white solid (2.98 g, 58.4 mmol, 80%) was collected 
at -78°C. The solid was immediately dissolved in water (47 mL) to give a 1M aqueous 
solution of cyanoacetylene 30: 1H NMR (600 MHz, D2O) 3.42 (1H, s, H-(C3)). 
13C 
NMR (151 MHz, D2O) 105.5 (C1); 77.1 (C3);  56.7 (C2).  
 
8.7. Cyanovinylation of pentose oxazolidinone thiones 
 
(S-Z-Cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120 
 
Arabinofuranosyl oxazolidinone thione arabino-103 (2.50 g, 13.1 mmol) was added 
to an aqueous solution of cyanoacetylene 30 (20 mL, 1M, 20.0 mmol). After stirring 
the reaction mixture for 1 h at rt, it was immediately lyophilised to yield (S-Z-
cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120 (3.26 g, 13.4 mmol, 
quant) as a white solid which was used without further purification: M.p 197-203°C. 
IR (solid, cm-1) 3372 (OH), 3068, 3056, 2956 (CH), 2212 (C≡N), 1601 (C=N), 1575 
(C=C). 1H NMR (500 MHz, D2O) δ 7.75 (1H, d, J = 10.5 Hz, H-(C4)), 6.10 (1H, d, J 
= 6.0 Hz, H-(C1`)), 5.90 (1H, d, J = 10.5 Hz, H-(C5)), 5.12 (1H, dd, J = 6.0, 1.4 Hz, 
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H-(C2`)), 4.35 (1H, ddd, J = 6.0, 3.4, 1.4, Hz, H-(C3`)), 4.06 (1H, ddd, J = 6.4, 4.7, 
3.4 Hz, H-(C4`)), 3.54 (1H, ABX, J = 12.4, 4.7 Hz, H-(C5`)), 3.45 (1H, ABX, J = 
12.4, 6.4 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) 167.3 (C2), 143.5 (C5), 115.9 
(C6), 100.3 (C4 and C1`), 91.5 (C2`), 86.4 (C4`), 76.0 (C3`), 61.5 (C5`). Analysis (% 
calcd, % found for C9H10N2O4S): C (44.62, 43.06), H (4.16, 4.03), N (11.56, 10.87). 
UV/Vis: λmax 265 nm. [α]D20.0 (c = 1.00, H2O) -1.83. HRMS (m/z): [M-H+]-  
C9H10N2O4S calcd 243.0440, found 243.0447. 
Crystal structure obtained see appendix for data. 
 
(S-Z-Cyanovinyl)-ribofuranosyl oxazolidinone thione ribo-120 
 
 
 
Ribofuranosyl oxazolidinone thione ribo-103 (331 mg, 1.73 mmol) was added to an 
aqueous solution of cyanoacetylene 30 (5.0 mL, 1M, 4.90 mmol). After stirring the 
reaction mixture for 1 h at rt, it was immediately lyophilised to yield (S-Z-cyanovinyl)-
ribofuranosyl oxazolidinone thione ribo-120 (400 mg, 1.65 mmol, 95%) as a white 
solid which was used without further purification: M.p 193-198°C. IR (solid, cm-1) 
3344 (OH), 3055, 2926, 2876 (CH), 2218 (C≡N), 1653 (C=N), 1601 (C=C). 1H NMR 
(600 MHz, D2O) δ 7.88 (1H, d, J = 10.8 Hz, H-(C4)), 6.10 (1H, d, J = 5.4 Hz, H-
(C1`)), 5.99 (1H, d, J = 10.8 Hz, H-(C5)), 5.22 (1H, t, J = 5.4 Hz, H-(C2`)), 4.27 (1H, 
dd, J = 9.3, 5.4 Hz, H-(C3`)), 3.95 (1H, dd, J = 13.2, 2.4 Hz, H-(C5`)), 3.76 (1H, dd, 
J = 13.2, 4.6 Hz, H-(C5``)), 3.60 (1H,   ddd, J = 9.3, 4.6, 2.4 Hz, H-(C4`)). 13C NMR 
(151 MHz, D2O) δ 168.4 (C2), 143.7 (C4), 116.0 (CN), 100.3 (C5), 98.9(C1`), 84.7 
(C3`), 78.9 (C4`), 70.9 (C3`), 59.9 (C5`).  UV/Vis: λmax 258 nm. [α]D20.0 (c = 1.00, 
H2O) +9.01. [M-H
+]-  C9H10N2O4S calcd 243.0493, found 243.0495. 
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8.7.1. One pot cyanovinylation of ribo- and arabino oxazolidinone 
thione  
 
To a solution of arabinofuranosyl oxazolidinone thione arabino-103 (47.0 mg, 0.24 
mmol) and ribfuranosyl oxazolidinone thione ribo-103 (47.0 mg, 0.24 mmol) in H2O 
(0.5 mL) at pH 7.0 was added aqueous cyanoacetylene 30 (1M, 0.25 mL, 0.24 mmol). 
The reaction mixture was stirred at rt for 1 h. After this time the sample was submitted 
for 1H NMR spectroscopy analysis using single solvent suppression, which showed 
that there was no observable difference in the rate of cyanovinylation of arabino-103 
and ribo-103 in the above reaction conditions. 
 
8.7.2. Cyanovinylation of arabino aminooxazoline 70 
 
In order to compare cyanovinylation of aminooxazoline arabino-70 with with 
oxazolinone thione arabino-103, arabinofuranosyl aminooxazoline arabino-70 (25.0 
mg, 0.14 mmol) and cyanoacetylene 30 (1M, 1.5 mL) was stirred over night at rt 
without altering the contact pH. After 24 h the reaction mixture was submitted for 1H 
NMR spectroscopic analysis using single solvent suppression indicating a range of 
cyanovinylated products including ancitabine arabino-73 and arabino cytidine 185.22 
 
Figure 8.6: Unbuffered cyanovinylation of arabinose aminooxazoline arabino-70 
with cyanoacetylene 30 after 24 h giving rise to a plethora of hydrolysis and 
cyanovinylated products. 
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8.7.3. Bis-cyanovinylation of S-cyanovinyl thione  
S-Z-O3`-biscyanovinyl-arabinofuranosyl oxazolidinone thione 122 
 
(S-Z-Cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120 (50 mg, 206 
mmol) was added to an aqueous solution of cyanoacetylene 30 (1M, 10 mL). The 
resultant solution was incubated at pH 7.0 and rt. After 72 h, the mixture was 
lyophilised to give a powder, which was purified by silica gel flash column 
chromatography eluting with CH2Cl2/MeOH (0-5% MeOH). After evaporation of the 
fractions containing product 122, S-Z-O3`-biscyanovinyl-arabinofuranosyl 
oxazolidinone thione 122 (12 mg, 41 mmol, 20%) was obtained as yellow powder. 
Unfortunately, the product obtained was not completely pure and contained residual 
peaks from the crude mixture, however both 1H and COZY NMR spectra of the solids 
obtained indicated formation of 122 (Figure 8.7) 
 
Figure 8.7: 1H NMR spectra (600 MHz, D2O, 3.5 – 8.1 ppm)  for partially purified 
biscyanovinylated product 122, the C3`-H is shifted upfield due to the presence of 
cyanovinyl group on C3`-O. 
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8.7.4. Cyanovinylation of oxazolidionone thiones in the presence of 
aminooxazoline 
 
To a solution of oxazolidinone thione arabino-103 (47.0 mg, 0.24 mmol) and 
aminooxazoline arabino-70 (42.0 mg 0.24 mmol) in H2O (0.5 mL) at pH 7.0 and rt 
was added cyanoacetylene 30 (0.50 mL, 0.55 M 0.24 mmol). The resultant solution 
was left to react and the pH was monitored every 30 min. After 2 h when an aliquot 
of the reaction mixture was submitted for 1H NMR spectroscopic analysis, it was 
observed that oxazolidinone thione arabino-103 was selectively cyanovinylated to 
form S-cyanovinylated oxazolidinone thione arabino-120 in the presence of 
aminooxazoline arabino-70. The ratio of arabino-70 to arabino-120 was 1:1, which 
was the same as the ratio of oxazolidinone thione arabino-44 and aminooxazoline 
arabino-81 in the beginning of the reaction (Figure 8.8).  
 
 
Figure 8.8: 1H NMR spectra (600 MHz, D2O, 3.3 – 8.2 ppm) for selective 
cyanovinylation of oxazolidionone thione arabino-103 to furnish S-cyanovinyl 
oxazolidinone thione arabino-120 in the presence of aminooxazoline arabino-70. A) 
Reaction at 0 h before addition of cyanoacetylene 30. B) 1 h after addition of 
cyanoacetylene 30. 
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8.7.5. Cyanovinylation of aminooxazoline in the presence of 
oxazolidionone thiones 
To as solution of aminooxazoline arabino-70 (0.06 mmol) and oxazolidinone thione 
arabino-103 (11.50 mg, 0.06 mmol) in H2O (0.25mL) at pH 6.3 and rt was added 
cyanoacetylene 30 (1.25 mL, 0.50 M, 0.61 mmol).The resultant solution was then left 
to stand without stirring. The pH of the reaction was monitored and did not require 
any adjustments. The reaction was then analysed by 1H NMR spectroscopy at 0, 1, 6, 
and 27 h (Figure 8.9). 
 
 
Figure 8.9: 1H NMR spectra (600 MHz, D2O, 3.3 – 8.2 ppm) co-cyanovinylation of 
oxazolidinone thione arabino-103 and aminooxazoline arabino-70 to furnish S-
cyanovinyl oxazolidinone thione arabino-120 and ancitabine arabino-73 
respectively. A) Reaction at 0 h before addition of cyanoacetylene 30. B) 1 h after 
addition of cyanoacetylene 30. C) 6 h after addition of cyanoacetylene 30. D) 27 h 
after addition of cyanoacetylene 30. 
 
Time (h) arabino-103 (%) arabino-70 (%) arabino-73 (%) arabino-120 (%) 
0 55 45 0 0 
1 30 45 0 25 
6 6 37 12 45 
27 0 0 45 55 
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8.7.6. Attempted cyanovinylation of aminooxazoline by S-cyanovinyl 
oxazolidinone thione 
 
Aminooxazoline arabino-70 (21.0 mg, 0.12 mmol), S-cyanovinyl oxazolidinone 
thione arabino-120 (29.0 mg, 0.12 mmol) and sodium hydrogen phosphate (15 uL, 1 
M) were dissolved in H2O (1.5 mL) at pH 6.3, the resultant solution was then left to 
stand at rt for 96 h. After this time an aliquot of the reaction mixture was submitted 
for 1H NMR spectroscopic analysis. The 1H NMR showed approximately 1:1 
oxazolidinone arabino-77 and aminooxazoline arabino-70. ancitabine arabino-73 
and arabino-120 were not observed (Figure 8.10).  
 
 
Figure 8.10: 1H NMR spectra for cyanovinylation of aminooxazoline arabino-70 with 
S-cyanovinyl oxazolidinone thione arabino-120 to furnish ancitabine arabino-73. A) 
0 h. B) 96 h. 
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8.8. Synthesis of S-methyl oxazolidionone thiones 
 
8.8.1. Conventional synthesis of S-methyl oxazolidionone thiones 
 
S-Methylated oxazolidinone thiones were synthesised using an adapted protocol 
from Davidson et al.176 
 
Arabinofuranosyl-(2-thiomethyl)-oxazoline arabino-126 
 
 
Arabinofuranosyl oxazolidinone thione arabino-103 (7.00 g, 36.4 mmol), 
iodomethane (5.84 g, 41.2 mmol) and NaOH (1.65 g, 41.2 mmol) were vigorously 
stirred in ethanol (280 mL) and H2O (140 mL) at rt for 30 min. The solution was then 
concentrated and purified withby flash column chromatography eluting by 
CHCl3/MeOH (9:1) to yield arabinofuranosyl-(2-thiomethyl)-oxazoline arabino-92 
(6.2 g, 30.2 mmol, 84%) as a white solid. M.p. 84-78°C: IR (solid, cm-1) 3289 (OH), 
2899, 2843 (CH), 1585 (C=N). 1H NMR (600 MHz, D2O) 6.10 (1H, d, J = 5.9 Hz, H-
(C1`)), 5.09 (1H, d, J = 5.9, 1.8 Hz, H-(C2`)), 4.38 (1H, dd, J = 3.2, J = 1.8 Hz, H-
(C3`)), 4.11 (1H, ddd, J = 6.9, 5.3, 3.2  Hz,  H-(C4`)), 3.59 (1H, ABX, J = 12.2, 5.3 
Hz, H-(C5`)), 3.51 (1H, ABX, J = 12.2, 6.9 Hz, H-(C5``)), 2.51 (3H, s, CH3).  
13C 
NMR (151 MHz, D2O) 174.5 (C2), 100.1 (C1`), 90.9 (C2`), 86.1 (C4`), 76.0 (C3`), 
61.6 (C5`), 14.2 (CH3). [α]D20.0 (c = 1.00, H2O) -23.52. m/z (EI+) 205 (20%, M+). Data 
matches literature data.176 
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Ribofuranosyl-(2-thiomethyl)-oxazoline ribo-126 
 
 
 
 
Ribofuranosyl oxazolidinone thione ribo-103 (2.00 g, 10.5 mmol), iodomethane (1.67 
g, 11.8 mmol) and NaOH (0.47 g, 11.8 mmol) were vigorously stirred in ethanol (80 
mL) and H20 (40 mL) at rt for 30 min. The solution was then concentrated and purified 
by flash column chromatography eluting with CHCl3/MeOH (9:1) to yield 
ribofuranosyl-(2-thiomethyl)-oxazoline ribo-126 (2.00 g, 9.74 mmol, 92%) as a white 
solid: M.p. 73-77°C. IR (solid, cm-1) 3272 (OH), 2903, 2836, 2693 (CH), 1578 (C=N). 
1H NMR (600 MHz, D2O) 6.00 (1H, d, J = 5.4 Hz, H-(C1`)), 5.10 (1H, t, J = 5.4 Hz, 
H-(C2`)), 4.21 (1H, dd, J = 9.4, 5.4 Hz, H-(C3`)), 3.94 (1H, ABX, J = 12.8, 2.1 Hz, 
H-(C5`)), 3.74 (1H, ABX, J = 12.8, 4.6 Hz, H-(C5``)), 3.56 (1H, ddd, J = 9.4, 4.6, 2.1 
Hz H-(C4`)), 2.55 (3H, s, CH3). 
13C NMR (151 MHz, D2O) 175.6 (C2), 98.7 (C1`), 
84.0 (C2`), 78.6 (C4`), 71.0 (C3`), 60.0 (C5`), 14.4 (CH3). [α]D20.0 (c = 1.00, H2O) 
+15.77. m/z (EI+) 205 (20%, M+). Data matches literature data.176 
 
8.8.2. Prebiotic synthesis of S-methyl oxazolidionone thiones  
 
(S-Z-Cyanovinyl)-arabinofuranosyl oxazolinone thione arabino-120 (24.2 mg, 0.1 
mmol) and 4,4-dimehtyl-4-silapentane-1-sulfonic acid (DSS, NMR standard, 15 mg) 
were dissolved in D2O (500 µL). Sodium acetate buffer (500 µL, 2M, pH 6, D2O) was 
added and the solution adjusted to pH 6 with 1M NaOH/HCl. Methanethiol 127* was 
bubbled through the solution for 10 min. Further methanethiol gas was added every 2 
h. After 6 h the solution was briefly sparged with nitrogen, then cyanoacetylene 30 
(200 µL, 1M) was added and the mixture was left to stand for 2 h. The solution was 
again saturated with methanethiol 127 gas for 10 min and incubated for 16 h before 
NMR spectra were acquired. NMR analysis indicated the presence of 
arabinofuranosyl-(2-thiomethyl)-oxazolinone arabino-126 (50%), arabinofuranosyl 
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oxazolidone thione arabino-103 (15%) and arabinofuranosyl oxazolidinone arabino-
77 (12%). (See Section 2.3.3 for NMR spectra) 
*Methanethiol 127 gas was generated by dropping sodium thiomethoxide solution 
(21% v/v) onto anhydrous monobasic sodium phosphate at rt.  
 
8.9. Stability of S-cyanovinyl oxazolidinone thione 
 
An aqueous solution of S-cyanovinyl oxazolidinone thione arabino-120 (50 mM) at 
the required pH was stirred at rt and 1H NMR spectra were periodically taken over 
448 h. Aliquots of the reaction mixtures, which contained 4-dimehtyl-4-silapentane-
1-sulfonic acid (DSS)  from the beginning of the experiment, were analysed by 1H 
NMR spectroscopy. Spectra were then carefully analysed for   the presence of 
oxazolidinone thione arabino-103, oxazolidinone arabino-77, and β-β-dicyanovinyl-
thioether 129, each compound was confirmed by spiking with authentic samples. 
(Figure 8.11 and 8.12). 
 
 
Figure 8.11: Graph for pH stability of S-cyanovinylated oxazolidinone thione 
arabino-120 at pH 8.0. 
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pH 7.0 
Time (h) arabino-120 129 arabino-103 arabino-77 
0 92 5 3 0 
2 90 6 4 0 
72 74 13 12 1.5 
120 63 18 20 3 
168 33 24 37 6 
480 0 27 55 18 
 
 
pH 8.0 
Time (h) arabino-120 129 arabino-103 arabino-77 
0 92 5 3 0 
2 90 6 4 0 
72 73 13 12 2 
120 56 18 21 6 
168 33 24 36 7 
480 0 27 56 17 
 
 
pH 11.0 
Time (h) arabino-120 129 arabino-103 arabino-77 
0 92 5 3 0 
2 90 6 4 0 
72 0 13 31 2 
120 - - - - 
168 - - - - 
480 - - - - 
 
Figure 8.12: Tabulated data showing pH stability of S-cyanovinyl oxazolidinone 
thione arabino-120 at pH 7.0, 8.0, and 11.0. 
 
Solution of sodium dihydrogen phosphate (50 mM) and S-cyanovinylated 
oxazolidinone thione arabino-120 (50 mM) at pH 6.2 were incubated at rt for 3 d. 
After this time 1H NMR spectra were acquired indicating: 75% oxazolidinone 
204 
 
arabino-77, 19% oxazolidinone thione arabino-103 6% β-β-dicyanovinyl-thioether 
129 were obsereved (Figure 8.13). 
 
Figure 8.13: 1H NMR spectra (600 MHz, D2O, 3.4 – 8.1 ppm) for pH stability of S-
cyanovinyl oxazolidinone thione arabino-120 in the presence of inorganic phosphate. 
A) 0 h. B) 10 h. C) 96 h. D) Spiked with oxazolidinone arabino-77. E) Spiked with 
oxazolidinone thione arabino-103.  
 
8.10. Activation of oxazolidinone thione by acrylonitrile  
 
Arabinofuranosyl-(N1-cyanoethyl)-oxazolidinone thione 131 
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Arabinofuranosyl oxazolidinone thione arabino-103 (500 mg, 2.60 mmol), 
acrylonitrile (2.68 mL, 26.0 mmol) and H2NaPO4 (2.40g, 20.0 mmol) dissolved in 
water (28.0 mL) were stirred at pH 9 for 10 h. After this time the solution was 
lyophilised and purified with flash column chromatography eluting with 
EtAOc/MeOH (9:1) to yield the unexpected product arabinofuranosyl-(N1-
cyanoethyl)-oxazolidinone thione 131 (606 mg, 2.48 mmol, 95%) as white solid: M.p 
190-194°C. IR (solid, cm-1) 3286 (OH), 3000, 2975, 2951, 2922 (CH), 2253 (C≡N), 
1495 (C=S). 1H (600 MHz, D2O) 6.16 (1H, d, J = 5.9 Hz, H-(C1`)), 5.24 (1H, d, J = 
5.9 Hz, H-(C2`)), 4.54 (1H, s, H-(C3`)), 4.33 – 4.27 (1H, m, H-(C4`)), 4.09 (2H, 
ABXY, J = 14.4, 7.5, 6.4 Hz, H-(C5), 4.02 (2H, ABXY, J = 14.4, 6.4, 6.4 Hz, H-
(C4)), 3.60 (1H, ABX, J = 12.2, 5.3 Hz, H-(C5`)), 3.51 (1H, ABX, J = 12.2, 7.1 Hz, 
H-(C5``)), 3.06 (1H, ABXY, J = 17.3, 7.5, 6.4 Hz, (C4)), 2.99 (1H, ABXY, J = 17.3, 
6.4, 6.4 Hz, (C4)). 13C NMR (151 MHz, D2O) 188.7 (C2), 120.0 (C6), 93.8 (C1`), 89.1 
(C4`), 88.4 (23`), 75.6 (C3`), 61.6 (C5`), 42.7 (C4), 16.4 (C5). UV/Vis: λmax 233 nm. 
[α]D20.0 (c = 1.00, H2O) -0.56. HRMS (m/z): [M-H+]- C9H12N2O4S calcd 245.0596, 
found 245.0587. 
 
Arabinofuranosyl-(N1, O3`-dicyanoethyl)-oxazolidinone thione 132 
 
 
The above procedure also yielded arabinofuranosyl-(N1, O3`-dicyanoethyl)-
oxazolidinone thione 132 (32.0 mg, 0.11 mol, 5%) as white solid: 1H (600 MHz, 
CDCl3) 5.91 (1H, d, J = 6.1 Hz, H-(C1`)), 5.14 (1H, d, J= 6.1 Hz, H-(C2`)), 4.28 (1H, 
d, J = 4.8 Hz, H-(C3`)), 4.22 (1H, dd, J = 8.7, 4.8 Hz, H-(C4`)), 4.06 (2H, ABXY, J 
= 14.0, 7.0, 7.0 Hz, H-(C5)), 3.83 (3H, m, H-(C5), H-(C5`) and H-(C5``)), 3.67 (2H, 
qd, J = 12.0, 4.9, 4.9 Hz, H-(C4)), 2.94 (2H, t, J = 6.6 Hz, H-(C8)), 2.67 (2H, t, J = 
6.6 Hz, H-(C9)). 13C NMR (151 MHz, CDCl3) 187.3 (C2), 118.1 (C6), 117.5 (C9), 
93.1 (C1`), 86.6 (C4`), 84.8 (C2`), 83.6 (C3`), 65.2 (C5`), 61.5 (C4), 42.6 (C5), 19.2 
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(C7), 16.3 (C8). HRMS (m/z): [M-Na+]- C12H15N3O4S calcd 320.0681, found 
320.0678. 
 
8.11. Nucleophilic additions 
 
 
8.11.1. General procedure  
 
The nucleophile (0.25 mmol) was dissolved in H2O (400 µL) at the desired pH. The 
activated thione (S-cyanovinyl arabino-120 or S-metheyl arabino-126) and 4,4-
dimethyl-4-silapentane-1-sulfonic acid (DSS, 50 µL, 244 mM; internal standard) were 
then added. The solution was readjusted to the desired pH and the pH was maintained 
over the course of the reaction by addition of 1M NaOH/HCl as required. The reaction 
was monitored by periodic acquisition of 1H NMR spectra with single solvent 
suppression technique. Each spectrum was acquired upon dilution of an aliquot (20 
µL) of the reaction mixture adjusted to pH 9 by addition of ammonium hydroxide (450 
µL, in 100mM D2O). 
Nucleophile additions to S-cyanovinyl oxazolidinone thione arabino-120 resulted in 
the precipitation of a white solid that was isolated, characterised and determinded to 
be β-β-dicyanovinyl-thioether 129. 
β-β-dicyanovinyl-thioether 129 
 
M.p 140-144°C (Lit.264 142.4-143.2°C). IR (Solid, cm-1) 3073, 3061, 3046 (=C-H), 
2214 (CN), 1578 (C=C), 1547 (C-C). 1H NMR (600 MHz, DMSO) δ 8.05 (2H, d, J = 
10.3 Hz, H-(CCN)), 6.12 (2H, d, J = 10.3 Hz, H-(CS)). 13C NMR (151 MHz, DMSO) 
δ 147.2 (C-S), 115.4 (CN), 97.2 (C-CN). UV/Vis: λmax 290 nm. m/z (CI+) 137 (100%, 
M+). 
Crystal structure obtained; see appendix for crystallographic data. 
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8.11.2. Anthranilic acid 
 
Arabinofuranosyl anthranilic quinazolinone arabino-124 
 
(S-Z-Cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120 (100 mg, 
0.041 mmol) was added to a solution of anthranilic acid 125 (113 mg, 0.082 mmol) in 
water (10.0 mL) at pH 3.8. The reaction was stirred for 8 h at rt, after this time the 
solution was lyophilised and purified by flash column chromatography eluting with 
EtAOc/MeOH (9:1) to yield arabinofuranosyl anthranilic quinazolinone arabino-124 
(40 mg, 0.14 mmol, 36%) as a white solid: M.p. 234-238°C. IR (solid, cm-1) 3422 
(OH), 3067, 2959, 2929, 2875 (CH), 1699 (C=O), 1644 (C=N), 1608 (C-N), 1562 
(C=C). 1H NMR (600 MHz, DMSO) δ 8.06 (1H, dd, J = 7.9, 1.3 Hz, H-(C10)), 7.82 
– 7.65 (1H, m, 1H, H-(C9)), 7.44 (1H, dd, J = 8.1, 0.5 Hz, (C7)), 7.38 (ddd, J = 8.1, 
7.2, 1.1 Hz, 1H, (C8)), 6.48 (1H, d, J = 5.6 Hz, H-(C1`)), 5.89 (1H, d, J = 4.3 Hz, H-
(3O`)), 5.18 (1H, d, J = 5.6 Hz, H-(C2`)), 4.93 (1H, t, J = 5.3 Hz, H-(5O`)), 4.40 (1H, 
dd, J = 4.3, 2.0 Hz, H-(C3`)), 4.07 (1H, td, J = 5.3, 2.0 Hz, H-(C4`)), 3.30 (1H, ABXY, 
J = 12.0, 5.3, 5.3 Hz, H-(C5`)), 3.27 (1H, ABXY, J = 12.0, 5.3, 5.3 Hz, H-(C5``)). 13C 
NMR (151 MHz, DMSO) δ 159.5 (C2), 155.0 (C10), 149.0 (C9), 135.1 (C8), 126.5 
(C7), 125.9, 124.6, 118.6, 89.0 (C4`), 88.3 (C2`), 87.0 (C1`), 74.4 (C3`), 60.8 (C5`). 
[α]D20.0 (c = 1.00, H2O) -32.5. HRMS (m/z): [M-H+]- C13H12N2O5 calcd 276.0746, 
found 276.0739. 
Time course and pH experiments of anthranilic quinazolinone arabino-124  
Following the general procedure for nucleophilic additions, (S-Z-cyanovinyl)-
arabinofuranosyl oxazolidinone thione arabino-120 (250 mM) and anthranilic acid 
125 (500 mM) were incubated at varying pH conditions for 8 h at rt, and 1H NMR 
spectroscopic data was collected (Figure 8.14). 
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Contact pH arabino-124 (%) arabino-103 (%) arabino-77 (%) 
3.8 96 3 1 
5.0 88 8 2 
6.0 81 12 3 
7.0 70 29 1 
8.5 70 30 0 
11.0 65 33 2 
 
Figure 8.14: Tabulated data illustrating, how pH increase hinders the formation of 
arabinofuranosyl anthranilic quinazolinone arabino-124 and promotes the formation 
of arabinofuranosyl oxazolidinone thione arabino-103. 
 
Ribofuranosyl anthranilic quinazolinone ribo-124 
Following general procedure for nucleophilic additions, (S-Z-cyanovinyl)-
ribofuranosyl oxazolidinone thione ribo-120 (250mM) and anthraniclic acid 125 
(500mM) in H2O (500 µL) at pH 6, incubated at rt for 1 h to furnish the addition 
product ribo-143 (Figure 8.15A). The reaction was then left to stand for 6 h and the 
cylisation of ribo-143 was moitored by 1H NMR spectroscopy. After 6 h, calibration 
to an internal standard (DSS) demonstrated that 70% ribofuranosyl anthranilic 
quinazolinone ribo-124 and 13% ribofuranosyl oxazolinone thione ribo-103 had been 
obtained (Figure 8.14B). 
Crystal structure obtained; see appendix for crystallographic data. 
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Figure 8.15:  1H NMR spectra (600 MHz, D2O, 3.75 – 6.75 ppm) for reaction of (S-
Z-cyanovinyl)-ribofuranosyl oxazolinone thione ribo-120 with anthranilic acid 125.  
A) 1h. B) 6 h. 
 
8.11.3. Ammonia (NH3) 
 
Reaction with S-cyanovinyl oxazolidinone thione 
Following the general procedure for nucleophilic additions, (S-Z-cyanovinyl)-
arabinofuranosyl oxazolidinone thione arabino-120  (250 mM) and ammonia (1M) 
were incubated at pH 9.5 and rt for 48 h.  1H NMR spectroscopic analysis indicated 
that 21% arabinofuranosyl aminooxazoline arabino-70, 35% arabinofuranosyl 
oxazolidinone thione arabino-103 and β-β-dicyanovinyl-thioether 129 precipitate 
were obtained. (See Section 2.5.2 for 1H NMR spectra). 
 
 
Time course and pH experiments of aminooxazoline arabino-70  
Following the general procedure for nucleophilic additions, (S-Z-cyanovinyl)-
arabinofuranosyl oxazolidinone thione arabino-120  (250 mM) and ammonia (1M) 
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were incubated at pH 9.5 and rt for 48 h. 1H NMR Data was collected periodically at 
time intervals of 0, 1, 18, 72, 96, 120, and 192 h (Figure 8.16) 
 
 
Time (h) arabino-120 arabino-103 arabino-70 
0 100 0 0 
24 87 9 0 
48 67 23 10 
72 53 33 13 
96 48 38 15 
168 23 56 21 
192 16 62 22 
 
Figure 8.16: Time course graph and tabulated data for the reaction of S-
cyanovinylated oxazolidinone thione arabino-120 with ammonia to furnish 
aminooxazoline arabino-70. Graph was plotted by taking 1H NMR time points at 0, 1, 
72, 96, 120 and 192 h of the crude reaction.  
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Reaction with S-methyl oxazolidinone thione 
To confirm Davidson et al. and Shaw et al. observations that S-methyl thione arabino-
126 was unreactive towards ammonia,175, 176 ammonia was reacted with arabino-126. 
Following the general procedure for nucleophilic additions, S-methyl oxazoline 126  
(250 mM) and ammonia (1M) were incubated at pH 9.5 and rt for 72 h.  1H NMR 
spectroscopic analysis did not indicate formation of aminooxazoline 70. The reaction 
was repeated at elevated temperature (40°C), but again no reaction was obsereved 
(Scheme 8.1). 
 
Scheme 8.1: Reaction of S-methyl oxazolidine thione 126 and ammonia (NH3). 
 
8.11.3.1. Regeneration of S-cyanovinylated oxazolidinone thione in ammonia 
displacement reaction 
 
(S-Z-cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120  (250 mM) and 
ammonia (1M) were incubated at pH 10.5 and rt for 24 h. After this time 
cyanoacetylene 30 (0.25 mL, 0.5 M) was added to the mixture. 1H NMR spectroscopic 
analysis of the solution indicated quantitative conversion of oxazolidinone thione 
arabino-103 to arabino-120 within 5 min. The pH of the reaction was at this point pH 
10.5 and did not require any adjustments. Therefore the reactions was left to stand for 
further 24 h. After this time cyanoacetylene 30 (0.25 mL, 0.5 M) was added to the 
mixture. The pH of the reaction was again 10.5 and did not require any adjustments. 
Therefore the reaction was incubated for further 24 h at rt. Following this second 
recyanovinylation, 1H NMR analysis revealed that 45% aminooxazoline arabino-70 
and 10% oxazolidinone thione arabino-103 were present in the reaction mixture (See 
Section 2.5.2.1 for 1H NMR spectra). 
The above method for regerarting S-cyanovinyl arabino-120 from oxazolidinone 
thione arabino-103, was also repeated for the ribo series. (S-Z-cyanovinyl)-
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ribofuranosyl oxazolidinone thione ribo-120 (250 mM) and ammonia (1M) were 
incubated at pH 10.5 at rt for 24 h and the mixture was then treated with 
cyanoacetylene 30 at pH 10.5 and rt for 5 min, which quantitatively converted 
oxazoidione thione ribo-103 to S-cyanovinyl thione ribo-120. This cycle was repeated 
and after the second treatment with cyanoacetylene 30 the reaction mixture was 
incubated for a further 24 h at pH 10.5 and rt. After 24 h, 1H NMR spectroscopic 
analysis calibrated to an internal DSS standard  indicated that 35% ribofuranosyl 
aminooxazoline ribo-70 and 11% ribofurnosyl oxazolidinone thione ribo-103 had 
been formed (Figure 8.17). Upon standing it was obsereved that ribo-70 (15 mg, 30%) 
directly crystalised from the mixture. 
  
Figure 8.17: 1H NMR spectra (600 MHz, 2.95 – 6.3 ppm) for the reaction of (S-Z-
cyanovinyl)-ribofuranosyl oxazolidinone thione ribo-120 with ammonia (NH3). A) 
ribo-120 (250 mM) and ammonia (1M) were incubated at pH 10.5 at rt for 24 h and 
the mixture was then treated with cyanoacetylene 30 at pH 10.5 and rt for 5 min. This 
cycle was repeated and after the 2nd treatment with 30 the reaction mixture was 
incubated for a further 24 h at pH 10.5 at rt. B) Crystals of ribofuranosyl 
aminooxazoline ribo-70 obtained from the crude reaction mixture (crystals were not 
washed before analysis and were contaminated with ribo-103, it is not clear if ribo-
103 had co-crystalised or was supernant contamination). 
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8.11.4. Cyanamide 
  
(3-Acetonitrile)-arabinofuranosyl oxazolidinone thione 144 
 
(S-Z-Cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-120 (192 mg, 0.79 
mmol) was added to a solution of cyanamide 68 (134 mg, 3.17 mol) in water (20.0 
mL) at pH 6.5. The reaction was then stirred for 48 h at rt, and after this time the 
solution was lyophilised and purified by flash column chromatography eluting with 
EtAOc/MeOH (9:1) to yield (3-acetonitrile)-arabinofuranosyl oxazolidinone thione 
144 (60.0 mg, 0.21 mmol, 26%) as white solid: M.p 192-195°C. IR (Solid, cm-1) 3331 
(NH), 3217 (OH), 2193 (CN), 1630 (C=C), 1551 (C=N). 1H NMR (600 MHz, D2O) 
6.10 (1H, d, J = 5.7 Hz, H-(C1`)), 5.35 (1H, d, J = 5.7 Hz, H-(C2`)), 4.56 (1H, d, J = 
1.8 Hz, H-(C3`)), 4.24 (1H, ddd, J = 6.8, 4.3, 1.8 Hz, H-(C4`)), 3.70 (1H, ABX, J = 
12.6, 4.3 Hz, H-(C5`)), 3.61 (1H, ABX, J = 12.6, 6.8 Hz, H-(C5``)). 13C NMR (151 
MHz, D2O) 166.6 (C2), 117.1 (CN), 91.7 (C1`), 89.6 (C4`), 88.1 (C2`), 75.3 (C3`), 
61.7 (C5`). UV/Vis: λmax 213 nm. [α]D20.0 (c = 1.00, H2O) -8.17.  HRMS (m/z): [M-
H+]-  C7H9N3O4 calcd 200.0671, found 200.0680. 
 
8.11.5. 2-Aminoacetonitrile (glycine nitrile) 
 
Reaction with S-cyanovinyl oxazolidinone  thione 
Following the general procedure for nucleophilic additions, a solution of glycine 
nitrile.HCl 145 (23.1 mg, 0.25 mmol) in H2O (0.50 mL) was adjusted to pH 5.2 with 
NaOHaq (1M) then (S-Z-cyanovinyl)-arabinofuranosyl oxazolidinone thione arabino-
120  (30.3 mg, 0.12 mmol) was added in a single portion and the solution was 
readjusted to pH 5.2.  The reaction was stirred for 6 h at rt. After 6 h an aliquot ( 50 
µL) was submitted to NMR studies. 1H NMR spectroscopic analysis revealed that 
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70% aminooxazoline 146 and 14% oxazolidinone thione arabino-103 had been 
formed (Figure 8.18). The identities of each compound in the crude mixture was 
confirmed by spiking with authentic samples. 
 
  
Figure 8.18: 1H NMR spectra (600 MHz, D2O, 3.5 – 6.3 ppm) showing spectroscopic 
evidence by sequential spiking for formation of aminooxazoline 146 from the reaction 
of S-cyanovinylated oxazolidinone thione arabino-120 and glycine nitrile 145 A) The 
crude reaction of glycine nitrile 145 (500mM) and arabino-120 (250mM) at pH 5.2 
after 10 h. B) Spiked with oxazolidinone thione arabino-103. C) Spiked with 
oxazolidinone arabino-77. D) Spiked with aminooxazoline arabino-70. 
 
To investigate the cyclisation in aminooxazoline 146, the above reaction was repeated 
then an aliquot (100 µL) was diluted with NaOH solution  to 400 µL, and the 
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specificed pH 8–10. After adjusting the reaction to specified pH (between pH 8–10), 
the reaction was monitor by NMR spectroscopy periodically for 24 h. 1H NMR 
spectroscopic analysis revealed that no cyclisation to 151 had occurred, only residual 
aminooxazoline 146 was observed at all pHs investigated. 
Reaction with S-methyl oxazolidinone thione 
Following the general procedure for nucleophilic additions, solution of glycine 
nitrile.HCl 145 (23.1 mg, 0.25 mmol) in H2O (0.5 mL) was adjusted to pH 4.5 with 
NaOHaq (1M) then S-methyl oxazolidinone thione arabino-126  (24.0 mg, 0.12 mmol) 
was added in a single portion and the solution was readjusted to pH 4.5.  The reaction 
was stirred for 2 h at rt, and after 2 h an aliquot (50 µL) was submitted for NMR 
studies. 1H NMR spectroscopic analysis  revealed that 76% aminooxazoline 146 and 
8% oxazolidinone arabino-77 were present in the solution. The identities of each 
compound in the crude mixture was confirmed by spiking with authentic samples. 
(See section 2.5.4.1 for NMR spectra) 
 
8.11.6. 2-Aminomalononitrile (HCN trimer) 
 
Reaction with S-cyanovinyl oxazoidione thione 
Following the general procedure for nucleophilic additions, solution of 
aminomalononitrile p-toluenesulfonate 17 (254 mg, 1.00 mol) in H2O (1 mL) was 
adjusted to required pH (3–10) with NaOHaq (1M) then S-cyanovinyl oxazolidinone 
thione arabino-49  (60.6 mg, 0.25 mmol) was added in a single portion and the 
solution was readjusted to the required pH (3–10).  The reaction was stirred for 24 h 
at rt, and aliquots (50 µL) were submitted periodically (every 2 h) for NMR studies. 
1H NMR spectroscopic analysis did not show the formation of  aminooxazoline 160 
and only oxazolidinone thione arabino-103 and oxazolidionone arabino-77 were 
obsereved (Scheme 8.2). The identity of each compound in the crude mixture was 
confirmed by spiking with authentic samples. 
 
216 
 
 
Scheme 8.2: Reaction of 2-aminomalononitrile 17 with S-cyanovinyl oxazolinone 
thione arabino-120. 
Reaction with S-cyanovinylated oxazolidinone thione (Slow addition method)52  
Following the adapted literature procedure of Orgel et al.52, for the synthesis of HCN 
tetramer 18, to an aqueous solution of S-cyanovinylated oxazolidinone thione 
arabino-120 (10 mL, 0.20 mM), adjusted to pH 3.5 with dilute HCl, and was added 
aminomalononitrile p-toluenesulfonate 17 (10 mL, 0.02 mM) over a 6 h period. The 
pH of the reaction was maintained between 3.5-4.0 by slow addition of dilute HCl. At 
1 h intervals, aliquots (0.2 mL) of the crude mixture were diluted with D2O (0.3 mL) 
and then submitted to 1H NMR spectroscopic analysis. 1H NMR analysis indicated 
that no addition of HCN trimer 17 had occurred, only oxazolidinone thione arabino-
103 and oxazolidinone arabino-77 was detected. 
Reaction with S-methyl oxazolidinone thione  
Following the general procedure for nucleophilic additions, solution of 
aminomalononitrile p-toluenesulfonate  17 (127 mg, 0.25 mol) in H2O (0.5 mL) was 
adjusted to pH 3.0 with NaOHaq (1M) then S-methyl oxazolidinone thione arabino-
126  (24.0 mg, 0.12 mmol) was added in a single portion and the solution was 
readjusted to pH 3.  The reaction was stirred for 3 h at rt, and after 3 h an aliquot (50 
µL) was submitted to NMR studies. 1H NMR spectroscopic analysis revealed that 
10% aminooxazoline 160 was present in the reaction mixture. To induce cylisation in 
160, an aliquot (50 µL) from the above reaction was added to 100 mM ammonium 
hydroxide in D2O (450 µL). The solution was adjusted to pH 9 with NaOH (4M) and 
incubated for 1 h at rt. 1H NMR spectroscopic analysis and calibration to an internal 
standard demonstrated that aminoimidazole-4-carbonitrile-β-furanosylarabinoside 95 
and oxazolidinone arabino-77 had been furnished in 15 and 8% yield, respectively 
(Scheme 8.3). The identity of each compound in the crude mixture was confirmed by 
spiking with authentic samples. (See section 2.5.4.2 for NMR spectra).   
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Scheme 8.3: Reaction of 2-aminomalononitrile 17 with S-methyl oxazolinone thione 
arabino-126. 
 
8.11.7. Diaminomalononitrile (HCN tetramer) 
 
Reaction with S-cyanovinyl and S-methyl oxazoidoinone thione 
Following the general procedure for nucleophilic additions, diaminomalononitrile 18 
(54 mg, 0.5 mmol) in H2O (1 mL) was adjusted to the required pH (pH 3–10) with 
NaOHaq (1M) then S-cyanovinyl oxazolidinone thione arabino-120  (60.6 mg, 0.25 
mmol) or S-methyl oxazolidinone thione arabino-126 (48.0 mg, 0.25 mmol) was 
added in a single portion. The resultant solution was readjusted to the required pH (3–
10).  The reaction was stirred for 24 h at rt, and aliquots (50 µL) were submitted 
periodically (every 2 h) to NMR studies. 1H NMR spectroscopic analysis did not show 
formation of aminooxazoline 162, only oxazolidinone thione arabino-103 and 
oxazolidionone arabino-77 were obsereved (Scheme 8.4). The identity of each 
compound in the crude NMR spectrum was confirmed by spiking with authentic 
samples. 
 
 
Scheme 8.4: Reaction of S-cyanovinyl oxazolidinone thione arabino-120 and S-
methyl oxazolidinone thione arabino-126 with diaminomalononitrile 18. 
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8.11.8. 2-Amino-2-cyanoacetamide  
 
Reaction with S-cyanovinyl oxazoidione thione 
 
Figure 8.19: 1H NMR spectra (600 MHz, D2O, 3.1 – 7.0 ppm) for reaction of S-
cyanovinyl oxazolinone thione arabino-120 with 2-aminocyanoacetamide 106.  A) 
arabino-120 (250mM) and 106 (500mM) in H2O (500 µL) at pH 4.5 incubated at rt 
for 12 h.  B) Aliquot of A incubated at pH 13 and rt for 1 h giving a yield of 41% 2,2ʹ-
anhydro-5-aminoimidazole-4-carboxamide-β-furanosylarabinoside 96.  C) An 
aliquot (50 µL) of A was added to ammonium hydroxide in H2O (450 µL, 100mM), 
the solution was adjusted to pH 9 with NaOH (4M) and incubated for 24 h at rt.  
Calibration to an internal standard gave yields of 33% 96, 24% oxazolinone thione 
arabino-103, 21% oxazolidinone arabino-77.  D) Spiked with arabino-77.  E) Spiked 
with arabino-103.  F) Spiked with 96. 
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Following the general procedure for nucleophilic additions, a solution of 2-amino-2-
cyanoacetamide 106 (24.8 mg, 0.25 mol) in H2O (0.5 mL) was adjusted to required 
pH 4.5 with NaOHaq (1M), then S-cyanovinyl oxazolidinone thione arabino-120  
(30.3 mg, 0.12 mmol) was added in a single portion. The resultant solution was 
readjusted to pH 4.5 and the reaction was stirred for 12 h at rt. After 12 h an aliquot 
(50 µL) of the reaction mixture was submitted for NMR studies. 1H NMR 
spectroscopic analysis revealed that aminooxazoline 168 had been furnished in 50% 
yield. (Figure 8.19A).  
To induce cylisation in 168, an aliquot (50 µL) from the above reaction was added to 
100 mM ammonium hydroxide in D2O (450 µL), the solution was then adjusted to pH 
13 with NaOH (4M) and incubated for 1 h at rt. 1H NMR spectroscopic analysis and 
calibration to an internal standard demonstrate that aminoimidazole-4-carbonitrile-β-
furanosylarabinoside 96, oxazolidinone arabino-77, and oxazolidinone thione 
arabino-103 have been synthesised in 41, 20 and 26% yield, respectively (Figure 
8.19B). Cyclisation of 168 was also investigated under milder alkaline conditions by 
incubation of a second aliquot of the above reaction at pH 9 and rt for 24 h. 1H  NMR 
spectra of this reaction revealed that 96, arabino-77, and arabino-103 had been 
furnished in 33, 21 and 24% yield, respectively (Figure 8.19C). The identity of each 
compound in the crude NMR spectrum was confirmed by spiking with authentic 
samples (Figure 8.19D-F).  
Time course and pH experiments of aminooxazoline 168 
Following the general procedure for nucleophilic additions, solution of 2-amino-2-
cyanoacetamide 106 (50.4 mg, 0.50 mol) in H2O (1 mL) was adjusted to required pH 
4.5 with NaOHaq (1M) then S-cyanovinyl oxazolidinone thione arabino-120  (60.6 
mg, 0.25 mmol) was added in a single portion and the solution was readjusted to pH 
4.5.  The reaction was stirred for 7 h at rt, and aliquots (50 µL) which had 4-dimehtyl-
4-silapentane-1-sulfonic acid (DSS, NMR standard) from the beginning of the 
experiment, were submitted for 1H NMR studies periodically (at 1 h intervals). 1H 
NMR data was then carefully analysed and presence of aminooxazoline 168, 
oxazolidinone thione arabino-103, and oxazolidinone arabino-77 were confirmed by 
spiking with authentic samples (Figure 8.20). 
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Figure 8.20: Time course reaction for formation of aminooxazoline 168 from S-
cyanovinyl oxazolidinone thione arabino-120. 
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Reaction with S-methyl oxazolidinone thione 
 
Following the general procedure for nucleophilic additions, solution of of 2-amino-2-
cyanoacetamide 106 (24.8 mg, 0.25 mol) in H2O (0.5 mL) was adjusted to pH 4.5 with 
NaOHaq (1M) then S-methyl oxazolidinone thione arabino-126  (24.0 mg, 0.12 mmol) 
was added in a single portion and the solution was readjusted to pH 4.5.  The reaction 
was stirred for 6 h at rt, after 6 h an aliquot (50 µL) was submitted for NMR studies. 
1H NMR spectroscopic analysis revealed that aminooxazoline 168 had been furnished 
in 81% yield. To induce cylisation in 168, an aliquot (50 µL), from the above reaction 
was added to 100 mM ammonium hydroxide in D2O (450 µL), the solution was 
adjusted to pH 13 with NaOH (4M) and incubated for 1 h at rt. 1H NMR spectroscopic 
analysis, and calibration to an internal standard, demonstrated that aminoimidazole-
4-carbonitrile-β-furanosylarabinoside 96 had been synthesised in 59% yield. 
Cyclisation of 168 was also investigated under mildly alkaine conditions; an aliquot 
(50 µL) from the above reaction was incubated at pH 9 and rt for 24 h to furnished a 
47% yield of 96 (Scheme 8.5). The identity of each compounds in the crude NMR 
spectrum was confirmed by spiking with authentic samples. (See section 2.5.4.3 for 
NMR spectra)   
 
Scheme 8.5: Reaction of 2-amino-2-cyanoacetamide 106 with S-methyl oxazolinone 
thione arabino-126. 
 
2,2ʹ-anhydro-5-aminoimidazole-4-carboxamide-β-furanosylarabinoside 96 
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To a solution of 2-amino-2-cyanoacetamide 106 (108 mg, 1.09 mmol) in water (1 mL) 
at pH 4.5 was added S-cyanovinyl oxazolidinone thione arabino-120 (354 mg, 1.46 
mmol). The resultant mixture was stirred for 3 h at 45°C and the solution was kept 
between pH 4.3–4.7 during the course of the reaction. After 3 h the pH of the reaction 
was raised to pH 8.1 and the reaction was left to stir overnight at 45°C. The mixture 
was then allowed to cool to rt and then placed in a fridge (7°C). After 3 h in the fridge 
white solids had precipitated from the crude reaction mixture. These solid were 
isolated by filteration, washed with cold methanol and dried to yield 2,2ʹ-anhydro-5-
aminoimidazole-4-carboxamide-β-furanosylarabinoside 96 (37.2 mg, 0.15 mmol, 
13%) as white solid:  M.p 234-238°C. IR (solid, cm-1) 3493 (NH2-C=O), 3359 (NH2-
C), 3210 (OH), 1638 (C=O), 1581 (C=N), 1533 (C=C). 1H NMR (600 MHz, D2O) 
6.46 (1H, d, J = 5.4 Hz, H-(C1`)), 5.68 (1H, d, J = 5.4 Hz, H-(C2`)), 4.60 (1H, br s, 
H-(C3`)), 4.38 (1H, ddd, J = 6.8, 4.9, 1.9 Hz, H-(C4`)), 3.56 (1H, ABX, J = 12.4, 4.9 
Hz, H-(C5`)), 3.42 (1H, ABX, J = 12.4, 6.8 Hz, H-(C5``)).  13C NMR (151 MHz, 
D2O) 169.1 (C6),152.6 (C2), 140.0 (C5), 109.9 (C4), 97.9 (C2`), 89.3 (C4`), 86.5 
(C1`), 75.3 (C3`), 61.5 (C5`). UV/Vis: λmax 240 nm. [α]D20.0 (c = 1.00, H2O) -14.92. 
HRMS (m/z): [M-H+]-C9H12N4O5 calcd 257.0886, found 257.0909. 
Crystal structure obtained; see appendix for crystallographic data. 
 
8.11.8.1. Displacement of S-cyanovinyl thiolate group by 2-amino-2-
cyanoacetamide in the presence of aminooxazoline arabino-70 
 
To a solution of aminooxazoline arabino-70 (0.04 mmol, 7.50 mg) and 2-amino-2-
cyanoacetamide 106 (0.12 mmol, 13 mg) in H2O (0.50 mL) and D2O (0.10 mL) at pH 
4.5, was added S-cyanovinylated oxazolidinone thione arabino-120 (0.04 mmol, 10.0 
mg). The resultant solution was left to stand at rt for 20 h, and the pH was verified 
every 30 minutes for the first 8 h and then after 20 h. After 20 h the sample was 
submitted to NMR spectroscopy. The acquired 1H NMR spectrum indicated that 48% 
aminooxazoline 168 had been obtained alongside the formation of 38% oxazolidionoe 
thione arabino-103 and 14% oxazoidione arabino-77, whist aminooxazoline arabino 
-70 remained unchanged (Scheme 8.6). 
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Scheme 8.6: Incubation of S-cyanovinyl thione arabino-120 with 2-amino-2-
cyanoacetamide 106 in the presence of aminooxazoline arabino-70 at pH 4.5 and rt 
for 20 h. 
 
8.11.8.2. Displacement of S-cyanovinyl thiolate group by 2-amino-2-
cyanoacetamide in the presence of ancitabine 
 
To a solution of 2-amino-2-cyanoacetamide 106 (0.83 mmol, 110 mg) in H2O (0.60 
mL) at pH 4.5 was added S-cyanovinyl oxazolidinone thione arabino-120 (0.08 mmol, 
20.0 mg) and ancitabine arabino-73 (0.08 mmol, 20.0 mg) in D2O (0.20 mL). The 
resultant solution was left to stand at rt for 5 h, and the pH was checked every hour. 
The sample was submitted periodically for 1H NMR spectroscopy after 0, 1, 3, 4 and 
5 h. Calibration to internal standard indicated that after 5 h 64% aminooxazoline 168, 
16% oxazolidinone thione arabino-103, 10% oxazolidinone arabino-77 had formed 
and 10% arabino-120 remaining, whilst ancitabine arabino-73  remained unchangaed 
(Figure 8.21).  
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Figure 8.21: Expanded 1H NMR spectra (600 MHz, D2O, 5.4 – 8.3 ppm) for the time 
course reaction of 2-amino-2-cyanoacetamide 106 with S-cyanovinyl oxazolidinone 
thione arabino-120 in the presence of ancitabine arabino-73. A) 0 h, B) 1 h. C) 3 h. 
D) 4 h. E) 5 h.  
 
In order to induce cyclisation in aminooxazoline 168, to furnish  2,2ʹ-anhydro-5-
aminoimidazole-4-carboxamide-β-furanosylarabinoside 96 in the presence of 
ancitabine arabino-73, the pH of the above reaction mixture was slowly raised to pH 
7.0 with NaOH (0.5M). The sample was submitted for NMR spectroscopy using single 
Time (h) arabino-120 (%) 168 (%) arabino-103 (%) arabino-77 (%) 
1 54 36 12 4 
3 26 54 14 8 
4 16 60 16 10 
5 10 64 16 10 
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solvent suppression. Calibration to internal standard was used to assess reaction yields 
at 30 mins, 2 h and then every 6 h for 96 h (Figure 8.22). After 96 h the sample was 
spiked with authentic compounds to confirm the identity of each species present.  
 
Time (h) arabino-73 185 168 96 arabino-103 arabino-77 Unknown 
0.5 96 0 72 0 20 10 2 
2 96 0 72 0 20 10 2 
6 96 0 66 4 20 10 4 
12 92 4 62 6 20 10 4 
18 90 8 54 8 22 10 8 
24 90 8 48 10 20 12 12 
36 88 12 38 14 20 12 12 
48 80 14 36 16 22 12 18 
60 68 18 34 20 20 12 24 
72 64 22 30 20 20 14 30 
84 58 26 28 20 22 14 32 
96 50 28 26 22 20 14 36 
 
Figure 8.22: Tabulated data for cyclisation of aminooxazoline 168 to AICA tricyclic 
moiety 96 in the presence of ancitabine arabino-73. Hydrolysis of arabino-73 to 
arabino cytidine 185 was reasonably slow to accommodate cyclisation of 168 to 96 at 
pH 7. The NMR data obtained was calibrated with inter NMR standard DSS. 
 
8.12. Conventional synthesis of 8,2`-anhydro-arabino-
cycloadenine 
 
9-β-Arabinofuranoside-8-chloroadenine 175 
 
Following the literature procedure described by Ryu et al.,215 to a solution of arabinose 
adenine 9-β-arabinofuranoside 169 (50.0 mg, 0.19 mmol) in 0.55 M HCl in DMF 
226 
 
(0.58 mL) was added mCPBA 176 (57.0 mg, 0.19 mmol) in DMF (0.20 mL). After 
30 min a second batch of mCPBA 176 (27.0 mg, 0.09 mmol) in DMF (0.1 mL) was 
added. The yellow/orange solution was stirred for 2 h at rt. After 2 h the mixture was 
concentrated by removing DMF in vacuo. Water (3 mL) was added and a white 
precipitate formed. The precipitate was isolated by filteration and washed with water 
(5 mL). The filtrate was then dried to yield a gummy residue which was purified by 
flash column chromatography (MeOH/CHCl3, 5:95). All fractions containing the 
required product were combined and evaporated to give 9-β-arabinofuranoside-8-
chloroadenine 175 (20 mg, mmol 0.07, 35%) as a white solid. No characterisation data 
available in literature. M.p. 225°C (decomp.). IR (Solid cm-1) 3316 (NH2), 3188 (OH), 
2940, 2866 (CH), 1668 (C=C), 1606, 1578 (C=N). 1H NMR (600 MHz, DMSO) δ 
8.10 (1H, s, H-(C2)), 7.45 (2H, s, H-(NH2)), 6.28 (1H, d, J = 7.0 Hz, H-(C1`)), 5.65 
(1H, d, J = 5.6 Hz, H-(2`OH), 5.49 (1H, d, J = 5.6 Hz,  H-(3`-OH)), 5.27 (1H, dd, J = 
6.2, 4.4 Hz,  H-(5`OH)), 4.37 (1H, td, J = 7.0, 5.6 Hz, H-(C2`)), 4.33 (1H, td, J = 7.0, 
5.6  Hz, H-(C3`)), 3.73 (3H, m, H-(C4`) and H-(C5`)). 13C NMR (151 MHz, DMSO) 
δ 155.0 (C6), 152.30 (C2), 150.2 (C4), 136.7 (C8), 117.5 (C5), 85.0 (C1`), 82.8 (C4`), 
76.4 (C2`), 74.2 (C3`), 60.9 (C5`). UV/Vis: λmax 256 nm. [α]D20.0 (c = 1.00, DMSO) 
+8.87. HRMS (m/z): [M-H+]-C10H12ClN5O4 calcd 302.0656, found 302.0642. 
 
9-β-Arabinofuranoside-8-bromoadenine 179 
 
 
Following the literature procedure described by Ikehara et al.,211 saturated bromine 
water (5.8 mL in 100 mL H2O) was added to a solution of arabinose adenine 9-β- 
arabinofuranoside 169 (10.0 g, 34.4 mmol) in sodium acetate solution (1.5 L, 1 M, pH 
4.0) at rt. The resultant solution was stirred vigorously for 3 h, during which time the 
reaction progress was followed by 1H NMR specrroscopy. After 3 h the solution was 
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decolourised with 5 M sodium bisulfite, and then adjusted to pH 7.0 with 5 M NaOH. 
The decolourised solution was then concentrated overnight by air-blowing over the 
solution, after 24 h a precipitate was formed. The resulting crystals were collected by 
filtration, and then washed with water (3 × 50.0 mL) and acetone (100 mL). The 
desired product 9-β-arabinofuranoside-8-bromoadenine 179 (6.72 g, 19.4 mmol, 56 
%) was isolated as white powder. An analytically pure sample was obtained by 
recrystallization of the product from EtOH-H2O. M.p. 203ºC (decomp.) (Lit.
265 202-
204°C, decomp). IR (Solid, cm-1) 3375 (NH2), 3177 (OH), 2866 (CH), 1736 (C=C), 
1603 (C=N). 1H NMR (600 MHz, DMSO) 8.07 (1H, s, H-(C2)), 7.46 (2H, br s, H-
NH2), 6.23 (1H, d, J = 7.1 Hz, H-(C1`)), 5.64 (1H, d, J = 5.8 Hz, H-(2`OH)), 5.49 (1H, 
d, J = 5.7 Hz, H-(3`OH)), 5.35 (1H, dd, J = 6.5, 4.4 Hz, H-(5`OH)), 4.45 (1H, td, J = 
7.1, 5.7 Hz, H-(C3`)), 4.34 (1H, td, J = 7.1, 5.8 Hz, H-(C2`)), 3.83 – 3.68 (3H, m, H-
(C4`), H-(C5`), H-(C5``)). 13C NMR (151 MHz, DMSO) 155.0 (C6), 152.0 (C2), 
150.4 (C4), 126.3 (C8), 119.3 (C5), 86.2 (C1`), 82.8 (C4`), 76.5 (C2`), 74.1 (C3`), 
60.9 (C5`).  UV/Vis: λmax 267 nm. [α]D20.0 (c = 1.00, DMSO) +6.90. HRMS (m/z): [M-
H+]-  C10H12BrN5O4 calcd 346.0151, found 346.0133. 
8,2`-O-anhydro-9-β-arabinofuranosyl-cycloadenosine 89 
 
 
9-β-Arabinofuranoside-8-bromoadenine 169 (3.28g, 9.48 mmol) was dissolved in 1M 
sodium acetate (20 mL). The solution was adjusted to pH 8.0 and stirred for 1 h. The 
reaction was followed by TLC and single solvent suppressed 1H NMR. A precipitate 
was observed to form during the course of the reaction and after 1h the resulting 
crystals were collected by filtration. The precipitate was washed with water (3 × 20 
mL) and acetone (20 mL), to give the desired product 8,2`-O-anhydro-9-β-
arabinofuranosyl-cycloadenosine 89 (2.0 g, 7.5 mmol, 80%) as white powder. An 
analytical sample was obtained by recrystallisation of 89 from hot water. M.p. 205°C 
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(decomp.). IR (Solid, cm-1) 3297 (NH2), 3142 (OH), 2962, 2883 (CH), 1667 (C=C), 
1623 (C=N). 1H NMR (600 MHz, D2O) δ 8.16 (1H, s, H-(C2)), 6.71 (1H, d, J = 5.5 
Hz, H-(C1`)), 5.90 (1H, d, J = 5.5 Hz, H-(C2`)), 4.72 (1H, s, H-(C3`)), 4.40 (1H, ddd, 
J = 6.5, 5.4, 4.3 Hz, H-(C4`)), 3.55 (1H, ABX, J = 12.7, 4.3 Hz, H-(C5`)), 3.48 (1H, 
ABX, J = 12.7, 5.4 Hz, H-(C5``)).  13C NMR (151 MHz, D2O) δ 161.2 (C8), 154.4 
(C5), 151.6 (C2), 146.2 (C4), 121.1 (C6), 99.5 (C2`), 89.6 (C4`), 86.5 (C1`), 75.6 
(C3`), 61.4 (C5`). Analysis (% calcd, % found for C10H11N5O4): C (45.12, 42.48), H 
(4.18, 4.45), N (26.41, 24.53), O (24.13, 28.14). UV/Vis: λmax 257 nm.  [α]D20.0 (c = 
1.00, H2O) -18.03. HRMS (m/z): [M-H
+]-  C10H11N5O4 calcd 266.0861, found 
266.0866.   
 
Crystal structure obtained; see appendix for crystallographic data. 
 
8.13. Conventional synthesis of 8,2`-anhydro-arabino-
cycloguanine 
 
9-β-Arabinofuranoside-8-bromoguanine 181 
 
This method was adapted from a reported literature procedure by Ikehara et al.211 To 
a solution of arabinose guanine 9-β-arabinofuranoside 180 (250.0 mg, 0.88 mmol) 
dissolved in sodium acetate solution (37.5 mL, 1M, pH 4.0) at rt was added saturated 
bromine water (145 µL in 2.5 mL H2O). The resultant solution was vigorously stirred 
at r.t for 24 h. The progress of the reaction was followed by single solvent suppressed 
1H NMR and TLC. The solution was decolourised with 5 M sodium bisulfite and then 
adjusted to pH 7.0 with 5 M NaOH. The decolourised solution was then concentrated 
overnight by blowing air over the solution and after 16 h a precipitate had formed. 
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The resulting crystals were collected by filtration, washed with water (3 × 5.0 mL) 
and acetone (20 mL), to give the desired product 9-β-arabinofuranoside-8-
bromoguanine 181 (265 mg, 0.73 mmol, 73%) as white powder. An analytical sample 
was obtained by recrystallisation of 181 from DMSO-H2O. M.p. 205°C (decomp.). IR 
(Solid, cm-1) 3397 (NH2), 3331 (NH), 3152 (OH), 2913, 2889 (CH), 1672 (C=O), 
1651 (C=C), 1599 (C=N). 1H NMR (600 MHz, DMSO) δ 10.77 (1H, s, H-(N1)), 6.45 
(2H, s, H-(NH2)), 6.06 (1H, d, J = 6.5 Hz, H-(C1`)), 5.55 (1H, d, J = 6.0 Hz, H-
(2`OH)), 5.35 (1H, d, J = 5.6 Hz, H-(3`OH)), 4.85 (1H, dd, J = 5.7, 4.2 Hz, H-(5`OH)), 
4.30 (1H, td, J = 6.5, 5.6 Hz, H-(C3`)), 4.22 (1H, td, J = 6.5.0, 6.0 Hz, H-(C2`)), 3.79 
– 3.73 (1H, m, H-(C4`)), 3.72 – 3.64 (2H, m, H-(C5`)). 13C NMR (151 MHz, DMSO) 
δ 155.5 (C6), 153.2 (C2), 152.2(C4), 120.6 (C8), 117.0 (C5), 85.0 (C1`), 83.0 (C4`), 
76.7 (C2`), 75.2 (C3`), 61.7 (C5`). UV/Vis: λmax 250 nm. [α]D20.0 (c = 1.00, DMSO) - 
4.22. HRMS (m/z): [M-H+]-  C10H10N5O4 calcd 362.0260, found 362.0223. 
8,2`-O-anhydro-9-β-arabinofuranosyl-cycloguanine 90 
 
 
9-β-Arabinofuranoside-8-bromoguanine 181 (100.0 mg, 0.28 mmol) was dissolved in 
1 M sodium acetate (5 mL). The solution was adjusted to pH 8.0 and stirred for 4 h. 
The progress of reaction was followed by TLC and 1H NMR. After 4 h a white 
precipitate was observed to form, and  the resulting crystals were collected by 
filtration, washed with water (3 × 5 mL) and acetone (5 mL), to give the desired 
product 8,2`-O-anhydro-9-β-arabinofuranosyl-cycloguanine 90 (63.0 mg, 0.22 mmol, 
80%) as white powder. An analytical sample was obtained by recrystallisation of 90 
from DMSO-H2O. M.p 285°C (decmp.). IR (Solid, cm
-1) 3440 (NH), 3352 (OH), 
2914, 2776 (CH), 1659 (C=O), 1605 (C=C), 1570 (C=N). 1H NMR (600 MHz, 
DMSO) δ 10.62 (1H, s, H-(N1), 6.45 (2H, s, H-(NH2)), 6.32 (1H, d, J = 5.4 Hz, H-
(C1`)), 5.86 (1H, d, J = 4.2 Hz, H-(3`OH)), 5.54 (1H, d, J = 5.4 Hz, H-(C2`)), 4.95 
(1H, t, J = 5.5 Hz, H-(5`OH)), 4.38 (1H, d, J = 4.2 Hz H-(C3`)), 4.04 – 3.97 (1H, m, 
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H-(C4`)), 3.20 (1H, ABXY, J = 11.4, 5.5, 5.5 Hz, H-(C5`)), 3.10 (1H, ABXY, J = 
11.4, 6.6, 5.5 Hz, H-(C5``)).13C NMR (151 MHz, DMSO) δ 156.1 (C2), 155.9 (C9), 
153.4 (C4), 147.4 (C5), 116.7 (C7), 97.8 (C2`), 88.4 (C4`), 84.9 (C1`), 74.2 (C3`), 
60.6 (C5`). Analysis (% calcd, % found for C10H11N5O5): C (42.71, 40.60), H (3.94, 
4.16), N (24.9, 23.50), O (28.46, 31.74). UV/Vis: λmax 255 nm. [α]D20.0 (c = 1.00, 
DMSO) -14.65. HRMS (m/z): [M-H+]-  C10H11N5O5 calcd 282.0838, found 282.0839. 
8.14. Synthesis of 8,2`-anhydro-arabino-cycloinosine 
 
8,2`-O-anhydro-9-β-arabinofuranosyl-cycloinosine 170 
 
Following a known literature procedure reported by Ikehara et al.,217 9-β-
arabinofuranosyl-cycloadenosine 89 (265 mg, 1.0 mmol) was dissolved in 2M AcOH 
(20 mL), and then sodium nitrite (345 mg, 5 mmol) dissolved in H2O (5 mL) was 
added. The resultant mixture was stirred at rt for 24 h, whlist the reaction progress was 
monitored by TLC. After 24 h the solvent was evaporated, and then repeatedly co-
evaporated with EtOH, until no odour of AcOH remained. The residue was 
recrystallised from H2O to give desired product 8,2`-O-anhydro-9-β-
arabinofuranosyl-cycloinosine 170 (180 mg, 0.68 mmol, 68%) as pale yellow plates. 
M.p. 255°C (decmp). IR (Solid, cm-1) 3216 (OH) or (NH), 3076, 2006, 2953 (CH), 
1673 (C=O), 1598 (C=C), 1572 (C=N). 1H NMR (600 MHz, D2O) δ 8.17 (H, s, H-
(C7)), 6.75 (1H, d, J = 5.5 Hz, H-(C1`)), 5.91 (1H, d, J = 5.5 Hz, H-(C2`)), 4.72 (1H, 
s, H-(C3`)), 4.42 (1H, ddd, J =5.5, 5.5, 4.1 Hz, H-(C4`)), 3.56 (1H, ABX, J = 12.7, 
4.1 Hz, H-(C5`)), 3.49 (1H, ABX, J = 12.7, 5.5 Hz, H-(C5``)). 13C NMR (151 MHz, 
D2O) δ 160.7 (C2), 158.4 (C9), 145.8 (C4), 145.6 (C7), 126.0 (C5), 99.5 (C2`), 89.9 
(C4`), 86.9 (C1`), 75.6 (C3`), 61.4 (C5`). UV/Vis: λmax 250 nm. Analysis (% calcd, % 
found for C10H10N4O5): C (45.12, 44.12), H (3.79, 3.70), N (21.05, 20.56), O (30.05, 
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31.62). [α]D20.0 (c = 1.00, H2O) -16.30. HRMS (m/z): [M-H+]-  C10H10N5O4 calcd 
267.0729, found 267.0723. 
Crystal structure obtained; see appendix for crystallographic data. 
 
8.16. Isomerisation of anhydronucleoside 
 
8,5`-O-anhydro-9-β-arabinofuranosyl-cycloadenine 182 
 
Following a known literature procedure reported by Ikehara and Ogiso,266 8,2`-O-
anhydro-9-β-arabinofuranosyl-cycloadenosine 89 (265 mg, 1.0 mmol) was heated in 
0.01 M NaOH (30 mL) at 60°C for 3 h then neutralised with 0.1 M HCl and evaporated 
in vacuo to approximately 5 mL, precipitating crystalline material. The crystals were 
collected by filtration and washed with MeOH, which dissolved the starting material. 
The residual crystals were recrystallised from water to give the desired product 8,5`-
O-anhydro-9-β-arabinofuranosyl-cycloadenine 182 (29 mg, 0.11 mmol, 11%) as 
white prisms. M.p. 236°C (decomp.). IR (Solid, cm-1) 3563 (NH), 3420 (OH), 2961, 
2916 (CH), 1620 (C=C), 1576 (C=N). 1H NMR (600 MHz, D6-DMSO) 8.06 (1H, s, 
H-(C2)), 6.30 (1H, d, J = 6.4 Hz, H-(C1`)), 4.53 (1H, ABX, J = 13.0, 2.6 Hz, H-(C5`)), 
4.38 (1H, d, J = 6.4 Hz, H-(C2`)), 4.35 (1H, d, J = 2.6 Hz, H-(C4`)), 4.18 (1H, s, H-
(C3`)), 4.12 (1H, ABX, J = 13.0 Hz, H-(C5``)). 13C NMR (151 MHz, DMSO) 155.0 
(C8), 153.9 (C6), 151.4 (C2), 148.4 (C4), 114.2 (C5), 86.6 (C4`), 83.8 (C2`), 79.8 
(C1`), 77.4 (C3`), 74.7 (C5`). UV/Vis: λmax 260 nm. [α]D20.0 (c = 1.00, H2O) -9.52. 
HRMS (m/z): [M-H+]-  C10H11N5O4 calcd 266.0889, found 266.0898. 
 
Crystal structure obtained; see appendix for crystallographic data. 
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2`,3`-epoxy-9-β-arabinofuranoside-8-oxoadenine 183 
 
 
 
This method was adapted from a reported literature procedure by Rees et al.,222 9-β-
arabinofuranoside-8-bromoadenine 179 (1.0 g, 2.89 mmol) was dissolved in NaOH (1 
M, 10 mL). The resultant mixture was then stirred for 2 h at r.t, whilst the reaction 
progress was monitored by TLC and 1H  NMR. After 2 h neutralised silica (6.0 g in 
1.50 mL aqueous ammonia) was added and the slurry was concentrated in vacuo to 
yield a fine free flowing powder. This silica was the applied to the top of a silica gel 
column. The column was then eluted with ethyl acetate and methanol (95:5) to yield  
desired product 2`,3`-epoxy-9-β-arabinofuranoside-8-oxoadenine 183 (260 mg, 0.98 
mmol, 34%) as white solids. An analytical sample of 183 was obtained by 
recrystallisation from hot water. M.p 202°C (decomp.). IR (Solid, cm-1) 3323 (NH2), 
3194 (OH), 1715 (C=O), 1651 (C=C), 1595 (C=N). 1H NMR (600 MHz, D2O) 8.13 
(1H, s, H-(C2)), 6.17 (1H, s, H-(C1`)), 4.56 (1H, d, J = 2.7 Hz, H-(C2`)), 4.40 (1H, 
dd, J = 7.7, 5.0 Hz, H-(C4`)), 4.27 (1H, d, J = 2.7 Hz, H-(C3`)), 3.82 (1H, ABX, J = 
12.1, 5.0 Hz, H-(C5`)), 3.72 (1H, ABX, J = 12.1, 7.7 Hz, H-(C5``)). 13C NMR (151 
MHz, D2O) 153.5 (C8), 151.8 (C2), 148.2 (C6), 147.1 (C4), 105.3 (C5), 81.5 (C4`), 
81.3 (C1`), 61.4 (C5`), 59.9 (C3`), 58.5 (C2`).  UV/Vis: λmax 301 nm. [α]D20.0 (c = 1.00, 
H2O) -7.89. HRMS (m/z): [M-H
+]-  C10H11N5O4 calcd 266.0895, found 266.0866.  
 
 
Crystal structure obtained; see appendix for crystallographic data. 
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8.17. Prebiotic phosphorylation of nucleosides 
 
8.17.1. General methods for prebiotic phosphorylation  
 
Method A: 
The nucleoside (0.06 mmol), ammonium dihydrogen phosphate (0.06 mmol) and urea 
(0.6 mmol) were dissolved in H2O (0.6 mL) by warming. The resultant suspension 
was evenly spread on glass fibre disc (2 × 25mm × 0.68 mm). The discs were dried at 
40°C for 48 h and then heated at 100°C for 24 h. The discs were then washed with 
H2O (10 mL) and D2O (10 mL), the washings were then lyophilised to yield a brown 
solid. The brown solids were dissolved in D2O (1 mL) and then the solids were 
removed by centrifuge. The resultant solution was left overnight and some precipitate 
formed which was further removed by centrifuge. The solution obtained was then 
submitted for 1H and 31P NMR analysis. Yields were calculated based on comparison 
with an internal standard (DSS) and nucleotide phosphates were purified using HPLC.  
Method B:  
The nucleoside (0.06 mmol), ammonium dihydrogen phosphate (0.06 mmol) and urea 
(0.6) were dissolved in H2O (0.5 mL) and formamide (0.1 mL) by warming. The 
resultant suspension was evenly spread on glass fibre disc (2 × 25 mm × 0.68 mm). 
The discs were dried at 40°C for 48 h and then heated at 100°C for 24 h. The discs 
were then washed with H2O (10 mL) and D2O (10 mL), the washings were then 
lyophilised to yield a brown solid. The brown solids were dissolved in D2O (1 mL) 
and then the solids were removed by centrifuge. The resultant solution was left 
overnight and some precipitate formed which was further removed by centrifuge. The 
solution obtained was then submitted for 1H and 31P NMR analysis. Yields were 
calculated based on comparison with an internal standard (DSS) and nucleotide 
phosphates were purified using HPLC. 
Method C:  
The nucleoside (0.06 mmol), and a mixture of salts containing dihydrogen 
phosphate/ammonium chloride/ammonium bicarbonate/urea (1:5:10:10 equiv.) were 
dissolved in H2O (0.6 mL). The resultant solution was evenly applied to glass fibre 
234 
 
discs (2 × 25 mm × 0.68 mm). The discs were dried at 40°C for 48 h and then heated 
at 100°C for 24 h. The disc was then washed with H2O (10 mL) and D2O (10 mL), the 
washings were then lyophilised to yield a brown solid. The brown solid was dissolved 
in D2O (1 mL) and then the solids were removed by centrifuge. The resultant solution 
was left overnight and some precipitate formed which was further removed by 
centrifuge. The solution obtained was then submitted for 1H and 31P NMR analysis. 
Yields were calculated based on comparison with an internal standard (DSS) and 
nucleotide phosphates were purified using HPLC. 
Method D: 
Nucleoside (0.06 mmol), ammonium dihydrogen phosphate (0.06 mmol) and urea (1.6 
mmol) were thoroughly mixed and heat at 140°C for 20 min. The reaction mixture 
was then cooled to rt, dissolved in D2O (3 mL) and lyophilised.  The residue was thrice 
dissolved in D2O (3 mL) and lyophilised. The final lyophilite was then dissolved in 
D2O (0.5 mL) and NMR spectra were acquired. Yields were calculated based on 
comparison with an internal standard (DSS) and nucleotide phosphates were purified 
using HPLC. 
Method E:   
Nucleoside (0.06 mmol), ammonium dihydrogen phosphate (0.06 mmol) and urea (0.6 
mmol) were suspended in formamide (0.6 mL). The reaction mixture was heated at 
100°C for 72 h. The reaction was diluted with D2O (3 mL) and lyophilised for 3 d (to 
remove formamide), diluted with D2O (3 mL) and further lyophilised. The lyophilite 
was dissolved in D2O (0.5 mL) and NMR spectra were acquired. Yields were 
calculated based on comparison with an internal standard (DSS). 
Method F: 
Nucleoside (0.03 mmol), ancitabine 11 (0.03 mmol), ammonium dihydrogen 
phosphate (0.06 mmol) and urea (0.6 mmol) were suspended in formamide (0.6 mL). 
The reaction mixture was heated at 100°C for 72 h. The reaction was diluted with D2O 
(3 mL) and lyophilised for 3 d (to remove formamide), diluted with D2O (3 mL) and 
further lyophilised. The lyophilite was dissolved in D2O (0.5 mL) and NMR spectra 
were acquired. Yields were calculated based on comparison with an internal standard 
(DSS). 
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 8.17.2. Synthesis of β-8-oxo- 2`,3`-cyclic phosphate purine 
ribonucleotides from anhydro purines. 
 
β-Ribofuranosyl-8-oxo-adenine-2`,3`-cyclic phosphate 93 
 
Following method E of phosphorylation: 8,2`-anhydro-adenosine 89 (32.0 mg, 0.12 
mmol), ammonium dihydrogen phosphate (13.5 mg, 0.12 mmol) and urea (72.0 mg, 
1.2 mmol) were suspended in formamide (1.2 mL). The reaction mixture was heated 
at 100°C for 48 h. The pale yellow solution was allowed to cool, diluted with H2O 
(1.8 mL) to make a 3 mL solution, which was then purified by HPLC with a gradient 
of 100 mM triethylammonium formate at pH 5 and acetonitrile from 80:20 at a flow 
rate of 5 ml/min. The product was detected at λ = 250 nm. The fractions containing 
the desired product were combined, and lyophilised to yield β-ribofuranosyl-8-oxo-
adenine-2`,3`-cyclic phosphate 93 (8.2 mg, 0.024 mmol, 20%) as white solids. M.p. 
220°C (decomp.). IR (Solid, cm-1) 1711 (N-C=N), 1649 (N-C=O), 1060 (PO4). 
1H 
NMR (600 MHz, D2O) 8.10 (1H, s, H(C2)), 6.11 (1H, d, J = 3.4 Hz, H-(C1`)), 5.61 
(1H, ddd, J = 7.8, 7.0, 3.4 Hz, H-(C2`)), 5.14 (1H, ddd, J = 10.9, 7.0, 4.9 Hz, H-(C3`)), 
4.40 (1H, ddd, J = 5.5, 4.9, 3.3 Hz,  H-(C4`)), 3.93 (1H, ABX, J = 12.3, 3.6 Hz, H-
(C5`)), 3.85 (1H, ABX, J = 12.3, 5.5 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) 153.3 
(C8), 151.8 (C2), 148.3 (C6), 146.7 (C4), 105.2 (C5), 87.0 (d, J = 5.5 Hz, (C1`)), 85.6 
(d, J = 2.2 Hz, (C4`)), 79.8 (d, J = 2.2 Hz, (C2`)), 78.3 (C3`), 62.0 (C5`). 31P NMR 
(162 MHz, D2O) δ 20.37 (dd, J = 10.5, 7.5 Hz). UV/Vis: λmax 273 nm. [α]D20.0 (c = 
1.00, H2O) -7.32. HRMS (m/z): [M-H
+]-  C10H11N5O7P
- calcd 344.0396, found 
344.0390.  
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β-Ribofuranosyl-8-oxo-adenine-2`,3`- cyclic-bis-5`-phosphate 188 
 
 
The above procedure also yielded β-ribofuranosyl-8-oxo-adenine-2`,3`- cyclic-bis-5`-
phosphate 188 (4.1 mg, 0.010 mol, 8%) as white solid. M.p. 235°C (decomp.). IR 
(Solid, cm-1) 1707 (N-C=N), 1655 (N-C=O), 1038 (PO4). 
1H NMR (600 MHz, D2O) 
8.12 (1H, s, H-(C2)), 6.11 (1H, d, J = 2.9 Hz, H-(C1`)), 5.69 (1H, td, J = 6.3, 2.9, H-
(C2`)), 5.19 (1H, ddd, J = 12.0, 6.3, 5.8, H-(C3`)), 4.44 (1H, ddd, J = 6.2, 5.8, 5.0 Hz,  
H-(C4`)), 4.14 (1H, ABXY, J = 11.4, 5.0, 5.0 Hz, H-(C5`)), 4.06 (1H, ABXY, J = 
11.4, 6.2, 6.2 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) 153.2 (C8), 151.9 (C2), 148.2 
(C6), 146.8 (C4), 105.1 (C5), 86.7 (d, J = 6.6 Hz, (C1`)), 84.4 (d, J = 7.2 Hz, (C4`)), 
79.4 (d, J = 2.8 Hz, (C2`)), 77.9 (C3`)), 64.5 (d, J = 3.9 Hz, (C5`)).31P {decoupled} 
NMR (162 MHz, D2O) δ 20.57, 0.85 (broad). 31P NMR (162 MHz, D2O) δ 20.58 (dd, 
J = 12.3, 5.5 Hz), 0.85 (s, broad). UV/Vis: λmax 265 nm. HRMS (m/z): [α]D20.0 (c = 
1.00, H2O) - 8.17. [M-H
+]-  C10H11N5O10P2
2- calcd 424.0060, found 424.0056. 
 
β-Ribofuranosyl-8-oxo-guanine-2`,3`-cyclic phosphate 94 
 
Following method E of phosphorylation: 8,2`-anhydro-guanosine 90 (16.0 mg, 0.056 
mmol), ammonium dihydrogen phosphate (6.5 mg, 0.056 mmol) and urea (90.0 mg, 
1.50 mmol) were thoroughly mixed together in a small test tube. The mixture was then 
pushed down the test making sure that there were no solids on the walls of the 
container. The test tube was then lowered in an oil bath (140°C) and left standing for 
237 
 
20 min. After this time the reaction mixture was allowed to cool, dissolved in H2O (2 
mL) and the pale yellow solution obtained was purified via HPLC with a gradient of 
100 mM triethylammonium formate at pH 5 and acetonitrile from 80:20 at a flow rate 
of 5 ml/min. The desired product was detected at λ = 250 nm. The fractions containing 
the desired product were combined, and lyophilised to yield β-ribofuranosyl-8-oxo-
guanine-2`,3`-cyclic phosphate 94 (6.15 mg, 0.017 mmol, 30%) as white solids. M.p. 
295°C (decomp.). IR (Solid, cm-1) 3557 (NH), 3312 (OH), 1720 (C=O), 1638 (C=C), 
1609 (C=N), 1053 (PO4). 
1H NMR (600 MHz, D2O) 6.03 (1H, d, J = 2.9 Hz, H-(C1`)), 
5.59 (1H, ddd, J = 7.0, 6.1, 2.9 Hz, H-(C2`)), 5.16 (1H, ddd, J = 12.0,  6.1, 4.8 Hz, H-
(C3`)), 4.34 (1H, ddd, J = 6.0, 4.8, 4.0 Hz, H-(C4`)), 3.91 (1H, ABX, J = 12.4, 4.0 Hz, 
H-(C5`)), 3.84 (1H, ABX, J = 12.4, 6.0 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) δ 
154.2 (C6), 153.8 (C5), 153.2 (C8), 148.7 (C4), 100.3 (C2), 86.7 (d, J = 7.1 Hz (C1`)), 
85.6 (C4`), 80.2 (d, J = 2.9 Hz (C2`)), 78.3 (C3`), 61.9 (C5`). 31P {decoupled} NMR 
(162 MHz, D2O) δ 20.44. 31P NMR (162 MHz, D2O) δ 20.4 (m). UV/Vis: λmax 300 
nm. [α]D20.0 (c = 1.00, H2O) -7.46. HRMS (m/z): [M-H+]-  C10H11N5O8P- calcd 
362.0496, found 362.0501. 
β-Ribofuranosyl-8-oxo-guanine-2`,3`- cyclic-bis-5`-phosphate 193 
 
 
The above procedure also yielded β-ribofuranosyl-8-oxo-guanine-2`,3`- cyclic-bis-5`-
phosphate 193 (2.5 mg, 0.006 mol, 10%) as white solid. M.p. 260°C (decomp.). IR 
(Solid, cm-1) 3337 (NH), 3242 (OH), 2918, 2851 (CH), 1659 (C=O), 1603 (C=C), 
1553 (C=N), 1047 (PO4). 
1H NMR (400 MHz, D2O) δ 6.00 1H NMR (400 MHz, D2O) 
6.00 (1H, d, J = 2.5 Hz, H-(C1`)), 5.57 (1H, td, J = 6.3, 2.5 Hz, H-(C2`)), 5.26 (1H, 
ddd, J = 12.0, 6.3, 5.8 Hz, H-(C3`)), 4.38 (1H, ddd, J = 6.0, 5.8, 5.3 Hz, H-(C4`)), 
4.11 (1H, ABXY, J = 11.3, 5.3, 5.3 Hz, H-(C5`)), 4.01 (1H, ABXY, J = 11.3, 6.0, 6.0 
Hz, H-(C5``)). 13C NMR (151 MHz, D2O) δ 154.3 (C6), 153.9 (C5), 153.3 (C8), 148.9 
(C4), 100.3 (C2), 86.7 (d, J = 6.8 Hz (C1`)), 84.6 (d, J = 8.1 Hz (C4`)), 80.1 (d, J = 
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3.0 Hz, (C2`)), 78.3 (C3`), 64.6 (d, J = 4.5 Hz, (C5`)). 31P {decoupled}NMR (162 
MHz, D2O) δ 20.51, 1.78 (broad). 31P NMR (162 MHz, D2O) δ 20.51 (m), 1.78 (m, 
broad). UV/Vis: λmax 290 nm. [α]D20.0 (c = 1.00, H2O) -6.20. HRMS (m/z): [M-H+]-   
C10H11N5O11P2
2- calcd 442.0160, found 442.0159. 
 
β-Ribofuranosyl-8-oxo-inosine-2`,3`-cyclic phosphate 187 
 
 
 
Following method D of phosphorylation: 8,2`-anhydro-inosine 170 (32.0 mg, 0.12 
mmol), ammonium dihydrogen phosphate (13.5 mg, 0.12 mmol) and urea (72.0 mg, 
1.2 mmol) were suspended in formamide (1.2 mL). The reaction mixture was heated 
at 100°C for 24 h. The colourless solution was allowed to cool, then diluted with H2O 
(1.8 mL) to make a 3 mL solution, which was purified via HPLC with a gradient of 
100 mM triethylammonium formate at pH 5 and acetonitrile from 100:0 to 80:20 at a 
flow rate of 5 ml/min. The desired product was detected at λ = 250 nm. The fractions 
containing the desired product were combined, and lyophilised to yield β-
ribofuranosyl-8-oxo-inosine-2`,3`-cyclic phosphate 187 (16.6 mg, 0.048 mmol, 40%) 
as white solids. M.p. 310°C (decomp.). IR (Solid, cm-1) 3404 (NH), 3183 (OH), 2967 
(CH), 1724 (C=O), 1674 (C=C), 1661 (C=N), 1063 (PO4). 
1H NMR (600 MHz, D2O) 
8.14 (1H, s, H-(C2)), 6.16 (1H, d, J = 2.9 Hz, H-(C1`)), 5.62 (1H, td, J = 6.6, 2.9 Hz, 
H-(C2`)), 5.17 (1H, ddd, J = 12.1, 6.6, 5.4 Hz, H-(C3`)), 4.38 (1H, ddd, J = 5.9, 5.4, 
3.9 Hz, H-(C4`)), 3.92 (1H, ABX, J = 12.4, 3.9 Hz, H-(C5`)), 3.85 (1H, ABX, J = 
12.4, 5.9 Hz, H-(5``)). 13C NMR (151 MHz, D2O) 153.3 (C6), 153.2 (C8), 145.9 (C2), 
145.7 (C4), 109.8 (C5), 87.0 (d, J = 6.6 Hz, C1`), 85.7 (d, J = 1.7 Hz, C4`), 80.2 (d, J 
= 2.2 Hz, C2`), 78.2 (C3`), 61.8 (C5`). 31P {decoupled} NMR (162 MHz, D2O) δ 
20.44. 31P NMR (162 MHz, D2O) δ 20.44 (m). UV/Vis: λmax 261 nm. [α]D20.0 (c = 1.00, 
H2O) -6.48. HRMS (m/z): [M-H
+]-  C10H10N4O8P
- calcd 346.0315, found 346.0318. 
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β-Ribofuranosyl-8-oxo-inosine-2`,3`- cyclic-bis-5`-phosphate 194 
 
 
The above procedure also yielded β-ribofuranosyl-8-oxo-inosine-2`,3`- cyclic-bis-5`-
phosphate 194 (5.9 mg, 0.014 mol, 12%) as white solid. M.P. 275°C (decomp.). IR 
(Solid cm-1) 3397 (NH), 3225 (OH), 2924, 2853 (CH), 1680 (C=O), 1059 (PO4). 
1H 
NMR (600 MHz, D2O) 8.15 (1H, s, H-(C2)), 6.16 (1H, d, J = 2.8 Hz, H-(C1`)), 5.67 
(1H, td, J = 6.4, 2.8 Hz, H-(C2`)), 5.22 (1H, ddd, J = 12.6, 6.4, 5.7, H-(C3`)), 4.45 
(1H, ddd, J = 6.1, 5.7, 4.9 Hz, H-(C4`)), 4.10 (1H, ABXY, J = 11.3, 4.9, 4.9 Hz, H-
(C5`)), 4.03 (1H, ABXY, J = 11.3, 6.1, 6.1 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) 
153.5 (C6), 153.2 (C8), 146.1 (C2), 145.8 (C4), 109.8 (C5), 86.8 (d, J = 6.6 Hz, C1`), 
84.7 (d, J = 8.3 Hz, C4`), 79.9 (d, J = 2.8 Hz, C2`), 78.2 (C3`), 64.4 (d, J = 4.4 Hz, 
C5`).   31P {decoupled} NMR (162 MHz, D2O) δ 20.58, 2.72 (broad). 31P NMR (162 
MHz, D2O) δ 20.58 (dd, J = 12.1, 4.1 Hz), 2.72 (m, broad). UV/Vis: λmax 256 nm. 
[α]D20.0 (c = 1.00, H2O) -4.79. HRMS (m/z): [M-H+]-  C10H10N4O11P22- calcd 424.9900, 
found 424.9904. 
8.17.3. Phosphorylation of 8,2`-anhydro adenosine using method B 
 
8,2`-Anhydro-adenosine 89 (15.0 mg, 0.06 mmol), ammonium dihydrogen phosphate 
(6.6 mg, 0.06 mmol) and urea (34.0 mg, 0.6) were dissolved in H2O (0.5 mL) and 
formamide (0.1 mL) by warming. The resultant suspension was evenly spread on glass 
fibre disc (2 × 25 mm × 0.68 mm). The discs were dried at 40°C for 48 h and then 
heated at 100°C for 48 h. The discs were then washed with H2O (10 mL) and D2O (10 
mL), the washings were then lyophilised to yield a brown solid. The brown solids 
were dissolved in D2O (1 mL) and then the residual solids were removed by 
centrifugation. The resultant solution was left overnight and some precipitate formed 
which was further removed by centrifuge. The orange solution obtained was diluted 
with H2O (1 mL) to make 2 mL solution, which was purified via HPLC with a gradient 
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of 100 mM triethylammonium formate at pH 5 and acetonitrile from 100:0 to 80:20 
at a flow rate of 5 ml/min. The desired products was detected at λ = 250 nm, to yield 
the following 2`,3`-cyclic phosphate compounds. 
2`, 3`-cyclic compound HPLC yield (%) 
Adenine-2`, 3`-cyclic phosphate 93 12 
Adenine-2`, 3`-cyclic-5`-bisphosphate 188 20 
Adenine-5`-carbamoyl-2`, 3`-cyclic phosphate  189 16 
Adenine-N9-carbamoyl-2`, 3`-cyclic-5`-bisphosphate 190 39 
Adenine-5`,N9-dicarbamoyl-2`, 3`-cyclic phosphate 191 11 
 
β- Ribofuranosyl adenine-5`-carbamoyl-2`, 3`-cyclic phosphate 189 
 
1H NMR (600 MHz, D2O) 8.13 (s, 1H, H-(C2)), 6.13 (1H, d,  J = 2.4 Hz, H-(C1`)), 
5.72 (1H, ddd, J = 7.0, 6.6, 2.4 Hz, H-(C2`)), 5.24 (1H, ddd,  J = 12.3, 6.6, 5.9 Hz, H-
(C3`)), 4.48 (1H, ddd,  J = 6.4, 5.9, 3.6 Hz, H-(C4`)), 4.41 (1H, ABX, J = 12.0, 3.6 
Hz, H-(C5`)), 4.33 (1H, ABX, J = 12.0, 6.4 Hz, H-(C5``)). 31P {decoupled} NMR (162 
MHz, D2O) δ 22.52. HRMS (m/z): [M-H+]-   C11H12N6O8P- calcd 387.1036, found 
387.1031. 
β-Ribofuranosyl adenine-N9-carbamoyl-2`, 3`-cyclic-5`-bisphosphate 190 
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1H NMR (600 MHz, D2O) δ 8.40 (1H, s, (H-(C2)), 6.17 (1H, d,  J = 2.8 Hz, H-(C1`)), 
5.73 (1H, td, J = 6.6, 2.8 Hz, H-(C2`)), 5.19 (1H, ddd,  J = 12.0, 6.6, 5.8 Hz, H-(C3`)), 
4.42 (1H, dt, J = 5.8, 5.0 Hz, H-(C4`)), 4.07 (1H, ABXY, J = 11.5, 5.0, 5.0 Hz, H-
(C5`)), 3.99 (1H, ABXY, J = 11.5, 5.8, 5.8 Hz, H-(C5``)).  31P {decoupled} NMR (162 
MHz, D2O) δ 22.89, 6.20 (broad). HRMS (m/z): [M-H+]-   C11H12N6O11P22- calcd 
466.8659, found 466.8668. 
β-ribofuranosyl adenine-5`,9-dicarbamoyl-2`, 3`-cyclic phosphate 
 
1H NMR (600 MHz, D2O) δ 8.33 (1H, s, H-(C2)), 6.17 (1H, d, J = 2.9 Hz, (C1`)), 5.74 
(1H, td, J = 6.1, 2.9 Hz, H-(C2`)), 5.27 (1H, ddd, J = 12.5, 6.1, 4.9 Hz, H-(C3`), 4.49 
(1H, ddd, J = 6.3, 4.9, 3.3 Hz, H-(C4`)), 4.42 (ABX, 1H, J = 12.0, 3.3 Hz, H-(C5`)), 
4.33 (ABX, 1H, J = 12.0, 6.3 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) δ 159.5 
(CONH2NH), 158.0 (CONH2), 150.3 (C8), 149.1 (C5), 141.5 (C4), 86.9 (d, J  = 6.7 Hz 
(C1`), 83.3 (C4`), 79.8 (C2`), 78.0 (C3`), 64.2 (C5`). 31P {decoupled} NMR (162 MHz, 
D2O) δ 22.62. HRMS (m/z): [M-H+]-   C12H13N7O9P- calcd 430.0011, found 430.0009. 
8.18. Synthesis of 8,2`-anhydro adenosine 5`-
monophosphate 
 
8,2`-O-Anhydro-9-β-arabinofuranosyl-cycloadenosine-5`-monophosphate 200 
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This method was adapted from a known literature procedure reported by Ikehara et 
al.211 To a solution of 9-β-arabinofuranoside-adenosine-5`-monophosphate 198 (573 
mg, 1.67 mmol) dissolved in sodium acetate solution (100 mL, 1 M, pH 4.0) at rt was 
added saturated bromine water (170 µL in 10 mL H2O). The resultant solution was 
vigorously stirred at rt for 24 h. The progress of the reaction was followed by 1H NMR 
spectroscopy and TLC. After 24 h the solution was decolourised with 5M sodium 
bisulfite, and then adjusted to pH 8.0 with 5M NaOH. The decolourised solution was 
then concentrated overnight by blowing air over the solution. After 16 h a precipitate 
had formed. The resulting crystals were collected by filtration, washed with water (3 
× 5.0 mL) and then thrice recrystallized from hot H2O, to give the desired product 
8,2`-O-Anhydro-9-β-arabinofuranosyl-cycloadenosine-5`-monophosphate 200 (365 
mg, 1.1 mmol, 63%) as colourless glass sheets. M.p. 285°C (decomp.). 1H NMR (600 
MHz, D2O) δ 8.18 (1H, s, H-(C2)), 6.66 (1H, d, J = 5.5 Hz, H-(C1`)), 5.92 (1H, dd, J 
= 5.5, 1.5 Hz, H-(C2`)), 4.80 (1H, dd, J = 3.6, 1.5 Hz, H(C3`)), 4.42 (1H, td, J = 6.0, 
3.6 Hz, H-(C4`)), 3.69 (1H, ABXY, J = 12.0, 6.0, 6.0 Hz, H-(C5`)), 3.61 (1H, ABXY, 
J = 12.0, 6.0, 6.0 Hz, H-(C5``)). 13C NMR (151 MHz, D2O) δ 160.9 (C8), 154.6 (C6), 
151.7 (C2), 146.3 (C4), 121.2 (C5), 99.39 (C2`), 86.7 (d, J = 7.8 Hz, (C4`)), 85.73 
(C1`), 75.2 (C3`), 63.27 (d, J = 4.4 Hz, (C5`)). 31P NMR (162 MHz, D2O) δ 3.15 (t, J 
= 6.2 Hz). 31P {decoupled} NMR (162 MHz, D2O) δ 3.15.  [α]D20.0 (c = 1.00, H2O) -
5.30. HRMS (m/z): [M-H+]- C10H12N5O7P+H calcd 346.0547, found 346.0545. 
 
8.19. Synthesis of S-cyanovinylated erythrose furanosyl 
oxazolidinone thione 
 
 
 
 
 
 
Erythrosefuranosyl oxazolidinone thione 224 
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Erythrose 223 (150.0 mg, 1.30 mmol) and potassium thiocyanate 97 (248.0 mg, 2.6 
mmol) were dissolved in water (2 mL) and then HCl (37%, 200 µL) was added 
dropwise at 0°C. The pink solution was kept at rt for 2 h and then heated to 60°C for 
18 h. After this time the solution was cooled to rt and mixed with silica gel (1.0 g) and 
then the solvent was evaporated to obtain a fine free flowing powder. The powder was 
then loaded on a silica gel column (10.0 g) and eluted with ethyl acetate and 
chloroform (1:1). Fractions containing the product were concentrated to give 
erythrosefuranosyl oxazolidinone thione 224 (67 mg, 0.41 mmol, 32%) as crystalline 
white solid. M.p. 160-163°C. IR (Solid, cm-1) 3298 (NH), 3167 (OH), 2984, 2864 
(CH), 1519 (C=S). 1H (600 MHz, D2O) 5.94 (1H, d, J = 5.4 Hz, H-(C1`)), 5.30 (1H, 
t, J = 5.4 Hz, H-(C2`)), 4.51 (1H, dt, J = 9.5, 5.4 Hz, H-(C3`)), 4.15 (1H, dd, J = 9.5, 
5.4 D2O Hz, H-C4`)), 3.47 (1H, t, J = 9.5 Hz, H-(C4``)). 
13C NMR (151 MHz, D2O) 
δ 191.1 (C2), 90.1 (C1`), 85.3 (C2`), 71.0 (C3`), 67.4 (C4`). UV/Vis: λmax 242 nm. 
[α]D20.0 (c = 1.00, H2O) +12.68. HRMS (m/z): [M-H+]-  C5H7NO3S calcd 162.0225, 
found 162.0226. 
 
Crystal structure obtained; see appendix for crystallographic data. 
 
α-(2-Cyanovinyl)-erythrosefuranosyl oxazolidinone thione 225 
 
Erythrose-furanosyl oxazolidinone thione 224 (30.0 mg, 0.186 mmol) was added to a 
solution of cyanoacetylene 30 (91.0 mg, 0.372 mmol) in water (1.0 mL). After stirring 
244 
 
the reaction mixture for 1 h at rt. The reaction was then lyophilised to yield α-(2-
cyanovinyl)-erythrosefuranosyl oxazolidinone thione 225 (38.0 mg, 0.179 mmol, 
96%) as white solid which was used without further purification: M.p. 136-138°C. IR 
(Solid, cm-1) 3298 (NH), 3167 (OH), 2984, 2864 (CH), 1519 (C=S). 1H NMR (600 
MHz, D2O) δ 7.87 (1H, d, J = 10.5 Hz, H-(C4)), 6.11 (1H, d, J = 5.4 Hz, H-(C1`)), 
5.99 (1H, d, J = 10.5 Hz, H-(C5)), 5.18 (1H, t, J = 5.4 Hz, H-(C2`)), 4.51 (1H, dt, J = 
9.7, 5.4 Hz, H-(C3`)), 4.11 (1H, dd, J = 9.7, 5.4 Hz, H-(C4`)), 3.29 (1H, t, J = 9.7 D2O 
Hz, H-(C4``)). 13C NMR (151 MHz, D2O) δ 168.2 (C2), 143.7 (C4), 115.9 (CN), 100.3 
(C1`), 100.1 (C5), 84.2 (C2`), 71.1 (C3`), 67.0 (C4`). UV/Vis: λmax 267 nm. [α]D20.0 (c 
= 1.00, H2O) +0.84.HRMS (m/z): [M-H
+]- C8H8N2O3S calcd 213.0335, found 
213.0334.  
Crystal structure obtained; see appendix for crystallographic data. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
245 
 
References 
 
1. C. Mora, D. P. Tittensor, S. Adl, A. G. B. Simpson and B. Worm, PLoS Biol., 2011, 
9, e1001127. 
2. L. A. Hug, B. J. Baker, K. Anantharaman, C. T. Brown, A. J. Probst, C. J. Castelle, 
C. N. Butterfield, A. W. Hernsdorf, Y. Amano, K. Ise, Y. Suzuki, N. Dudek, D. A. 
Relman, K. M. Finstad, R. Amundson, B. C. Thomas and J. F. Banfield, Nat. 
Microbiol., 2016, 1, 16048. 
3. R. N. Glud, F. Wenzhofer, M. Middelboe, K. Oguri, R. Turnewitsch, D. E. Canfield 
and H. Kitazato, Nat. Geosci., 2013, 6, 284-288. 
4. D. Wacey, M. R. Kilburn, M. Saunders, J. Cliff and M. D. Brasier, Nat. Geosci., 
2011, 4, 698-702. 
5. A. P. Nutman, V. C. Bennett, C. R. L. Friend, M. J. Van Kranendonk and A. R. 
Chivas, Nature, 2016, 537, 535-538. 
6. S. J. Mojzsis, G. Arrhenius, K. D. McKeegan, T. M. Harrison, A. P. Nutman and C. 
R. L. Friend, Nature, 1996, 384, 55-59. 
7. S. A. Wilde, J. W. Valley, W. H. Peck and C. M. Graham, Nature, 2001, 409, 175-
178. 
8. https://www.nasa.gov/press-release/nasa-releases-kepler-survey-catalog-with-
hundreds-of-new-planet-candidates 
9. S. A. Benner, Astrobiology, 2010, 10, 1021-1030. 
10. http://www.merriam-webster.com/dictionary/life 
11. G. Joyce, Origins of Life: The Central Concepts, 1994. 
12. P. Luisi, Origins Life Evol. Biosphere, 1998, 28, 613-622. 
13. A. Eschenmoser and M. Volkan Kisakürek, Helv. Chim. Acta, 1996, 79, 1249-1259. 
14. J. W. Szostak, J. Biomol. Struct. Dyn., 2012, 29, 599-600. 
15. P. Ball, Sci. Amer., 2011, 305, 48-53. 
16. Clancy, S., Nat. Ed., 2008, 7(1), 60 
17. E. A. Harwood, P. B. Hopkins and S. T. Sigurdsson, J. Org. Chem, 2000, 65, 2959-
2964. 
18. E. R. Kandimalla, D. Yu, Q. Zhao and S. Agrawal, Biorg. Med. Chem., 2001, 9, 
807-813. 
19. Y. Ambroise, C. Mioskowski, G. Leblanc and B. Rousseau, Bioorg. Med. Chem. 
Lett., 2000, 10, 1125-1127. 
20. F. Crick, Nature, 1970, 227, 561-563. 
21. J. Xu, M. Tsanakopoulou, C. J. Magnani, R. Szabla, J. E. Sponer, J. Sponer, R. W. 
Góra and J. D. Sutherland, Nat. Chem., 2017, 9, 303-309. 
22. M. W. Powner, B. Gerland and J. D. Sutherland, Nature, 2009, 459, 239-242. 
23. R. H. Symons, Annu. Rev. Biochem, 1992, 61, 641-671. 
24. T. R. Cech, Angew. Chem. Int. Ed., 1990, 29, 759-768. 
25. S. Altman, Angew. Chem. Int. Ed., 1990, 29, 749-758. 
26. T. Inoue, G. F. Joyce, K. Grzeskowiak, L. E. Orgel, J. M. Brown and C. B. Reese, J. 
Mol. Biol., 1984, 178, 669-676. 
27. A. Zaug and T. Cech, Science, 1986, 231, 470-475. 
28. A. J. Zaug, M. D. Been and T. R. Cech, Nature, 1986, 324, 429-433. 
29. J. Piccirilli, T. McConnell, A. Zaug, H. Noller and T. Cech, Science, 1992, 256, 
1420-1424. 
30. J. A. Doudna and J. W. Szostak, Nature, 1989, 339, 519-522. 
31. P. Khaitovich, A. S. Mankin, R. Green, L. Lancaster and H. F. Noller, Proc. Natl. 
Acad. Sci., 1999, 96, 85-90. 
32. H. White, III, J. Mol. Evol., 1976, 7, 101-104. 
33. S. An, R. Kumar, E. D. Sheets and S. J. Benkovic, Science, 2008, 320, 103-106. 
246 
 
34. K. Leu, B. Obermayer, S. Rajamani, U. Gerland and I. A. Chen, Nucleic Acids Res., 
2011, 39, 8135-8147. 
35. G. F. Joyce, Nature, 2002, 418, 214-221. 
36. J. F. Kasting, The Chemistry of Life’s Origins, 1993, 149-176. 
37. H. Cleaves, Life, 2013, 3, 331. 
38. S. L. Miller, Science, 1953, 117, 528-529. 
39. F. Wöhler, Annalen der Physik, 1828, 88, 253-256. 
40. J. L. Bada, Chem. Soc. Rev., 2013, 42, 2186-2196. 
41. P. H. Abelson, Proc. Natl. Acad. Sci., 1966, 55, 1365-1372. 
42. R. A. Sanchez, J. P. Ferris and L. E. Orgel, Science, 1966, 154, 784-785. 
43. J. P. Ferris and W. J. Hagan Jr, Tetrahedron, 1984, 40, 1093-1120. 
44. J. R. Cronin, Adv Space Res:The Official Journal of the Committee on Space Res, 
1989, 9, 59-64. 
45. P. Thaddeus, Philos. Trans. R. Soc. London, Ser. B, 2006, 361, 1681-1687. 
46. J. Oró, Biochem. Biophys. Res. Commun., 1960, 2, 407-412. 
47. J. Oro, Nature, 1961, 191, 1193-1194. 
48. J. Oró and A. P. Kimball, Arch. Biochem. Biophys., 1961, 94, 217-227. 
49. J. Oró and A. P. Kimball, Arch. Biochem. Biophys., 1962, 96, 293-313. 
50. J. P. Ferris and L. E. Orgel, J. Am. Chem. Soc., 1966, 88, 1074-1074. 
51. J. P. Ferris and L. E. Orgel, J. Am. Chem. Soc., 1966, 88, 3829-3831. 
52. R. A. Sanchez, J. P. Ferris and L. E. Orgel, J. Mol. Biol., 1967, 30, 223-253. 
53. L. E. Orgel and R. Lohrmann, Acc. Chem. Res., 1974, 7, 368-377. 
54. O. Leslie E., Origins Life Evol. Biosphere, 2004, 34, 361-369. 
55. S. Miyakawa, H. James Cleaves and S. L. Miller, Origins Life Evol. Biosphere, 
2002, 32, 195-208. 
56. S. Miyakawa, H. J. Cleaves and S. L. Miller, Origins Life Evol. Biosphere, 2002, 
32, 209-218. 
57. H. Yamada and T. Okamoto, Chem. Pharm. Bull, 1972, 20, 623-624. 
58. W. Traube, Ber. Dtsch. Chem. Ges, 1900, 33, 1371-1383. 
59. S. Becker, I. Thoma, A. Deutsch, T. Gehrke, P. Mayer, H. Zipse and T. Carell, 
Science, 2016, 352, 833-836. 
60. Z. Wang, in Comprehensive Organic Name Reactions and Reagents, John Wiley & 
Sons, Inc., 2010, pp. 2789-2792. 
61. S. L. Miller and H. J. Cleaves, Syst. Biol., 2006, 1, 3-56. 
62. M. P. Robertson and S. L. Miller, Nature, 1995, 375, 772-774. 
63. R. Shapiro, Origins Life Evol. Biosphere, 1995, 25, 83-98. 
64. R. Shapiro, Origins Life Evol. Biosphere, 2002, 32, 275-278. 
65. R. Shapiro, Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 4396-4401. 
66. P. Decker, H. Schweer and R. Pohlamnn, J. Chromatogr. A, 1982, 244, 281-291. 
67. A. Butlerow, Justus Liebigs Ann. Chem., 1861, 120, 295-298. 
68. H. J. Cleaves, Encyclopedia of Astrobiology, 2014, 1-8. 
69. R. F. Socha, A. H. Weiss and M. M. Sakharov, J. Catal., 1981, 67, 207-217. 
70. R. Shapiro, Origins Life Evol. Biosphere, 1988, 18, 71-85. 
71. R. Larralde, M. P. Robertson and S. L. Miller, Proc. Natl. Acad. Sci., 1995, 92, 
8158-8160. 
72. H.-J. Kim, A. Ricardo, H. I. Illangkoon, M. J. Kim, M. A. Carrigan, F. Frye and S. 
A. Benner, J. Am. Chem. Soc., 2011, 133, 9457-9468. 
73. R. Shapiro, Origins of Life, 1984, 14, 565-570. 
74. A. W. Schwartz, Origins Life Evol. Biosphere, 1993, 23, 185-194. 
75. A. W. Schwartz and R. M. de Graaf, J. Mol. Evol., 1993, 36, 101-106. 
76. S. Chapelle and J.-F. Verchere, Tetrahedron, 1988, 44, 4469-4482. 
77. A. Ricardo, M. A. Carrigan, A. N. Olcott and S. A. Benner, Science, 2004, 303, 196. 
78. B. E. Prieur, Comptes Rendus de l'Académie des Sciences - Series IIC - Chemistry, 
2001, 4, 667-670. 
247 
 
79. Y. Furukawa, M. Horiuchi and T. Kakegawa, Origins Life Evol. Biosphere, 2013, 
43, 353-361. 
80. D. Müller, S. Pitsch, A. Kittaka, E. Wagner, C. E. Wintner and A. Eschenmoser, 
Helv. Chim. Acta, 1990, 73, 1410-1468. 
81. R. Krishnamurthy, G. Arrhenius and A. Eschenmoser, Origins Life Evol. Biosphere, 
1999, 29, 333-354. 
82. R. Krishnamurthy, S. Guntha and A. Eschenmoser, Angew. Chem. Int. Ed., 2000, 
39, 2281-2285. 
83. S. Islam and M. W. Powner, Chem, 2, 470-501. 
84. R. Breslow and Z.-L. Cheng, Proc. Natl. Acad. Sci., 2009, 106, 9144-9146. 
85. A. Eschenmoser, Angew. Chem. Int. Ed., 2011, 50, 12412-12472. 
86. E. Fischer, Ber. Dtsch. Chem. Ges, 1889, 22, 2204-2205. 
87. A. S. Serianni, E. L. Clark and R. Barker, Carbohydr. Res., 1979, 72, 79-91. 
88. D. Ritson and J. D. Sutherland, Nat. Chem., 2012, 4, 895-899. 
89. B. H. Patel, C. Percivalle, D. J. Ritson, C. D. Duffy and J. D. Sutherland, Nat. 
Chem., 2015, 7, 301–307  
90. G. Schlesinger and S. L. Miller, J. Am. Chem. Soc., 1973, 95, 3729-3735. 
91. T. Arrhenius, G. Arrhenius and W. Paplawsky, Origins Life Evol. Biosphere, 1994, 
24, 1-17. 
92. D. J. Ritson and J. D. Sutherland, Angew. Chem. Int. Ed., 2013, 52, 5845-5847. 
93. G. Zubay, Origins Life Evol. Biosphere, 1998, 28, 13-26. 
94. C. Meinert, I. Myrgorodska, P. de Marcellus, T. Buhse, L. Nahon, S. V. Hoffmann, 
L. L. S. d’Hendecourt and U. J. Meierhenrich, Science, 2016, 352, 208-212. 
95. R. Krishnamurthy, Acc. Chem. Res., 2017, 50, 455-459. 
96. W. D. Fuller, R. A. Sanchez and L. E. Orgel, J. Mol. Biol., 1972, 67, 25-33. 
97. W. D. Fuller, R. A. Sanchez and L. E. Orgel, J. Mol. Evol., 1972, 1, 249-257. 
98. K. N. Drew, J. Zajicek, G. Bondo, B. Bose and A. S. Serianni, Carbohydr. Res., 
1998, 307, 199-209. 
99. C. Fonseca Guerra, F. M. Bickelhaupt, S. Saha and F. Wang, J. Phys. Chem. A, 
2006, 110, 4012-4020. 
100. O. Leslie E., Crit. Rev. Biochem. Mol. Biol., 2004, 39, 99-123. 
101. A. Eschenmoser and E. Loewenthal, Chem. Soc. Rev., 1992, 21, 1-16. 
102. A. Eschenmoser, Chem. & Biod., 2007, 4, 554-573. 
103. S. Pitsch, S. Wendeborn, R. Krishnamurthy, A. Holzner, M. Minton, M. Bolli, C. 
Miculca, N. Windhab, R. Micura, M. Stanek, B. Jaun and A. Eschenmoser, Helv. 
Chim. Acta, 2003, 86, 4270-4363. 
104. A. Eschenmoser and M. Dobler, Helv. Chim. Acta, 1992, 75, 218-259. 
105. M. Beier, F. Reck, T. Wagner, R. Krishnamurthy and A. Eschenmoser, Science, 
1999, 283, 699-703. 
106. A. A. Koshkin, P. Nielsen, M. Meldgaard, V. K. Rajwanshi, S. K. Singh and J. 
Wengel, J. Am. Chem. Soc., 1998, 120, 13252-13253. 
107. K.-U. Schöning, P. Scholz, X. Wu, S. Guntha, G. Delgado, R. Krishnamurthy and 
A. Eschenmoser, Helv. Chim. Acta, 2002, 85, 4111-4153. 
108. S. Islam, J. A. Aguilar, M. W. Powner, M. Nilsson, G. A. Morris and J. D. 
Sutherland, Chem. Eur. J., 2013, 19, 4586-4595. 
109. X. Wu, G. Delgado, R. Krishnamurthy and A. Eschenmoser, Org. Lett., 2002, 4, 
1283-1286. 
110. P. Nielsen, Origins Life Evol. Biosphere, 1993, 23, 323-327. 
111. H. Knudsen and P. E. Nielsen, Nucleic Acids Res., 1996, 24, 494-500. 
112. J. G. Schmidt, P. E. Nielsen and L. E. Orgel, Nucleic Acids Res., 1997, 25, 4797-
4802. 
113. L. Zhang, A. Peritz and E. Meggers, J. Am. Chem. Soc., 2005, 127, 4174-4175. 
114. C.-H. Tsai, J. Chen and J. W. Szostak, Proc. Natl. Acad. Sci., 2007, 104, 14598-
14603. 
115. M. P. Robertson and G. F. Joyce, Cold Spring Harb Perspect Biol., 2012, 4. 
248 
 
116. J. D. Sutherland, Nat. Rev. Chem., 2017, 1, 1-7. 
117. J. D. Sutherland, Angew. Chem. Int. Ed., 2015, 55, 104-121. 
118. M. W. Powner, Nat. Chem., 2013, 5, 355-357. 
119. J. W. Szostak, Nature, 2009, 459, 171-172. 
120. G. Springsteen and G. F. Joyce, J. Am. Chem. Soc., 2004, 126, 9578-9583. 
121. C. Anastasi, M. A. Crowe, M. W. Powner and J. D. Sutherland, Angew. Chem. Int. 
Ed., 2006, 45, 6176-6179. 
122. J. E. Hein and D. G. Blackmond, Acc. Chem. Res., 2012, 45, 2045-2054. 
123. M. W. Powner and J. D. Sutherland, Angew. Chem., 2010, 122, 4745-4747. 
124. R. A. Sanchez and L. E. Orgel, J. Mol. Biol., 1970, 47, 531-543. 
125. M. W. Powner, C. Anastasi, M. A. Crowe, A. L. Parkes, J. Raftery and J. D. 
Sutherland, ChemBioChem, 2007, 8, 1170-1179. 
126. A. Choudhary, K. J. Kamer, M. W. Powner, J. D. Sutherland and R. T. Raines, ACS 
Chem. Biol., 2010, 5, 655-657. 
127. M. W. Powner and J. D. Sutherland, ChemBioChem, 2008, 9, 2386-2387. 
128. M. W. Powner, J. D. Sutherland and J. W. Szostak, J. Am. Chem. Soc., 2010, 132, 
16677-16688. 
129. M. W. Powner, S.-L. Zheng and J. W. Szostak, J. Am. Chem. Soc., 2012, 134, 
13889-13895. 
130. S. A. Benner, H.-J. Kim and Z. Yang, Cold Spring Harb Perspect Biol., 2012, 4, 
a003541. 
131. Nicholas V. Hud, Brian J. Cafferty, R. Krishnamurthy and Loren D. Williams, 
Chem. & Biol., 2013, 20, 466-474. 
132. A. W. Schwartz, Astrobiology, 2013, 13, 784-789. 
133. R. W. Nagorski and J. P. Richard, J. Am. Chem. Soc., 2001, 123, 794-802. 
134. S. Islam, D.-K. Bučar and M. W. Powner, Nat. Chem., 2017, 9, 584–589  
135. A. D. Keefe, G. L. Newton and S. L. Miller, Nature, 1995, 373, 683-685. 
136. M. C. L. Rosaly and A. W. David, Rep. Prog. Phys., 2005, 68, 303. 
137. R. V. Eck and M. O. Dayhoff, Science, 1966, 152, 363-366. 
138. J. E. Goldford, H. Hartman, T. F. Smith and D. Segrè, Cell, 2017, 168, 1126-1134. 
139. C. Bonfio, L. Valer, S. Scintilla, S. Shah, D. J. Evans, L. Jin, J. W. Szostak, D. D. 
Sasselov, J. D. Sutherland and S. S. Mansy, Nat. Chem., 2017, DOI: 
10.1038/nchem.2817. 
140. P. Dawson, T. Muir, I. Clark-Lewis and S. Kent, Science, 1994, 266, 776-779. 
141. C.-F. Liu, C. Rao and J. P. Tam, Tetrahedron Lett., 1996, 37, 933-936. 
142. F. R. Bowler, C. K. W. Chan, C. D. Duffy, B. Gerland, S. Islam, M. W. Powner, J. 
D. Sutherland and J. Xu, Nat. Chem., 2013, 5, 383-389. 
143. H. H. Zepik, S. Rajamani, M. C. Maurel and D. Deamer, Origins Life Evol. 
Biosphere, 2007, 37, 495-505. 
144. M.-C. Maurel and L. E. Orgel, Origins Life Evol. Biosphere, 2000, 30, 423-430. 
145. L. Leman, L. Orgel and M. R. Ghadiri, Science, 2004, 306, 283-286. 
146. M. W. Powner, J. D. Sutherland and J. W. Szostak, Synlett, 2011, 2011, 1956-1964. 
147. S. Kanvah, J. Joseph, G. B. Schuster, R. N. Barnett, C. L. Cleveland and U. 
Landman, Acc. Chem. Res., 2010, 43, 280-287. 
148. K. C. Cheng, D. S. Cahill, H. Kasai, S. Nishimura and L. A. Loeb, J. Biol. Chem., 
1992, 267, 166-172. 
149. K. V. Nguyen and C. J. Burrows, J. Am. Chem. Soc., 2011, 133, 14586-14589. 
150. L. Haracska, S.-L. Yu, R. E. Johnson, L. Prakash and S. Prakash, Nat. Genet., 2000, 
25, 458-461. 
151. K. D. Carlson and M. T. Washington, Mol. Cell. Biochem., 2005, 25, 2169-2176. 
152. L. A. Lipscomb, M. E. Peek, M. L. Morningstar, S. M. Verghis, E. M. Miller, A. 
Rich, J. M. Essigmann and L. D. Williams, Proc. Natl. Acad. Sci., 1995, 92, 719-
723. 
153. Y. Oda, S. Uesugi, M. Ikehara, S. Nishimura, Y. Kawase, H. Ishikawa, H. Inoue and 
E. Ohtsuka, Nucleic Acids Res., 1991, 19, 1407-1412. 
249 
 
154. S. K. Kim, S. H. Lee, O. S. Kwon and B. J. Moon, J. Biochem. Mol. Bio., 2004, 37, 
657-662. 
155. T. Hofer, A. Y. Seo, M. Prudencio and C. Leeuwenburgh, Biol. Chem., 2006, 387, 
103-111. 
156. G. Gosselin, M. C. Bergogne, J. De Rudder, E. De Clercq and J. L. Imbach, J. Med. 
Chem., 1986, 29, 203-213. 
157. J. Girniene, S. Tardy, A. Tatibouët, A. Sačkus and P. Rollin, Tetrahedron Lett., 
2004, 45, 6443-6446. 
158. J. Girniene, G. Apremont, A. Tatibouët, A. Sackus and P. Rollin, Tetrahedron, 
2004, 60, 2609-2619. 
159. J. Girniene, D. Gueyrard, A. Tatibouët, A. Sackus and P. Rollin, Tetrahedron Lett., 
2001, 42, 2977-2980. 
160. A. F. Cockerill, A. Deacon, R. G. Harrison, D. J. Osborne, D. M. Prime, W. J. Ross, 
A. Todd and J. P. Verge, Synthesis, 1976, 1976, 591-593. 
161. C. Chyba and C. Sagan, Nature, 1992, 355, 125-132. 
162. J. K. Bartlett and D. A. Skoog, Anal. Chem., 1954, 26, 1008-1011. 
163. N. Leconte, S. Silva, A. Tatibouët, A. P. Rauter and P. Rollin, Synlett, 2006, 2006, 
301-305. 
164. M. T. Beltrán, C. Codella, S. Viti, R. Neri and R. Cesaroni, Astrophys. J. Lett., 
2009, 690, L93. 
165. J. P. Ferris, Philos. Trans. R. Soc. London, Ser. B, 2006, 361, 1777-1786. 
166. R. Loos, S. Kobayashi and H. Mayr, J. Am. Chem. Soc., 2003, 125, 14126-14132. 
167. Y.-B. Xiang, S. Drenkard, K. Baumann, D. Hickey and A. Eschenmoser, Helv. 
Chim. Acta, 1994, 77, 2209-2250. 
168. G. Lacasse and J. M. Muchowski, Can. J. Chem., 1972, 50, 3082-3083. 
169. W. A. Jr. and J. S. Chickos, J. Phys. Chem. Ref. Data, 2010, 39, 043101. 
170. L. Orgel, Origins Life Evol. Biosphere, 2002, 32, 279-281. 
171. H. Bader, L. C. Cross, I. Heilbron and E. R. H. Jones, J. Chem. Soc, 1949, DOI: 
10.1039/jr9490000619, 619-623. 
172. H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem. Int. Ed. Engl., 2001, 40, 
2004-2021. 
173. E. R. Walwich, Roberts, W. K. & Dekker, C. A., Proc. Chem. Soc, 1959, DOI: 
10.1039/ps9590000073, 73-108. 
174. C. Fernandez-Garcia, N. M. Grefenstette and M. W. Powner, Chem. Commun., 
2017, DOI: 10.1039/c7cc02183f. 
175. H. J. Brown, G. Shaw and D. Wright, J. Chem. Soc., Perkin Trans. 1, 1981, DOI: 
10.1039/p19810000657, 657-660. 
176. R. M. Davidson, G. D. Byrd, E. White, V. Samm, A. Margolis and B. Coxon, Magn. 
Reson. Chem., 1986, 24, 929-937. 
177. C. E. Hand and J. F. Honek, J. Nat. Prod., 2005, 68, 293-308. 
178. G. M. Tener, J. Am. Chem. Soc., 1961, 83, 159-168. 
179. R. L. Letsinger and K. K. Ogilvie, J. Am. Chem. Soc., 1969, 91, 3350-3355. 
180. V. A. Efimov, A. A. Buryakova, S. V. Reverdatto, O. G. Chakhmakhcheva and Y. 
A. Ovchinnikov, Nucleic Acids Res., 1983, 11, 8369-8387. 
181. C. B. Reese, Tetrahedron, 1978, 34, 3143-3179. 
182. S. Pizzarello, L. B. Williams, J. Lehman, G. P. Holland and J. L. Yarger, Proc. Natl. 
Acad. Sci. U.S.A., 2011, 108, 4303-4306. 
183. B. Donn, J. Mol. Evol., 1982, 18, 157-160. 
184. A. T. Tokunaga, S. C. Beck, T. R. Geballe, J. H. Lacy and E. Serabyn, Icarus, 1981, 
48, 283-289. 
185. R. Hanel, B. Conrath, F. M. Flasar, V. Kunde, W. Maguire, J. Pearl, J. Pirraglia, R. 
Samuelson, L. Herath, M. Aallison, C. D., D. Gautier, P. Gierasch, L. Horn, R. 
Koppany and C. Ponnamperuma, Science, 1981, 212, 192-200. 
186. C. U. Lowe, M. W. Rees and R. Markham, Nature, 1963, 199, 219-222. 
187. F. Freeman, Synthesis, 1981, 12, 925-954. 
250 
 
188. M. Ikehara, T. Nagura and E. Ohtsuka, Chem. Pharm. Bull, 1974, 22, 2578-2586. 
189. A. Belloche, K. M. Menten, C. Comito, H. S. P. Müller, P. Schilke, J. Ott, S. 
Thorwirth and C. Hieret, Astron. Astrophys., 2008, 482, 179-196. 
190. G. Moutou, J. Taillades, S. Bénefice-Malouet, A. Commeyras, G. Messina and R. 
Mansani, J. Phys. Org. Chem., 1995, 8, 721-730. 
191. G. W. Stevenson and D. Williamson, J. Am. Chem. Soc., 1958, 80, 5943-5947. 
192. N. J. Cusack, G. Shaw and G. J. Litchfield, J. Chem. Soc. C, 1971, DOI: 
10.1039/j39710001501, 1501-1507. 
193. G. J. Litchfield and G. Shaw, Chem. Commun., 1965, DOI: 10.1039/c19650000563, 
563-565. 
194. R. M. Beesley, C. K. Ingold and J. F. Thorpe, J. Chem. Soc, Trans., 1915, 107, 
1080-1106. 
195. S. Stairs and M. W. Powner, Synlett, DOI: 10.1055/s-0036-1590968. 
196. K. Koch, W. B. Schweizer and A. Eschenmoser, Chem. & Biod., 2007, 4, 541-553. 
197. J. D. Sutherland, Cold Spring Harb Perspect Biol., 2010, 2. 
198. H. S. Bernhardt and R. K. Sandwick, J. Mol. Evol., 2014, 79, 91-104. 
199. K. Ace and J. D. Sutherland, Chem. & Biod., 2004, 1, 1678-1693. 
200. I. Alseth, B. Dalhus and M. Bjørås, Current Opinion in Genet. & Dev., 2014, 26, 
116-123. 
201. M. Levy, S. L. Miller and J. Oró, J. Mol. Evol., 1999, 49, 165-168. 
202. B. Basile, A. Lazcano and J. Oró, Adv. Space Res., 1984, 4, 125-131. 
203. R. A. Sanchez, J. P. Ferris and L. E. Orgel, J. Mol. Biol., 1968, 38, 121-128. 
204. R. J. Capon and N. S. Trotter, J. Nat. Prod., 2005, 68, 1689-1691. 
205. A. P. Martinez, W. W. Lee and L. Goodman, J. Org. Chem, 1966, 31, 3263-3267. 
206. V. M. Clark, A. R. Todd and J. Zussman, J. Chem. Soc, 1951, DOI: 
10.1039/jr9510002952, 2952-2958. 
207. K. K. Ogilvie and L. A. Slotin, Can. J. Chem., 1973, 51, 2397-2405. 
208. K. K. Ogilvie, L. A. Slotin, J. H. Westmore and D. C. K. Lin, J. Heterocycl. Chem., 
1972, 9, 1179-1180. 
209. M. Ikehara, Acc. Chem. Res., 1969, 2, 47-53. 
210. J. Nagyvary, J. Am. Chem. Soc., 1969, 91, 5409-5410. 
211. M. Ikehara, S. Uesugi and M. Kaneko, Chem. Commun., 1967, DOI: 
10.1039/c19670000017, 17-18. 
212. M. Ikehara and T. Maruyama, Tetrahedron, 1975, 31, 1369-1372. 
213. M. Ikehara, S. Uesugi and J. Yano, J. Am. Chem. Soc., 1974, 96, 4966-4972. 
214. K. K. Ogilvie, L. Slotin, J. B. Westmore and D. Lin, Can. J. Chem., 1972, 50, 2249-
2253. 
215. E. K. Ryu and M. MacCoss, J. Org. Chem, 1981, 46, 2819-2823. 
216. E. J. Reist, D. F. Calkins, L. V. Fisher and L. Goodman, J. Org. Chem, 1968, 33, 
1600-1603. 
217. M. Ikehara and M. Muraoka, Chem. Pharm. Bull, 1976, 24, 672-682. 
218. R. Shapiro and S. H. Pohl, Biochem, 1968, 7, 448-455. 
219. M. W. Powner and J. D. Sutherland, Philos. Trans. R. Soc. London, Ser. B, 2011, 
366, 2870-2877. 
220. A. F. Russell, S. Greenberg and J. G. Moffatt, J. Am. Chem. Soc., 1973, 95, 4025-
4030. 
221. A. Benitez, O. P. Crews, L. Goodman and B. R. Baker, J. Org. Chem, 1960, 25, 
1946-1950. 
222. J. B. Chattopadhyaya and C. B. Reese, J. Chem. Soc., Chem. Commun., 1976, DOI: 
10.1039/c39760000860, 860-862. 
223. M. Ikehara and Y. Ogiso, Tetrahedron, 1972, 28, 3695-3704. 
224. V. P. Sokhan, A. P. Jones, F. S. Cipcigan, J. Crain and G. J. Martyna, Proc. Natl. 
Acad. Sci. U.S.A., 2015, 112, 6341-6346. 
225. C. Fernández-García, A. J. Coggins and M. W. Powner, Life, 2017, 7, 31. 
226. M. Gull, Challenges, 2014, 5, 193-221. 
251 
 
227. M. Halmann, R. A. Sanchez and L. E. Orgel, J. Org. Chem, 1969, 34, 3702-3703. 
228. M. Karki, C. Gibard, S. Bhowmik and R. Krishnamurthy, Life, 2017, 7, 32. 
229. O. T. Quimby and T. J. Flautt, Z. Anorg. Allg. Chem., 1958, 296, 220-228. 
230. B. Burcar, M. Pasek, M. Gull, B. J. Cafferty, F. Velasco, N. V. Hud and C. Menor-
Salván, Angew. Chem. Int. Ed., 2016, 55, 13249-13253. 
231. R. Lohrmann and L. E. Orgel, Science, 1971, 171, 490-494. 
232. C. Ponnamperuma and R. Mack, Science, 1965, 148, 1221-1223. 
233. J. Škoda and J. Morávek, Tetrahedron Lett., 1966, 7, 4167-4172. 
234. A. Beck, R. Lohrmann and L. E. Orgel, Science, 1967, 157, 952-952. 
235. G. W. Cooper and J. R. Cronin, Geochim. Cosmochim. Acta, 1995, 59, 1003-1015. 
236. R. E. D. Clark, Nature, 1951, 168, 876-876. 
237. G. Imperato, S. Hoger, D. Lenoir and B. Konig, Green Chem., 2006, 8, 1051-1055. 
238. M. Gull, M. Zhou, F. M. Fernández and M. A. Pasek, J. Mol. Evol., 2014, 78, 109-
117. 
239. R. Österberg, L. E. Orgel and R. Lohrmann, J. Mol. Evol., 1973, 2, 231-234. 
240. R. Kluger, P. P. Davis and P. D. Adawadkar, J. Am. Chem. Soc., 1979, 101, 5995-
6000. 
241. R. Osterberg and L. E. Orgel, J. Mol. Evol., 1972, 1, 241-248. 
242. A. M. Schoffstall, Origins of Life, 1976, 7, 399-412. 
243. C. M. Tapiero and J. Nagyvary, Nature, 1971, 231, 42-43. 
244. P. A. Gerakines, M. H. Moore and R. L. Hudson, Icarus, 2004, 170, 202-213. 
245. M. P. Bernstein, L. J. Allamandola and S. A. Sandford, Adv. Space Res., 1997, 19, 
991-998. 
246. A. Segura and R. Navarro-González, Geophy. Res. Lett., 2005, 32, 1-4. 
247. R. L. Hudson and M. H. Moore, Icarus, 2004, 172, 466-478. 
248. G. Yu, L. C. Chris, M. S. Philip and A. V. B. Paul, Astrophys. J. Lett., 2007, 660, 
L93. 
249. G. A. Krudy and R. S. Macomber, J. Chem. Educ., 1979, 56, 109. 
250. H. Mita, S. Nomoto, M. Terasaki, A. Shimoyama and Y. Yamamoto, Int. J. 
Astrobiol., 2005, 4, 145-154. 
251. R. Mengel and W. Muhs, Chem. Ber., 1979, 112, 625-639. 
252. G. S. G. De Carvalho, J.-L. Fourrey, R. H. Dodd and A. D. Da Silva, Tetrahedron 
Lett., 2009, 50, 463-466. 
253. E. T. Parker, H. J. Cleaves, M. P. Callahan, J. P. Dworkin, D. P. Glavin, A. Lazcano 
and J. L. Bada, Origins Life Evol. Biosphere, 2011, 41, 201-212. 
254. H. J. Cleaves Ii, Monatshefte für Chemie / Chemical Monthly, 2003, 134, 585-593. 
255. M. Fiore and P. Strazewski, Angew. Chem. Int. Ed., 2016, 55, 13930-13933. 
256. K. Tekenaka, T. Tsuji and M. Muraoka, Nucleosides and Nucleotides, 1998, 17, 
869-874. 
257. V. Skaric and J. Matulic-Adamic, J. Chem. Soc., Perkin Trans. 1, 1985, DOI: 
10.1039/p19850000779, 779-783. 
258. R. A. Mathes and A. J. Beber, J. Am. Chem. Soc., 1948, 70, 1451-1452. 
259. J. C. Jochims, A. Seeliger and G. Taigel, Chem. Ber., 1967, 100, 845-854. 
260. J. D. Street, O. S. Mills and J. A. Joule, Acta Crystallographica Section C, 1991, 47, 
1523-1525. 
261. W. H. Bromund and R. M. Herbst, J. Org. Chem, 1945, 10, 267-276. 
262. J. Kovács, I. Pintér, U. Lendering and P. Köll, Carbohydr. Res., 1991, 210, 155-166. 
263. EU Pat., EP1007509, 2000. 
264. F. Scotti and E. J. Frazza, J. Org. Chem, 1964, 29, 1800-1808. 
265. W. R. Mancini, M. S. Williams and T. S. Lin, Biochem, 1988, 27, 8832-8839. 
266. M. Ikehara and Y. Ogiso, Tetrahedron, 1972, 28, 3695-3704. 
252 
 
Appendix 
 
Crystallographic and refinement parameters 
 
Compound xylo-103 arabino-120 98 arabino-124 
chemical 
formula  
C6H9NO4S  C9H10N2O4S  C3H3NOS  C13H12N2O5  
Mr/gmol-1  191.20  242.25  101.12  276.25  
crystal system  orthorhombic  triclinic  monoclinic  monoclinic  
space group  P212121  P1  P21/c  C2  
a/Å  4.7529(2)  5.6835(2)  3.985(3)  21.1572(7)  
b/Å  7.0665(2)  5.6922(2)  10.002(3)  8.1067(3)  
c/Å  22.8605(7)  17.1686(5)  10.602(3)  6.8795(2)  
α/°  90  94.661(2)  90  90  
β/°  90  95.058(2)  95.398(4)  107.2490(10)  
γ/°  90  109.588(2)  90  90  
V/Å3  767.80(5)  517.60(3)  420.7(3)  1126.87(6)  
Z  4  2  4  4  
Dc/gcm−3  1.654  1.554  1.596  1.628  
F(000)  400  252  208  576  
λ/Å  0.71073  0.71073  0.71073  1.54178  
μ/mm−1  0.394  0.313  0.590  1.080  
T/K  100(2)  100(2)  100(2)  100(2)  
crystal size/mm  0.28 × 0.14 × 
0.12  
0.34 × 0.20 × 
0.16  
0.22 × 0.18 × 
0.16  
0.24 × 0.16 × 
0.12  
index range  -6 → 6  
-9 → 9  
-30 → 30  
-7 → 7  
-7 → 7  
-23 → 23  
-5 → 5  
-13 → 13  
-14 → 14  
-24 → 24  
-9 → 9  
-8 → 8  
collected 
reflections  
11456  14693  7757  13377  
unique 
reflections  
2008  5322  1099  1835  
Rint  0.0453  0.0305  0.0275  0.0330  
reflections with 
I > 2σ(I)  
1911  5030  1030  1831  
no. parameters  121  308  59  190  
R(F), F > 2σ(F)  0.0272  0.0306  0.0233  0.0217  
wR(F2), F > 
2σ(F)  
0.0291  0.0332  0.0248  0.0217  
R(F), all data  0.0671  0.0691  0.0618  0.0556  
wR(F2), all data  0.0679  0.0704  0.0629  0.0556  
Δr (min., max.)/e 
Å−3  
-0.181, 0.279  -0.190, 0.281  -0.304, 0.308  -0.200, 0.226  
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Compound ribo-124 129 96 D-96 
chemical 
formula  
C13H14N2O6  C6H4N2S  C9H10N4O4  C9H12N4O5  
Mr/gmol-1  294.26  136.17  238.21  256.23  
crystal system  orthorhombic  monoclinic  orthorhombic  orthorhombic  
space group  P212121  Pc  P212121  P212121  
a/Å  6.6843(4)  3.8091(2)  6.36040(10)  5.16040(10)  
b/Å  8.0162(4)  9.4498(5)  9.83730(10)  13.4735(2)  
c/Å  24.7739(14)  9.2941(4)  16.07840(10)  14.8581(2)  
α/°  90  90  90  90  
β/°  90  100.940(4)  90  90  
γ/°  90  90  90  90  
V/Å3  1327.45(13)  328.46(3)  1006.01(2)  1033.06(3)  
Z  4  2  4  4  
Dc/gcm−3  1.472  1.377  1.573  1.647  
F(000)  616  140  496  536  
λ/Å  1.54178  1.54178  1.54184  1.54184  
μ/mm−1  1.009  3.567  1.081  1.172  
T/K  100(2)  100(2)  150.0(1)  152(5)  
crystal size/mm  0.28 × 0.16 × 
0.10  
0.20 × 0.18 × 
0.08  
0.23 × 0.14 × 
0.11  
0.26 × 0.08 × 
0.03  
index range  -6 → 7  
-9 → 9  
-29 → 29  
-4 → 4  
-11 → 11  
-11 → 10  
-7 → 7  
-12 → 11  
-20 → 20  
-6 → 6  
-16 → 16  
-17 → 17  
collected 
reflections  
30166  5548  34327  33377  
unique 
reflections  
2274  1006  2022  1821  
Rint  0.0771  0.0667  0.0340  0.0804  
reflections with 
I > 2σ(I)  
2168  921  2010  1771  
no. parameters  206  82  164  177  
R(F), F > 2σ(F)  0.0546  0.0761  0.0279  0.0289  
wR(F2), F > 
2σ(F)  
0.0558  0.0813  0.0280  0.0289  
R(F), all data  0.1495  0.1814  0.0730  0.0747  
wR(F2), all data  0.1505  0.1872  0.0731  0.0754  
Δr (min., max.)/e 
Å−3  
-0.250, 0.413  -0.293, 0.924  -0.215, 0.250  -0.195, 0.180  
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Compound  L-96 89 170 182 
chemical 
formula  
C9H12N4O5  C10H17N5O7  C10H10N4O5  C10H11N5O4  
Mr/gmol-1  256.23  319.28  266.22  265.24  
crystal system  orthorhombic  orthorhombic  monoclinic  monoclinic  
space group  P212121  P212121  P21  P21  
a/Å  5.16330(10)  5.9577(2)  8.59170(10)  8.3830(3)  
b/Å  13.4533(2)  8.6625(3)  6.88950(10)  6.73040(10)  
c/Å  14.8581(2)  27.0257(8)  9.4985(2)  10.1823(3)  
α/°  90  90  90  90  
β/°  90  90  109.654(2)  112.672(4)  
γ/°  90  90  90  90  
V/Å3  1032.09(3)  1394.76(8)  529.484(16)  530.10(3)  
Z  4  4  2  2  
Dc/gcm−3  1.649  1.521  1.670  1.662  
F(000)  536  672  276  276  
λ/Å  1.5418  1.54184  1.54184  1.54184  
μ/mm−1  1.174  1.119  1.178  1.127  
T/K  100(1)  200(1)  150(1)  150(1)  
crystal size/mm  0.38 × 0.06 × 
0.04  
0.37 × 0.04 × 
0.02  
0.40 × 0.23 × 
0.13  
0.47 × 0.08 × 
0.07  
index range  -6 → 6  
-16 → 16  
-17 → 17  
-5 → 7  
-10 → 10  
-32 → 28  
-10 → 10  
-8 → 8  
-10 → 11  
-9 → 9  
-8 → 5  
-11 → 12  
collected 
reflections  
14385  3241  6422  2041  
unique 
reflections  
1820  2132  1851  1393  
Rint  0.0603  0.0186  0.0131  0.0181  
reflections with 
I > 2σ(I)  
1772  2022  1838  1374  
no. parameters  177  225  178  182  
R(F), F > 2σ(F)  0.0320  0.0281  0.0245  0.0239  
wR(F2), F > 
2σ(F)  
0.0330  0.0307  0.0248  0.0243  
R(F), all data  0.0835  0.0686  0.0645  0.0613  
wR(F2), all data  0.0844  0.0703  0.0646  0.0619  
Δr (min., max.)/e 
Å−3  
-0.204, 0.284  -0.182, 0.156  -0.183, 0.178  -0.176, 0.192  
 
 
 
 
 
255 
 
 
 
 
 
 
 
Compound 183 
chemical 
formula  
C10H11N5O4  
Mr/gmol-1  265.24  
crystal system  orthorhombic  
space group  P212121  
a/Å  6.9590(2)  
b/Å  7.4942(2)  
c/Å  20.5342(5)  
α/°  90  
β/°  90  
γ/°  90  
V/Å3  1070.90(5)  
Z  4  
Dc/gcm−3  1.645  
F(000)  552  
λ/Å  1.54184  
μ/mm−1  1.116  
T/K  150(1)  
crystal size/mm  0.13 × 0.12 × 
0.09  
index range  -8 → 5  
-7 → 8  
-19 → 24  
collected 
reflections  
2611  
unique 
reflections  
1707  
Rint  0.0190  
reflections with 
I > 2σ(I)  
1631  
no. parameters  182  
R(F), F > 2σ(F)  0.0292  
wR(F2), F > 
2σ(F)  
0.0311  
R(F), all data  0.0712  
wR(F2), all data  0.0724  
Δr (min., 
max.)/e Å−3  
-0.215, 0.176  
